# RGD-PIPELINE: ftp-file-extracts # MODULE: cell lines build 2020-05-19 # GENERATED-ON: 2024/09/28 00:31:27 # CONTACT: rgd.data@mcw.edu # FORMAT: tab delimited text # NOTES: # This file provides cell line data in RGD. # The cell line data is either curated in RGD, or imported from Cellosaurus resource. # The file is in the tab-delimited format. # Multiple values in a single column are separated by ';' # COUNT: 152271 cell lines RGD ID Symbol Name Type Species Cellosaurus ID Description Source SO_ACC_ID Genomic Alteration Notes Origin Research Use Availability Gender Characteristics Phenotype Germline Competent Groups Caution 10053737 Crlj:WI-ES1/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced by mating Crlj:WI female with WI-Tg(L2-Venus)Nips male. has germ-line transmission Cryopreserved Female media used: 3i+LIF This ES cell line has ubiquitous venus gene expression. Yes 10053738 Crlj:WI-ES5/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced by mating Crlj:WI female with WI-Tg(L2-Venus)Nips male. has germ-line transmission Cryopreserved Female media used: 3i+LIF This ES cell line has ubiquitous Venus gene expression. Yes 10053739 Crlj:WI-ES10/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced by mating Crlj:WI female with WI-Tg(L2-Venus)Nips male. Cryopreserved Male media used: 3i+LIF This ES cell line has ubiquitous Venus gene expression. No 10053740 WI-Tg(CAG/Venus)Nips-ES4/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips Cryopreserved Male media used: 3i+LIF This ES cell line has ubiquitous Venus gene expression. No 10053741 BN/CrlCrlj-ES4/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj has germ-line transmission Cryopreserved Male media used: 2i+LIF Yes 10053742 BN/CrlCrlj-ES6/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj Cryopreserved Female media used: 2i+LIF No 10053744 BN/CrlCrlj-ES3/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj Cryopreserved Male media used: 3i+LIF No 10053745 BN/CrlCrlj-ES5/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj has germ-line transmission Cryopreserved Male media used: 3i+LIF Yes 10054005 DA/Slc-ES1/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from DA/Slc has germ-line transmission Cryopreserved Male media used: 3i+LIF Yes 10054006 Crlj:WI-ES11/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from Crlj:WI has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054007 Crlj:WI-ES13/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from Crlj:WI has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054008 BN/CrlCrlj-ES7/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was electroporated with humanized Kusabira-Orange (huKO) gene (CAG/huKO-neo plasmid; 7.5 kb) into BN/CrlCrlj-ES4/Nips. has germ-line transmission Cryopreserved Male media used: 2i+rLIF This ES cell line has ubiquitous huKO gene expression. Yes 10054009 DA/Slc-ES2/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was electroporated with humanized Kusabira-Orange (huKO) gene (CAG/huKO-neo plasmid; 7.5 kb) into DA/Slc-ES1/Nips. has germ-line transmission Cryopreserved Male media used: 3i+LIF This ES cell line has ubiquitous huKO gene expression. Yes 10054010 WDB/Nips-ES1/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF This ES cell lines can participate in chimerae and transmit the characteristics through germline at high efficiency. Yes 10054011 WDB/Nips-ES41/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF Yes 10054012 WDB/Nips-ES47/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips Cryopreserved Male media used: 2i+LIF No 10054013 WDB/Nips-ES48/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054014 WDB/Nips-ES3/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054015 WDB/Nips-ES4/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054016 WDB/Nips-ES6/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+Forskolin Yes 10054017 WDB/Nips-ES7/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPANi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips Cryopreserved Male media used: 2i+Forskolin No 10054019 WDB/Nips-ES8/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPANi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+Forskolin Yes 10054021 WDB/Nips-ES14/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i Yes 10054022 WDB/Nips-ES32/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i Yes 10054023 WDB/Nips-ES37/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i Yes 10054025 WI-Tg(CAG/Venus)Nips-ES13/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips Cryopreserved Male media used: 2i+LIF This ES cell line has ubiquitous Venus gene expression. No 10054026 WI-Tg(CAG/Venus)Nips-ES17/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips Cryopreserved Male media used: 2i+LIF This ES cell line has ubiquitous Venus gene expression. No 10054027 F344/NSlc-ES37/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from F344/NSlc has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054029 WI-Tg(CAG/Venus)Nips-ES12/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. Yes 10054030 WI-Tg(CAG/Venus)Nips-ES20/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. Yes 10054032 WDB-Rosa26em1(RT2)Nips-ES2/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB-Rosa26em1(RT2)Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin This ES cell line has ubiquitous tdTomato gene expression. Yes 10054033 WI-Tg(CAG/Venus)Nips-ES2/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst prepared by treatment of ovulated homozygote of WI-Tg(CAG/Venus)Nips female rat oocytes with ionomycin and cycloheximide. Cryopreserved Female Parthenogenetic ES cell line; media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. No 10054034 WI-Tg(CAG/Venus)Nips-ES5/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst prepared by treatment of ovulated homozygote of WI-Tg(CAG/Venus)Nips female rat oocytes with ionomycin and cycloheximide. has germ-line transmission Cryopreserved Female Parthenogenetic ES cell line; media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. Yes 10054035 WI-Tg(CAG/Venus)Nips-ES10/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst prepared by treatment of ovulated homozygote of WI-Tg(CAG/Venus)Nips female rat oocytes with ionomycin and cycloheximide. Cryopreserved Female Parthenogenetic ES cell line; media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. No 127227593 CVCL_A2JC MDCK-C09 transformed cell line dog CVCL_A2JC CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Omics: Transcriptome analysis by RNAseq Female Characteristics: Has a low tumorigenic potential 127227594 CVCL_A2JD MDCK-C35 transformed cell line dog CVCL_A2JD CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Omics: Transcriptome analysis by RNAseq Female Characteristics: Has a low tumorigenic potential 127227595 CVCL_A2JE MDCK-W73 transformed cell line dog CVCL_A2JE CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female Characteristics: Has a high tumorigenic potential 127227596 CVCL_A8BA THP1-Dual KO-MAVS cancer cell line human CVCL_A8BA CL:0000010 Knockout cell: Method=Not specified; HGNC; 29233; MAVS; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227597 CVCL_A8BC THP1-Dual KO-RIG-I cancer cell line human CVCL_A8BC CL:0000010 Knockout cell: Method=Not specified; HGNC; 19102; RIGI; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227598 CVCL_A8BB THP1-Dual KO-MDA5 cancer cell line human CVCL_A8BB CL:0000010 Knockout cell: Method=Not specified; HGNC; 18873; IFIH1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227599 CVCL_A8BE THP1-HMGB1-Lucia cancer cell line human CVCL_A8BE CL:0000010 Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 4983; HMGB1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses a HMGN1-Lucia construct 127227600 CVCL_A8BD THP1-Dual KI-mSTING cancer cell line human CVCL_A8BD CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: MGI; MGI:1919762; Sting1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227601 CVCL_A8BG THP1-Dual KI-hSTING-H232 cancer cell line human CVCL_A8BG CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1 (with p.Arg232His); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227602 CVCL_A8BF THP1-Dual KI-hSTING-A162 cancer cell line human CVCL_A8BF CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1 (with p.Ser162Ala); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227603 CVCL_A8AX THP1-Dual KO-TLR4 cancer cell line human CVCL_A8AX CL:0000010 Knockout cell: Method=Not specified; HGNC; 11850; TLR4; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227604 CVCL_A8AW THP1-Dual KO-TLR2 cancer cell line human CVCL_A8AW CL:0000010 Knockout cell: Method=Not specified; HGNC; 11848; TLR2; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227605 CVCL_A8AZ THP1-Dual KO-IKKepsilon cancer cell line human CVCL_A8AZ CL:0000010 Knockout cell: Method=Not specified; HGNC; 14552; IKBKE; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227606 CVCL_A8AY THP1-Dual KO-TBK1 cancer cell line human CVCL_A8AY CL:0000010 Knockout cell: Method=Not specified; HGNC; 11584; TBK1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227607 CVCL_A8AP THP1-KO-CASP4 cancer cell line human CVCL_A8AP CL:0000010 Knockout cell: Method=Not specified; HGNC; 1505; CASP4; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227608 CVCL_A8AR THP1-KO-NLRC4 cancer cell line human CVCL_A8AR CL:0000010 Knockout cell: Method=Not specified; HGNC; 16412; NLRC4; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227609 CVCL_A8AQ THP1-KO-GSDMD cancer cell line human CVCL_A8AQ CL:0000010 Knockout cell: Method=Not specified; HGNC; 25697; GSDMD; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227610 CVCL_A8AT THP1-ASC-GFP cancer cell line human CVCL_A8AT CL:0000010 Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 16608; PYCARD; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses a PYCARD-GFP construct under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227611 CVCL_A8AS THP1-KO-NLRP3 cancer cell line human CVCL_A8AS CL:0000010 Knockout cell: Method=Not specified; HGNC; 16400; NLRP3; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227612 CVCL_A8AV THP1-Dual KO-IRF3 cancer cell line human CVCL_A8AV CL:0000010 Knockout cell: Method=Not specified; HGNC; 6118; IRF3; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227613 CVCL_A8AU THP1-Dual KO-IFI16 cancer cell line human CVCL_A8AU CL:0000010 Knockout cell: Method=Not specified; HGNC; 5395; IFI16; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227614 CVCL_A8AH THP1-Dual KO-STING cancer cell line human CVCL_A8AH CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227615 CVCL_A8AG Raji-hVISTA cancer cell line human CVCL_A8AG CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 30085; VSIR; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227616 CVCL_A8AJ THP1-Dual KO-TREX1 cancer cell line human CVCL_A8AJ CL:0000010 Knockout cell: Method=Not specified; HGNC; 12269; TREX1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227617 CVCL_A8AI THP1-Dual KO-cGAS cancer cell line human CVCL_A8AI CL:0000010 Knockout cell: Method=Not specified; HGNC; 21367; CGAS; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227618 CVCL_A8AL THP1-Dual KO-IFNAR2 cancer cell line human CVCL_A8AL CL:0000010 Knockout cell: Method=Not specified; HGNC; 5433; IFNAR2; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227619 CVCL_A8AK THP1-Null2 cancer cell line human CVCL_A8AK CL:0000010 Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227620 CVCL_A8AN THP1-KO-ASC cancer cell line human CVCL_A8AN CL:0000010 Knockout cell: Method=Not specified; HGNC; 16608; PYCARD; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227621 CVCL_A8AM THP1-Dual KO-TRIF cancer cell line human CVCL_A8AM CL:0000010 Knockout cell: Method=Not specified; HGNC; 18348; TICAM1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227622 CVCL_A8CB RAW-Difluo mLC3 cancer cell line house mouse CVCL_A8CB CL:0000010 Transfected with: MGI; MGI:1914693; Map1lc3b; Transfected with: UniProtKB; Q9U6Y8; Discosoma sp red fluorescent protein drFP583 (DsRed, RFP).; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen).; Characteristics: Stably expresses a RFP-GFP-Map1lc3b construct 127227623 CVCL_A8CA HeLa-Difluo hLC3 cancer cell line human CVCL_A8CA CL:0000010 Transfected with: HGNC; 13352; MAP1LC3B; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; Q9U6Y8; Discosoma sp red fluorescent protein drFP583 (DsRed, RFP).; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen).; Characteristics: Stably expresses a RFP-GFP-MAP1LC3B construct 127227624 CVCL_A8CD 293-hMyD88 transformed cell line human CVCL_A8CD CL:0000010 Transfected with: HGNC; 7562; MYD88 (with p.Leu252Pro); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to study SARS-CoV-2-host cell fusion Upon transient transfection, with a spike expression plasmid, these cells become a SARS-CoV-2 mimic, which can then fuse with permissive reporter cells (InvivoGen). Group: SARS-CoV-2 research cell line 127227625 CVCL_A8CC THP1-Blue KI-IP10 cancer cell line human CVCL_A8CC CL:0000010 Knockout cell: Method=Not specified; HGNC; 10637; CXCL10; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: The coding sequence of CXCL10 has been replaced with the Lucia luciferase reporter gene under the control of the endogenous promoter and thus allows the direct study of CXCL10 induction; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 copies of the NF-kappaB consensus TRE and 3 copies of the c-Rel binding site 127227626 CVCL_A8CF HEK-Blue IL-10 transformed cell line human CVCL_A8CF CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 5964; IL10RA; Transfected with: HGNC; 5965; IL10RB; Transfected with: HGNC; 11364; STAT3; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human IL10 (and to a lesser extent mouse IL10) by monitoring the activation of the STAT3 pathway (InvivoGen); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter 127227627 CVCL_A8CE HEK-Blue CD40L transformed cell line human CVCL_A8CE CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 11919; CD40; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive CD40L by monitoring the activation of the NF-kappaB pathway (InvivoGen); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127227628 CVCL_A8CH HEK-Blue IL-23 transformed cell line human CVCL_A8CH CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 5971; IL12RB1; Transfected with: HGNC; 19100; IL23R; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse IL23 by monitoring the activation of the STAT3 pathway (InvivoGen); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter 127227629 CVCL_A8CG HEK-Blue IL-22 transformed cell line human CVCL_A8CG CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 5965; IL10RB; Transfected with: HGNC; 13700; IL22RA1; Transfected with: HGNC; 11364; STAT3; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse IL22 by monitoring the activation of the STAT3 pathway (InvivoGen); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter 127227630 CVCL_A8BY HEK-Blue STAT6-hSTING-R232 transformed cell line human CVCL_A8BY CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 11368; STAT6; Transfected with: HGNC; 27962; STING1; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT6-responsive promoter 127227631 CVCL_A8BX HT29-Lucia AhR cancer cell line human CVCL_A8BX CL:0000010 Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Female Characteristics: Used for the study of aryl hydrocarbon receptor (AhR) genomic signaling induction (InvivoGen); Characteristics: The Lucia luciferase reporter gene is under the control of a minimal promoter coupled with the human CYP1A1 gene entire regulatory sequence which contains 6 dioxin responsive elements (DRE) 127227632 CVCL_A8BZ THP1-Difluo hLC3 cancer cell line human CVCL_A8BZ CL:0000010 Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 13352; MAP1LC3B; Transfected with: UniProtKB; Q9U6Y8; Discosoma sp red fluorescent protein drFP583 (DsRed, RFP).; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen).; Characteristics: Stably expresses a RFP-GFP-MAP1LC3B construct 127227633 CVCL_A8BQ HEK-Blue ISG transformed cell line human CVCL_A8BQ CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227634 CVCL_A8BP 293-Dual mSTING transformed cell line human CVCL_A8BP CL:0000010 Knockout cell: Method=Not specified; HGNC; 5434; IFNB1; Transfected with: HGNC; 439; ALPP; Transfected with: MGI; MGI:1919762; Sting1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia. 127227635 CVCL_A8BS HepG2-Dual cancer cell line human CVCL_A8BS CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227636 CVCL_A8BR HEK-Blue ISG-KO-STING transformed cell line human CVCL_A8BR CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227637 CVCL_A8BU HEK-Blue KO-ALPK1 transformed cell line human CVCL_A8BU CL:0000010 Knockout cell: Method=Not specified; HGNC; 20917; ALPK1; Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127227638 CVCL_A8BT HepG2-Lucia AhR cancer cell line human CVCL_A8BT CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Used for the study of aryl hydrocarbon receptor (AhR) genomic signaling induction (InvivoGen); Characteristics: The Lucia luciferase reporter gene is under the control of a minimal promoter coupled with the human CYP1A1 gene entire regulatory sequence which contains 6 dioxin responsive elements (DRE) 127227639 CVCL_A8BW THP1-Dual KO-TLR8 cancer cell line human CVCL_A8BW CL:0000010 Knockout cell: Method=Not specified; HGNC; 15632; TLR8; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227640 CVCL_A8BV HEK-Blue KO-TIFA transformed cell line human CVCL_A8BV CL:0000010 Knockout cell: Method=Not specified; HGNC; 19075; TIFA; Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127227641 CVCL_A8BI THP1-Dual KI-hSTING-R232 cancer cell line human CVCL_A8BI CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227642 CVCL_A8BH THP1-Dual KI-hSTING-M155 cancer cell line human CVCL_A8BH CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1 (with p.Val155Met); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227643 CVCL_A8BK 293-Dual Null transformed cell line human CVCL_A8BK CL:0000010 Knockout cell: Method=Not specified; HGNC; 5434; IFNB1; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia. 127227644 CVCL_A8BJ THP1-Dual KI-hSTING-S154 cancer cell line human CVCL_A8BJ CL:0000010 Knockout cell: Method=Not specified; HGNC; 27962; STING1; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1 (with p.Asn154Ser); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227645 CVCL_A8BM 293-Dual hSTING-H232 transformed cell line human CVCL_A8BM CL:0000010 Knockout cell: Method=Not specified; HGNC; 5434; IFNB1; Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1 (with p.Arg232His); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia. 127227646 CVCL_A8BL 293-Dual hSTING-A162 transformed cell line human CVCL_A8BL CL:0000010 Knockout cell: Method=Not specified; HGNC; 5434; IFNB1; Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1 (with p.Ser162Ala); Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia. 127227647 CVCL_A8BN 293-Dual hSTING-R232 transformed cell line human CVCL_A8BN CL:0000010 Knockout cell: Method=Not specified; HGNC; 5434; IFNB1; Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 27962; STING1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia. 127227648 CVCL_A8AB Raji-Null cancer cell line human CVCL_A8AB CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227649 CVCL_A8AA Raji-hLAG3 cancer cell line human CVCL_A8AA CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 6476; LAG3; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227650 CVCL_A8AD Raji-hPD-1 cancer cell line human CVCL_A8AD CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 8760; PDCD1; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227651 CVCL_A8AC Raji-hOX40 cancer cell line human CVCL_A8AC CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 11918; TNFRSF4; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227652 CVCL_A8AF Raji-hTIGIT cancer cell line human CVCL_A8AF CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 26838; TIGIT; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227653 CVCL_A8AE Raji-hPD-L1 cancer cell line human CVCL_A8AE CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 17635; CD274; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227654 CVCL_A7ZZ Raji-hICOS cancer cell line human CVCL_A7ZZ CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 5351; ICOS; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227655 CVCL_A7ZY Raji-HER2 cancer cell line human CVCL_A7ZY CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 3430; ERBB2; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227656 CVCL_A7ZR A549-Dual KO-MDA5 hACE2-TMPRSS2 cancer cell line human CVCL_A7ZR CL:0000010 Knockout cell: Method=Not specified; HGNC; 18873; IFIH1; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 13557; ACE2; Transfected with: HGNC; 11876; TMPRSS2; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen).; Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). Group: SARS-CoV-2 research cell line 127227657 CVCL_A7ZQ A549-Dual hACE2-TMPRSS2 cancer cell line human CVCL_A7ZQ CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 13557; ACE2; Transfected with: HGNC; 11876; TMPRSS2; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen).; Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). Group: SARS-CoV-2 research cell line 127227658 CVCL_A7ZT Jurkat-Lucia NFAT-CD16 cancer cell line human CVCL_A7ZT CL:0000010 Sequence variation: Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 3619; FCGR3A; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements 127227659 CVCL_A7ZS A549-Dual KO-RIG-I hACE2-TMPRSS2 cancer cell line human CVCL_A7ZS CL:0000010 Knockout cell: Method=Not specified; HGNC; 19102; RIGI; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 13557; ACE2; Transfected with: HGNC; 11876; TMPRSS2; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen).; Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). Group: SARS-CoV-2 research cell line 127227660 CVCL_A7ZV Raji-h4-1BB cancer cell line human CVCL_A7ZV CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 11924; TNFRSF9; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227661 CVCL_A7ZU Jurkat-Lucia NFAT-CD32 cancer cell line human CVCL_A7ZU CL:0000010 Sequence variation: Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 3616; FCGR2A; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements 127227662 CVCL_A7ZX Raji-hEGFR cancer cell line human CVCL_A7ZX CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 3236; EGFR; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227663 CVCL_A7ZW Raji-hCTLA4 cancer cell line human CVCL_A7ZW CL:0000010 Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 2505; CTLA4; Transfected with: UniProtKB; P33967; B.cereus Bsr Population: African; Nigerian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Male 127227664 CVCL_A7ZJ RAW-ASC KO-NLRC4 cancer cell line house mouse CVCL_A7ZJ CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:3036243; Nlrc4; Transfected with: MGI; MGI:1931465; Pycard; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227665 CVCL_A7ZI RAW-ASC KO-CASP11 cancer cell line house mouse CVCL_A7ZI CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:107700; Casp4; Transfected with: MGI; MGI:1931465; Pycard; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227666 CVCL_A7ZL RAW-Dual KO-TLR4 cancer cell line house mouse CVCL_A7ZL CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:1340094; Cxcl2; Knockout cell: Method=Not specified; MGI; MGI:96824; Tlr4; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression depends on the activation of the endogenous MIP-2/CXCL2 promoter as the Cxcl2 gene has been replaced by ALPP. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227667 CVCL_A7ZK RAW-Dual cancer cell line house mouse CVCL_A7ZK CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:1340094; Cxcl2; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression depends on the activation of the endogenous MIP-2/CXCL2 promoter as the Cxcl2 gene has been replaced by ALPP. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227668 CVCL_A7ZN A549-Dual KO-RIG-I cancer cell line human CVCL_A7ZN CL:0000010 Knockout cell: Method=Not specified; HGNC; 19102; RIGI; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227669 CVCL_A7ZM A549-Dual KO-MAVS cancer cell line human CVCL_A7ZM CL:0000010 Knockout cell: Method=Not specified; HGNC; 29233; MAVS; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227670 CVCL_A7ZP A549-Dual KO-MDA5 cancer cell line human CVCL_A7ZP CL:0000010 Knockout cell: Method=Not specified; HGNC; 18873; IFIH1; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). 127227671 CVCL_A7ZB RAW-Lucia ISG-KO-TRIF cancer cell line house mouse CVCL_A7ZB CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:2147032; Ticam1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227672 CVCL_A7ZA RAW-Lucia ISG-KO-IRF1 cancer cell line house mouse CVCL_A7ZA CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:96590; Irf1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227673 CVCL_A7ZD RAW-Lucia ISG-KO-IRF7 cancer cell line house mouse CVCL_A7ZD CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1859212; Irf7; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227674 CVCL_A7ZC RAW-Lucia ISG-KO-IRF5 cancer cell line house mouse CVCL_A7ZC CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1350924; Irf5; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227675 CVCL_A7ZF RAW-Lucia ISG-KO-MDA5 cancer cell line house mouse CVCL_A7ZF CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1918836; Ifih1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227676 CVCL_A7ZE RAW-Lucia ISG-KO-MAVS cancer cell line house mouse CVCL_A7ZE CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:2444773; Mavs; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227677 CVCL_A7ZH RAW-ASC KO-GSDMD cancer cell line house mouse CVCL_A7ZH CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:1916396; Gsdmd; Transfected with: MGI; MGI:1931465; Pycard; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227678 CVCL_A7ZG RAW-ASC cancer cell line house mouse CVCL_A7ZG CL:0000010 Transfected with: MGI; MGI:1931465; Pycard; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Abelson mouse leukemia virus (AbMuLV)(NCBI-Taxonomy; 11788); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227679 CVCL_A8JI 3G7 hybridoma house mouse CVCL_A8JI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227680 CVCL_A8JH 3G6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227681 CVCL_A8JK 3H4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227682 CVCL_A8JJ 3H2 hybridoma house mouse CVCL_A8JJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227683 CVCL_A8JM 5A1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227684 CVCL_A8JL 3H6 hybridoma house mouse CVCL_A8JL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227685 CVCL_A8JN 9F2 hybridoma house mouse CVCL_A8JN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227686 CVCL_A8JA 3F1 hybridoma house mouse CVCL_A8JA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227687 CVCL_A8JC 3F4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227688 CVCL_A8JB 3F2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227689 CVCL_A8JE 3F6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227690 CVCL_A8JD 3F5 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JD CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227691 CVCL_A8JG 3G2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227692 CVCL_A8JF 3G1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227693 CVCL_A8IX 3E1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227694 CVCL_A8IW 3D7 hybridoma house mouse CVCL_A8IW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227695 CVCL_A8IZ 3E5 hybridoma house mouse CVCL_A8IZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227696 CVCL_A8IY 3E4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227697 CVCL_A8IP 3C2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227698 CVCL_A8IR 3C6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227699 CVCL_A8IQ 3C4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227700 CVCL_A8IT 3D2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227701 CVCL_A8IS 3D1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227702 CVCL_A8IV 3D5 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227703 CVCL_A8IU 3D3 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227704 CVCL_A8HG DHMi002-A induced pluripotent stem cell human CVCL_A8HG From: German Heart Center Munich; Munich; Germany CL:0000010 Population: African; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227705 CVCL_A8HF DHMi001-A induced pluripotent stem cell human CVCL_A8HF From: German Heart Center Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227706 CVCL_A8HI MLi004-A induced pluripotent stem cell human CVCL_A8HI From: Faculty of Medicine, University of Ljubljana; Ljubljana; Slovenia CL:0000010 Sequence variation: Mutation; HGNC; 2214; COL7A1; Simple; p.Arg682Ter (c.2044C>T); ClinVar=VCV001047976; Zygosity=Heterozygous (PubMed=34284275); Sequence variation: Mutation; HGNC; 2214; COL7A1; Simple; c.6900+4A>G (IVS87+4A>G) (p.Gly2278_Gln2300del); ClinVar=VCV000374314; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34284275) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Female 127227707 CVCL_A8HH DHMi003-A induced pluripotent stem cell human CVCL_A8HH From: German Heart Center Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227708 CVCL_A8HK JHUi003-A induced pluripotent stem cell human CVCL_A8HK From: Johns Hopkins University; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; 9305; PPP2R2B; Repeat_expansion; CAG[69]; ClinVar=VCV000005614; Zygosity=Heterozygous (PubMed=34087983); Sequence variation: Mutation; HGNC; 9305; PPP2R2B; Repeat_expansion_edited; CAG[72]; ClinVar=VCV000005614; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087983) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227709 CVCL_A8HJ MUi023-A induced pluripotent stem cell human CVCL_A8HJ From: Mahidol University; Bangkok; Thailand CL:0000010 Discontinued: hPSCreg; MUi023-A; true. 127227710 CVCL_A8HM RCPFi005-A induced pluripotent stem cell human CVCL_A8HM From: Principe Felipe Centro de Investigacion; Valencia; Spain CL:0000010 Sequence variation: Mutation; HGNC; 9039; PLA2G6; Simple; p.Leu337Gln (c.1010T>A); Zygosity=Heterozygous (PubMed=34087982); Sequence variation: Mutation; HGNC; 9039; PLA2G6; Simple; p.Ala343Thr (c.1027G>A); ClinVar=VCV000159725; Zygosity=Heterozygous (PubMed=34087982) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227711 CVCL_A8HL RCPFi004-A induced pluripotent stem cell human CVCL_A8HL From: Principe Felipe Centro de Investigacion; Valencia; Spain CL:0000010 Sequence variation: Mutation; HGNC; 9039; PLA2G6; Simple; p.Glu786Lys (c.2356G>A); ClinVar=VCV001012262; Zygosity=Homozygous (PubMed=34087982) Population: Arab; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227712 CVCL_A8HA BJTTHi001-A induced pluripotent stem cell human CVCL_A8HA From: Beijing Tiantan Hospital; Beijing; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227713 CVCL_A8HC BJTTHi001-A-2 induced pluripotent stem cell human CVCL_A8HC From: Beijing Tiantan Hospital; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 10586; SCN1B Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227714 CVCL_A8HB BJTTHi001-A-1 induced pluripotent stem cell human CVCL_A8HB From: Beijing Tiantan Hospital; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 10585; SCN1A Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227715 CVCL_A8HE SCMCi001-A-1 induced pluripotent stem cell human CVCL_A8HE From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 9585; PTCH1 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227716 CVCL_A8HD SCMCi001-A induced pluripotent stem cell human CVCL_A8HD From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227717 CVCL_A8GV ZIPi015-F induced pluripotent stem cell human CVCL_A8GV From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227718 CVCL_A8GU ZIPi015-E induced pluripotent stem cell human CVCL_A8GU From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227719 CVCL_A8GX ZIPi015-H induced pluripotent stem cell human CVCL_A8GX From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227720 CVCL_A8GW ZIPi015-G induced pluripotent stem cell human CVCL_A8GW From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227721 CVCL_A8GZ ZIPi015-J induced pluripotent stem cell human CVCL_A8GZ From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227722 CVCL_A8GY ZIPi015-I induced pluripotent stem cell human CVCL_A8GY From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227723 CVCL_A8GN CHO.DogSLAMtag spontaneously immortalized cell line CVCL_A8GN CL:0000010 Transfected with: VGNC; 46206; Dog SLAMF1 (with a N-terminal HA tag); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127227724 CVCL_A8GM CHO.CowSLAMtag spontaneously immortalized cell line CVCL_A8GM CL:0000010 Transfected with: VGNC; 34653; Bovine SLAMF1 (with a N-terminal HA tag); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127227725 CVCL_A8GP SAS-R cancer cell line human CVCL_A8GP CL:0000010 Population: Japanese; Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Female Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=21716292). 127227726 CVCL_A8GR ZIPi015-B induced pluripotent stem cell human CVCL_A8GR From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227727 CVCL_A8GQ ZIPi015-A induced pluripotent stem cell human CVCL_A8GQ From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227728 CVCL_A8GT ZIPi015-D induced pluripotent stem cell human CVCL_A8GT From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227729 CVCL_A8GS ZIPi015-C induced pluripotent stem cell human CVCL_A8GS From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227730 CVCL_A8IH 3A2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227731 CVCL_A8IG 3A1 hybridoma house mouse CVCL_A8IG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227732 CVCL_A8IJ 3A7 hybridoma house mouse CVCL_A8IJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227733 CVCL_A8II 3A6 hybridoma house mouse CVCL_A8II CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227734 CVCL_A8IL 3B3 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227735 CVCL_A8IK 3B1 hybridoma house mouse CVCL_A8IK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227736 CVCL_A8IN 3B6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227737 CVCL_A8IM 3B4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127227738 CVCL_A8IB ESi101-A induced pluripotent stem cell human CVCL_A8IB From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; 11782; TH; Simple; p.Arg233His (c.698G>A); ClinVar=VCV000016236; Zygosity=Homozygous (BNLC) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227739 CVCL_A8IA ESi084-A induced pluripotent stem cell human CVCL_A8IA From: El Instituto de Investigacion Biomedica de A Coruna, University of Coruna; Barcelona; Spain CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227740 CVCL_A8ID ESi103-A induced pluripotent stem cell human CVCL_A8ID CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227741 CVCL_A8IC ESi102-A induced pluripotent stem cell human CVCL_A8IC From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; 11782; TH; Simple; p.Arg328Trp (c.982C>T); Zygosity=Heterozygous (BNLC); Sequence variation: Mutation; HGNC; 11782; TH; Simple; p.Thr399Met (c.1196C>T) (p.Thr368Met, c.1103C>T); ClinVar=VCV000378729; Zygosity=Heterozygous (BNLC) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227742 CVCL_A8IF HepG2-N10 cancer cell line human CVCL_A8IF From: Xia N.-S.; Xiamen University; Xiamen; China CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Transfected with a hepatitis B virus (HBV) subtype adw2 genome 127227743 CVCL_A8IE M9-ENL1 transformed cell line human CVCL_A8IE CL:0000010 Transfected with: HGNC; 7132; KMT2A (KMT2A-MLLT1 fusion); Transfected with: HGNC; 7134; MLLT1 (KMT2A-MLLT1 fusion); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: KMT2A-MLLT1; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptome analysis by microarray Characteristics: Expresses a transfected KMT2A-MLLT1 (MLL-ENL) fusion protein Mimics the features of primary human pro-B cell acute lymphoblastic leukemia (PubMed=22160482). 127227744 CVCL_A8HW IMT-KO9 conditionally immortalized cell line house mouse CVCL_A8HW CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Astrocyte; CL=CL_0000127; Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic. Male 127227745 CVCL_A8HV IMT-KO4 conditionally immortalized cell line house mouse CVCL_A8HV CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Astrocyte; CL=CL_0000127; Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic. Male 127227746 CVCL_A8HY ESi085-A induced pluripotent stem cell human CVCL_A8HY From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227747 CVCL_A8HX SBKMS-KS1 cancer cell line human CVCL_A8HX CL:0000010 Sequence variation: Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=19289832) Derived from site: Metastatic; Groin; UBERON=UBERON_0008337. Female 127227748 CVCL_A8HZ ESi083-A induced pluripotent stem cell human CVCL_A8HZ From: El Instituto de Investigacion Biomedica de A Coruna, University of Coruna; Barcelona; Spain CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227749 CVCL_A8HN RCPFi006-A induced pluripotent stem cell human CVCL_A8HN From: Principe Felipe Centro de Investigacion; Valencia; Spain CL:0000010 Sequence variation: Mutation; HGNC; 9039; PLA2G6; Simple; p.Tyr790Ter (c.2370T>G); ClinVar=VCV000006195; Zygosity=Homozygous (PubMed=34087982) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227750 CVCL_A8HQ AND-1 EGFP-2A-SCL embryonic stem cell human CVCL_A8HQ From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Transfected with: HGNC; 11556; TAL1; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Karyotypic information: 47,XY,-1,+der(1)dup(1q11->1qter::1q11->1qter)-7,+i(7)p,+13 (BNLC); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-SCL-PGK-Neo construct Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227751 CVCL_A8HP CQ4ed-iPSC induced pluripotent stem cell human CVCL_A8HP From: Josep Carreras Leukemia Research Institute; Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; 19693; COQ4; Simple_corrected; p.Glu161Asp (c.483G>C); ClinVar=VCV000380493; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28465093) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227752 CVCL_A8HS HS181 EGFP-2A-RUNX1c embryonic stem cell human CVCL_A8HS From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Transfected with: HGNC; 10471; RUNX1 (isoform AML-1C); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-RUNX1c-PGK-Neo construct Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227753 CVCL_A8HR HS181 EGFP-2A-SCL embryonic stem cell human CVCL_A8HR From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Transfected with: HGNC; 11556; TAL1; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Karyotypic information: 46,XX [15]; 46,XX,der(5)t(q35;?)+der(12)t(q11;?) [7] (BNLC); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-SCL-PGK-Neo construct Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227754 CVCL_A8HU IMT-KO2 conditionally immortalized cell line house mouse CVCL_A8HU CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Astrocyte; CL=CL_0000127; Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic. Male 127227755 CVCL_A8HT K562/GM-CSF cancer cell line human CVCL_A8HT CL:0000010 Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 2434; CSF2; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Biotechnology: Used for the production of the Sorento Therapeutics STI-6991 SARS-CoV-2 (COVID-19) vaccine candidate The cell line which is lethally irradiated is used to produce the recombinant SARS-CoV-2 spike protein rSARS-CoV-2 which is the active part of the vaccine formulation (PubMed=32289117). Female Characteristics: Does not express HLA class I or II antigens, potentially decreasing the magnitude of the alloresponses generated on repeated immunizations (PubMed=10466632) 127227756 CVCL_A8FE HT43 hybridoma house mouse CVCL_A8FE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227757 CVCL_A8FD HT41 hybridoma house mouse CVCL_A8FD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227758 CVCL_A8FG HT45 hybridoma house mouse CVCL_A8FG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227759 CVCL_A8FF HT44 hybridoma house mouse CVCL_A8FF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227760 CVCL_A8FI HT53 hybridoma house mouse CVCL_A8FI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227761 CVCL_A8FH HT52 hybridoma house mouse CVCL_A8FH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227762 CVCL_A8FK HT58 [Mouse hybridoma against human TLR4] hybridoma house mouse CVCL_A8FK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227763 CVCL_A8FJ HT55 hybridoma house mouse CVCL_A8FJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227764 CVCL_A8FA HT3 hybridoma house mouse CVCL_A8FA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227765 CVCL_A8FC HT40 hybridoma house mouse CVCL_A8FC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227766 CVCL_A8FB HT4 [Mouse hybridoma against human TLR4] hybridoma house mouse CVCL_A8FB CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227767 CVCL_A8ET mTX11 hybridoma CVCL_A8ET CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227768 CVCL_A8ES 5A5 [Mouse/rat hybridoma against human CD14] hybridoma CVCL_A8ES CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227769 CVCL_A8EV HT16 hybridoma house mouse CVCL_A8EV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227770 CVCL_A8EU HT11 hybridoma house mouse CVCL_A8EU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227771 CVCL_A8EX HT2 [Mouse hybridoma against human TLR4] hybridoma house mouse CVCL_A8EX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227772 CVCL_A8EW HT17 hybridoma house mouse CVCL_A8EW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227773 CVCL_A8EZ HT29 hybridoma house mouse CVCL_A8EZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227774 CVCL_A8EY HT26 hybridoma house mouse CVCL_A8EY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227775 CVCL_A8EL mTX12 hybridoma CVCL_A8EL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227776 CVCL_A8EK mTX10 hybridoma CVCL_A8EK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227777 CVCL_A8EN 1B12 [Mouse hybridoma against human CD14] hybridoma CVCL_A8EN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227778 CVCL_A8EM GFP5 hybridoma CVCL_A8EM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P42212; GFP (Note=With p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). 127227779 CVCL_A8EP 1E1 [Mouse hybridoma against human CD14] hybridoma CVCL_A8EP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227780 CVCL_A8ER 1F1 [Mouse hybridoma against human CD14] hybridoma CVCL_A8ER CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227781 CVCL_A8EQ 1E12 hybridoma CVCL_A8EQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227782 CVCL_A8GF hLp4 hybridoma CVCL_A8GF CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P18428; Human LBP. 127227783 CVCL_A8GE hLp1 hybridoma CVCL_A8GE CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P18428; Human LBP. 127227784 CVCL_A8GH CLC12N2 cancer cell line human CVCL_A8GH CL:0000010 Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 16412; NLRC4 (with p.Leu152_Ala1024del, CARD domain, C12N2 construct); Transfected with: HGNC; 5331; NOD2 (with p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 127227785 CVCL_A8GG HeLa-R cancer cell line human CVCL_A8GG CL:0000010 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=27681752). 127227786 CVCL_A8GJ MAIL8-19 transformed cell line human CVCL_A8GJ CL:0000010 Transfected with: HGNC; 16412; NLRC4 (with p.Leu152_Ala1024del, CARD domain, C12N2 construct); Transfected with: HGNC; 5331; NOD2 (with p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct); Transfected with: HGNC; 16608; PYCARD; Transfected with: UniProtKB; P42212; GFP; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127227787 CVCL_A8GI NUC12N2 cancer cell line human CVCL_A8GI CL:0000010 Transfected with: HGNC; 16412; NLRC4 (with p.Leu152_Ala1024del, CARD domain, C12N2 construct); Transfected with: HGNC; 5331; NOD2 (with p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct) Population: Japanese; Derived from site: Metastatic; Paragastric lymph node; UBERON=UBERON_8480059. Female 127227788 CVCL_A8GL CHO.B95aSLAMtag spontaneously immortalized cell line CVCL_A8GL CL:0000010 Transfected with: UniProtKB; Q9GJT3; Saguinus oedipus SLAMF1 (with a N-terminal HA tag); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127227789 CVCL_A8GK Vero.DogSLAMtag spontaneously immortalized cell line green monkey CVCL_A8GK CL:0000010 Transfected with: VGNC; 46206; SLAMF1 (with a N-terminal HA tag); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 127227790 CVCL_A8GB M14-23 hybridoma CVCL_A8GB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227791 CVCL_A8GA M14-21 hybridoma CVCL_A8GA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227792 CVCL_A8GD M14-29 hybridoma CVCL_A8GD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227793 CVCL_A8GC M14-26 hybridoma CVCL_A8GC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227794 CVCL_A8FU M14-9 hybridoma CVCL_A8FU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227795 CVCL_A8FT HepG2-R cancer cell line human CVCL_A8FT CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=21716292). 127227796 CVCL_A8FW M14-11 hybridoma CVCL_A8FW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227797 CVCL_A8FV M14-10 hybridoma CVCL_A8FV CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227798 CVCL_A8FY M14-16 hybridoma CVCL_A8FY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227799 CVCL_A8FX M14-14 hybridoma CVCL_A8FX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227800 CVCL_A8FZ M14-17 hybridoma CVCL_A8FZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227801 CVCL_A8FM HT60 hybridoma house mouse CVCL_A8FM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227802 CVCL_A8FL HT59 hybridoma house mouse CVCL_A8FL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227803 CVCL_A8FN HT66 hybridoma house mouse CVCL_A8FN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227804 CVCL_A8FQ HTB1 hybridoma house mouse CVCL_A8FQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227805 CVCL_A8FP HT68 hybridoma house mouse CVCL_A8FP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227806 CVCL_A8FS HepG2-8960-R cancer cell line human CVCL_A8FS CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=19215227). 127227807 CVCL_A8FR HTB2 hybridoma house mouse CVCL_A8FR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227808 CVCL_A8DC Sf9 SARS-CoV-2 Spike S1 spontaneously immortalized cell line CVCL_A8DC CL:0000010 Transfected with: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S) (AA 1-685; S1) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Group: Insect cell line; Group: SARS-CoV-2 research cell line 127227809 CVCL_A8DB HEK293T SARS-CoV-2 Spike transformed cell line human CVCL_A8DB CL:0000010 Transfected with: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: ABM; T6793; probable Female Group: SARS-CoV-2 research cell line 127227810 CVCL_A8DE MUi028-A induced pluripotent stem cell human CVCL_A8DE From: Mahidol University; Bangkok; Thailand CL:0000010 Population: Southeast Asian; Thai; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227811 CVCL_A8DD Sf9 SARS-CoV-2 Spike S2 spontaneously immortalized cell line CVCL_A8DD CL:0000010 Transfected with: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S) (AA 816-1273; S2) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Group: Insect cell line; Group: SARS-CoV-2 research cell line 127227812 CVCL_A8DG PCIi030-A induced pluripotent stem cell human CVCL_A8DG From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227813 CVCL_A8DF PCIi029-A induced pluripotent stem cell human CVCL_A8DF From: Phenocell SAS; Grasse; France CL:0000010 Sequence variation: Mutation; HGNC; 8617; PAX3; Simple; c.-70_85+366del; Zygosity=Heterozygous (PubMed=36989619) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227814 CVCL_A8DI WAe009-A-60 embryonic stem cell human CVCL_A8DI From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Transfected with: HGNC; 9886; KDM5A (NUP98-KDM5 fusion); Transfected with: HGNC; 8068; NUP98 (NUP98-KDM5 fusion); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127227815 CVCL_A8DH PCIi031-A induced pluripotent stem cell human CVCL_A8DH From: Phenocell SAS; Grasse; France CL:0000010 Sequence variation: Mutation; HGNC; 8617; PAX3; Simple; c.-70_85+366del; Zygosity=Heterozygous (PubMed=36989619) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227816 CVCL_A8CZ HEK-Blue TGF-beta transformed cell line human CVCL_A8CZ CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 6769; SMAD3; Transfected with: HGNC; 6770; SMAD4; Transfected with: HGNC; 11772; TGFBR1; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive TGF-beta by monitoring the activation of the TGF-beta/SMAD pathway (InvivoGen); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a beta-globin minimal promoter fused to 3 SMAD3/4-binding elements (SBE) 127227817 CVCL_A8CY HEK-Dual IFN-gamma transformed cell line human CVCL_A8CY CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 11362; STAT1; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Allows the detection of bioactive human IFN-gamma by monitoring the activation of the JAK/STAT1 pathway; Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line both genes are under the control of an ISG54 minimal promoter in conjunction with four IFN-gamma activated sites (GAS). 127227818 CVCL_A8DA HEK-Blue IL-4/IL-13 transformed cell line human CVCL_A8DA CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 11368; STAT6; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human IL4 and human/murine IL13 by monitoring the activation of the STAT-6 pathway (InvivoGen); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT6-responsive promoter 127227819 CVCL_A8CR HEK-Dual hTLR2 (NF/IL8) transformed cell line human CVCL_A8CR CL:0000010 Knockout cell: Method=Not specified; HGNC; 6025; CXCL8; Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 1628; CD14; Transfected with: HGNC; 11848; TLR2; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia. 127227820 CVCL_A8CQ HEK-Dual Null transformed cell line human CVCL_A8CQ CL:0000010 Knockout cell: Method=Not specified; HGNC; 6025; CXCL8; Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia. 127227821 CVCL_A8CT HEK-Dual hTLR5 (NF/IL8) transformed cell line human CVCL_A8CT CL:0000010 Knockout cell: Method=Not specified; HGNC; 6025; CXCL8; Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 11851; TLR5; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia. 127227822 CVCL_A8CS HEK-Dual hTLR3 (NF/IL8) transformed cell line human CVCL_A8CS CL:0000010 Knockout cell: Method=Not specified; HGNC; 6025; CXCL8; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 11849; TLR3; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia. 127227823 CVCL_A8CV HEK-Dual mTLR4 (NF/IL8) transformed cell line human CVCL_A8CV CL:0000010 Knockout cell: Method=Not specified; HGNC; 6025; CXCL8; Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: MGI; MGI:88318; Cd14; Transfected with: MGI; MGI:1341909; Ly96; Transfected with: MGI; MGI:96824; Tlr4; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia. 127227824 CVCL_A8CU HEK-Dual hTLR9 (NF/IL8) transformed cell line human CVCL_A8CU CL:0000010 Knockout cell: Method=Not specified; HGNC; 6025; CXCL8; Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 15633; TLR9; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia. 127227825 CVCL_A8CX HEK-Dual TNF-alpha transformed cell line human CVCL_A8CX CL:0000010 Knockout cell: Method=Not specified; HGNC; 7562; MYD88; Transfected with: HGNC; 439; ALPP; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line both genes are under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites. 127227826 CVCL_A8CW HEK-Dual mTLR7 (NF/IL8) transformed cell line human CVCL_A8CW CL:0000010 Knockout cell: Method=Not specified; HGNC; 6025; CXCL8; Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: MGI; MGI:2176882; Tlr7; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia. 127227827 CVCL_A8CJ HEK-Blue RANKL transformed cell line human CVCL_A8CJ CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 11908; TNFRSF11A; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse TNFSF11/RANKL by monitoring the activation of the NF-kappaB and AP-1 pathway; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a promoter with NF-kappaB and AP-1-binding sites 127227828 CVCL_A8CI HEK-Blue TPO transformed cell line human CVCL_A8CI CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 7217; MPL; Transfected with: HGNC; 11367; STAT5B; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse TPO by monitoring the activation of the STAT5 pathway; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT5 promoter 127227829 CVCL_A8CL HEK-Blue IL-1beta transformed cell line human CVCL_A8CL CL:0000010 Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse IL1B monitoring the activation of the NF-kappaB and AP-1 pathways In addition, the TNF-alpha, TLR3 and TLR5 responses have been blocked (InvivoGen).; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127227830 CVCL_A8CK HEK-Blue IL-17C transformed cell line human CVCL_A8CK CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 5985; IL17RA; Transfected with: HGNC; 18439; IL17RE; Transfected with: HGNC; 1343; TRAF3IP2; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and murine IL17C and IL17F by monitoring the activation of the NF-kappaB and AP-1 pathways (InvivoGen); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the IFN-beta minimal promoter fused to five NF-kappaB and five AP-1 binding sites 127227831 CVCL_A8CN HEK-Lucia Null transformed cell line human CVCL_A8CN CL:0000010 Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227832 CVCL_A8CM HEK-Blue IL-1R transformed cell line human CVCL_A8CM CL:0000010 Knockout cell: Method=Not specified; HGNC; 11849; TLR3; Knockout cell: Method=Not specified; HGNC; 11851; TLR5; Knockout cell: Method=Not specified; HGNC; 11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; 11917; TNFRSF1B; Transfected with: HGNC; 439; ALPP; Transfected with: MGI; MGI:96545; Il1r1; Transfected with: MGI; MGI:104975; Il1rap; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse IL1A and IL1B by monitoring the activation of the NF-kappaB and AP-1 pathways In addition, the TNF-alpha, TLR3 and TLR5 responses have been blocked (InvivoGen).; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127227833 CVCL_A8CP HEK-Lucia RIG-I transformed cell line human CVCL_A8CP CL:0000010 Transfected with: HGNC; 19102; RIGI; Transfected with: Lucia luciferase, a synthetic gene designed on natural secreted luciferase genes from marine copepods; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) 127227834 CVCL_A8ED TES101 hybridoma house mouse CVCL_A8ED CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227835 CVCL_A8EC mTX6 hybridoma CVCL_A8EC CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227836 CVCL_A8EF mTES101-RP(N6035) hybridoma house mouse CVCL_A8EF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227837 CVCL_A8EE mTES101-RP(N6002) hybridoma house mouse CVCL_A8EE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227838 CVCL_A8EH mTX7 hybridoma CVCL_A8EH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227839 CVCL_A8EG Ts4 hybridoma house mouse CVCL_A8EG CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227840 CVCL_A8EJ mTX9 hybridoma CVCL_A8EJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227841 CVCL_A8EI mTX8 hybridoma CVCL_A8EI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227842 CVCL_A8DZ mTX3 hybridoma CVCL_A8DZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227843 CVCL_A8EB mTX5.2 hybridoma CVCL_A8EB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227844 CVCL_A8EA mTX4 hybridoma CVCL_A8EA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227845 CVCL_A8DS NCC-CC4-3 cancer cell line human CVCL_A8DS CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227846 CVCL_A8DR NCC-CC4-2 cancer cell line human CVCL_A8DR CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227847 CVCL_A8DU NCC-CC6-2 cancer cell line human CVCL_A8DU CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227848 CVCL_A8DT NCC-CC6-1 cancer cell line human CVCL_A8DT CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227849 CVCL_A8DW GFP2 hybridoma CVCL_A8DW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P42212; GFP (Note=With p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP). 127227850 CVCL_A8DV HeLa NEK1 KO cancer cell line human CVCL_A8DV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 7744; NEK1 Miscellaneous: Cell line information from personal communication of Laflamme C Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127227851 CVCL_A8DY mTX1 hybridoma CVCL_A8DY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227852 CVCL_A8DX mk34 hybridoma CVCL_A8DX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9CWP4; Mouse Ly6k. 127227853 CVCL_A8DK RCPCMi007-A-1 induced pluripotent stem cell human CVCL_A8DK From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 914; B2M Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227854 CVCL_A8DJ RCPCMi007-A induced pluripotent stem cell human CVCL_A8DJ From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227855 CVCL_A8DM UM281-1 PGD embryonic stem cell human CVCL_A8DM From: University of Michigan; Ann Arbor; USA CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-21-0486 127227856 CVCL_A8DL PS1 finite cell line human CVCL_A8DL CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: JCRB; KURB2002; probable Female 127227857 CVCL_A8DN NCC-BD3 cancer cell line human CVCL_A8DN CL:0000010 Population: Japanese; Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. Male 127227858 CVCL_A8DQ NCC-BD4-2 cancer cell line human CVCL_A8DQ CL:0000010 Population: Japanese; Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. Male 127227859 CVCL_A8DP NCC-BD4-1 cancer cell line human CVCL_A8DP CL:0000010 Population: Japanese; Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. Male 127227860 CVCL_A4SV UMGi079-A induced pluripotent stem cell human CVCL_A4SV From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227861 CVCL_A4SU UMGi078-A induced pluripotent stem cell human CVCL_A4SU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227862 CVCL_A4SX UMGi081-A induced pluripotent stem cell human CVCL_A4SX From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227863 CVCL_A4SW UMGi080-A induced pluripotent stem cell human CVCL_A4SW From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227864 CVCL_A4SZ UMGi083-A induced pluripotent stem cell human CVCL_A4SZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227865 CVCL_A4SY UMGi082-A induced pluripotent stem cell human CVCL_A4SY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227866 CVCL_A4SN UMGi072-A induced pluripotent stem cell human CVCL_A4SN From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227867 CVCL_A4SM UMGi071-A induced pluripotent stem cell human CVCL_A4SM From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227868 CVCL_A4SP UMGi073-A induced pluripotent stem cell human CVCL_A4SP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227869 CVCL_A4SR UMGi075-A induced pluripotent stem cell human CVCL_A4SR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227870 CVCL_A4SQ UMGi074-A induced pluripotent stem cell human CVCL_A4SQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227871 CVCL_A4ST UMGi077-A induced pluripotent stem cell human CVCL_A4ST From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227872 CVCL_A4SS UMGi076-A induced pluripotent stem cell human CVCL_A4SS From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227873 CVCL_A4SF WT1-iPSC induced pluripotent stem cell human CVCL_A4SF CL:0000010 Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127227874 CVCL_A4SE ActiCre-B1 embryonic stem cell CVCL_A4SE CL:0000010 Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Ubiquitously expresses the tamoxifen-inducible Cre-driver ERT2CreERT2 Using CRISPR/Cas9 a IRES-ERT2CreERT2-IRES-Hyg construct was introduced into the 3'UTR of ACTB (PubMed=33453576). Group: Non-human primate cell line 127227875 CVCL_A4SH WT3-iPSC induced pluripotent stem cell human CVCL_A4SH CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227876 CVCL_A4SG WT2-iPSC induced pluripotent stem cell human CVCL_A4SG CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227877 CVCL_A4SJ SAA2-iPSC induced pluripotent stem cell human CVCL_A4SJ CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227878 CVCL_A4SI SAA1-iPSC induced pluripotent stem cell human CVCL_A4SI CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227879 CVCL_A4SL UMGi070-A induced pluripotent stem cell human CVCL_A4SL From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227880 CVCL_A4SK SAA3-iPSC induced pluripotent stem cell human CVCL_A4SK CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227881 CVCL_A5LN TMMR-1 hybridoma house mouse CVCL_A5LN CL:0000010 Monoclonal antibody isotype: IgG1. 127227882 CVCL_A5LM H14-YAP1 embryonic stem cell human CVCL_A5LM CL:0000010 Transfected with: HGNC; 16262; YAP1; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227883 CVCL_A5LP TMMR-2 hybridoma house mouse CVCL_A5LP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human 26 kDa protein on osteosarcoma cell lines. 127227884 CVCL_A5LR OSEV cancer cell line human CVCL_A5LR CL:0000010 Unspecified 127227885 CVCL_A5LQ TMMR-3 hybridoma house mouse CVCL_A5LQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human 97 kDa protein on osteosarcoma cell lines. 127227886 CVCL_A5LT OSFN cancer cell line human CVCL_A5LT CL:0000010 Unspecified 127227887 CVCL_A5LS OSFL cancer cell line human CVCL_A5LS CL:0000010 Unspecified 127227888 CVCL_A5LF FM3A AC2 cancer cell line house mouse CVCL_A5LF CL:0000010 Selected for resistance to: ChEBI; CHEBI:2766; Aphidicolin; Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female 127227889 CVCL_A5LE FM3A AC1 cancer cell line house mouse CVCL_A5LE CL:0000010 Selected for resistance to: ChEBI; CHEBI:2766; Aphidicolin; Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female 127227890 CVCL_A5LH BC3H1#1 cancer cell line house mouse CVCL_A5LH CL:0000010 Transformant: N-ethyl-N-nitrosourea (ENU)(ChEBI; CHEBI:23995); Derived from site: Metastatic; Brain; UBERON=UBERON_0000955; Breed/subspecies: C3H. Unspecified Characteristics: Spontaneously fusing clone of BC3H1 Can form multinucleated myocytes (PubMed=10852349). 127227891 CVCL_A5LG FM3A AC3 cancer cell line house mouse CVCL_A5LG CL:0000010 Selected for resistance to: ChEBI; CHEBI:2766; Aphidicolin; Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female 127227892 CVCL_A5LJ MF2S cancer cell line house mouse CVCL_A5LJ CL:0000010 127227893 CVCL_A5LI EUE6 cancer cell line human CVCL_A5LI CL:0000010 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (EUE) has been shown to be a HeLa derivative. 127227894 CVCL_A5LL H7-YAP1 embryonic stem cell human CVCL_A5LL CL:0000010 Transfected with: HGNC; 16262; YAP1; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127227895 CVCL_A5LK H7v1,17q,i20 embryonic stem cell human CVCL_A5LK CL:0000010 Karyotypic information: 47,XX,+del(1)(p22p22),der(6)t(6;17)(q27;q1),t(12;20)(q13;q11.2),i(2)(q10)ish dup(20)(q11.21;q11.21) (PubMed=34407428); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 1 that has an interstitial deletion at 1p22, gain of chromosome 17q and isochromosome of the long (q) arm of chromosome 20 (PubMed=34407428) 127227896 CVCL_A5LB FM3A SR-01 cancer cell line house mouse CVCL_A5LB CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072) 127227897 CVCL_A5LA FM3A G258 cancer cell line house mouse CVCL_A5LA CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Temperature-sensitive Deficient in cell growth, asparagine glycosylation and synthesis of oligosaccharide-lipid. Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated mannose and stored so as to allow time for cells that had taken up the mannose to be killed by radiation damage (PubMed=1995072; PubMed=6725415). 127227898 CVCL_A5LD FM3A SR-12 cancer cell line house mouse CVCL_A5LD CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072) 127227899 CVCL_A5LC FM3A SR-11 cancer cell line house mouse CVCL_A5LC CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072) 127227900 CVCL_A5KU H14.BJ1 embryonic stem cell human CVCL_A5KU CL:0000010 Karyotypic information: 48,XY,+12,+der(17)hsr(17)(p11.2) del(17)(p13.3); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Aneuploid WA14 subline with gain of chromosome 12 and chromosome 17 that incorporates an hsr comprising amplification of chromosomal region 17p13.3 127227901 CVCL_A5KT H7v20q embryonic stem cell human CVCL_A5KT CL:0000010 Karyotypic information: 46,XX,ish dup(20)(q11.21;q11.21) (PubMed=34407428); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of a copy number variant 20q11.21 (PubMed=34407428) 127227902 CVCL_A5KW H7.s6-GFP embryonic stem cell human CVCL_A5KW CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Karyotypic information: 48,XX,+del(1)(p22;p22),der(6)t(6;17)(q27;q1),+12,ish dup(q11.21;q11.21) (PubMed=27829140); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 1 that has an interstitial deletion at 1p22, gain of chromosome 17q, trisomy chromosome 12 and gain of copy number variant 20q11.21 (PubMed=27829140) 127227903 CVCL_A5KV H14.s9 embryonic stem cell human CVCL_A5KV CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227904 CVCL_A5KY H7.s14-Tomato embryonic stem cell human CVCL_A5KY CL:0000010 Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127227905 CVCL_A5KX H14.BJ1-GFP embryonic stem cell human CVCL_A5KX CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Karyotypic information: 48,XY,+12,+der(17)hsr(17)(p11.2) del(17)(p13.3); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Aneuploid WA14 subline with gain of chromosome 12 and chromosome 17 that incorporates an hsr comprising amplification of chromosomal region 17p13.3 127227906 CVCL_A5KZ ND15079 transformed cell line human CVCL_A5KZ CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15079; probable Male 127227907 CVCL_A5MN GM27925 induced pluripotent stem cell human CVCL_A5MN CL:0000010 Sequence variation: Mutation; HGNC; 2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM27925) Population: Caucasian; Amish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227908 CVCL_A5MQ GM27938 induced pluripotent stem cell human CVCL_A5MQ CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: The donor is mosaic for the disease causing KIF1A mutation, this cell line originate from a wildtype cell 127227909 CVCL_A5MP GM27937 induced pluripotent stem cell human CVCL_A5MP CL:0000010 Sequence variation: Mutation; HGNC; 888; KIF1A; Simple; p.Arg203Ser (c.609G>T); Zygosity=Mosaic (Coriell=GM27937) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: The donor is mosaic for the disease causing KIF1A mutation, this cell line originate from a diseased cell 127227910 CVCL_A5MS 77-1 cancer cell line human CVCL_A5MS CL:0000010 Population: Japanese; Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Male Doubling time: 1.4 days (PubMed=7817386) 127227911 CVCL_A5MR GM27978 induced pluripotent stem cell human CVCL_A5MR CL:0000010 Sequence variation: Mutation; HGNC; 20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous (Coriell=GM27978) Population: Caucasian and Native North American; Alaskan; Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227912 CVCL_A5MU SNUe004-A-2 embryonic stem cell human CVCL_A5MU From: Seoul National University; Seoul; South Korea CL:0000010 Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227913 CVCL_A5MT SNUe004-A-1 embryonic stem cell human CVCL_A5MT From: Seoul National University; Seoul; South Korea CL:0000010 Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227914 CVCL_A5MG GM28029 finite cell line human CVCL_A5MG CL:0000010 Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28029); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Arg230Ter (c.688C>T); ClinVar=VCV000280010; Zygosity=Heterozygous (Coriell=GM28029) Population: Native North American; Cherokee, Caucasian and Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227915 CVCL_A5MF GM28026 transformed cell line human CVCL_A5MF CL:0000010 Sequence variation: Mutation; HGNC; 6408; MAFB; Simple; p.Pro71Arg (c.212C>G); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28026) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227916 CVCL_A5MI GM28031 finite cell line human CVCL_A5MI CL:0000010 Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28031); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28031) Population: Caucasian; Polish; Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227917 CVCL_A5MH GM28030 finite cell line human CVCL_A5MH CL:0000010 Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227918 CVCL_A5MK GM27901 transformed cell line human CVCL_A5MK CL:0000010 Sequence variation: Mutation; HGNC; 11497; SYNGAP1; Simple; p.Arg1240Ter (c.3718C>T); ClinVar=VCV000225077; Zygosity=Heterozygous (Coriell=GM27901) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227919 CVCL_A5MJ GM28032 finite cell line human CVCL_A5MJ CL:0000010 Population: Caucasian; Polish; Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227920 CVCL_A5MM GM27918 induced pluripotent stem cell human CVCL_A5MM CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227921 CVCL_A5ML GM27957 induced pluripotent stem cell human CVCL_A5ML CL:0000010 Sequence variation: Mutation; HGNC; 11497; SYNGAP1; Simple; p.Arg1240Ter (c.3718C>T); ClinVar=VCV000225077; Zygosity=Heterozygous (Coriell=GM27957) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227922 CVCL_A5MA GM28019 finite cell line human CVCL_A5MA CL:0000010 Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28019); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28019); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28019) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227923 CVCL_A5MC GM28021 finite cell line human CVCL_A5MC CL:0000010 Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28021); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28021) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227924 CVCL_A5MB GM28020 finite cell line human CVCL_A5MB CL:0000010 Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28020); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28020); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28020) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227925 CVCL_A5ME GM28023 finite cell line human CVCL_A5ME CL:0000010 Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28023); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28023) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227926 CVCL_A5MD GM28022 finite cell line human CVCL_A5MD CL:0000010 Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28022) Population: Caucasian; Dutch; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227927 CVCL_A5LV OSPR cancer cell line human CVCL_A5LV CL:0000010 Unspecified 127227928 CVCL_A5LU OSON cancer cell line human CVCL_A5LU CL:0000010 Unspecified 127227929 CVCL_A5LX OSSM cancer cell line human CVCL_A5LX CL:0000010 Unspecified 127227930 CVCL_A5LW OSSK cancer cell line human CVCL_A5LW CL:0000010 Unspecified 127227931 CVCL_A5LZ U2OS-ATRkd cancer cell line human CVCL_A5LZ CL:0000010 Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 882; ATR (with p.Asp2494Glu = ATRkd); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127227932 CVCL_A5LY OSWO cancer cell line human CVCL_A5LY CL:0000010 Unspecified 127227933 CVCL_A5JL ND15114 transformed cell line human CVCL_A5JL CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15114; probable Male 127227934 CVCL_A5JK ND15099 transformed cell line human CVCL_A5JK CL:0000010 Population: Caucasian; British; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15099; probable Male 127227935 CVCL_A5JN ND15139 transformed cell line human CVCL_A5JN CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15139; probable Female 127227936 CVCL_A5JM ND15118 transformed cell line human CVCL_A5JM CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15118; probable Female 127227937 CVCL_A5JP ND15147 transformed cell line human CVCL_A5JP CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15147; probable Male 127227938 CVCL_A5JR ND15149 transformed cell line human CVCL_A5JR CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15149; probable Female 127227939 CVCL_A5JQ ND15148 transformed cell line human CVCL_A5JQ CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15148; probable Female 127227940 CVCL_A5JD ND14972 transformed cell line human CVCL_A5JD CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14972; probable Male 127227941 CVCL_A5JC ND14970 transformed cell line human CVCL_A5JC CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14970; probable Female 127227942 CVCL_A5JF ND14974 transformed cell line human CVCL_A5JF CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14974; probable Female 127227943 CVCL_A5JE ND14973 transformed cell line human CVCL_A5JE CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14973; probable Male 127227944 CVCL_A5JH ND15056 transformed cell line human CVCL_A5JH CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15056; probable Male 127227945 CVCL_A5JG ND15001 transformed cell line human CVCL_A5JG CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15001; probable Male 127227946 CVCL_A5JJ ND15096 transformed cell line human CVCL_A5JJ CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15096; probable Male 127227947 CVCL_A5JI ND15058 transformed cell line human CVCL_A5JI CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15058; probable Male 127227948 CVCL_A5IZ ND14720 transformed cell line human CVCL_A5IZ CL:0000010 Population: Jewish; Ashkenazi; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14720; probable Male 127227949 CVCL_A5JB ND14883 transformed cell line human CVCL_A5JB CL:0000010 Population: Jewish; Ashkenazi; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14883; probable Female 127227950 CVCL_A5JA ND14761 transformed cell line human CVCL_A5JA CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14761; probable Female 127227951 CVCL_A5IS MP 4112 hybrid cell line human CVCL_A5IS CL:0000010 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine. Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2128 127227952 CVCL_A5IR MP 4109 hybrid cell line human CVCL_A5IR CL:0000010 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine. Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2129 127227953 CVCL_A5IU UKAi004-A induced pluripotent stem cell human CVCL_A5IU From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Cys973Alafs*34 (c.2917delT); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127227954 CVCL_A5IT MP 4126 hybrid cell line human CVCL_A5IT CL:0000010 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine. Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2615 127227955 CVCL_A5IW UKAi004-C induced pluripotent stem cell human CVCL_A5IW From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227956 CVCL_A5IV UKAi004-B induced pluripotent stem cell human CVCL_A5IV From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Cys973Alafs*34 (c.2917delT); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127227957 CVCL_A5IY UKAi004-E induced pluripotent stem cell human CVCL_A5IY From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227958 CVCL_A5IX UKAi004-D induced pluripotent stem cell human CVCL_A5IX From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227959 CVCL_A5KM CHO-K1 mutant 29 transformed cell line CVCL_A5KM CL:0000010 Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Defective in the incorporation of ethanolamine into phosphatidylethanolamine (PubMed=2684962) 127227960 CVCL_A5KL CHO-tsH1-C9D9 spontaneously immortalized cell line CVCL_A5KL CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Compared to the parent cell line, it has reduced system L transport activity Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage. 127227961 CVCL_A5KN CHO-K1 PSA-1 transformed cell line CVCL_A5KN CL:0000010 Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470) 127227962 CVCL_A5KQ CHO-K1 PSA-3 transformed cell line CVCL_A5KQ CL:0000010 Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470) Defective for phosphatidylserine synthase 1 (Ptdss1) (PubMed=1748687). 127227963 CVCL_A5KP CHO-K1 PSA-2 transformed cell line CVCL_A5KP CL:0000010 Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470) 127227964 CVCL_A5KS H7v17q embryonic stem cell human CVCL_A5KS CL:0000010 Miscellaneous: Cell line information from personal communication of Price C.J Karyotypic information: 46,XX,der(6)t(6;17)(q27;q1) (Direct_author_submission); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 17q 127227965 CVCL_A5KR H7v1q embryonic stem cell human CVCL_A5KR CL:0000010 Karyotypic information: 46,XX,dup(1)(q21;q42) (PubMed=34407428); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 1q (PubMed=34407428) 127227966 CVCL_A5KE CHO-K1 Mev-SM transformed cell line CVCL_A5KE CL:0000010 Transfected with: RGD; 2804; Hmgcs2 Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Repairs the deficiency in mevalonate biosynthesis of the parent cell line (PubMed=7961793) 127227967 CVCL_A5KD CHO-K1 Mev-1 transformed cell line CVCL_A5KD CL:0000010 Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Deficient for mevalonate biosynthesis Lacks hydroxymethylglutaryl-CoA synthase activity (PubMed=4019518). 127227968 CVCL_A5KG CHO-tsH1-D10 spontaneously immortalized cell line CVCL_A5KG CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284) 127227969 CVCL_A5KF CHO-tsH1-C11 spontaneously immortalized cell line CVCL_A5KF CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284) 127227970 CVCL_A5KI CHO-tsH1-C11B6 spontaneously immortalized cell line CVCL_A5KI CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=2777768) 127227971 CVCL_A5KH CHO-tsH1-F10 spontaneously immortalized cell line CVCL_A5KH CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284) 127227972 CVCL_A5KK CHO-tsH1-C5D9 spontaneously immortalized cell line CVCL_A5KK CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Compared to the parent cell line, it has reduced system L transport activity Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage. 127227973 CVCL_A5KJ CHO-tsH1-C4B4 spontaneously immortalized cell line CVCL_A5KJ CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Compared to the parent cell line, it has reduced system L transport activity Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage. 127227974 CVCL_A5KA A549-hACE2 [Invivogen] cancer cell line human CVCL_A5KA CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 13557; ACE2; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Permissive to infection by SARS-CoV-2 and/or spike-pseudotyped lentiviral particles (InvivoGen) Group: SARS-CoV-2 research cell line 127227975 CVCL_A5KC HUES 17v12,17 embryonic stem cell human CVCL_A5KC CL:0000010 Miscellaneous: Cell line information from personal communication of Price C.J Karyotypic information: 48,XY,+12,+17 (Direct_author_submission); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Aneuploid HUES 17 subline with gain of chromosomes 12 and 17 127227976 CVCL_A5KB A549-hACE2-TMPRSS2 cancer cell line human CVCL_A5KB CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 13557; ACE2; Transfected with: HGNC; 11876; TMPRSS2; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) and/or spike-pseudotyped lentiviral particles (InvivoGen) Group: SARS-CoV-2 research cell line 127227977 CVCL_A5JT ND15167 transformed cell line human CVCL_A5JT CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15167; probable Male 127227978 CVCL_A5JS ND15150 transformed cell line human CVCL_A5JS CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15150; probable Male 127227979 CVCL_A5JV K9STS cancer cell line dog CVCL_A5JV CL:0000010 Unspecified Doubling time: 35.04 +- 8.1 hours (PubMed=18562222). 127227980 CVCL_A5JU ND15171 transformed cell line human CVCL_A5JU CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15171; probable Male 127227981 CVCL_A5JX FM3A tsFT5 cancer cell line house mouse CVCL_A5JX CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Temperature sensitive phenotype Stop growing at 39 Celsius. Defective in DNA replication. Contains a thermolabile Uba1 (PubMed=8344958). Doubling time: ~18 hours (PubMed=8344958) 127227982 CVCL_A5JW FM3A ts85R-MN3 cancer cell line house mouse CVCL_A5JW CL:0000010 Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line (ts85) 127227983 CVCL_A5JZ BW5147.PHAR2.1 cancer cell line house mouse CVCL_A5JZ CL:0000010 Selected for resistance to: UniProtKB; P05087; Phaseolus vulgaris leucoagglutinating phytohemagglutinin (PHA-L); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Breed/subspecies: AKR/J. Characteristics: Deficient in alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase (Mgat5) (PubMed=6216250) 127227984 CVCL_A5JY FM3A tsFT50 cancer cell line house mouse CVCL_A5JY CL:0000010 Sequence variation: Mutation; MGI; MGI:1927222; Diaph3; Simple; p.Gln668Ter (c.2002C>T); Zygosity=Homozygous (PubMed=33187357) Transformant: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)(ChEBI; CHEBI:21759); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Temperature sensitive phenotype Cytokinesis is blocked at 39 Celsius. 127227985 CVCL_A5HJ UCLAi004-A induced pluripotent stem cell human CVCL_A5HJ From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Caucasian; Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227986 CVCL_A5HI UCLAi003-C induced pluripotent stem cell human CVCL_A5HI From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227987 CVCL_A5HL UCLAi004-C induced pluripotent stem cell human CVCL_A5HL From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Caucasian; Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227988 CVCL_A5HK UCLAi004-B induced pluripotent stem cell human CVCL_A5HK From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Caucasian; Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227989 CVCL_A5HN aMoS7 transformed cell line house mouse CVCL_A5HN CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Small intestine, ileum, intestinal crypt; UBERON=UBERON_0013481; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: BALB/c. Female 127227990 CVCL_A5HM aMoC1 transformed cell line house mouse CVCL_A5HM CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Colon, intestinal crypt; UBERON=UBERON_0013485; Cell type: Epithelial cell of colon; CL=CL_0011108; Breed/subspecies: BALB/c. Female 127227991 CVCL_A5HP U-251MG IDH1 R132C cancer cell line human CVCL_A5HP CL:0000010 Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 5382; IDH1 (with p.Arg132Cys); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127227992 CVCL_A5HB HES-3 NKX2.1GFP/w embryonic stem cell human CVCL_A5HB CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the NKX2.1 locus 127227993 CVCL_A5HA ESIBIe003-A-6 embryonic stem cell human CVCL_A5HA From: Universite Libre de Bruxelles; Brussels; Belgium CL:0000010 Transfected with: HGNC; 11825; NKX2-1; Transfected with: HGNC; 8622; PAX8; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Transduced with a lentiviral cassette containing an NKX2.1-IRES-PAX8 construct under the control of a promoter inducible by doxycycline via a tetracycline response element; Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the INS locus 127227994 CVCL_A5HD UCLAi002-A induced pluripotent stem cell human CVCL_A5HD From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227995 CVCL_A5HC HOC-I cancer cell line human CVCL_A5HC CL:0000010 Population: Japanese; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: ~75 hours (PubMed=2723484) 127227996 CVCL_A5HF UCLAi002-C induced pluripotent stem cell human CVCL_A5HF From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227997 CVCL_A5HE UCLAi002-B induced pluripotent stem cell human CVCL_A5HE From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227998 CVCL_A5HH UCLAi003-B induced pluripotent stem cell human CVCL_A5HH From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227999 CVCL_A5HG UCLAi003-A induced pluripotent stem cell human CVCL_A5HG From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228000 CVCL_A5GY IBMS-iPSC-068-02 induced pluripotent stem cell human CVCL_A5GY From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan CL:0000010 Population: Asian. Male 127228001 CVCL_A5GX TBN spontaneously immortalized cell line CVCL_A5GX CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Neural cell; CL=CL_0002319. Omics: Transcriptome analysis by RNAseq Unspecified Characteristics: Optimal growth temperature is 32 Celsius Does not grow at 16 Celsius. Doubling time: 4.84 days (Note=In 2.5% FBS), 2.66 days (Note=In 7.5% FBS), 2.44 days (Note=In 10% FBS), 2.59 days (Note=In 15% FBS), 4.84 days (Note=In 20% FBS) (PubMed=33258111) Group: Fish cell line 127228002 CVCL_A5GZ UNIBSi014-A induced pluripotent stem cell human CVCL_A5GZ From: University of Brescia; Brescia; Italy CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228003 CVCL_A5GQ UKAi001-A-1 induced pluripotent stem cell human CVCL_A5GQ From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 5358; IRF8; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-A-1) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228004 CVCL_A5GP UKAi001-C induced pluripotent stem cell human CVCL_A5GP From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-C) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228005 CVCL_A5GS UKAi001-C-1 induced pluripotent stem cell human CVCL_A5GS From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 5358; IRF8; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-C-1) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228006 CVCL_A5GR UKAi001-B-1 induced pluripotent stem cell human CVCL_A5GR From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 5358; IRF8; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-B-1) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228007 CVCL_A5GU ZZUi029-A induced pluripotent stem cell human CVCL_A5GU From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China. CL:0000010 127228008 CVCL_A5GT ZZUi027-A induced pluripotent stem cell human CVCL_A5GT From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 16499; RAB39B; Simple; p.Glu179fs*48 (c.536dupA); Zygosity=Hemizygous (PubMed=34247111) Population: Chinese; Han; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228009 CVCL_A5GW NOSCC1 cancer cell line human CVCL_A5GW CL:0000010 Population: Japanese; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Characteristics: Established from tumors in super-immunodeficient NSG (NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ) mice subcutanously injected with the patient tumor pieces (PubMed=33300248) 127228010 CVCL_A5GV EZB-ICR cancer cell line human CVCL_A5GV CL:0000010 Population: Iranian; Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Female Doubling time: ~31 hours (Note=At 25th passage) (PubMed=33507685) 127228011 CVCL_A5IK ips#202 induced pluripotent stem cell house mouse CVCL_A5IK CL:0000010 Transfected with: UniProtKB; P42212; YFP (modified GFP at G-65, L-68, A-72, Y-203 and L-231) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic. Unspecified 127228012 CVCL_A5IJ NCC-DDLPS2-C1 cancer cell line human CVCL_A5IJ CL:0000010 Population: Japanese; Derived from site: In situ; Right thigh; UBERON=UBERON_0000376. Omics: SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.); Doubling time: ~54 hours (PubMed=33555519) Part of: NCC sarcoma cell line panel 127228013 CVCL_A5IM ips#137 induced pluripotent stem cell house mouse CVCL_A5IM CL:0000010 Transfected with: UniProtKB; P00722; Escherichia coli lacZ Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-LacZ transgenic. Unspecified 127228014 CVCL_A5IL ips#231 induced pluripotent stem cell house mouse CVCL_A5IL CL:0000010 Transfected with: UniProtKB; P42212; YFP (modified GFP at G-65, L-68, A-72, Y-203 and L-231) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic. Unspecified 127228015 CVCL_A5IN NS-(f)iPS Isl1C somatic stem cell house mouse CVCL_A5IN CL:0000010 Transfected with: UniProtKB; P42212; YFP (modified GFP at G-65, L-68, A-72, Y-203 and L-231) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic. Unspecified Characteristics: Neural stem cell 127228016 CVCL_A5IQ hTERT-1604-PMS134 telomerase immortalized cell line human CVCL_A5IQ CL:0000010 Transfected with: HGNC; 9122; PMS2 (with p.Arg134Ter = PMS134); Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: African American; Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Male 127228017 CVCL_A5IP HEK293 HADH-/- transformed cell line human CVCL_A5IP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 4799; HADH Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127228018 CVCL_A5IC UM-Chor5C cancer cell line human CVCL_A5IC CL:0000010 Population: Caucasian; Derived from site: Metastatic; Salivary gland, parotid gland; UBERON=UBERON_0001831. Male 127228019 CVCL_A5IB Vero-SCARB2 spontaneously immortalized cell line green monkey CVCL_A5IB CL:0000010 Transfected with: HGNC; 1665; SCARB2; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614) Group: Non-human primate cell line 127228020 CVCL_A5IE U-CH18 cancer cell line human CVCL_A5IE CL:0000010 Derived from site: In situ; Bone, chest; UBERON=UBERON_0003459. Male Doubling time: ~7-8 days (Chordoma_Foundation) 127228021 CVCL_A5ID UM-Chor5D cancer cell line human CVCL_A5ID CL:0000010 Population: Caucasian; Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108. Male Doubling time: 4.632 days (Chordoma_Foundation) 127228022 CVCL_A5IG UM-Chor6 cancer cell line human CVCL_A5IG CL:0000010 Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108. Male Doubling time: ~21 days (Chordoma_Foundation) 127228023 CVCL_A5IF U-CH19 cancer cell line human CVCL_A5IF CL:0000010 Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690. Male Doubling time: ~7 days (Chordoma_Foundation) 127228024 CVCL_A5II U-CHCF365 cancer cell line human CVCL_A5II CL:0000010 Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108. Male Characteristics: Established from the CF365 patient-derived xenograft Doubling time: ~4 days (Chordoma_Foundation) 127228025 CVCL_A5IH U-CHCF359B cancer cell line human CVCL_A5IH CL:0000010 Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108. Female Characteristics: Established from the CF359B patient-derived xenograft Doubling time: 5-6 days (Chordoma_Foundation) 127228026 CVCL_A5HZ 293-SCARB2 transformed cell line human CVCL_A5HZ CL:0000010 Transfected with: HGNC; 1665; SCARB2; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614) 127228027 CVCL_A5HY TS516 cancer cell line human CVCL_A5HY CL:0000010 Miscellaneous: Cell line has been lost (personal communication of Weis-Garcia F.M.B.); Miscellaneous: Doubling time from MSKCC antibody and bioresource core facility Derived from site: In situ; Brain; UBERON=UBERON_0000955. Doubling time: ~2 days (Direct_author_submission) 127228028 CVCL_A5IA RD-SCARB2 cancer cell line human CVCL_A5IA CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 1665; SCARB2; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325. Female Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614) 127228029 CVCL_A5HR U-251MG IDH1 WT cancer cell line human CVCL_A5HR CL:0000010 Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 5382; IDH1; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228030 CVCL_A5HQ U-251MG IDH1 R132H cancer cell line human CVCL_A5HQ CL:0000010 Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 5382; IDH1 (with p.Arg132His); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228031 CVCL_A5HT NCH645 cancer cell line human CVCL_A5HT CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228032 CVCL_A5HS NCH620 cancer cell line human CVCL_A5HS CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228033 CVCL_A5HV NCH1681 cancer cell line human CVCL_A5HV CL:0000010 Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33504762) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228034 CVCL_A5HU NCH551b cancer cell line human CVCL_A5HU CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228035 CVCL_A5HX TS676 cancer cell line human CVCL_A5HX CL:0000010 Miscellaneous: STR profile and doubling time from MSKCC antibody and bioresource core facility Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male Doubling time: ~7 days (Direct_author_submission) 127228036 CVCL_A5HW TS603 cancer cell line human CVCL_A5HW CL:0000010 Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=23558169; PubMed=33504762) Miscellaneous: STR profile and doubling time from MSKCC antibody and bioresource core facility Derived from site: In situ; Brain; UBERON=UBERON_0000955. Doubling time: ~7 days (Direct_author_submission) 127228037 CVCL_A5FH IBBISTi001-D induced pluripotent stem cell human CVCL_A5FH From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228038 CVCL_A5FG IBBISTi001-C induced pluripotent stem cell human CVCL_A5FG From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228039 CVCL_A5FJ IBBISTi002-B induced pluripotent stem cell human CVCL_A5FJ From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228040 CVCL_A5FI IBBISTi002-A induced pluripotent stem cell human CVCL_A5FI From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228041 CVCL_A5FL IBBISTi003-B induced pluripotent stem cell human CVCL_A5FL From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228042 CVCL_A5FK IBBISTi003-A induced pluripotent stem cell human CVCL_A5FK From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228043 CVCL_A5FN IBBISTi003-D induced pluripotent stem cell human CVCL_A5FN From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (from autologous cell lines IBBISTi003-A, IBBISTi003-B and IBBISTi003-C) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228044 CVCL_A5FM IBBISTi003-C induced pluripotent stem cell human CVCL_A5FM From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228045 CVCL_A5FB HPIi001-B induced pluripotent stem cell human CVCL_A5FB From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; 129; ACTA1; Simple; p.Arg185Ser (c.553C>A); ClinVar=VCV000420099; Zygosity=Heterozygous (PubMed=33740643) Population: Turkish; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228046 CVCL_A5FA HPIi001-A induced pluripotent stem cell human CVCL_A5FA From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; 129; ACTA1; Simple; p.Arg185Ser (c.553C>A); ClinVar=VCV000420099; Zygosity=Heterozygous (PubMed=33740643) Population: Turkish; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228047 CVCL_A5FD HPIi002-B induced pluripotent stem cell human CVCL_A5FD From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; 129; ACTA1; Simple; p.Asp179Asn (c.541G>A); Zygosity=Heterozygous (PubMed=34388489) Population: Caucasian; French; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228048 CVCL_A5FC HPIi002-A induced pluripotent stem cell human CVCL_A5FC From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; 129; ACTA1; Simple; p.Asp179Asn (c.541G>A); Zygosity=Heterozygous (PubMed=34388489) Population: Caucasian; French; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228049 CVCL_A5FF IBBISTi001-B induced pluripotent stem cell human CVCL_A5FF From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228050 CVCL_A5FE IBBISTi001-A induced pluripotent stem cell human CVCL_A5FE From: Simao Jose Teixeira da Rocha; Porto Salvo; Portugal CL:0000010 Sequence variation: Mutation; HGNC; 1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228051 CVCL_A5EW EHTJUi003-A induced pluripotent stem cell human CVCL_A5EW From: East Hospital Affiliated to Tongji University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple; p.Leu460Trpfs*6 (c.1377delC); ClinVar=VCV000188548; Zygosity=Heterozygous (PubMed=34087980) Population: Chinese; Han; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Deep exome analysis Female 127228052 CVCL_A5EV CRICKi002-A induced pluripotent stem cell human CVCL_A5EV From: The Francis Crick Institute Limited; London; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Unspecified 127228053 CVCL_A5EY FDCHi005-B induced pluripotent stem cell human CVCL_A5EY From: Children's Hospital of Fudan University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; 3091; DYRK1A; Simple_corrected; p.Val577Asp (c.1730T>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33813175) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228054 CVCL_A5EX FDCHi005-A induced pluripotent stem cell human CVCL_A5EX From: Children's Hospital of Fudan University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; 3091; DYRK1A; Simple; p.Val577Asp (c.1730T>A); Zygosity=Heterozygous (PubMed=33813175) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228055 CVCL_A5EZ GZHMCi005-A induced pluripotent stem cell human CVCL_A5EZ From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China CL:0000010 Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Male 127228056 CVCL_A5EN 2T9 transformed cell line house mouse CVCL_A5EN CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: Bmp2 promoter T-Ag-3 transgenic. Unspecified 127228057 CVCL_A5EQ WAe009-A-56 embryonic stem cell human CVCL_A5EQ From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 6694; LRP2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228058 CVCL_A5EP WAe009-A-50 embryonic stem cell human CVCL_A5EP From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 11167; SNTA1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Caution: There seems to be two H9SNTA1KO cell line established in China, this one and CVCL_C5TU 127228059 CVCL_A5ES WTC-DMD-mEGFP-cl96 induced pluripotent stem cell human CVCL_A5ES CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 DMD has been endogenously tagged in one allele at the C-terminus with mEGFP (Coriell=AICS-0063-096) Part of: Allen Cell Collection 127228060 CVCL_A5ER MDA-MB-231 met2 cancer cell line human CVCL_A5ER CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Metastatic to lung Established from a lung tumor after injection of the parent cell line into the tail vein of athymic nude mice (PubMed=30337562). Group: Triple negative breast cancer (TNBC) cell line 127228061 CVCL_A5EU CRICKi001-A induced pluripotent stem cell human CVCL_A5EU From: The Francis Crick Institute Limited; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 11100; SMARCA4; Simple; p.Arg1203Cys (c.3607C>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33799280) Population: Caucasian; Derived from site: In situ; Hair root; UBERON=UBERON_0000329; Cell type: Keratinocyte; CL=CL_0000312. Male 127228062 CVCL_A5ET WTC-CLYBL-dCas9-TagBFP-KRAB-cl391 induced pluripotent stem cell human CVCL_A5ET CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Tyr66His and p.Tyr145Phe = BFP); Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (with p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 a dCas9-TagBFP-KRAB construct is expressed from a CAGGS promoter edited into the 2nd intron of the CLYBL safe harbor Part of: Allen Cell Collection 127228063 CVCL_A5GI UNCi002-A induced pluripotent stem cell human CVCL_A5GI From: University of North Carolina at Chapel Hill; Chapel Hill; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228064 CVCL_A5GK UMi030-A induced pluripotent stem cell human CVCL_A5GK From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; 4284; GJB2; Simple; p.Val37Ile (c.109G>A); ClinVar=VCV000017023; Zygosity=Homozygous (PubMed=34883447) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228065 CVCL_A5GJ UMGi156-A induced pluripotent stem cell human CVCL_A5GJ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228066 CVCL_A5GM UKAi001-A induced pluripotent stem cell human CVCL_A5GM From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-A) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228067 CVCL_A5GL WMUi021-A induced pluripotent stem cell human CVCL_A5GL From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 10912; SLC12A3; Simple; p.Thr60Met (c.179C>T); ClinVar=VCV000101514; Zygosity=Homozygous (PubMed=33735743) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228068 CVCL_A5GN UKAi001-B induced pluripotent stem cell human CVCL_A5GN From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-B) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228069 CVCL_A5GA SCVI-19 induced pluripotent stem cell human CVCL_A5GA From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 127228070 CVCL_A5GC SCVI-273 induced pluripotent stem cell human CVCL_A5GC From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228071 CVCL_A5GB SCVI-15 induced pluripotent stem cell human CVCL_A5GB From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 127228072 CVCL_A5GE TIGETi003-A induced pluripotent stem cell human CVCL_A5GE From: San Raffaele Telethon Institute for Gene Therapy, Ospedale San Raffaele; Milan; Italy CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228073 CVCL_A5GD TIGETi001-A induced pluripotent stem cell human CVCL_A5GD From: San Raffaele Telethon Institute for Gene Therapy, Ospedale San Raffaele; Milan; Italy CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228074 CVCL_A5FX SCVIi004-A induced pluripotent stem cell human CVCL_A5FX From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple; p.Arg79Ter (c.235C>T); ClinVar=VCV000006754; Zygosity=Heterozygous (PubMed=33743362) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228075 CVCL_A5FW SCVIi003-A induced pluripotent stem cell human CVCL_A5FW From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple; p.His733Alafs*8 (c.2197_2202delinsG) (p.His689fs, c.2065_2070delinsG); ClinVar=VCV000045063; Zygosity=Heterozygous (PubMed=33743362) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228076 CVCL_A5FZ SCVI-114 induced pluripotent stem cell human CVCL_A5FZ From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 127228077 CVCL_A5FY SCVIi005-A induced pluripotent stem cell human CVCL_A5FY From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple; p.Arg577Aspfs*5 (c.1725_1728dupGATG); ClinVar=VCV000406551; Zygosity=Heterozygous (PubMed=33743362) Population: East Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228078 CVCL_A5FP MRIi025-A induced pluripotent stem cell human CVCL_A5FP From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228079 CVCL_A5FR MUNIe009-A embryonic stem cell human CVCL_A5FR From: Masaryk University; Brno; Czech Republic CL:0000010 Donor information: Embryo is sibling to that giving rise to MUNIe008-A (Cellosaurus=CVCL_A5FQ); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228080 CVCL_A5FQ MUNIe008-A embryonic stem cell human CVCL_A5FQ From: Masaryk University; Brno; Czech Republic CL:0000010 Donor information: Embryo is sibling to that giving rise to MUNIe009-A (Cellosaurus=CVCL_A5FR); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228081 CVCL_A5FT RCMGi005-A induced pluripotent stem cell human CVCL_A5FT From: Research Centre for Medical Genetics; Moscow; Russia CL:0000010 Sequence variation: Mutation; HGNC; 1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=36067639) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228082 CVCL_A5FS NCKDi002-A induced pluripotent stem cell human CVCL_A5FS From: National Center of Kidney Diseases; Nanjing; China CL:0000010 Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg363Gly (c.1087A>G) (p.Arg219Gly, c.655A>G); Zygosity=Heterozygous (PubMed=33780729) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228083 CVCL_A5FV SCVIi002-A induced pluripotent stem cell human CVCL_A5FV From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple; c.3330+2T>G; ClinVar=VCV000008621; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33743363) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228084 CVCL_A5FU SCVIi001-A induced pluripotent stem cell human CVCL_A5FU From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple; c.3330+2T>G; ClinVar=VCV000008621; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33743363) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228085 CVCL_A5TV U-251MG PAX6-/- 2A.28 cancer cell line human CVCL_A5TV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 8620; PAX6; Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228086 CVCL_A5TU U-251MG PAX6-/- 2.10 cancer cell line human CVCL_A5TU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 8620; PAX6; Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228087 CVCL_A5TX CEM/ara-G cancer cell line human CVCL_A5TX CL:0000010 Sequence variation: Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:73141; 9-beta-D-arabinofuranosylguanine (ara-G); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Doubling time: 21.4 hours (PubMed=25070259) 127228088 CVCL_A5TW U-251MG PAX6-/- 2A.3 cancer cell line human CVCL_A5TW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 8620; PAX6; Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228089 CVCL_A5TZ CCRF/CEM/ara-C/D cancer cell line human CVCL_A5TZ CL:0000010 Sequence variation: Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228090 CVCL_A5TY CCRF/CEM/ara-C/B cancer cell line human CVCL_A5TY CL:0000010 Sequence variation: Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228091 CVCL_A5TN UM-SCC-5PT cancer cell line human CVCL_A5TN CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=16020667) Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Male 127228092 CVCL_A5TM irPSCc3 transformed cell line Norway rat CVCL_A5TM CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: Sprague Dawley. Unspecified 127228093 CVCL_A5TP UM-SCC-10BPT cancer cell line human CVCL_A5TP CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; None_reported; -; Zygosity=- (PubMed=16020667) Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: Metastatic; Submental lymph node; UBERON=UBERON_0016397. Male 127228094 CVCL_A5TR CalH2 cancer cell line human CVCL_A5TR CL:0000010 127228095 CVCL_A5TQ Ca1 cancer cell line human CVCL_A5TQ CL:0000010 127228096 CVCL_A5TT UK1 cancer cell line human CVCL_A5TT CL:0000010 127228097 CVCL_A5TS CalH3 cancer cell line human CVCL_A5TS CL:0000010 127228098 CVCL_A5TF sciCHO:hACE2:hTMPRSS2 spontaneously immortalized cell line CVCL_A5TF CL:0000010 Transfected with: HGNC; 13557; ACE2; Transfected with: HGNC; 11876; TMPRSS2; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Adapted to growth in suspension (CLS=603483) Doubling time: 18-22 hours (CLS=603483) Group: SARS-CoV-2 research cell line; Group: Serum/protein free medium cell line 127228099 CVCL_A5TE sciCHO:hACE2 spontaneously immortalized cell line CVCL_A5TE CL:0000010 Transfected with: HGNC; 13557; ACE2; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Can be used for ACE2 binding assays, flow cytometry, screening of ACE2 antibodies (CLS=603482); Characteristics: Adapted to growth in suspension (CLS=603482) Doubling time: 18-22 hours (CLS=603482) Group: SARS-CoV-2 research cell line; Group: Serum/protein free medium cell line 127228100 CVCL_A5TH imPSCc1 transformed cell line house mouse CVCL_A5TH CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: C57BL/6. Unspecified Doubling time: 45 hours (PubMed=20847583) 127228101 CVCL_A5TG RLT-PSC transformed cell line human CVCL_A5TG CL:0000010 Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410. Unspecified Doubling time: 28.6 +- 2.5 hours (PubMed=30621293) 127228102 CVCL_A5TJ imPSCc3 transformed cell line house mouse CVCL_A5TJ CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: C57BL/6. Unspecified Doubling time: 51 hours (PubMed=20847583) 127228103 CVCL_A5TI imPSCc2 transformed cell line house mouse CVCL_A5TI CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: C57BL/6. Unspecified Doubling time: 45 hours (PubMed=20847583) 127228104 CVCL_A5TL irPSCc2 transformed cell line Norway rat CVCL_A5TL CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: Sprague Dawley. Unspecified 127228105 CVCL_A5TK irPSCc1 transformed cell line Norway rat CVCL_A5TK CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: Sprague Dawley. Unspecified 127228106 CVCL_A5TB HSC-Li transformed cell line human CVCL_A5TB CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Chinese; Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632. Unspecified Characteristics: Produces both HGF and TGFB1 in a time-dependent manner (PubMed=25678842) Doubling time: 8 hours (PubMed=25678842) 127228107 CVCL_A5TA ASHe spontaneously immortalized cell line CVCL_A5TA CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Cardiac endothelial cell; CL=CL_0010008. Unspecified Group: Fish cell line 127228108 CVCL_A5TD sciCHO spontaneously immortalized cell line CVCL_A5TD CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Adapted to growth in suspension Optimized for the generation of stable populations and clones for high-yield recombinant protein production (CLS=603481). Doubling time: 18-22 hours (CLS=603481) Group: Serum/protein free medium cell line 127228109 CVCL_A5TC CAISMOV24 cancer cell line human CVCL_A5TC CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=29132324) Population: Brazilian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Omics: Array-based CGH Female Doubling time: 71.2 hours (PubMed=29132324) 127228110 CVCL_A5UW JW18 spontaneously immortalized cell line fruit fly CVCL_A5UW CL:0000010 Transfected with: UniProtKB; P42212; GFP Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Omics: Transcriptome analysis by RNAseq Unspecified Characteristics: Expresses a Jupiter-GFP fusion protein; Characteristics: Constitutively infected with Wolbachia Group: Insect cell line 127228111 CVCL_A5UV S2-DGRC-attP-25C6 spontaneously immortalized cell line fruit fly CVCL_A5UV CL:0000010 Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853) Group: Insect cell line 127228112 CVCL_A5UY CCRF/CEM/ara-C/C cancer cell line human CVCL_A5UY CL:0000010 Sequence variation: Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228113 CVCL_A5UX JW18DOX spontaneously immortalized cell line fruit fly CVCL_A5UX CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Expresses a Jupiter-GFP fusion protein; Characteristics: Cured of Wolbachia infection through doxycycline treatment Group: Insect cell line 127228114 CVCL_A5UZ S2:DER2f spontaneously immortalized cell line fruit fly CVCL_A5UZ CL:0000010 Transfected with: FlyBase_Gene; FBgn0000434; Der; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228115 CVCL_A5UN S2R+-(FEx-10%) spontaneously immortalized cell line fruit fly CVCL_A5UN CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Characteristics: Adapted to growth in M3 + 10% Fly Extract (FEx) medium Group: Insect cell line; Group: Serum/protein free medium cell line 127228116 CVCL_A5UQ Kc167-(M3-FEx-2.5%) spontaneously immortalized cell line fruit fly CVCL_A5UQ CL:0000010 Female Characteristics: Adapted to growth in M3 + 2.5% Fly Extract (FEx) medium. Group: Insect cell line; Group: Serum/protein free medium cell line 127228117 CVCL_A5UP Kc167-(M3) spontaneously immortalized cell line fruit fly CVCL_A5UP CL:0000010 Female Characteristics: Adapted to growth in M3 medium. Group: Insect cell line; Group: Serum/protein free medium cell line 127228118 CVCL_A5US Kc167-attP-25C6 spontaneously immortalized cell line fruit fly CVCL_A5US CL:0000010 Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed). Female Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853) Group: Insect cell line 127228119 CVCL_A5UR Kc167-(M3BPYE-FEx2.5%) spontaneously immortalized cell line fruit fly CVCL_A5UR CL:0000010 Female Characteristics: Adapted to growth in M3 + BPYE + 2.5% Fly Extract (FEx) medium. Group: Insect cell line; Group: Serum/protein free medium cell line 127228120 CVCL_A5UU S2R+-attP-99F8 spontaneously immortalized cell line fruit fly CVCL_A5UU CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228121 CVCL_A5UT Kc167-attP-99F8 spontaneously immortalized cell line fruit fly CVCL_A5UT CL:0000010 Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed). Female Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 99F8 locus (PubMed=33963853) Group: Insect cell line 127228122 CVCL_A5UG S2R+-Apc-KO-E5 spontaneously immortalized cell line fruit fly CVCL_A5UG CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0015589; Apc; Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228123 CVCL_A5UF S2R+-Moe-KO-21B4 spontaneously immortalized cell line fruit fly CVCL_A5UF CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0011661; Moe; Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228124 CVCL_A5UI S2R+-Pex19-KO-A1 spontaneously immortalized cell line fruit fly CVCL_A5UI CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0032407; Pex19; Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228125 CVCL_A5UH S2R+-TSC1-KO-C5 spontaneously immortalized cell line fruit fly CVCL_A5UH CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0026317; Tsc1; Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228126 CVCL_A5UK S2R+-Slik-KO-22C2 spontaneously immortalized cell line fruit fly CVCL_A5UK CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0035001; Slik; Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228127 CVCL_A5UJ S2R+-Pten-KO-1A4 spontaneously immortalized cell line fruit fly CVCL_A5UJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0026379; Pten; Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228128 CVCL_A5UM S2R+-(FEx-2.5%) spontaneously immortalized cell line fruit fly CVCL_A5UM CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Characteristics: Adapted to growth in M3 + 2.5% Fly Extract (FEx) medium Group: Insect cell line; Group: Serum/protein free medium cell line 127228129 CVCL_A5UL S2R+-Yki-KO-G7 spontaneously immortalized cell line fruit fly CVCL_A5UL CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0034970; yki; Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127228130 CVCL_A5UA CCRF/CEM/ara-C/G cancer cell line human CVCL_A5UA CL:0000010 Sequence variation: Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228131 CVCL_A5UC CCRF/CEM/ara-C/J cancer cell line human CVCL_A5UC CL:0000010 Sequence variation: Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228132 CVCL_A5UB CCRF/CEM/ara-C/I cancer cell line human CVCL_A5UB CL:0000010 Sequence variation: Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228133 CVCL_A5UE HFF-2 IRR finite cell line human CVCL_A5UE CL:0000010 Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Discontinued: ATCC; SCRC-1042.1; true Male Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state; Characteristics: Growth-arrested by irradiation with 6000 rads 127228134 CVCL_A5UD SACC-LM-KRT19-KD cancer cell line human CVCL_A5UD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 6436; KRT19 Miscellaneous: Cell line information from personal communication of Kong L Population: Chinese; Derived from site: In situ; Salivary gland, sublingual gland; UBERON=UBERON_0001832. Female 127228135 CVCL_A5RT CD#01 iPSC induced pluripotent stem cell human CVCL_A5RT CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Glu129Argfs*8 (c.382delC); ClinVar=VCV000551932; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Arg168Cys (c.502C>T); ClinVar=VCV000813438; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228136 CVCL_A5RS FFF0082001 induced pluripotent stem cell human CVCL_A5RS CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Glu129Argfs*8 (c.382delC); ClinVar=VCV000551932; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Arg168Cys (c.502C>T); ClinVar=VCV000813438; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228137 CVCL_A5RV HBLT-11 transformed cell line human CVCL_A5RV CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767). Male Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847) Problematic cell line: Misidentified Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin. 127228138 CVCL_A5RU CD#68T-13 iPSC induced pluripotent stem cell human CVCL_A5RU CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Homozygous (PubMed=33304759); Transfected with: HGNC; 756; ASPA; Transfected with: HGNC; 1633; CD19 (with p.Lys324_Arg556del = CD19t) Population: Jewish; Cell type: Fibroblast; CL=CL_0000057. Male Characteristics: Using TALEN a EF1a promoter-ASPA-T2A-CD19t construct was introduced in the AAVS1 safe harbor locus (PubMed=33304759) 127228139 CVCL_A5RX HBLT-13 transformed cell line human CVCL_A5RX CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767). Male Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847) Problematic cell line: Misidentified Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin. 127228140 CVCL_A5RW HBLT-12 transformed cell line human CVCL_A5RW CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767). Male Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847) Problematic cell line: Misidentified Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin. 127228141 CVCL_A5RZ ARD-pUTX cancer cell line human CVCL_A5RZ CL:0000010 Sequence variation: Gene deletion; HGNC; 12637; KDM6A; Zygosity=Homozygous (PubMed=29045832); Sequence variation: Gene fusion; HGNC; 5722; IGKJ4 + HGNC; 5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; 5723; IGKJ5 + HGNC; 5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (from parent cell line); Transfected with: HGNC; 12637; KDM6A Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Omics: Transcriptome analysis by RNAseq Female Characteristics: KDM6A/UTX expression is inducible by doxycycline (PubMed=29045832) 127228142 CVCL_A5RY ARD-EZH2i-R cancer cell line human CVCL_A5RY CL:0000010 Sequence variation: Gene deletion; HGNC; 12637; KDM6A; Zygosity=Homozygous (PubMed=29045832); Sequence variation: Gene fusion; HGNC; 5722; IGKJ4 + HGNC; 5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; 5723; IGKJ5 + HGNC; 5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (from parent cell line) Selected for resistance to: ChEBI; CHEBI:167693; 1-isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide (GSK343); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Omics: Transcriptome analysis by RNAseq Female 127228143 CVCL_A5RL CD#60 ipsC induced pluripotent stem cell human CVCL_A5RL CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=33304759) Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Fibroblast; CL=CL_0000057. Male 127228144 CVCL_A5RK CD#59 ipsC induced pluripotent stem cell human CVCL_A5RK CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; 4878; HEXA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000126510; Zygosity=Homozygous (from parent cell line) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228145 CVCL_A5RN FF08711992 finite cell line human CVCL_A5RN CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Met82Asnfs*7 (c.244dupA); Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Female 127228146 CVCL_A5RM CD#68 iPSC induced pluripotent stem cell human CVCL_A5RM CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Homozygous (PubMed=33304759) Population: Jewish; Cell type: Fibroblast; CL=CL_0000057. Male 127228147 CVCL_A5RP CD#92 iPSC induced pluripotent stem cell human CVCL_A5RP CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.Met82Asnfs*7 (c.244dupA); Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Female 127228148 CVCL_A5RR CD#00 iPSC induced pluripotent stem cell human CVCL_A5RR CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.His244Arg (c.731A>G); ClinVar=VCV000371086; Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228149 CVCL_A5RQ FFF0282000 finite cell line human CVCL_A5RQ CL:0000010 Sequence variation: Mutation; HGNC; 756; ASPA; Simple; p.His244Arg (c.731A>G); ClinVar=VCV000371086; Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228150 CVCL_A5RD KCLi013-A induced pluripotent stem cell human CVCL_A5RD From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 535; ANXA11; Simple; p.Arg235Gln (c.704G>A); dbSNP=rs765489119; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228151 CVCL_A5RC KCLi012-A induced pluripotent stem cell human CVCL_A5RC From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 535; ANXA11; Simple; p.Asp40Gly (c.119A>G); ClinVar=VCV000488353; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228152 CVCL_A5RF ICANi001-A-1 induced pluripotent stem cell human CVCL_A5RF From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple_corrected; p.Arg403Leu (c.1208G>T); ClinVar=VCV000014101; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33610018) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228153 CVCL_A5RE ICANi001-A induced pluripotent stem cell human CVCL_A5RE From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple_edited; p.Arg403Leu (c.1208G>T); ClinVar=VCV000014101; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33610018) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228154 CVCL_A5RH IEC6-Cdx2L1 finite cell line Norway rat CVCL_A5RH CL:0000010 Transfected with: MGI; MGI:88361; Cdx2; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: Charles River Sprague Dawley (CD(SD)). Male Characteristics: Cdx2 can conditionally be expressed by addition of IPTG in the culture media This cell line was engineered with the LacSwitch system in this case composed of two plasmids, pOPRSVI-Cdx2 that contains a RSV LTR promoter, 2 lacO sites (lactose repressor), cdX2 and a neo gene and p3'SS that contains the LacI and hph genes. Thus when IPTG is added to the culture media, repression mediated by lacI is removed and Cdx2 is expressed (PubMed=8552090). 127228155 CVCL_A5RG THCE telomerase immortalized cell line human CVCL_A5RG CL:0000010 Transfected with: HGNC; 11730; TERT Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772; Cell type: Epithelial cell of cornea; CL=CL_0000575. 127228156 CVCL_A5RJ IEC6-Cdx2MT15 finite cell line Norway rat CVCL_A5RJ CL:0000010 Transfected with: MGI; MGI:88361; Cdx2; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: Charles River Sprague Dawley (CD(SD)). Male Characteristics: The transfected Cdx2 gene is under the csheep MT1 gene (PubMed=8552090) 127228157 CVCL_A5RI IEC6-Cdx2L2 finite cell line Norway rat CVCL_A5RI CL:0000010 Transfected with: MGI; MGI:88361; Cdx2; Transfected with: UniProtKB; P03023; Escherichia coli LacI; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: Charles River Sprague Dawley (CD(SD)). Male Characteristics: Cdx2 can conditionally be expressed by addition of IPTG in the culture media This cell line was engineered with the LacSwitch system in this case composed of two plasmids, pOPRSVI-Cdx2 that contains a RSV LTR promoter, 2 lacO sites (lactose repressor), cdX2 and a neo gene and p3'SS that contains the LacI and hph genes. Thus when IPTG is added to the culture media, repression mediated by lacI is removed and Cdx2 is expressed (PubMed=8552090). 127228158 CVCL_A5QZ KCLi009-A induced pluripotent stem cell human CVCL_A5QZ From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 4010; FUS; Simple; p.Arg521His (c.1562G>A); ClinVar=VCV000016225; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228159 CVCL_A5RB KCLi011-A induced pluripotent stem cell human CVCL_A5RB From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 535; ANXA11; Simple; p.Gly38Arg (c.112G>A); ClinVar=VCV000488354; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228160 CVCL_A5RA KCLi010-A induced pluripotent stem cell human CVCL_A5RA From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 4010; FUS; Simple; p.Arg522Gly (c.1564A>G); ClinVar=VCV000540279; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228161 CVCL_A5SU KDM/JuB2 cancer cell line dog CVCL_A5SU CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Labrador Retriever. Female Characteristics: Established from the xenograft Ju Doubling time: 31.6 hours (PubMed=22839755) 127228162 CVCL_A5ST KDM/JuA1 cancer cell line dog CVCL_A5ST CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Labrador Retriever. Female Characteristics: Established from the xenograft Ju 127228163 CVCL_A5SW KDM/Re12 cancer cell line dog CVCL_A5SW CL:0000010 Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078; Breed/subspecies: Golden Retriever. Male Characteristics: Established from the xenograft Re 127228164 CVCL_A5SV KDM/JuB4 cancer cell line dog CVCL_A5SV CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Labrador Retriever. Female Characteristics: Established from the xenograft Ju 127228165 CVCL_A5SY KDM/Ud2 cancer cell line dog CVCL_A5SY CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Papillion. Female Characteristics: Established from the xenograft Ud Doubling time: 23.5 hours (PubMed=22839755) 127228166 CVCL_A5SX KDM/Re21 cancer cell line dog CVCL_A5SX CL:0000010 Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078; Breed/subspecies: Golden Retriever. Male Characteristics: Established from the xenograft Re 127228167 CVCL_A5SZ KDM/Ud6 cancer cell line dog CVCL_A5SZ CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Papillion. Female Characteristics: Established from the xenograft Ud 127228168 CVCL_A5SM Wilms11 finite cell line human CVCL_A5SM CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Homozygous; Note=Somatic (PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228169 CVCL_A5SL Wilms10T finite cell line human CVCL_A5SL CL:0000010 Sequence variation: Gene deletion; HGNC; 12796; WT1; Zygosity=Homozygous; Note=Nested within a heterozygous 11p13 deletion (PubMed=27213811; PubMed=33379206); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=27213811; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Omics: Transcriptome analysis by microarray Female 127228170 CVCL_A5SN imWilms1 conditionally immortalized cell line human CVCL_A5SN CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=33379206); Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female 127228171 CVCL_A5SQ imWilms6 conditionally immortalized cell line human CVCL_A5SQ CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206); Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228172 CVCL_A5SP imWilms3 conditionally immortalized cell line human CVCL_A5SP CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Val432Serfs*87 (c.1293_1294insA); Zygosity=Homozygous; Note=Somatic (PubMed=33379206); Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228173 CVCL_A5SS PEC transformed cell line pig CVCL_A5SS CL:0000010 Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Endometrium; UBERON=UBERON_0001295. Female Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=31426793) 127228174 CVCL_A5SR Y79/EDR cancer cell line human CVCL_A5SR CL:0000010 Sequence variation: Mutation; HGNC; 9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Omics: Transcriptome analysis by RNAseq Female Doubling time: 14.5 hours (DOI=10.3969/j.issn.1673-713X.2017.04.002) 127228175 CVCL_A5SE Wilms2 finite cell line human CVCL_A5SE CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Tyr (c.134C>A); ClinVar=VCV000375895; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg362Ter (c.1084C>T) (p.Arg435Ter, c.1303C>T); ClinVar=VCV000003497; Zygosity=Homozygous (PubMed=20106868; PubMed=24619359; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228176 CVCL_A5SD Wilms1-2r finite cell line human CVCL_A5SD CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Cys (c.134C>G); ClinVar=VCV000376242; Zygosity=Heterozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Donor information: Established from the right kidney of the recurrence (2nd tumor) of the patient; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female 127228177 CVCL_A5SG Wilms4 finite cell line human CVCL_A5SG CL:0000010 Sequence variation: Gene deletion; HGNC; 12796; WT1; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.His438Profs*7 (c.1311_1312insC); Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228178 CVCL_A5SF Wilms3 finite cell line human CVCL_A5SF CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Val432Serfs*87 (c.1293_1294insA); Zygosity=Homozygous; Note=Somatic (PubMed=20106868; PubMed=24619359; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228179 CVCL_A5SI Wilms6 finite cell line human CVCL_A5SI CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228180 CVCL_A5SH Wilms5 finite cell line human CVCL_A5SH CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg433Profs*84 (c.1296_1299delGC); Zygosity=Homozygous; Note=Somatic (PubMed=20106868; PubMed=33379206) Population: Caucasian; Donor information: The patient has a germline WT1 p.Arg390Ter (c.1168C>T) mutation that was lost in the tumor; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228181 CVCL_A5SK Wilms10M finite cell line human CVCL_A5SK CL:0000010 Sequence variation: Gene deletion; HGNC; 12796; WT1; Zygosity=Homozygous; Note=Nested within a heterozygous 11p13 deletion (PubMed=33379206); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Female 127228182 CVCL_A5SJ Wilms8 finite cell line human CVCL_A5SJ CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Ala (c.133T>G); ClinVar=VCV000376241; Zygosity=Heterozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Omics: Deep exome analysis Male 127228183 CVCL_A5SA KMS-34-SCC1 cancer cell line human CVCL_A5SA CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 127228184 CVCL_A5SC Wilms1-2l finite cell line human CVCL_A5SC CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=20106868; PubMed=33379206) Population: Caucasian; Donor information: Established from the left kidney of the recurrence (2nd tumor) of the patient; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female 127228185 CVCL_A5SB KMS-34-SCC2 cancer cell line human CVCL_A5SB CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 127228186 CVCL_A5PR NB90-6 cancer cell line human CVCL_A5PR CL:0000010 127228187 CVCL_A5PQ NB90-4 cancer cell line human CVCL_A5PQ CL:0000010 127228188 CVCL_A5PT A2780/CP8 cancer cell line human CVCL_A5PT CL:0000010 Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Unspecified (from parent cell line) Population: African American; Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: 22.1 +- 0.7 hours (PubMed=3539322) 127228189 CVCL_A5PS A2780/CP20 cancer cell line human CVCL_A5PS CL:0000010 Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Val173Phe (c.517G>T); Zygosity=Unspecified (PubMed=8557231) Population: African American; Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228190 CVCL_A5PV EG [Human ovarian carcinoma] cancer cell line human CVCL_A5PV CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Val143fs (c.427_458del32); Zygosity=Unspecified (PubMed=8557231) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228191 CVCL_A5PU EC [Human ovarian carcinoma] cancer cell line human CVCL_A5PU CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228192 CVCL_A5PX NMH spontaneously immortalized cell line house mouse CVCL_A5PX CL:0000010 Karyotypic information: Near diploid karyotype; Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: CD-1. Male Doubling time: 19 hours (PubMed=7525051) 127228193 CVCL_A5PW ML3B transformed cell line human CVCL_A5PW CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228194 CVCL_A5PJ AAKIPSi001-A induced pluripotent stem cell human CVCL_A5PJ From: INSERM; Paris; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228195 CVCL_A5PI LRVA-4 cancer cell line human CVCL_A5PI CL:0000010 Miscellaneous: Cell line has been lost (PubMed=14518029) Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Male 127228196 CVCL_A5PL AAKIPSi003-A induced pluripotent stem cell human CVCL_A5PL From: INSERM; Paris; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228197 CVCL_A5PK AAKIPSi002-A induced pluripotent stem cell human CVCL_A5PK From: INSERM; Paris; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228198 CVCL_A5PN BALB/3T3 clone A31T spontaneously immortalized cell line house mouse CVCL_A5PN CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 127228199 CVCL_A5PM N11 [Mouse microglial] transformed cell line house mouse CVCL_A5PM CL:0000010 Transformant: Recombinant retrovirus 3RV/VN-11; Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006237; Cell type: Microglial cell; CL=CL_0000129; Breed/subspecies: CD-1. Unspecified 127228200 CVCL_A5PP PNET-1 cancer cell line human CVCL_A5PP CL:0000010 127228201 CVCL_A5PB GM25134 transformed cell line human CVCL_A5PB CL:0000010 Sequence variation: Mutation; HGNC; 758; ASS1; Simple; p.Gly156Asp (c.467G>A); Zygosity=Homozygous (Coriell=GM25134) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228202 CVCL_A5PA GM25995 transformed cell line human CVCL_A5PA CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228203 CVCL_A5PD GM25154 transformed cell line human CVCL_A5PD CL:0000010 Sequence variation: Mutation; HGNC; 8512; OTC; Simple; p.Ter355Aspext*48 (c.1063delT) (X355D); Zygosity=Unspecified (Coriell=GM25154) Population: Asian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228204 CVCL_A5PC GM25153 transformed cell line human CVCL_A5PC CL:0000010 Sequence variation: Mutation; HGNC; 8512; OTC; Simple; p.Ter355Aspext*48 (c.1063delT) (X355D); Zygosity=Unspecified (Coriell=GM25153) Population: Asian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228205 CVCL_A5PF GM25166 transformed cell line human CVCL_A5PF CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228206 CVCL_A5PE GM25155 transformed cell line human CVCL_A5PE CL:0000010 Population: African American; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228207 CVCL_A5PH GM25170 transformed cell line human CVCL_A5PH CL:0000010 Sequence variation: Gene deletion; HGNC; 2928; DMD; Zygosity=Hemizygous (Coriell=GM25170) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228208 CVCL_A5PG GM25168 transformed cell line human CVCL_A5PG CL:0000010 Sequence variation: Mutation; HGNC; 4289; GK; Simple; p.Trp114Glnfs*7 (c.338-1G>A) (IVS4-1G>A) (Ex5del); Zygosity=Hemizygous; Note=Splice acceptor mutation (Coriell=GM25168) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228209 CVCL_A5QS UMi028-A-2 induced pluripotent stem cell human CVCL_A5QS From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; 12393; TTC3; Simple_edited; p.Ser1038Cys (c.3113C>G); dbSNP=rs377155188; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33626494) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228210 CVCL_A5QR CEIi001-A induced pluripotent stem cell human CVCL_A5QR From: Cole Eye Institute, Cleveland Clinic; Cleveland; USA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 29021; CEP290 Population: Caucasian; Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Female 127228211 CVCL_A5QU WAe001-A-55 embryonic stem cell human CVCL_A5QU From: University of Manchester; Manchester; United Kingdom CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 6847; MAP2K7 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228212 CVCL_A5QT WAe001-A-54 embryonic stem cell human CVCL_A5QT From: University of Manchester; Manchester; United Kingdom CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 6847; MAP2K7 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228213 CVCL_A5QW WAe001-A-30 embryonic stem cell human CVCL_A5QW From: University of Houston; Houston; USA CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228214 CVCL_A5QV WAe001-A-56 embryonic stem cell human CVCL_A5QV From: University of Houston; Houston; USA CL:0000010 Transfected with: HGNC; 7059; MGMT (with p.Gly180_Asn_207del and 19 mutations = SNAP-tag) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a SNAP-tag was in-frame inserted at the C-terminus of the SOD1 coding region following a 3 amino-acid linker (PubMed=34118566) 127228215 CVCL_A5QY KCLi008-A induced pluripotent stem cell human CVCL_A5QY From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 4010; FUS; Simple; p.Gln519Glu (c.1555C>G); ClinVar=VCV000650787; Zygosity=Heterozygous (PubMed=33610019) Population: Chinese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228216 CVCL_A5QX WAe014-A-1 embryonic stem cell human CVCL_A5QX From: Korea University Cell Function Regulation Lab; Seoul; South Korea CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 61; ABCD1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228217 CVCL_A5QK WMUi022-A induced pluripotent stem cell human CVCL_A5QK From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (PubMed=33901818) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228218 CVCL_A5QJ WMUi020-A induced pluripotent stem cell human CVCL_A5QJ From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 17985; ROBO4; Simple; p.Gln54Arg (c.161A>G); dbSNP=rs59648931; Zygosity=Heterozygous (PubMed=33631418) Population: Chinese; Han; Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002. Female 127228219 CVCL_A5QM WMUi006-A induced pluripotent stem cell human CVCL_A5QM From: Wenzhou Medical University; Wenzhou; China. CL:0000010 127228220 CVCL_A5QL WMUi023-A induced pluripotent stem cell human CVCL_A5QL From: Wenzhou Medical University; Wenzhou; China. CL:0000010 Female 127228221 CVCL_A5QN NUIGi040-B induced pluripotent stem cell human CVCL_A5QN From: National University of Ireland Galway; Galway; Ireland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228222 CVCL_A5QQ Ep-1 induced pluripotent stem cell human CVCL_A5QQ CL:0000010 Population: Caucasian; Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Female 127228223 CVCL_A5QP UMGi157-A induced pluripotent stem cell human CVCL_A5QP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228224 CVCL_A5QC ciPSC line 3 induced pluripotent stem cell dog CVCL_A5QC CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Beagle. Male 127228225 CVCL_A5QB JLUEYEi001-A induced pluripotent stem cell human CVCL_A5QB From: Eye Center of Second Hospital, Jilin University; Changchun; China CL:0000010 Sequence variation: Mutation; HGNC; 2200; COL2A1; Unexplicit; IVS22-1C>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33647874) Population: Mongolian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228226 CVCL_A5QE ciPSC P9 induced pluripotent stem cell dog CVCL_A5QE CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Breed/subspecies: Beagle. Female 127228227 CVCL_A5QD ciPSC line 6 induced pluripotent stem cell dog CVCL_A5QD CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Beagle. Male 127228228 CVCL_A5QG UMGi041-B.3 induced pluripotent stem cell human CVCL_A5QG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10484; RYR2; Simple; p.Ala2254Val (c.6761C>T); Zygosity=Heterozygous (PubMed=33640691) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228229 CVCL_A5QF JLUEYEi002-A induced pluripotent stem cell human CVCL_A5QF From: Eye Center of Second Hospital, Jilin University; Changchun; China CL:0000010 Population: Mongolian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228230 CVCL_A5QI JMUi001-A-3 induced pluripotent stem cell human CVCL_A5QI From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 3049; DSG2 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228231 CVCL_A5QH JMUi001-A-2 induced pluripotent stem cell human CVCL_A5QH From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 9024; PKP2 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228232 CVCL_A5PZ COS-7 1C7 transformed cell line CVCL_A5PZ CL:0000010 Transfected with: HGNC; 3180; EDNRB; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40) [Note=pSV6-1](NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Useful to study endothelin analogues for agonist or antagonist activity Group: Non-human primate cell line 127228233 CVCL_A5PY UOK85 cancer cell line human CVCL_A5PY CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified 127228234 CVCL_A5QA COS-F2-130 transformed cell line CVCL_A5QA CL:0000010 Transfected with: HGNC; 2590; CYP11A1; Transfected with: HGNC; 3638; FDX1; Transfected with: HGNC; 3642; FDXR; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40) [Note=pSV6-1](NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Useful system for studying steroidogenesis Converts cholesterol to pregnenolone but lack downstream enzymes that catalyze other steroidogenic reactions (PubMed=11356706).; Characteristics: Transfected with the F2 construct that consist of the fusion of P450scc-adrenodoxin reductase-adrenodoxin (PubMed=11356706) Group: Non-human primate cell line 127228235 CVCL_A5NP GM25858 transformed cell line human CVCL_A5NP CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228236 CVCL_A5NR GM25861 transformed cell line human CVCL_A5NR CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228237 CVCL_A5NQ GM25860 transformed cell line human CVCL_A5NQ CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228238 CVCL_A5NT GM25873 transformed cell line human CVCL_A5NT CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228239 CVCL_A5NS GM25872 transformed cell line human CVCL_A5NS CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228240 CVCL_A5NV GM25929 transformed cell line human CVCL_A5NV CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228241 CVCL_A5NU GM25886 transformed cell line human CVCL_A5NU CL:0000010 Population: Caucasian; English/German; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228242 CVCL_A5NH STF-4 finite cell line human CVCL_A5NH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228243 CVCL_A5NG STF-6 finite cell line human CVCL_A5NG CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228244 CVCL_A5NJ H7-H2B-RFP embryonic stem cell human CVCL_A5NJ CL:0000010 Transfected with: HGNC; 4761; H2BC11; Transfected with: UniProtKB; A0A4V4ND72; mRFP1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter 127228245 CVCL_A5NI STF-5 finite cell line human CVCL_A5NI CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228246 CVCL_A5NL HUES 17-H2B-RFP embryonic stem cell human CVCL_A5NL CL:0000010 Transfected with: HGNC; 4761; H2BC11; Transfected with: UniProtKB; A0A4V4ND72; mRFP1 Miscellaneous: Cell line information from personal communication of Price C.J Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter 127228247 CVCL_A5NK H14-H2B-RFP embryonic stem cell human CVCL_A5NK CL:0000010 Transfected with: HGNC; 4761; H2BC11; Transfected with: UniProtKB; A0A4V4ND72; mRFP1 Miscellaneous: Cell line information from personal communication of Price C.J Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter 127228248 CVCL_A5NN GM25857 transformed cell line human CVCL_A5NN CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228249 CVCL_A5NM GM25856 transformed cell line human CVCL_A5NM CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228250 CVCL_A5NB UKAi008-A induced pluripotent stem cell human CVCL_A5NB From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127228251 CVCL_A5NA UKAi007-B induced pluripotent stem cell human CVCL_A5NA From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Gly725Ser (c.2173G>A) (p.Gly706Ser, c.2116G>A); ClinVar=VCV000133445; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 10471; RUNX1; Simple; p.Met133Ile (c.399G>A); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 10783; SRSF2; Simple; p.Pro95_Arg102del (c.284_307del); dbSNP=rs766200080; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Arg1261Cys (c.3781C>T); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ser1292Arg (c.3876C>G); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228252 CVCL_A5ND UKAi008-C induced pluripotent stem cell human CVCL_A5ND From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228253 CVCL_A5NC UKAi008-B induced pluripotent stem cell human CVCL_A5NC From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127228254 CVCL_A5NF BRE finite cell line human CVCL_A5NF CL:0000010 Sequence variation: Mutation; HGNC; 43; TAP1; Simple; p.Asp273fs (c.819delC); Zygosity=Homozygous (PubMed=10074495) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228255 CVCL_A5NE STF-1 finite cell line human CVCL_A5NE CL:0000010 Sequence variation: Mutation; HGNC; 44; TAP2; Simple; p.Arg273Ter (c.817C>T) (R253*); ClinVar=VCV000013727; Zygosity=Homozygous (from autologous cell line ST-EMO) Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228256 CVCL_A5MW SNUe003-A-2 embryonic stem cell human CVCL_A5MW From: Seoul National University; Seoul; South Korea CL:0000010 Transfected with: UniProtKB; X5DSL3; Anaplasma marginale mCherry fluorescent protein; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a T2A-mCherry-polyA-PGKp-Neo-polyA construct was introduced at the C-terminus of one allele of Brachyury (PubMed=33878708) 127228257 CVCL_A5MV SNUe003-A-1 embryonic stem cell human CVCL_A5MV From: Seoul National University; Seoul; South Korea CL:0000010 Population: Korean; Karyotypic information: 47,XY,+12 (hPSCreg=SNUe003-A-1); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228258 CVCL_A5MY UKAi006-A induced pluripotent stem cell human CVCL_A5MY From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=30720580) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228259 CVCL_A5MX UKAi005-A induced pluripotent stem cell human CVCL_A5MX From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=30720580) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228260 CVCL_A5MZ UKAi007-A induced pluripotent stem cell human CVCL_A5MZ From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 76; ABL1; Simple; p.Gly725Ser (c.2173G>A) (p.Gly706Ser, c.2116G>A); ClinVar=VCV000133445; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 10471; RUNX1; Simple; p.Val101Alafs*31 (c.302_318del); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 10783; SRSF2; Simple; p.Pro95_Arg102del (c.284_307del); dbSNP=rs766200080; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Ser1292Arg (c.3876C>G); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 25941; TET2; Simple; p.Arg1465Ter (c.4393C>T); ClinVar=VCV001899776; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127228261 CVCL_A5NX GM25933 transformed cell line human CVCL_A5NX CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228262 CVCL_A5NW GM25932 finite cell line human CVCL_A5NW CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228263 CVCL_A5NZ GM25991 transformed cell line human CVCL_A5NZ CL:0000010 Population: Asian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: No OTC mutation found 127228264 CVCL_A5NY GM25944 finite cell line human CVCL_A5NY CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Female 127228265 CVCL_A4ZU ZZUNEUi019-A induced pluripotent stem cell human CVCL_A4ZU From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 10259; RORB; Simple; c.94-1G>A; ClinVar=VCV001683646; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33540281) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228266 CVCL_A4ZT ZZUNEUi018-A induced pluripotent stem cell human CVCL_A4ZT From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China. CL:0000010 127228267 CVCL_A4ZW Muntjak-T4 undefined cell line type CVCL_A4ZW CL:0000010 Discontinued: ATCC; CRL-6573; true. Male Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982) 127228268 CVCL_A4ZV PoEKC spontaneously immortalized cell line CVCL_A4ZV CL:0000010 Unspecified Group: Fish cell line. 127228269 CVCL_A4ZY 250 MK finite cell line human CVCL_A4ZY CL:0000010 Derived from site: In situ; Milk; UBERON=UBERON_0001913; Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662. Female 127228270 CVCL_A4ZX Muntjak(Fe) undefined cell line type CVCL_A4ZX CL:0000010 Discontinued: ATCC; CRL-6572; true. Female Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982) 127228271 CVCL_A4ZZ KIJ308T cancer cell line human CVCL_A4ZZ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. 127228272 CVCL_A4ZM BGUi009-A induced pluripotent stem cell human CVCL_A4ZM From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; 29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384. Male 127228273 CVCL_A4ZL BGUi008-A induced pluripotent stem cell human CVCL_A4ZL From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; 29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Heterozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228274 CVCL_A4ZN BGUi010-A induced pluripotent stem cell human CVCL_A4ZN From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; 29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228275 CVCL_A4ZQ ZZUNEUi015-A induced pluripotent stem cell human CVCL_A4ZQ From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 17574; ALPK3; Simple; p.Thr338lle (c.1013T>C); ClinVar=VCV000389853; Zygosity=Heterozygous (PubMed=33607470) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228276 CVCL_A4ZP BGUi014-A induced pluripotent stem cell human CVCL_A4ZP From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228277 CVCL_A4ZS ZZUNEUi017-A induced pluripotent stem cell human CVCL_A4ZS From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 12403; TTN; Simple; p.Glu12513fs (c.37537delG); Zygosity=Heterozygous (PubMed=33610015) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228278 CVCL_A4ZR ZZUNEUi016-A induced pluripotent stem cell human CVCL_A4ZR From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple; p.Ala355Thr (c.1063G>A); ClinVar=VCV000042820; Zygosity=Heterozygous (PubMed=33636496) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228279 CVCL_A4ZE UMGi014-C induced pluripotent stem cell human CVCL_A4ZE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228280 CVCL_A4ZD UMGi141-A induced pluripotent stem cell human CVCL_A4ZD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228281 CVCL_A4ZG UMGi092-A induced pluripotent stem cell human CVCL_A4ZG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228282 CVCL_A4ZF UMGi014-D induced pluripotent stem cell human CVCL_A4ZF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228283 CVCL_A4ZI UMGi099-B induced pluripotent stem cell human CVCL_A4ZI From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228284 CVCL_A4ZH UMGi099-A induced pluripotent stem cell human CVCL_A4ZH From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228285 CVCL_A4ZK BGUi007-A induced pluripotent stem cell human CVCL_A4ZK From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; 5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous (PubMed=34419746) Population: Jewish; Ashkenazi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228286 CVCL_A4ZJ BGUi006-A induced pluripotent stem cell human CVCL_A4ZJ From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; 5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous (PubMed=34419746) Population: Jewish; Ashkenazi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228287 CVCL_A4XZ WMUi018-A induced pluripotent stem cell human CVCL_A4XZ From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 9208; POR; Simple; p.Arg454His (c.1361G>A) (p.Arg457His, c.1370G>A); ClinVar=VCV000016907; Zygosity=Homozygous (PubMed=33631521) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 127228288 CVCL_A4YB WMUi016-A induced pluripotent stem cell human CVCL_A4YB From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 2023; CLCN5; Simple; p.Arg718Ter (c.2152C>T); ClinVar=VCV000011797; Zygosity=Hemizygous (PubMed=33545640) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228289 CVCL_A4YA WMUi019-A induced pluripotent stem cell human CVCL_A4YA From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 10910; SLC12A1; Simple; p.Ala244Asp (c.731C>A); Zygosity=Homozygous (PubMed=33607471) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 127228290 CVCL_A4XS SDQLCHi036-A induced pluripotent stem cell human CVCL_A4XS From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 8512; OTC; Unexplicit; Ex3-9del; Zygosity=Heterozygous (PubMed=33550136) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228291 CVCL_A4XR SDQLCHi035-A induced pluripotent stem cell human CVCL_A4XR From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Heterozygous (PubMed=33517119); Sequence variation: Mutation; HGNC; 4284; GJB2; Simple; p.His100Argfs*14 (c.299_300delAT); ClinVar=VCV000044736; Zygosity=Heterozygous (PubMed=33517119) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228292 CVCL_A4XU SDQLCHi040-A induced pluripotent stem cell human CVCL_A4XU From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 5964; IL10RA; Simple; p.Arg101Trp (c.301C>T); ClinVar=VCV000039432; Zygosity=Homozygous (PubMed=34530396) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228293 CVCL_A4XT SDQLCHi038-A induced pluripotent stem cell human CVCL_A4XT From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228294 CVCL_A4XW SDUBMSi009-A induced pluripotent stem cell human CVCL_A4XW From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 8108; OCRL; Simple; c.940-11G>A; ClinVar=VCV000279859; Zygosity=Hemizygous (PubMed=33540283) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228295 CVCL_A4XV SDQLCHi041-A induced pluripotent stem cell human CVCL_A4XV From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 7632; NAGLU; Simple; p.Arg203Gln (c.608G>A); ClinVar=VCV001029750; Zygosity=Heterozygous (PubMed=33550137); Sequence variation: Mutation; HGNC; 7632; NAGLU; Simple; p.Glu446Lys (c.1336G>A); ClinVar=VCV000553423; Zygosity=Heterozygous (PubMed=33550137) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228296 CVCL_A4XY WMUi014-A induced pluripotent stem cell human CVCL_A4XY From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 61; ABCD1; Simple; c.2013insA; Zygosity=Hemizygous (PubMed=33472124) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228297 CVCL_A4XX WMUi017-A induced pluripotent stem cell human CVCL_A4XX From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 9330; PQBP1; Simple; p.Pro609Ala (c.1825C>G); Zygosity=Hemizygous (PubMed=33477035) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228298 CVCL_A4XK SDQLCHi028-A induced pluripotent stem cell human CVCL_A4XK From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228299 CVCL_A4XJ SDQLCHi027-A induced pluripotent stem cell human CVCL_A4XJ From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228300 CVCL_A4XM SDQLCHi030-A induced pluripotent stem cell human CVCL_A4XM From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228301 CVCL_A4XL SDQLCHi029-A induced pluripotent stem cell human CVCL_A4XL From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228302 CVCL_A4XN SDQLCHi031-A induced pluripotent stem cell human CVCL_A4XN From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228303 CVCL_A4XQ SDQLCHi034-A induced pluripotent stem cell human CVCL_A4XQ From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228304 CVCL_A4XP SDQLCHi032-A induced pluripotent stem cell human CVCL_A4XP From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 5154; HPGD; Simple; p.Leu104Alafs*3 (c.308_309CT[1]) (c.310_311delCT); ClinVar=VCV000156027; Zygosity=Homozygous (PubMed=33550138) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228305 CVCL_A4XC UUMCBi002-A induced pluripotent stem cell human CVCL_A4XC From: Department of Medical Cell Biology, Biomedical Centre; Uppsala; Sweden CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228306 CVCL_A4XB UUMCBi001-A induced pluripotent stem cell human CVCL_A4XB From: Department of Medical Cell Biology, Biomedical Centre; Uppsala; Sweden CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228307 CVCL_A4XE FINCBi003-A induced pluripotent stem cell human CVCL_A4XE From: Fondazione IRCCS Istituto Neurologico C Besta; Milan; Italy. CL:0000010 Sequence variation: Mutation; HGNC; Group_1972; MT-@; Unexplicit; m.8469_13460del; Zygosity=Heteroplasmic; Note=In 30% (PubMed=33434818) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Male 127228308 CVCL_A4XD FINCBi002-A induced pluripotent stem cell human CVCL_A4XD From: Fondazione IRCCS Istituto Neurologico C Besta; Milan; Italy. CL:0000010 Sequence variation: Mutation; HGNC; Group_1972; MT-@; Unexplicit; m.9449_14550del; Zygosity=Heteroplasmic; Note=In 80% (PubMed=33434818) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Male 127228309 CVCL_A4XG SDQLCHi039-A induced pluripotent stem cell human CVCL_A4XG From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 1133; BTK; Simple; p.Tyr510_Glu513delGluTyrLeuGluinsGlu (c.1530_1538delATACCTGGA); Zygosity=Hemizygous (PubMed=33453577) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228310 CVCL_A4XF GWCMCi003-A induced pluripotent stem cell human CVCL_A4XF From: Guangzhou Women and Children's Medical Center; Guangzhou; China. CL:0000010 127228311 CVCL_A4XI PLAFMCi003-A induced pluripotent stem cell human CVCL_A4XI From: Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Gene deletion; HGNC; 9008; PKD1; Zygosity=Heterozygous (PubMed=33485185); Sequence variation: Gene deletion; HGNC; 12363; TSC2; Zygosity=Heterozygous (PubMed=33485185) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228312 CVCL_A4XH SDQLCHi037-A induced pluripotent stem cell human CVCL_A4XH From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 6188; JAG1; Simple; p.Gln539Ter (c.1615C>T); ClinVar=VCV000488807; Zygosity=Heterozygous (PubMed=33465531) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228313 CVCL_A4ZA UMGi101-A induced pluripotent stem cell human CVCL_A4ZA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228314 CVCL_A4ZC UMGi140-A induced pluripotent stem cell human CVCL_A4ZC From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228315 CVCL_A4ZB UMGi132-A induced pluripotent stem cell human CVCL_A4ZB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228316 CVCL_A4YT SUi002-B induced pluripotent stem cell human CVCL_A4YT From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228317 CVCL_A4YS SUi002-A induced pluripotent stem cell human CVCL_A4YS From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228318 CVCL_A4YV SUi003-B induced pluripotent stem cell human CVCL_A4YV From: Semmelweis University; Budapest; Hungary CL:0000010 Sequence variation: Mutation; HGNC; 6316; KHSRP; Simple; p.Gly403Cys (c.1207G>T) (chr19:g.6416869C>A); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A); Sequence variation: Mutation; HGNC; 6329; KIR2DL1; Simple; c.412A>T (chr19:g.55286658A>T); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A); Sequence variation: Mutation; HGNC; 18531; LRRC7; Simple; p.Val1158Ile (c.3472G>A) (chr1:g.70505093G>A); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228319 CVCL_A4YU SUi003-A induced pluripotent stem cell human CVCL_A4YU From: Semmelweis University; Budapest; Hungary CL:0000010 Sequence variation: Mutation; HGNC; 6316; KHSRP; Simple; p.Gly403Cys (c.1207G>T) (chr19:g.6416869C>A); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521); Sequence variation: Mutation; HGNC; 6329; KIR2DL1; Simple; c.412A>T (chr19:g.55286658A>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521); Sequence variation: Mutation; HGNC; 18531; LRRC7; Simple; p.Val1158Ile (c.3472G>A) (chr1:g.70505093G>A); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228320 CVCL_A4YX KRIBBi001-A induced pluripotent stem cell human CVCL_A4YX From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea CL:0000010 Population: Brazilian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female 127228321 CVCL_A4YW IBMS-iPSC-070-02 induced pluripotent stem cell human CVCL_A4YW From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan CL:0000010 Sequence variation: Mutation; HGNC; 15894; PANK2; Simple; p.Leu111Gln (c.332T>A); ClinVar=VCV000193506; Zygosity=Heterozygous (PubMed=33517123); Sequence variation: Mutation; HGNC; 15894; PANK2; Simple; c.1413-9_-14dupTTCCCC; Zygosity=Heterozygous (PubMed=33517123); Sequence variation: Mutation; HGNC; 15894; PANK2; Simple; p.Asn500Ile (c.1499A>T); dbSNP=rs759332123; Zygosity=Heterozygous (PubMed=33517123) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228322 CVCL_A4YZ UMGi150-A induced pluripotent stem cell human CVCL_A4YZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228323 CVCL_A4YY UMGi153-A induced pluripotent stem cell human CVCL_A4YY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228324 CVCL_A4YL BGUi012-A induced pluripotent stem cell human CVCL_A4YL From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Population: Jewish; Ashkenazi; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228325 CVCL_A4YK BGUi011-A induced pluripotent stem cell human CVCL_A4YK From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; 4588; GRIN2D; Simple; p.Val667Ile (c.1999G>A); ClinVar=VCV000267211; Zygosity=Heterozygous (PubMed=33482465) Population: Jewish; Ashkenazi; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228326 CVCL_A4YN BGUi015-A induced pluripotent stem cell human CVCL_A4YN From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228327 CVCL_A4YM BGUi013-A induced pluripotent stem cell human CVCL_A4YM From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358. Female 127228328 CVCL_A4YP STBCi026-A-4 induced pluripotent stem cell human CVCL_A4YP From: StemBANCC; Oxford; United Kingdom CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: ECACC; 66541208; true Female Characteristics: Using CRISPR/Cas9 a GFP tag was introduced at the C-terminus of PITX3 127228329 CVCL_A4YR SUi001-B induced pluripotent stem cell human CVCL_A4YR From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228330 CVCL_A4YQ SUi001-A induced pluripotent stem cell human CVCL_A4YQ From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228331 CVCL_A4YD UKWMPi002-A-1 induced pluripotent stem cell human CVCL_A4YD From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 1753; CDH13 (Note=1 of 2 alleles) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228332 CVCL_A4YC UKWMPi002-A induced pluripotent stem cell human CVCL_A4YC From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228333 CVCL_A4YF UKWMPi002-B induced pluripotent stem cell human CVCL_A4YF From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228334 CVCL_A4YE UKWMPi002-A-2 induced pluripotent stem cell human CVCL_A4YE From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 1753; CDH13 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228335 CVCL_A4YH UKWMPi001-A induced pluripotent stem cell human CVCL_A4YH From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228336 CVCL_A4YG UKWMPi002-C induced pluripotent stem cell human CVCL_A4YG From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228337 CVCL_A4YJ ZZUi028-A induced pluripotent stem cell human CVCL_A4YJ From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228338 CVCL_A4YI UKWMPi001-B induced pluripotent stem cell human CVCL_A4YI From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228339 CVCL_A4VY 4.3-01 induced pluripotent stem cell house mouse CVCL_A4VY CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57-/- z (M+Z-) genotype 127228340 CVCL_A4VX 4.2-05 induced pluripotent stem cell house mouse CVCL_A4VX CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57+/- (M+Z+) genotype 127228341 CVCL_A4VZ 4.3-04 induced pluripotent stem cell house mouse CVCL_A4VZ CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57-/- z (M+Z-) genotype 127228342 CVCL_A4VQ PN1-iPSC induced pluripotent stem cell human CVCL_A4VQ From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Sequence variation: Mutation; HGNC; 25792; USB1; Simple; c.693+1G>T; ClinVar=VCV000496749; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26987923) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228343 CVCL_A4VP M3O-lenti-iPSC-LIF(-) induced pluripotent stem cell house mouse CVCL_A4VP CL:0000010 Male 127228344 CVCL_A4VS D1902 embryonic stem cell house mouse CVCL_A4VS CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228345 CVCL_A4VR PN2-iPSC induced pluripotent stem cell human CVCL_A4VR From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Sequence variation: Mutation; HGNC; 25792; USB1; Simple; c.693+1G>T; ClinVar=VCV000496749; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26987923) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228346 CVCL_A4VU D1904 embryonic stem cell house mouse CVCL_A4VU CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228347 CVCL_A4VT D1903 embryonic stem cell house mouse CVCL_A4VT CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228348 CVCL_A4VW D1911 embryonic stem cell house mouse CVCL_A4VW CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228349 CVCL_A4VV D1906 embryonic stem cell house mouse CVCL_A4VV CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228350 CVCL_A4VI FORTHi001A induced pluripotent stem cell human CVCL_A4VI From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Omics: Transcriptome analysis by microarray Male 127228351 CVCL_A4VH TLE3-447-D08-A01 embryonic stem cell human CVCL_A4VH From: Broad Institute of MIT and Harvard; Cambridge; USA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 11839; TLE3 (Note=1 of 2 alleles) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228352 CVCL_A4VK FORTHi001C induced pluripotent stem cell human CVCL_A4VK From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Omics: Transcriptome analysis by microarray Male 127228353 CVCL_A4VJ FORTHi001B induced pluripotent stem cell human CVCL_A4VJ From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Omics: Transcriptome analysis by microarray Male 127228354 CVCL_A4VM iPSC(OCT4) 2 induced pluripotent stem cell human CVCL_A4VM From: McMaster Stem Cell and Cancer Research Institute, Michael G DeGroote School of Medicine, McMaster University; Hamilton; Canada. CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Male 127228355 CVCL_A4VL iPSC(OCT4) 1 induced pluripotent stem cell human CVCL_A4VL From: McMaster Stem Cell and Cancer Research Institute, Michael G DeGroote School of Medicine, McMaster University; Hamilton; Canada. CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Female 127228356 CVCL_A4VN iPSC(OCT4) 3 induced pluripotent stem cell human CVCL_A4VN From: McMaster Stem Cell and Cancer Research Institute, Michael G DeGroote School of Medicine, McMaster University; Hamilton; Canada. CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Female 127228357 CVCL_A4VA UMGi093-A induced pluripotent stem cell human CVCL_A4VA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228358 CVCL_A4VC GWCMCi002-A induced pluripotent stem cell human CVCL_A4VC From: Guangzhou Women and Children's Medical Center; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 2207; COL4A5; Simple; c.1517-1G>T; ClinVar=VCV000024421; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=34088015) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228359 CVCL_A4VB UMGi094-A induced pluripotent stem cell human CVCL_A4VB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228360 CVCL_A4VE CREM040i-SA82-2 induced pluripotent stem cell human CVCL_A4VE From: Boston University School of Medicine; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279) Population: Saudi Arabian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Next Generation Genetic Association studies (Next Gen) program cell lines 127228361 CVCL_A4VD CREM039i-SA108 induced pluripotent stem cell human CVCL_A4VD From: Boston University School of Medicine; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279) Population: Saudi Arabian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Next Generation Genetic Association studies (Next Gen) program cell lines 127228362 CVCL_A4VG iPS-CTX-R395S induced pluripotent stem cell human CVCL_A4VG From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 2605; CYP27A1; Simple; p.Arg395Ser (c.1183C>A); ClinVar=VCV000004261; Zygosity=Homozygous (PubMed=27879219) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228363 CVCL_A4VF CREM043i-SA210-1 induced pluripotent stem cell human CVCL_A4VF From: Boston University School of Medicine; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279) Population: Saudi Arabian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Next Generation Genetic Association studies (Next Gen) program cell lines 127228364 CVCL_A4WZ IGIBi002-A [2021] induced pluripotent stem cell human CVCL_A4WZ From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India CL:0000010 Sequence variation: Mutation; HGNC; 4827; HBB; Simple; c.92+5G>C (IVS1,G>C,+5) (IVS1-5G>C); ClinVar=VCV000015447; Zygosity=Homozygous (PubMed=33338925) Population: Indian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Two different cell lines were established by CSIR-IGIB with the same IGIBi002-A designation 127228365 CVCL_A4WY MCRIi019-A-1 induced pluripotent stem cell human CVCL_A4WY From: Murdoch Children's Research Institute; Melbourne; Australia CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 31612; MIR26B Population: African American; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228366 CVCL_A4XA HUi002-A induced pluripotent stem cell human CVCL_A4XA From: Hanyang Biomedical Research Institute, Hanyang University; Seoul; South Korea CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228367 CVCL_A4WR LIBDi015-A induced pluripotent stem cell human CVCL_A4WR From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228368 CVCL_A4WQ LIBDi014-A induced pluripotent stem cell human CVCL_A4WQ From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Gene deletion; HGNC; 11634; TCF4; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228369 CVCL_A4WT LIBDi017-A induced pluripotent stem cell human CVCL_A4WT From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228370 CVCL_A4WS LIBDi016-A induced pluripotent stem cell human CVCL_A4WS From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; 11634; TCF4; Simple; c.922+3G>T; ClinVar=VCV001204043; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228371 CVCL_A4WV LIBDi019-A induced pluripotent stem cell human CVCL_A4WV From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Gene deletion; HGNC; 11634; TCF4; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228372 CVCL_A4WU LIBDi018-A induced pluripotent stem cell human CVCL_A4WU From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228373 CVCL_A4WX SCSe001-A-3 embryonic stem cell human CVCL_A4WX From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Transfected with: UniProtKB; Q9U6Y8; Discosoma sp red fluorescent protein drFP583 (DsRed, RFP).; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using homologous recombination an EGFP reporter gene was introduced in the INS locus and using CRISPR/Cas9 a tandem-dimer RFP was introduced in the SST gene (PubMed=33316598) 127228374 CVCL_A4WW LIBDi010-A induced pluripotent stem cell human CVCL_A4WW From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228375 CVCL_A4WJ MHHi019-A induced pluripotent stem cell human CVCL_A4WJ From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; 7853; NME5; Simple; p.Ile139Tyrfs*8 (c.415delA); ClinVar=VCV001705858; Zygosity=Homozygous (PubMed=32950024) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228376 CVCL_A4WI MPIi007-A induced pluripotent stem cell human CVCL_A4WI From: Max Planck Institute for Molecular Biomedicine; Munster; Germany CL:0000010 Sequence variation: Mutation; HGNC; 713; ARSA; Simple; p.Thr393Ser (c.1178C>G) (p.Thr391Ser, c.1172C>G); ClinVar=VCV000021184; Zygosity=Heterozygous (PubMed=32950023) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228377 CVCL_A4WL MHHi020-A induced pluripotent stem cell human CVCL_A4WL From: Hannover Medical School, LEBAO (MHH); Hannover; Germany. CL:0000010 127228378 CVCL_A4WK MHHi019-B induced pluripotent stem cell human CVCL_A4WK From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; 7853; NME5; Simple; p.Ile139Tyrfs*8 (c.415delA); ClinVar=VCV001705858; Zygosity=Homozygous (PubMed=32950024) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228379 CVCL_A4WN LIBDi012-A induced pluripotent stem cell human CVCL_A4WN From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; 11634; TCF4; Simple; p.Arg385Ter (c.1153C>T); ClinVar=VCV000007372; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228380 CVCL_A4WM LIBDi011-A induced pluripotent stem cell human CVCL_A4WM From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; 11634; TCF4; Simple; p.Arg76Ter; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228381 CVCL_A4WP LIBDi013-A induced pluripotent stem cell human CVCL_A4WP From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228382 CVCL_A4WB WAe001-A-80 embryonic stem cell human CVCL_A4WB From: University of Wisconsin; Madison; USA CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using ZFN a 2A-PuroR-CD43_promoter-eGFP was introduced in the AAVS1 safe harbor locus and CDH5(CD144) promoter-tdTomato-Zeo construct was transferred using a PiggyBac transposon vector (PubMed=27879215) 127228383 CVCL_A4WA 7.2-02 induced pluripotent stem cell house mouse CVCL_A4WA CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57-/- mz (M-Z-) genotype 127228384 CVCL_A4WD PH1-iPSC#2 induced pluripotent stem cell human CVCL_A4WD From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; 341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228385 CVCL_A4WC PH1-iPSC#1 induced pluripotent stem cell human CVCL_A4WC From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; 341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228386 CVCL_A4WF WT-iPSC#2 induced pluripotent stem cell human CVCL_A4WF From: University of Bordeaux; Bordeaux; France CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228387 CVCL_A4WE WT-iPSC#1 induced pluripotent stem cell human CVCL_A4WE From: University of Bordeaux; Bordeaux; France CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228388 CVCL_A4WH PH1-iPSC#2-TTRp-eGFP induced pluripotent stem cell human CVCL_A4WH From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; 341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: The transduced eGFP gene expression is under the control of transthyretin promoter (TTRp) (PubMed=31151050) 127228389 CVCL_A4WG PH1-iPSC#2-TTRp-AGXT induced pluripotent stem cell human CVCL_A4WG From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; 341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Heterozygous; Note=No longer homozygous because of transduced wild-type gene (PubMed=31151050); Transfected with: HGNC; 341; AGXT Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: The transduced AGXT gene expression is under the control of transthyretin promoter (TTRp) (PubMed=31151050) 127228390 CVCL_A4TW CALM1-F142L iPSC c2 induced pluripotent stem cell human CVCL_A4TW CL:0000010 Sequence variation: Mutation; HGNC; 1442; CALM1; Simple; p.Phe142Leu (c.426C>G) (c.9406C>G); ClinVar=VCV000183231; Zygosity=Heterozygous (PubMed=28158429) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228391 CVCL_A4TV CALM1-F142L iPSC c1 induced pluripotent stem cell human CVCL_A4TV CL:0000010 Sequence variation: Mutation; HGNC; 1442; CALM1; Simple; p.Phe142Leu (c.426C>G) (c.9406C>G); ClinVar=VCV000183231; Zygosity=Heterozygous (PubMed=28158429) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228392 CVCL_A4TY WAe001-A-57 embryonic stem cell human CVCL_A4TY From: Institute for Cardiovascular Science of Soochow University; Suzhou; China CL:0000010 Transfected with: UniProtKB; X5DSL3; Anaplasma marginale mCherry fluorescent protein Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a 2A-mCherry cassette was integrated in front of the stop codon of EFNB2 in one allele (PubMed=33611045) 127228393 CVCL_A4TX WAe001-A-47 embryonic stem cell human CVCL_A4TX From: Wenzhou Medical University; Wenzhou; China CL:0000010 Transfected with: HGNC; 28966; VGLL4; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR); Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Dox-inducible expression of VGLL4 The cell has been transfected with a PB-TRE6P-VGLL4-P2A-EGFP-3Flag-PA-EF1a-5'LTR-rtTA-T2A-puroR construct (PubMed=33385792). 127228394 CVCL_A4TZ WAe009-A-48 embryonic stem cell human CVCL_A4TZ From: Shenzhen People's Hospital; Shenzhen; China CL:0000010 Sequence variation: Mutation; HGNC; 10593; SCN5A; Simple; p.Glu1784Lys (c.5350G>A) (p.Glu1783Lys, c.5347G>A); ClinVar=VCV000009377; Zygosity=Heterozygous; Note=By method not specified (PubMed=33517120) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228395 CVCL_A4TN CCD2-iPS 9 induced pluripotent stem cell human CVCL_A4TN From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228396 CVCL_A4TQ UMGi090-A induced pluripotent stem cell human CVCL_A4TQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228397 CVCL_A4TP CCD2-iPS 12 induced pluripotent stem cell human CVCL_A4TP From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228398 CVCL_A4TS Rev1-iPSC induced pluripotent stem cell human CVCL_A4TS From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple_corrected; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228399 CVCL_A4TR UMGi091-A induced pluripotent stem cell human CVCL_A4TR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228400 CVCL_A4TU UMGi130-A induced pluripotent stem cell human CVCL_A4TU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228401 CVCL_A4TT UMGi014-E induced pluripotent stem cell human CVCL_A4TT From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228402 CVCL_A4TG IHLPC transformed cell line human CVCL_A4TG CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Pericyte; CL=CL_0000669. Characteristics: Retains pericyte-specific characteristics, including normal pericyte morphology and expression of the commonly used pericyte markers, PDGFRB and NG2 (PubMed=33446892) 127228403 CVCL_A4TF UMGi148-A induced pluripotent stem cell human CVCL_A4TF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228404 CVCL_A4TI CCD1-iPS 4 induced pluripotent stem cell human CVCL_A4TI From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228405 CVCL_A4TH CCD1-iPS 2 induced pluripotent stem cell human CVCL_A4TH From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228406 CVCL_A4TK CCD2-iPS 4 induced pluripotent stem cell human CVCL_A4TK From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228407 CVCL_A4TJ CCD1-iPS 6 induced pluripotent stem cell human CVCL_A4TJ From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228408 CVCL_A4TM CCD2-iPS 8 induced pluripotent stem cell human CVCL_A4TM From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228409 CVCL_A4TL CCD2-iPS 7 induced pluripotent stem cell human CVCL_A4TL From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; 10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228410 CVCL_A4TA UMGi084-A induced pluripotent stem cell human CVCL_A4TA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228411 CVCL_A4TC UMGi086-A induced pluripotent stem cell human CVCL_A4TC From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228412 CVCL_A4TB UMGi085-A induced pluripotent stem cell human CVCL_A4TB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228413 CVCL_A4TE UMGi154-A induced pluripotent stem cell human CVCL_A4TE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 127228414 CVCL_A4TD UMGi155-A induced pluripotent stem cell human CVCL_A4TD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228415 CVCL_A4UX UMGi102-A induced pluripotent stem cell human CVCL_A4UX From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228416 CVCL_A4UW UMGi109-A induced pluripotent stem cell human CVCL_A4UW From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228417 CVCL_A4UZ UMGi104-A induced pluripotent stem cell human CVCL_A4UZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228418 CVCL_A4UY UMGi103-A induced pluripotent stem cell human CVCL_A4UY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228419 CVCL_A4UP UMGi105-A induced pluripotent stem cell human CVCL_A4UP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228420 CVCL_A4UR UMGi106-B induced pluripotent stem cell human CVCL_A4UR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228421 CVCL_A4UQ UMGi106-A induced pluripotent stem cell human CVCL_A4UQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228422 CVCL_A4UT UMGi107-B induced pluripotent stem cell human CVCL_A4UT From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228423 CVCL_A4US UMGi107-A induced pluripotent stem cell human CVCL_A4US From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228424 CVCL_A4UV UMGi108-B induced pluripotent stem cell human CVCL_A4UV From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228425 CVCL_A4UU UMGi108-A induced pluripotent stem cell human CVCL_A4UU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228426 CVCL_A4UH UMGi128-A induced pluripotent stem cell human CVCL_A4UH From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228427 CVCL_A4UG UMGi127-A induced pluripotent stem cell human CVCL_A4UG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228428 CVCL_A4UJ iMSMD-cohet.7 induced pluripotent stem cell human CVCL_A4UJ CL:0000010 Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666); Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228429 CVCL_A4UI iMSMD-cohet.5 induced pluripotent stem cell human CVCL_A4UI CL:0000010 Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666); Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228430 CVCL_A4UL iMSMD-het.4 induced pluripotent stem cell human CVCL_A4UL CL:0000010 Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666) Donor information: While obtained from a patient suffering from Mendelian susceptibility to mycobacterial diseases, this iPSC originates from the sister of this patient who was the donor for a hematopoietic stem cell transplantation; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228431 CVCL_A4UK iMSMD-cohet.17 induced pluripotent stem cell human CVCL_A4UK CL:0000010 Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666); Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228432 CVCL_A4UN ZZUNEUi020-A induced pluripotent stem cell human CVCL_A4UN From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple; p.Arg719Gln (c.2156G>A); ClinVar=VCV000014107; Zygosity=Heterozygous (PubMed=33453578) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228433 CVCL_A4UM iMSMD-het.9 induced pluripotent stem cell human CVCL_A4UM CL:0000010 Sequence variation: Mutation; HGNC; 5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666) Donor information: While obtained from a patient suffering from Mendelian susceptibility to mycobacterial diseases, this iPSC originates from the sister of this patient who was the donor for a hematopoietic stem cell transplantation; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228434 CVCL_A4UB WAe009-A-47 embryonic stem cell human CVCL_A4UB From: Peking University Third Hospital; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 2279; COX6A2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228435 CVCL_A4UA SPHi001-A induced pluripotent stem cell human CVCL_A4UA From: Shenzhen People's Hospital; Shenzhen; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228436 CVCL_A4UD UMGi126-A.9 induced pluripotent stem cell human CVCL_A4UD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349); Sequence variation: Mutation; HGNC; 10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones 127228437 CVCL_A4UC WAe009-A-46 embryonic stem cell human CVCL_A4UC From: The Second People's Hospital of Liaocheng; Liaocheng; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 7576; MYH6 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228438 CVCL_A4UF UMGi126-A.13 induced pluripotent stem cell human CVCL_A4UF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349); Sequence variation: Mutation; HGNC; 10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones 127228439 CVCL_A4UE UMGi126-A.12 induced pluripotent stem cell human CVCL_A4UE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349); Sequence variation: Mutation; HGNC; 10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones 127228440 CVCL_A5DF CTR4#5 induced pluripotent stem cell human CVCL_A5DF CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228441 CVCL_A5DE 11H4-1C7 hybridoma CVCL_A5DE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mouse osteocyte antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12397 127228442 CVCL_A5DH CTR8#14 induced pluripotent stem cell human CVCL_A5DH CL:0000010 127228443 CVCL_A5DG CTR2#6 induced pluripotent stem cell human CVCL_A5DG CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228444 CVCL_A5DJ MS-HIPS RR16#5 induced pluripotent stem cell human CVCL_A5DJ CL:0000010 Miscellaneous: Sampling site from personal communication of ISENET Biobanking Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228445 CVCL_A5DI MS-HIPS PP9#1 induced pluripotent stem cell human CVCL_A5DI CL:0000010 Miscellaneous: Sampling site from personal communication of ISENET Biobanking Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Female 127228446 CVCL_A5DL WFS2_3 finite cell line human CVCL_A5DL CL:0000010 Sequence variation: Mutation; HGNC; 24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228447 CVCL_A5DK WFS2_4 finite cell line human CVCL_A5DK CL:0000010 Sequence variation: Mutation; HGNC; 24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228448 CVCL_A5DB 9A3-2G8 hybridoma CVCL_A5DB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mouse osteocyte antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12395 127228449 CVCL_A5DA 2T3 transformed cell line house mouse CVCL_A5DA CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: Bmp2 promoter T-Ag-3 transgenic. Unspecified 127228450 CVCL_A5DD 9D9-2F5 hybridoma CVCL_A5DD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mouse osteocyte antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12396 127228451 CVCL_A5DC 9C11 [Rat hybridoma against mouse Pdpn] hybridoma CVCL_A5DC CL:0000010 Miscellaneous: This hybridoma was lost (Patent=US6358737). Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q62011; Mouse Pdpn 127228452 CVCL_A5CU HCCLM9 cancer cell line human CVCL_A5CU CL:0000010 Sequence variation: Mutation; HGNC; 14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line) Population: Chinese; Transformant: Hepatitis B virus (HBV)(NCBI-Taxonomy; 10407). Male Characteristics: Established from pulmonary metastatic lesions produced in nude mice by 9 rounds of subcutaneous inoculation of parent cell line 127228453 CVCL_A5CT Hep-G2 VL-17A cancer cell line human CVCL_A5CT CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: HGNC; 2631; CYP2E1; Transfected with: MGI; MGI:87921; Adh1; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 127228454 CVCL_A5CW AF22 somatic stem cell human CVCL_A5CW CL:0000010 Miscellaneous: Sex of donor from personal communication of ISENET Biobanking Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239) 127228455 CVCL_A5CV CTR4#9 induced pluripotent stem cell human CVCL_A5CV CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228456 CVCL_A5CY AF24 somatic stem cell human CVCL_A5CY CL:0000010 Cell type: Neuroepithelial stem cell; CL=CL_0002259. Unspecified Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239) 127228457 CVCL_A5CX AF23 somatic stem cell human CVCL_A5CX CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Neuroepithelial stem cell; CL=CL_0002259. Female Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239) 127228458 CVCL_A5CZ HEK293 APPswe transformed cell line human CVCL_A5CZ CL:0000010 Transfected with: HGNC; 620; APP (with p.Lys670Asn and p.Met671Leu); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127228459 CVCL_A5CM CH12F3-2 cancer cell line house mouse CVCL_A5CM CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000027; Breed/subspecies: B10.H-2aH-4bp/Wts. 127228460 CVCL_A5CL U87DND cancer cell line human CVCL_A5CL CL:0000010 Sequence variation: Mutation; HGNC; 7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line). Population: Caucasian Male Characteristics: Exhibits a remarkably low competence at producing ceramide de novo (PubMed=27894925) Problematic cell line: Misidentified Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala. 127228461 CVCL_A5CN F180 finite cell line human CVCL_A5CN CL:0000010 Cell type: Fibroblast; CL=CL_0000057. 127228462 CVCL_A5CQ Hep-G2 VA-13 cancer cell line human CVCL_A5CQ CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: MGI; MGI:87921; Adh1; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 127228463 CVCL_A5CP F184 finite cell line human CVCL_A5CP CL:0000010 Cell type: Fibroblast; CL=CL_0000057. 127228464 CVCL_A5CS Hep-G2 VI-7 cancer cell line human CVCL_A5CS CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Control cell line for Hep-G2 VA-13 (Cellosaurus=CVCL_A5CQ) and Hep-G2 VA-28 (Cellosaurus=CVCL_A5CR) (PubMed=11981770) 127228465 CVCL_A5CR Hep-G2 VA-28 cancer cell line human CVCL_A5CR CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: MGI; MGI:87921; Adh1; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 127228466 CVCL_A5EG HEK293T-GIGYF1/2-null transformed cell line human CVCL_A5EG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 9126; GIGYF1; Knockout cell: Method=CRISPR/Cas9; HGNC; 11960; GIGYF2; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Transformant: Simian virus 40 (SV40) [Note=tsA](NCBI-Taxonomy; 1891767); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~30-40 hours (DSMZ=ACC-874) 127228467 CVCL_A5EF HEK293T-DDX6-null transformed cell line human CVCL_A5EF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 2747; DDX6; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Transformant: Simian virus 40 (SV40) [Note=tsA](NCBI-Taxonomy; 1891767); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~30-40 hours (DSMZ=ACC-873) 127228468 CVCL_A5EI HEK293T-XRN1-null transformed cell line human CVCL_A5EI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 30654; XRN1; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Transformant: Simian virus 40 (SV40) [Note=tsA](NCBI-Taxonomy; 1891767); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~24-30 hours (DSMZ=ACC-876) 127228469 CVCL_A5EH HEK293T-HELZ-null transformed cell line human CVCL_A5EH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 16878; HELZ; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Transformant: Simian virus 40 (SV40) [Note=tsA](NCBI-Taxonomy; 1891767); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Omics: Transcriptome analysis by RNAseq Female Doubling time: ~24-30 hours (DSMZ=ACC-875) 127228470 CVCL_A5EK NS46C somatic stem cell house mouse CVCL_A5EK CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: 129P2/Ola. Male Characteristics: Expresses eGFP under the control of the Sox-1 promoter Doubling time: ~24 hours (PubMed=16086633) 127228471 CVCL_A5EJ Quad-GL261 cancer cell line house mouse CVCL_A5EJ CL:0000010 Transfected with: HGNC; 10880; PMEL (with p.Met1_Leu18del and p.Arg40_Val661del); Transfected with: MGI; MGI:95900; H2-Ea (with p.Met1_Leu70del and p.Glu100_Leu255del); Transfected with: UniProtKB; P01012; Chicken ovalbumin (SERPINB14) (with p.Met1_Ser251del, p.Asn272_Ser317del and p.Glu347_Pro386del); Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: 3-methylcholanthrene (3-MC(ChEBI; CHEBI:34342); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: C57BL/6. Characteristics: Transfected with the Quad Ag cassette encoding four peptides presented by H-2b class I or II molecules as a single coding sequence The peptides are human PMEL/gp100 AA 25-33 (presented by H-2Db), chicken OVA epitope OT-I (AA 258-265; presented by H-2Kb), chicken OVA epitope OT-II (AA 324-340; presented by I-Ab) and mouse H2-Ea/I-Ea AA 77-93(52-68) (presented by I-Ab). To facilitate processing, each peptide is flanked on both sides by the 6 amino acid residues that surrounded the peptide in the corresponding native protein. 127228472 CVCL_A5EM Cor1 somatic stem cell house mouse CVCL_A5EM CL:0000010 Miscellaneous: Sex of donor from personal communication of ISENET Biobanking Derived from site: In situ; Embryonic brain, neocortex; UBERON=UBERON_0006237+UBERON_0001950; Cell type: Neural stem cell; CL=CL_0000047. Male 127228473 CVCL_A5EL CGR8-NS somatic stem cell house mouse CVCL_A5EL CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: 129P2/Ola. Male 127228474 CVCL_A5EA FAIK1-10 transformed cell line house mouse CVCL_A5EA CL:0000010 Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: B6D2;C57BL6N-Tg(EPO::Cre)1Rhw x B6.Cg-Gt(ROSA)26Sor/J). Omics: Transcriptome analysis by RNAseq 127228475 CVCL_A5EC FAIK3-5 transformed cell line house mouse CVCL_A5EC CL:0000010 Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: B6D2;C57BL6N-Tg(EPO::Cre)1hw x B6.Cg-Gt(ROSA)26Sor/J). Omics: Transcriptome analysis by RNAseq Female Characteristics: Produces Epo under hypoxia Doubling time: ~20-30 hours (DSMZ=ACC-861) 127228476 CVCL_A5EB FAIK2-5 transformed cell line house mouse CVCL_A5EB CL:0000010 Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: B6D2;C57BL6N-Tg(EPO::Cre)1Rhw x B6.Cg-Gt(ROSA)26Sor/J). Omics: Transcriptome analysis by RNAseq 127228477 CVCL_A5EE HEK293T-CAF40-null transformed cell line human CVCL_A5EE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 10445; CNOT9; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Transformant: Simian virus 40 (SV40) [Note=tsA](NCBI-Taxonomy; 1891767); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~30-40 hours (DSMZ=ACC-872) 127228478 CVCL_A5ED SB-28-Ohlfest cancer cell line house mouse CVCL_A5ED CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P08659; Firefly luciferase Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: C57BL/6. Omics: Deep exome analysis Characteristics: Glioma was induced by intraventricular transfection of pT2/C-Luc/PGK-SB100 and Sleeping Beauty (SB)-flanked pT2/CAG-NRasV12 and pT2/shp53/mPDGF Doubling time: ~30 hours (DSMZ=ACC-880) 127228479 CVCL_A5DV CB660SP somatic stem cell human CVCL_A5DV CL:0000010 Derived from site: In situ; Fetal spinal cord; UBERON=UBERON_0006241; Cell type: Neural stem cell; CL=CL_0000047. Female 127228480 CVCL_A5DU Sai3 somatic stem cell human CVCL_A5DU CL:0000010 Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277. Characteristics: Neuroepithelial stem cell 127228481 CVCL_A5DX O4ANS somatic stem cell house mouse CVCL_A5DX CL:0000010 Derived from site: In situ; Brain, subventricular zone; UBERON=UBERON_0014940; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: 129 x MF1. Female Doubling time: ~30 hours (PubMed=16766697) 127228482 CVCL_A5DW aNS-1 somatic stem cell house mouse CVCL_A5DW CL:0000010 Derived from site: In situ; Brain, subventricular zone; UBERON=UBERON_0014940; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: CD-1. Male Doubling time: ~30 hours (PubMed=16766697) 127228483 CVCL_A5DZ JK-6L.39L cancer cell line human CVCL_A5DZ CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7795; NFKB2; Simple; p.Arg725Glufs*18 (c.2171delC); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Tyr64Asp (c.190T>G); dbSNP=rs752508313; Zygosity=Unspecified (from parent cell line) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Produces low quantity of IgG kappa; Characteristics: IL6 independent 127228484 CVCL_A5DY JK-6L.31H cancer cell line human CVCL_A5DY CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7795; NFKB2; Simple; p.Arg725Glufs*18 (c.2171delC); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Tyr64Asp (c.190T>G); dbSNP=rs752508313; Zygosity=Unspecified (from parent cell line) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Produces high quantity of IgG kappa; Characteristics: IL6 independent 127228485 CVCL_A5DN WFS2_1 finite cell line human CVCL_A5DN CL:0000010 Sequence variation: Mutation; HGNC; 24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228486 CVCL_A5DM WFS2_2 finite cell line human CVCL_A5DM CL:0000010 Sequence variation: Mutation; HGNC; 24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228487 CVCL_A5DP MGM18004E finite cell line human CVCL_A5DP CL:0000010 Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228488 CVCL_A5DR F0075E finite cell line human CVCL_A5DR CL:0000010 Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228489 CVCL_A5DQ F0022E finite cell line human CVCL_A5DQ CL:0000010 Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228490 CVCL_A5DT Sai2 somatic stem cell human CVCL_A5DT CL:0000010 Miscellaneous: Sex of donor from personal communication of ISENET Biobanking Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277. Male Characteristics: Neuroepithelial stem cell 127228491 CVCL_A5DS Sai1 somatic stem cell human CVCL_A5DS CL:0000010 Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277. Male Characteristics: Neuroepithelial stem cell 127228492 CVCL_A5BD SW1573/S1neo cancer cell line human CVCL_A5BD CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228493 CVCL_A5BC SW1573/S1(MRP) cancer cell line human CVCL_A5BC CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Transfected with: HGNC; 51; ABCC1; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228494 CVCL_A5BF MCTs transformed cell line house mouse CVCL_A5BF CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Rib, cartilage; UBERON=UBERON_0006288; Cell type: Chondrocyte; CL=CL_0000138. 127228495 CVCL_A5BE SW1573/S1ou cancer cell line human CVCL_A5BE CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Transfected with: MGI; MGI:88105; Atp1a1 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228496 CVCL_A5BH Hepa 1-6/10R cancer cell line house mouse CVCL_A5BH CL:0000010 Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57L. Female 127228497 CVCL_A5BG Vero 2.2 spontaneously immortalized cell line green monkey CVCL_A5BG CL:0000010 Transfected with: UniProtKB; Q9J0X9; Human herpesvirus 1 (isolate KOS) ICP27 (UL54); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 127228498 CVCL_A5BJ WIF-B9 hybrid cell line CVCL_A5BJ CL:0000010 Doubling time: 2.6 +- 0.1 days (PubMed=17276572). 127228499 CVCL_A5BI LS174T/R cancer cell line human CVCL_A5BI CL:0000010 Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Female 127228500 CVCL_A5AZ GLC-4/ADRpr cancer cell line human CVCL_A5AZ CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line) Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Characteristics: Partial revertant of GLC-4/ADR obtained after culturing in drug-free medium for a number of months (3 according to PubMed=3040227 and 6 according to PubMed=7809167) 127228501 CVCL_A5BB SW1573/S1(MDR1) cancer cell line human CVCL_A5BB CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Transfected with: HGNC; 40; ABCB1 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR); Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228502 CVCL_A5BA SW1573/S1 cancer cell line human CVCL_A5BA CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228503 CVCL_A5AS B203L-CD80 cancer cell line human CVCL_A5AS CL:0000010 Transfected with: HGNC; 1700; CD80; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Unspecified 127228504 CVCL_A5AR B1203L-CD80 cancer cell line human CVCL_A5AR CL:0000010 Transfected with: HGNC; 1700; CD80; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228505 CVCL_A5AU Rosi EBV-B transformed cell line human CVCL_A5AU HLA typing: A*24:02,32:01; B*35:03,44:031; C*04:01,04:01 (PubMed=17131342) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228506 CVCL_A5AT B901L-CD80 cancer cell line human CVCL_A5AT CL:0000010 Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 1700; CD80; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228507 CVCL_A5AW HepG2.105 cancer cell line human CVCL_A5AW CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386). 127228508 CVCL_A5AV Huh7.93 cancer cell line human CVCL_A5AV CL:0000010 Sequence variation: Mutation; HGNC; 6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line); Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Japanese; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386). 127228509 CVCL_A5AY HMR10-3 conditionally immortalized cell line Norway rat CVCL_A5AY CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40) [Note=U19tsa](NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006237+UBERON_0002421; Breed/subspecies: Holtzman. Characteristics: Grows at the permissive temperature (33 Celsius) Differentiates to a neuronal phenotype at the nonpermissive temperature (39 Celsius). 127228510 CVCL_A5AX HepG2.117 cancer cell line human CVCL_A5AX CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386). 127228511 CVCL_A5AK G613M cancer cell line human CVCL_A5AK HLA typing: A*24:02,11:01; B*52:01,55:02; C*12:02,12:03 (PubMed=17131342). CL:0000010 Unspecified 127228512 CVCL_A5AJ Rosi cancer cell line human CVCL_A5AJ CL:0000010 Miscellaneous: Age/sex of donor and cancer type from personal communication of van Baren N Derived from site: Metastatic; Not specified. Male 127228513 CVCL_A5AM A904L-CD80 cancer cell line human CVCL_A5AM CL:0000010 Transfected with: HGNC; 1700; CD80; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228514 CVCL_A5AL A904-EBV-B transformed cell line human CVCL_A5AL HLA typing: A*24:02,26:03; B*07:02,39:01; C*07:02 (PubMed=15994973) CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228515 CVCL_A5AN A904L-A26 cancer cell line human CVCL_A5AN CL:0000010 Transfected with: HGNC; 1700; CD80; Transfected with: HGNC; 4931; HLA-A (allele A*26:03); Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228516 CVCL_A5AQ A529L-CD80 cancer cell line human CVCL_A5AQ CL:0000010 Transfected with: HGNC; 1700; CD80; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228517 CVCL_A5AP A904L-B39 cancer cell line human CVCL_A5AP CL:0000010 Transfected with: HGNC; 1700; CD80; Transfected with: HGNC; 4932; HLA-B (allele B*39:01); Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228518 CVCL_A5CE UNIPDi007-A induced pluripotent stem cell human CVCL_A5CE From: University of Padova; Padova; Italy CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228519 CVCL_A5CD UNIPDi006-A induced pluripotent stem cell human CVCL_A5CD From: University of Padova; Padova; Italy. CL:0000010 127228520 CVCL_A5CG CV-1 D 5.2 transformed cell line CVCL_A5CG CL:0000010 Transfected with: MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228521 CVCL_A5CF TEX transformed cell line human CVCL_A5CF CL:0000010 Transfected with: HGNC; 4010; FUS (FUS-ERG fusion); Transfected with: HGNC; 3446; ERG (FUS-ERG fusion); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptome analysis by microarray Unspecified Characteristics: Expresses a transfected FUS-ERG (TLS-ERG) fusion protein Mimics the features of primary human acute myeloid leukemia and of leukemia-initiating cells (LIC) and are more than 90% CD34+. Underwent step-wise transformation and immortalization through acquisition of additional genetic changes, such as expression of TERT, expression of LIC markers CD34, CD44 and CD123 and the stem cell gene BMI1 (PubMed=16094415; PubMed=22160482). 127228522 CVCL_A5CI CV-1 D 7.3 transformed cell line CVCL_A5CI CL:0000010 Transfected with: MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228523 CVCL_A5CH CV-1 D 6.1 transformed cell line CVCL_A5CH CL:0000010 Transfected with: MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228524 CVCL_A5CK CV-1 E 5.5 transformed cell line CVCL_A5CK CL:0000010 Transfected with: MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228525 CVCL_A5CJ CV-1 E 4.1 transformed cell line CVCL_A5CJ CL:0000010 Transfected with: MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228526 CVCL_A5CA PCIi026-A induced pluripotent stem cell human CVCL_A5CA From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228527 CVCL_A5CC PCIi028-A induced pluripotent stem cell human CVCL_A5CC From: Phenocell SAS; Grasse; France. CL:0000010 127228528 CVCL_A5CB PCIi027-A induced pluripotent stem cell human CVCL_A5CB From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228529 CVCL_A5BT Bm7brm cancer cell line human CVCL_A5BT CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Metastatic to brain Established from intracardiac injection of parent cell in SCID mice and cultured from brain tissue. 127228530 CVCL_A5BS Bm7 cancer cell line human CVCL_A5BS CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Metastatic to brain Established from intracardiac injection of parent cell in SCID mice and cultured from brain tissue. 127228531 CVCL_A5BV Hki-8 transformed cell line human CVCL_A5BV CL:0000010 Transfected with: HGNC; 8022; NT5C2; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127228532 CVCL_A5BU HKiG2 transformed cell line human CVCL_A5BU CL:0000010 Transfected with: HGNC; 8022; NT5C2; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transfected with a NT5C2 fused to EGFP 127228533 CVCL_A5BX UMCGi008-B induced pluripotent stem cell human CVCL_A5BX From: University Medical Center Groningen; Groningen; Netherlands CL:0000010 Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228534 CVCL_A5BW U937-ASPI3K cancer cell line human CVCL_A5BW CL:0000010 Sequence variation: Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line); Sequence variation: Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 795; ATM (anti-sense); Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Male 127228535 CVCL_A5BZ UMCGi008-D induced pluripotent stem cell human CVCL_A5BZ From: University Medical Center Groningen; Groningen; Netherlands CL:0000010 Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228536 CVCL_A5BY UMCGi008-C induced pluripotent stem cell human CVCL_A5BY From: University Medical Center Groningen; Groningen; Netherlands CL:0000010 Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228537 CVCL_A5BL WIF-B9/Rev hybrid cell line CVCL_A5BL CL:0000010 Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP). Characteristics: Established by culturing the parent cell line without cisplatin in the medium for 2 months Doubling time: 2.7 +- 0.1 days (PubMed=17276572) 127228538 CVCL_A5BK WIF-B9/R hybrid cell line CVCL_A5BK CL:0000010 Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP). Doubling time: 2.9 +- 0.3 days (PubMed=17276572) 127228539 CVCL_A5BN WIF12 hybrid cell line CVCL_A5BN CL:0000010 127228540 CVCL_A5BM WIF12-1 TGdelta hybrid cell line CVCL_A5BM CL:0000010 Karyotypic information: Has lost the human chromosome X; Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine. 127228541 CVCL_A5BP WIF12-6 hybrid cell line CVCL_A5BP CL:0000010 127228542 CVCL_A5BR CL1-5-F4-Luc cancer cell line human CVCL_A5BR CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228543 CVCL_A5BQ SCC-25/CP cancer cell line human CVCL_A5BQ CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Male 127228544 CVCL_A5AC A2780/m175 cancer cell line human CVCL_A5AC CL:0000010 Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 11998; TP53 (with p.Arg175His); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228545 CVCL_A5AB A2780/cmv cancer cell line human CVCL_A5AB CL:0000010 Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Unspecified (from parent cell line); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Characteristics: Control cell line for A2780/m175, A2780/m248 and A2780/m273 127228546 CVCL_A5AE A2780/m273 cancer cell line human CVCL_A5AE CL:0000010 Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 11998; TP53 (with p.Arg273His); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228547 CVCL_A5AD A2780/m248 cancer cell line human CVCL_A5AD CL:0000010 Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 11998; TP53 (with p.Arg248Trp); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228548 CVCL_A5AG 76N finite cell line human CVCL_A5AG CL:0000010 Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008359; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Omics: Transcriptome analysis by microarray Female 127228549 CVCL_A5AF Tera-CP cancer cell line human CVCL_A5AF CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male 127228550 CVCL_A5AI Mull cancer cell line human CVCL_A5AI CL:0000010 Miscellaneous: Age/sex of donor, exact cancer type and sampling site from personal communication of van Baren N Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072. Female 127228551 CVCL_A5AH 76N-F2V transformed cell line human CVCL_A5AH CL:0000010 Transfected with: UniProtKB; P03126; Human papillomavirus type 16 protein E6 (with p.Phe9Val) Transformant: Human papillomavirus type 16 (HPV16)(NCBI-Taxonomy; 333760); Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008359; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Omics: H2BK120ub ChIP-seq epigenome analysis; Omics: H3K23ac ChIP-seq epigenome analysis; Omics: H3K27ac ChIP-seq epigenome analysis; Omics: H3K27me3 ChIP-seq epigenome analysis; Omics: H3K36me3 ChIP-seq epigenome analysis; Omics: H3K4me1 ChIP-seq epigenome analysis; Omics: H3K4me3 ChIP-seq epigenome analysis; Omics: H3K79me2 ChIP-seq epigenome analysis; Omics: H3K9ac ChIP-seq epigenome analysis; Omics: H3K9me3 ChIP-seq epigenome analysis; Omics: H4K8ac ChIP-seq epigenome analysis Female 127228552 CVCL_A5AA PK-15(CD163) spontaneously immortalized cell line pig CVCL_A5AA CL:0000010 Transfected with: UniProtKB; E1AQW7; Pig CD163; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire. Male Characteristics: A construct containing a CMV promoter-pig CD163 and EF1a promoter-GFP-T2-Pac was transferred using a PiggyBac transposon vector; Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus type 1 and type 2 (PRRSV-1/2) 127228553 CVCL_A6NN MANCHO18-3C1 hybridoma house mouse CVCL_A6NN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228554 CVCL_A6NQ MANCHO3-8A4 hybridoma house mouse CVCL_A6NQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228555 CVCL_A6NP MANCHO2-9G3 hybridoma house mouse CVCL_A6NP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228556 CVCL_A6NS MANCHO5-4F11 hybridoma house mouse CVCL_A6NS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228557 CVCL_A6NR MANCHO4-2G5 hybridoma house mouse CVCL_A6NR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228558 CVCL_A6NU MANCHO7-7F3 hybridoma house mouse CVCL_A6NU CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228559 CVCL_A6NT MANCHO6-5A6 hybridoma house mouse CVCL_A6NT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228560 CVCL_A6NG MSH3MAB10-9B11 hybridoma house mouse CVCL_A6NG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228561 CVCL_A6NF MSH3MAB9-7A10 hybridoma house mouse CVCL_A6NF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228562 CVCL_A6NI MANCHO11-9F2 hybridoma house mouse CVCL_A6NI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228563 CVCL_A6NH MANCHO10-9E10 hybridoma house mouse CVCL_A6NH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228564 CVCL_A6NK MANCHO14-4E1 hybridoma house mouse CVCL_A6NK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228565 CVCL_A6NJ MANCHO13-2G12 hybridoma house mouse CVCL_A6NJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228566 CVCL_A6NM MANCHO17-4C8 hybridoma house mouse CVCL_A6NM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228567 CVCL_A6NL MANCHO15-5C3 hybridoma house mouse CVCL_A6NL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228568 CVCL_A6NA MSH3MAB4-8E6 hybridoma house mouse CVCL_A6NA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3 (Note=Also reacts with human). 127228569 CVCL_A6NC MSH3MAB6-5D6 hybridoma house mouse CVCL_A6NC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228570 CVCL_A6NB MSH3MAB5-7H12 hybridoma house mouse CVCL_A6NB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228571 CVCL_A6NE MSH3MAB8-2A9 hybridoma house mouse CVCL_A6NE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228572 CVCL_A6ND MSH3MAB7-9E11 hybridoma house mouse CVCL_A6ND CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228573 CVCL_A6MV MANFU11-3E4 hybridoma house mouse CVCL_A6MV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228574 CVCL_A6MU MANFU10-5H10 hybridoma house mouse CVCL_A6MU CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228575 CVCL_A6MX MSH3MAB1-1F6 hybridoma house mouse CVCL_A6MX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228576 CVCL_A6MW MANFU12-6B5 hybridoma house mouse CVCL_A6MW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228577 CVCL_A6MZ MSH3MAB3-5A5 hybridoma house mouse CVCL_A6MZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3 (Note=Also reacts with human). 127228578 CVCL_A6MY MSH3MAB2-2F11 hybridoma house mouse CVCL_A6MY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228579 CVCL_A6NW 45E10 hybridoma house mouse CVCL_A6NW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P35992; Drosophila melanogaster Ptp10D. 127228580 CVCL_A6NV 3B7B5 hybridoma house mouse CVCL_A6NV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9W266; Drosophila melanogaster wdp. 127228581 CVCL_A6NY 9D82B3 hybridoma house mouse CVCL_A6NY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16621; Drosophila melanogaster Lar. 127228582 CVCL_A6NX 4C71B7 hybridoma house mouse CVCL_A6NX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P35832; Drosophila melanogaster Ptp99A. 127228583 CVCL_A6NZ MANEX1A-4C7 hybridoma house mouse CVCL_A6NZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228584 CVCL_A6LM 6F9 hybridoma house mouse CVCL_A6LM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-1006 127228585 CVCL_A6LL 15G7 hybridoma house mouse CVCL_A6LL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. 127228586 CVCL_A6LN U2OS OPTN KO cancer cell line human CVCL_A6LN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 17142; OPTN; Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Miscellaneous: Cell line information from personal communication of Laflamme C Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127228587 CVCL_A6LQ U2OS TBK1 KO cancer cell line human CVCL_A6LQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 11584; TBK1; Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127228588 CVCL_A6LP U2OS SQSTM1 KO cancer cell line human CVCL_A6LP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 11280; SQSTM1; Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127228589 CVCL_A6LS MANSIX5A2-3B4 hybridoma house mouse CVCL_A6LS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228590 CVCL_A6LR MANSIX5A1-2A6 hybridoma house mouse CVCL_A6LR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228591 CVCL_A6LE 11/9 hybridoma house mouse CVCL_A6LE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127228592 CVCL_A6LD 182-D1106-362 hybridoma house mouse CVCL_A6LD CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized IMAB362 (claudiximab; zolbetuximab) therapeutic antibody Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2810 127228593 CVCL_A6LG 1D4 [Mouse hybridoma against Drosophila fas2] hybridoma house mouse CVCL_A6LG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P34082; Drosophila melanogaster fas2. 127228594 CVCL_A6LF 10C9 [Mouse hybridoma against Drosophila lmb] hybridoma house mouse CVCL_A6LF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q24188; Drosophila melanogaster lbm. 127228595 CVCL_A6LI BP102 hybridoma house mouse CVCL_A6LI CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Drosophila melanogaster CNS axons. 127228596 CVCL_A6LH 23C7 hybridoma house mouse CVCL_A6LH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; M9PE88; Drosophila melanogaster wit. 127228597 CVCL_A6LK 15C12 hybridoma house mouse CVCL_A6LK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. 127228598 CVCL_A6LJ MDA-MB-435S/1 cancer cell line human CVCL_A6LJ CL:0000010 Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072. Male Problematic cell line: Contaminated Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative. 127228599 CVCL_A6LA 182-D1106-061 hybridoma house mouse CVCL_A6LA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2748 127228600 CVCL_A6LC 182-D1106-294 hybridoma house mouse CVCL_A6LC CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2809 127228601 CVCL_A6LB 182-D1106-279 hybridoma house mouse CVCL_A6LB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2808 127228602 CVCL_A6KT 182-D1106-058 hybridoma house mouse CVCL_A6KT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2740 127228603 CVCL_A6KS 182-D1106-057 hybridoma house mouse CVCL_A6KS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2739 127228604 CVCL_A6KV 182-D1106-062 hybridoma house mouse CVCL_A6KV CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2742 127228605 CVCL_A6KU 182-D1106-059 hybridoma house mouse CVCL_A6KU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2741 127228606 CVCL_A6KX 182-D758-035 hybridoma house mouse CVCL_A6KX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2745 127228607 CVCL_A6KW 182-D1106-067 hybridoma house mouse CVCL_A6KW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2743 127228608 CVCL_A6KZ 182-D758-040 hybridoma house mouse CVCL_A6KZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2747 127228609 CVCL_A6KY 182-D758-036 hybridoma house mouse CVCL_A6KY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2746 127228610 CVCL_A6MN MANFU4-3C7 hybridoma house mouse CVCL_A6MN CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228611 CVCL_A6MM MANFU3-4E6 hybridoma house mouse CVCL_A6MM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228612 CVCL_A6MP MANFU5-7H2 hybridoma house mouse CVCL_A6MP CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228613 CVCL_A6MR MANFU7-1B5 hybridoma house mouse CVCL_A6MR CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228614 CVCL_A6MQ MANFU6-4H8 hybridoma house mouse CVCL_A6MQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228615 CVCL_A6MT MANFU9-4E12 hybridoma house mouse CVCL_A6MT CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228616 CVCL_A6MS MANFU8-2F5 hybridoma house mouse CVCL_A6MS CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228617 CVCL_A6MF MANSIX5B3-10D2 hybridoma house mouse CVCL_A6MF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228618 CVCL_A6ME MANSIX5B2-10B3 hybridoma house mouse CVCL_A6ME CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228619 CVCL_A6MH MANSIX5C2a-6C1 hybridoma house mouse CVCL_A6MH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228620 CVCL_A6MG MANSIX5B4-9G10 hybridoma house mouse CVCL_A6MG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228621 CVCL_A6MJ DAG-6F4 hybridoma house mouse CVCL_A6MJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (AA 30-653 = Alpha-dystroglycan) (Note=Also reacts with mouse). 127228622 CVCL_A6MI MANSIX5C2b-3A1 hybridoma house mouse CVCL_A6MI CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228623 CVCL_A6ML MANFU2-10F9 hybridoma house mouse CVCL_A6ML CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228624 CVCL_A6MK MANFU1-7A2 hybridoma house mouse CVCL_A6MK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228625 CVCL_A6MB MANSIX5A11-2H1 hybridoma house mouse CVCL_A6MB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228626 CVCL_A6MA MANSIX5A10-4H7 hybridoma house mouse CVCL_A6MA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228627 CVCL_A6MD MANSIX5B1-6E10 hybridoma house mouse CVCL_A6MD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228628 CVCL_A6MC MANSIX5A12-4E7 hybridoma house mouse CVCL_A6MC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228629 CVCL_A6LU MANSIX5A4-3E11 hybridoma house mouse CVCL_A6LU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228630 CVCL_A6LT MANSIX5A3-3D9 hybridoma house mouse CVCL_A6LT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5 127228631 CVCL_A6LW MANSIX5A6-1C11 hybridoma house mouse CVCL_A6LW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228632 CVCL_A6LV MANSIX5A5-10B12 hybridoma house mouse CVCL_A6LV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228633 CVCL_A6LY MANSIX5A8-7G4 hybridoma house mouse CVCL_A6LY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228634 CVCL_A6LX MANSIX5A7-3G10 hybridoma house mouse CVCL_A6LX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228635 CVCL_A6LZ MANSIX5A9-2G8 hybridoma house mouse CVCL_A6LZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228636 CVCL_A6JK NU-RMESO-9 cancer cell line Norway rat CVCL_A6JK CL:0000010 Transformant: Crocidolite asbestos(ChEBI; CHEBI:46666). 127228637 CVCL_A6JJ NU-RMESO-2 cancer cell line Norway rat CVCL_A6JJ CL:0000010 Transformant: Crocidolite asbestos(ChEBI; CHEBI:46666). 127228638 CVCL_A6JM NU-RMESO-20 cancer cell line Norway rat CVCL_A6JM CL:0000010 Transformant: Crocidolite asbestos(ChEBI; CHEBI:46666). 127228639 CVCL_A6JL NU-RMESO-14 cancer cell line Norway rat CVCL_A6JL CL:0000010 Transformant: Crocidolite asbestos(ChEBI; CHEBI:46666). 127228640 CVCL_A6JN NU-RMESO-26 cancer cell line Norway rat CVCL_A6JN CL:0000010 Transformant: Crocidolite asbestos(ChEBI; CHEBI:46666). 127228641 CVCL_A6JQ NU-RMESO-79 cancer cell line Norway rat CVCL_A6JQ CL:0000010 Transformant: Crocidolite asbestos(ChEBI; CHEBI:46666). 127228642 CVCL_A6JP NU-RMESO-40 cancer cell line Norway rat CVCL_A6JP CL:0000010 Transformant: Crocidolite asbestos(ChEBI; CHEBI:46666). 127228643 CVCL_A6JC MUi022-A induced pluripotent stem cell human CVCL_A6JC From: Mahidol University; Bangkok; Thailand. CL:0000010 127228644 CVCL_A6JB MUi024-A induced pluripotent stem cell human CVCL_A6JB From: Mahidol University; Bangkok; Thailand. CL:0000010 127228645 CVCL_A6JE SDR-P-1D5 finite cell line Norway rat CVCL_A6JE CL:0000010 Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007; Breed/subspecies: Spontaneous dwarf rat (SDR). 127228646 CVCL_A6JD SDRL-2 finite cell line Norway rat CVCL_A6JD CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Spontaneous dwarf rat (SDR). 127228647 CVCL_A6JG IWT-1 cancer cell line human CVCL_A6JG CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; ClinVar=VCV001074338; Zygosity=Unspecified (PubMed=24587255) Population: Japanese; Derived from site: In situ; Ascites; UBERON=UBERON_0007795. Male 127228648 CVCL_A6JF MSH-P3 finite cell line pig CVCL_A6JF CL:0000010 Derived from site: In situ; Fetal pituitary gland; UBERON=UBERON_0034875; Breed/subspecies: Miniature pig. Unspecified Characteristics: Secretes prolactin (PubMed=29949606) 127228649 CVCL_A6JI bTS11 somatic stem cell human CVCL_A6JI CL:0000010 Male Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4941); Doubling time: 21.7 +- 3.0 hours (PubMed=29249463). 127228650 CVCL_A6JH bTS5 somatic stem cell human CVCL_A6JH CL:0000010 Female Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4940); Doubling time: 22.6 +- 2.5 hours (PubMed=29249463). 127228651 CVCL_A6IZ MUi026-A induced pluripotent stem cell human CVCL_A6IZ From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; 9008; PKD1; Simple; p.Gln1960Ter (c.5878C>T); ClinVar=VCV000562298; Zygosity=Heterozygous (PubMed=33799277) Population: Southeast Asian; Thai; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228652 CVCL_A6IY ZZUNEUi021-A induced pluripotent stem cell human CVCL_A6IY From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 11949; TNNT2; Simple; p.Arg140Cys (c.418C>T); ClinVar=VCV000043636; Zygosity=Heterozygous (PubMed=34929444) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228653 CVCL_A6JA MUi027-A induced pluripotent stem cell human CVCL_A6JA From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; 9008; PKD1; Simple; c.7946_7947delCT; Zygosity=Heterozygous (PubMed=35629189) Population: Southeast Asian; Thai; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228654 CVCL_A6IR FA-AML1C cancer cell line human CVCL_A6IR CL:0000010 Sequence variation: Mutation; HGNC; 1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12750298); Sequence variation: Mutation; HGNC; 1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted (PubMed=12750298) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: IL3 dependent 127228655 CVCL_A6IQ FA-AML1 cancer cell line human CVCL_A6IQ CL:0000010 Sequence variation: Mutation; HGNC; 1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12750298); Sequence variation: Mutation; HGNC; 1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted (PubMed=12750298) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: CSF2 and IL3 dependent 127228656 CVCL_A6IT IBL-SLO-7B spontaneously immortalized cell line CVCL_A6IT CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: 20.8 hours (Note=At 28 Celsius) (DOI=10.1303/aez.32.179); 28.45 hours (DOI=10.6660/TESFE.1999004) Group: Insect cell line 127228657 CVCL_A6IS COL [Human plasma cell myeloma] cancer cell line human CVCL_A6IS CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228658 CVCL_A6IV SNU-899 R1 cancer cell line human CVCL_A6IV CL:0000010 Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Heterozygous (from parent cell line) Population: Korean; Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Larynx; UBERON=UBERON_0001737. Male 127228659 CVCL_A6IU PNUH-12 R1 cancer cell line human CVCL_A6IU CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Unspecified (from parent cell line) Population: Korean; Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP); Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051. Female 127228660 CVCL_A6IX ZZUNEUi022-A induced pluripotent stem cell human CVCL_A6IX From: Zhengzhou University First Affiliated Hospital; Zhengzhou; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228661 CVCL_A6IW MDCK-UT-A1 spontaneously immortalized cell line dog CVCL_A6IW CL:0000010 Transfected with: HGNC; 10919; SLC14A2 (isoform UT-A1); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00722; Escherichia coli lacZ; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female Characteristics: Transfected with the pFRT/lacZeo and pcDNA5/FRT/UT-A1 plasmids 127228662 CVCL_A6KL 2E12 [Human/mouse hybridoma] hybridoma CVCL_A6KL CL:0000010 Monoclonal antibody isotype: IgM. 127228663 CVCL_A6KK TM-1 [Human leukemia] cancer cell line human CVCL_A6KK CL:0000010 Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. 127228664 CVCL_A6KN 3E9 [Human/mouse hybridoma against leukemia cell surface antigen] hybridoma CVCL_A6KN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human leukemia cell surface antigen. 127228665 CVCL_A6KM 3E10 [Human/mouse hybridoma] hybridoma CVCL_A6KM CL:0000010 Monoclonal antibody isotype: IgM. 127228666 CVCL_A6KP BD9-D12 hybridoma house mouse CVCL_A6KP CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: Human antigen on A-549 lung cancer cells. 127228667 CVCL_A6KR 182-D1106-056 hybridoma house mouse CVCL_A6KR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2738 127228668 CVCL_A6KQ 182-D1106-055 hybridoma house mouse CVCL_A6KQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2737 127228669 CVCL_A6KD RF-S1 hybrid cell line CVCL_A6KD CL:0000010 Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine. Group: Hybridoma fusion partner cell line 127228670 CVCL_A6KC APM-3 hybridoma house mouse CVCL_A6KC CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI:34905; Paraquat. 127228671 CVCL_A6KF MAb-G2 hybridoma CVCL_A6KF CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228672 CVCL_A6KE MAb-G1 hybridoma CVCL_A6KE CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228673 CVCL_A6KH MAb-G4 hybridoma CVCL_A6KH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228674 CVCL_A6KG MAb-G3 hybridoma CVCL_A6KG CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228675 CVCL_A6KJ A4H12 cancer cell line human CVCL_A6KJ CL:0000010 Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Group: Hybridoma fusion partner cell line 127228676 CVCL_A6KI MAb-G6 hybridoma CVCL_A6KI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228677 CVCL_A6JZ PQXB2/2 hybridoma house mouse CVCL_A6JZ CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI:34905; Paraquat. 127228678 CVCL_A6KB APM-2 hybridoma house mouse CVCL_A6KB CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI:34905; Paraquat. 127228679 CVCL_A6KA APM-1 hybridoma house mouse CVCL_A6KA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI:34905; Paraquat. 127228680 CVCL_A6JS rasSFME transformed cell line house mouse CVCL_A6JS CL:0000010 Transfected with: HGNC; 5173; HRAS (with p.Gly12Val) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Group: Serum/protein free medium cell line 127228681 CVCL_A6JR ChR2-C2C12 spontaneously immortalized cell line house mouse CVCL_A6JR CL:0000010 Transfected with: UniProtKB; Q8RUT8; Chlamydomonas reinhardtii channelrhodopsin-2 (cop4); Transfected with: Venus, a bright yellow fluorescent protein derived from YFP Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Female 127228682 CVCL_A6JU r/mHM-SFME-1 transformed cell line house mouse CVCL_A6JU CL:0000010 Transfected with: HGNC; 5173; HRAS (with p.Gly12Val); Transfected with: MGI; MGI:97250; Myc Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Established after 7 passages of the original cell line into BALB/c mice; Characteristics: Spontaneously metastasize into the lungs of syngeneic mice when injected subcutaneously Group: Serum/protein free medium cell line 127228683 CVCL_A6JT ras/mycSFME transformed cell line house mouse CVCL_A6JT CL:0000010 Transfected with: HGNC; 5173; HRAS (with p.Gly12Val); Transfected with: MGI; MGI:97250; Myc Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Group: Serum/protein free medium cell line 127228684 CVCL_A6JW KDS 101-2 hybridoma house mouse CVCL_A6JW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02788; Human LTF. 127228685 CVCL_A6JV KDS 101-1 hybridoma house mouse CVCL_A6JV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02788; Human LTF. 127228686 CVCL_A6JY PQXB1/2 hybridoma house mouse CVCL_A6JY CL:0000010 Discontinued: ECACC; 89050503; true. Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI:34905; Paraquat 127228687 CVCL_A6JX KDS 301-1 hybridoma house mouse CVCL_A6JX CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P24627; Bovine LTF. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8852 127228688 CVCL_A6HI LO-DNP-68 hybridoma Norway rat CVCL_A6HI CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228689 CVCL_A6HH LO-DNP-66 hybridoma Norway rat CVCL_A6HH CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228690 CVCL_A6HK LO-DNP-9 hybridoma Norway rat CVCL_A6HK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228691 CVCL_A6HJ LO-DNP-7 hybridoma Norway rat CVCL_A6HJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228692 CVCL_A6HM LO-DNP-58 hybridoma Norway rat CVCL_A6HM CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228693 CVCL_A6HL LO-DNP-41 hybridoma Norway rat CVCL_A6HL CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228694 CVCL_A6HN LO-DNP-67 hybridoma Norway rat CVCL_A6HN CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228695 CVCL_A6HA LO-DNP-47 hybridoma Norway rat CVCL_A6HA CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228696 CVCL_A6HC LO-DNP-49 hybridoma Norway rat CVCL_A6HC CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228697 CVCL_A6HB LO-DNP-48 hybridoma Norway rat CVCL_A6HB CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228698 CVCL_A6HE LO-DNP-55 hybridoma Norway rat CVCL_A6HE CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228699 CVCL_A6HD LO-DNP-51 hybridoma Norway rat CVCL_A6HD CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228700 CVCL_A6HG LO-DNP-62 hybridoma Norway rat CVCL_A6HG CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228701 CVCL_A6HF LO-DNP-56 hybridoma Norway rat CVCL_A6HF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228702 CVCL_A6GX LO-DNP-39 hybridoma Norway rat CVCL_A6GX CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228703 CVCL_A6GW LO-DNP-3 hybridoma Norway rat CVCL_A6GW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228704 CVCL_A6GZ LO-DNP-44 hybridoma Norway rat CVCL_A6GZ CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228705 CVCL_A6GY LO-DNP-4 hybridoma Norway rat CVCL_A6GY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228706 CVCL_A6GP LO-DNP-10 hybridoma Norway rat CVCL_A6GP CL:0000010 Monoclonal antibody isotype: IgE, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228707 CVCL_A6GR LO-DNP-34 hybridoma Norway rat CVCL_A6GR CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228708 CVCL_A6GQ LO-DNP-30 hybridoma Norway rat CVCL_A6GQ CL:0000010 Monoclonal antibody isotype: IgE, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228709 CVCL_A6GT LO-DNP-15 hybridoma Norway rat CVCL_A6GT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228710 CVCL_A6GS LO-DNP-40 hybridoma Norway rat CVCL_A6GS CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228711 CVCL_A6GV LO-DNP-22 hybridoma Norway rat CVCL_A6GV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228712 CVCL_A6GU LO-DNP-20 hybridoma Norway rat CVCL_A6GU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228713 CVCL_A6IJ FRTL-5/T transformed cell line Norway rat CVCL_A6IJ CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer. Unspecified Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5 in C3H nu/nu nude mice (PubMed=1694496) 127228714 CVCL_A6II FRT-L KiKi transformed cell line Norway rat CVCL_A6II CL:0000010 Transformant: Kirsten murine sarcoma virus (Ki-MSV)(NCBI-Taxonomy; 11808); Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer. Unspecified 127228715 CVCL_A6IL FRTL-5/TP transformed cell line Norway rat CVCL_A6IL CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer. Unspecified Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5/T in C3H nu/nu nude mice (PubMed=1694496) 127228716 CVCL_A6IK FRTL-5/TA transformed cell line Norway rat CVCL_A6IK CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer. Unspecified Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5/T in C3H nu/nu nude mice (PubMed=1694496) 127228717 CVCL_A6IN 5UD5 transformed cell line Norway rat CVCL_A6IN CL:0000010 Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer. Unspecified Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10849 127228718 CVCL_A6IM FRA cancer cell line Norway rat CVCL_A6IM CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Fischer. 127228719 CVCL_A6IP HNTB-2K finite cell line human CVCL_A6IP CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Cell type: Follicular cell; CL=CL_0002258. Unspecified Doubling time: 69 hours (Note=At 45th passage) (PubMed=8090760) 127228720 CVCL_A6IB OM-B hybridoma house mouse CVCL_A6IB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen. 127228721 CVCL_A6IA OM-A hybridoma house mouse CVCL_A6IA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen. 127228722 CVCL_A6ID FRT-U10 spontaneously immortalized cell line Norway rat CVCL_A6ID CL:0000010 Transfected with: HGNC; 1706; CD8A; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. Unspecified 127228723 CVCL_A6IC OM-C hybridoma house mouse CVCL_A6IC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen. 127228724 CVCL_A6IF CW39-1B10 hybridoma house mouse CVCL_A6IF CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P56202; Human CTSW. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2511 127228725 CVCL_A6IE FRT spontaneously immortalized cell line Norway rat CVCL_A6IE CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer. Unspecified 127228726 CVCL_A6IH CW40-1B1 hybridoma house mouse CVCL_A6IH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P56202; Human CTSW. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2513 127228727 CVCL_A6IG CW39-2B6 hybridoma house mouse CVCL_A6IG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P56202; Human CTSW. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2512 127228728 CVCL_A6HY HH09A3 hybridoma human CVCL_A6HY CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC). 127228729 CVCL_A6HX HH09A2 hybridoma human CVCL_A6HX CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC). 127228730 CVCL_A6HZ 71-5.2F9 hybridoma CVCL_A6HZ CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human gastric carcinoma cell surface carbohydrate epitope. 127228731 CVCL_A6HQ WIL2 AGr9 clone 35-1 transformed cell line human CVCL_A6HQ CL:0000010 Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Male 127228732 CVCL_A6HP LO-DNP-65 hybridoma Norway rat CVCL_A6HP CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127228733 CVCL_A6HS WIL2 MTI-TG transformed cell line human CVCL_A6HS CL:0000010 Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:44081; 6-methylthioinosine (6-methylmercaptopurine riboside); Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Male 127228734 CVCL_A6HR WIL2 MTIr-107 transformed cell line human CVCL_A6HR CL:0000010 Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:44081; 6-methylthioinosine (6-methylmercaptopurine riboside); Transformant: Ethyl methanesulfonate (Methylsulfonic acid ethyl ester(ChEBI; CHEBI:23994); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Male 127228735 CVCL_A6HU WIL2 H35.1.1 transformed cell line human CVCL_A6HU CL:0000010 Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Male Group: Hybridoma fusion partner cell line 127228736 CVCL_A6HT WIL2 AGr9 clone 3-1 transformed cell line human CVCL_A6HT CL:0000010 Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Male 127228737 CVCL_A6HW MAC 40/43 hybridoma human CVCL_A6HW CL:0000010 Monoclonal antibody isotype: IgM, lambda; Monoclonal antibody target: Human breast cancer cells 47 kDa glycoprotein. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 86111001 127228738 CVCL_A6HV 0467.3 transformed cell line human CVCL_A6HV CL:0000010 Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Group: Hybridoma fusion partner cell line 127228739 CVCL_A6VW MDCK-II Rab29-KO spontaneously immortalized cell line dog CVCL_A6VW CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45270; RAB29 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228740 CVCL_A6VV MDCK-II Rab28-KO spontaneously immortalized cell line dog CVCL_A6VV CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45269; RAB28 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228741 CVCL_A6VY MDCK-II Rab30-KO spontaneously immortalized cell line dog CVCL_A6VY CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45273; RAB30 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228742 CVCL_A6VX MDCK-II Rab3-KO spontaneously immortalized cell line dog CVCL_A6VX CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45282; RAB3A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45283; RAB3B; Knockout cell: Method=CRISPR/Cas9; VGNC; 45284; RAB3C; Knockout cell: Method=CRISPR/Cas9; VGNC; 45285; RAB3D Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228743 CVCL_A6VZ MDCK-II Rab32/38-KO spontaneously immortalized cell line dog CVCL_A6VZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 53757; RAB32; Knockout cell: Method=CRISPR/Cas9; VGNC; 45280; RAB38 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228744 CVCL_A6VN MDCK-II Rab22-KO spontaneously immortalized cell line dog CVCL_A6VN CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45262; RAB22A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45274; RAB31 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228745 CVCL_A6VQ MDCK-II Rab24-KO spontaneously immortalized cell line dog CVCL_A6VQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45264; RAB24 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228746 CVCL_A6VP MDCK-II Rab23-KO spontaneously immortalized cell line dog CVCL_A6VP CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45263; RAB23 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228747 CVCL_A6VS MDCK-II Rab26-KO spontaneously immortalized cell line dog CVCL_A6VS CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45266; RAB26 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228748 CVCL_A6VR MDCK-II Rab25-KO spontaneously immortalized cell line dog CVCL_A6VR CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45265; RAB25 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228749 CVCL_A6VU MDCK-II Rab27-KO spontaneously immortalized cell line dog CVCL_A6VU CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45267; RAB27A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45268; RAB27B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228750 CVCL_A6VT MDCK-II Rab26/37-KO spontaneously immortalized cell line dog CVCL_A6VT CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45266; RAB26; Knockout cell: Method=CRISPR/Cas9; VGNC; 45279; RAB37 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228751 CVCL_A6VG MDCK-II Rab19-KO spontaneously immortalized cell line dog CVCL_A6VG CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45258; RAB19 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228752 CVCL_A6VF MDCK-II Rab18-KO spontaneously immortalized cell line dog CVCL_A6VF CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45257; RAB18 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228753 CVCL_A6VI MDCK-II Rab1A-KO spontaneously immortalized cell line dog CVCL_A6VI CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45259; RAB1A Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228754 CVCL_A6VH MDCK-II Rab19/43-KO spontaneously immortalized cell line dog CVCL_A6VH CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45258; RAB19; Knockout cell: Method=CRISPR/Cas9; VGNC; 45289; RAB43 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228755 CVCL_A6VK MDCK-II Rab2-KO spontaneously immortalized cell line dog CVCL_A6VK CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45271; RAB2A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45272; RAB2B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228756 CVCL_A6VJ MDCK-II Rab1B-KO spontaneously immortalized cell line dog CVCL_A6VJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 52037; RAB1B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228757 CVCL_A6VM MDCK-II Rab21-KO spontaneously immortalized cell line dog CVCL_A6VM CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45261; RAB21 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228758 CVCL_A6VL MDCK-II Rab20-KO spontaneously immortalized cell line dog CVCL_A6VL CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45260; RAB20 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228759 CVCL_A6VA MDCK-II Rab12-KO spontaneously immortalized cell line dog CVCL_A6VA CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 103700; RAB12 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228760 CVCL_A6VC MDCK-II Rab14-KO spontaneously immortalized cell line dog CVCL_A6VC CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45254; RAB14 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228761 CVCL_A6VB MDCK-II Rab13-KO spontaneously immortalized cell line dog CVCL_A6VB CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45253; RAB13 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228762 CVCL_A6VE MDCK-II Rab17-KO spontaneously immortalized cell line dog CVCL_A6VE CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45256; RAB17 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228763 CVCL_A6VD MDCK-II Rab15-KO spontaneously immortalized cell line dog CVCL_A6VD CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45255; RAB15 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228764 CVCL_A6WX ECCD-2 hybridoma CVCL_A6WX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P09803; Mouse Cdh1/Cd324. 127228765 CVCL_A6WW ECCD-1 hybridoma CVCL_A6WW CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P09803; Mouse Cdh1/Cd324. 127228766 CVCL_A6WZ NCC-CAD-299 hybridoma house mouse CVCL_A6WZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P22223; Human CDH3. 127228767 CVCL_A6WY HECD-1 hybridoma house mouse CVCL_A6WY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. 127228768 CVCL_A6WP MDCK-II Rab6-KO spontaneously immortalized cell line dog CVCL_A6WP CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 59055; RAB6A; Knockout cell: Method=CRISPR/Cas9; VGNC; 59057; RAB6B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228769 CVCL_A6WR MDCK-II Rab7B-KO spontaneously immortalized cell line dog CVCL_A6WR CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45294; RAB7B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228770 CVCL_A6WQ MDCK-II Rab7A-KO spontaneously immortalized cell line dog CVCL_A6WQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45293; RAB7A Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228771 CVCL_A6WT MDCK-II Rab9-KO spontaneously immortalized cell line dog CVCL_A6WT CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45297; RAB9A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45298; RAB9B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228772 CVCL_A6WS MDCK-II Rab8-KO spontaneously immortalized cell line dog CVCL_A6WS CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45295; RAB8A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45296; RAB8B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228773 CVCL_A6WV MDCK-II Rab7AB-KO spontaneously immortalized cell line dog CVCL_A6WV CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45293; RAB7A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45294; RAB7B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228774 CVCL_A6WU MDCK-II Rab7A/9-KO spontaneously immortalized cell line dog CVCL_A6WU CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45293; RAB7A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45297; RAB9A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45298; RAB9B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228775 CVCL_A6WH MDCK-II Rab39/42-KO spontaneously immortalized cell line dog CVCL_A6WH CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; -; RAB39A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45281; RAB39B; Knockout cell: Method=CRISPR/Cas9; VGNC; -; RAB42 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228776 CVCL_A6WG MDCK-II Rab39-KO spontaneously immortalized cell line dog CVCL_A6WG CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; -; RAB39A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45281; RAB39B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228777 CVCL_A6WJ MDCK-II Rab40-KO spontaneously immortalized cell line dog CVCL_A6WJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; -; RAB40B; Knockout cell: Method=CRISPR/Cas9; VGNC; -; RAB40C Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228778 CVCL_A6WI MDCK-II Rab4-KO spontaneously immortalized cell line dog CVCL_A6WI CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45290; RAB4A; Knockout cell: Method=CRISPR/Cas9; VGNC; 53756; RAB4B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228779 CVCL_A6WL MDCK-II Rab43-KO spontaneously immortalized cell line dog CVCL_A6WL CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45289; RAB43 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228780 CVCL_A6WK MDCK-II Rab42-KO spontaneously immortalized cell line dog CVCL_A6WK CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; -; RAB42 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228781 CVCL_A6WN MDCK-II Rab5C-KO spontaneously immortalized cell line dog CVCL_A6WN CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 55798; RAB5C Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228782 CVCL_A6WM MDCK-II Rab5AB-KO spontaneously immortalized cell line dog CVCL_A6WM CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45291; RAB5A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45292; RAB5B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228783 CVCL_A6WB MDCK-II Rab34-KO spontaneously immortalized cell line dog CVCL_A6WB CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45277; RAB34 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228784 CVCL_A6WA MDCK-II Rab33-KO spontaneously immortalized cell line dog CVCL_A6WA CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45275; RAB33A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45276; RAB33B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228785 CVCL_A6WD MDCK-II Rab35-KO spontaneously immortalized cell line dog CVCL_A6WD CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45278; RAB35 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228786 CVCL_A6WC MDCK-II Rab34/36-KO spontaneously immortalized cell line dog CVCL_A6WC CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45277; RAB34; Knockout cell: Method=CRISPR/Cas9; VGNC; 49953; RAB36 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228787 CVCL_A6WF MDCK-II Rab37-KO spontaneously immortalized cell line dog CVCL_A6WF CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45279; RAB37 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228788 CVCL_A6WE MDCK-II Rab36-KO spontaneously immortalized cell line dog CVCL_A6WE CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 49953; RAB36 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228789 CVCL_A6TT ED-40810(-) cancer cell line human CVCL_A6TT CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Lost its original IL2 dependency 127228790 CVCL_A6TW ED-70423C(-) cancer cell line human CVCL_A6TW CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Lost its original IL2 dependency 127228791 CVCL_A6TV ED-41214(-) cancer cell line human CVCL_A6TV CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228792 CVCL_A6TY T3 [Human LCL] transformed cell line human CVCL_A6TY CL:0000010 Population: Japanese; Karyotypic information: 46,XX,add(19)(p13) (PubMed=15262425); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228793 CVCL_A6TX N6803-2 transformed cell line human CVCL_A6TX CL:0000010 Population: Japanese; Karyotypic information: 47,XY,dup(1)(25q32),add(4)(q35),+12,add(18)(p11),add(20)(q13.3) (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228794 CVCL_A6TZ T3-2 [Human type 2 diabetes] transformed cell line human CVCL_A6TZ CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228795 CVCL_A6TM Sez507 cancer cell line human CVCL_A6TM CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Characteristics: IL2 dependent 127228796 CVCL_A6TL SezM3(-) transformed cell line human CVCL_A6TL CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Lost its original IL2 dependency 127228797 CVCL_A6TN ATL-72b(-) transformed cell line human CVCL_A6TN CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228798 CVCL_A6TQ ATL-21C(-)/3.8 transformed cell line human CVCL_A6TQ CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency Cultured for 3.8 years without IL2. 127228799 CVCL_A6TP ATL-21C(-)/8.9 transformed cell line human CVCL_A6TP CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency Cultured for 8.9 years without IL2. 127228800 CVCL_A6TS CATL-3 transformed cell line human CVCL_A6TS CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Characteristics: IL2 dependent 127228801 CVCL_A6TR CATL-2 transformed cell line human CVCL_A6TR CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Characteristics: IL2 dependent 127228802 CVCL_A6TE ATL-72/2(-) transformed cell line human CVCL_A6TE CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228803 CVCL_A6TD ATL-45T transformed cell line human CVCL_A6TD CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228804 CVCL_A6TG Sez627(-) cancer cell line human CVCL_A6TG CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Lost its original IL2 dependency 127228805 CVCL_A6TF ATL-2(-) transformed cell line human CVCL_A6TF CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228806 CVCL_A6TI ATL-21C(-)/2 transformed cell line human CVCL_A6TI CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency Cultured for 2 years without IL2. 127228807 CVCL_A6TH ED-50823(-) transformed cell line human CVCL_A6TH CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Lost its original IL2 dependency 127228808 CVCL_A6TK SezM3 transformed cell line human CVCL_A6TK CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: IL2 dependent 127228809 CVCL_A6TJ SezM transformed cell line human CVCL_A6TJ CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: IL2 dependent 127228810 CVCL_A6TA ATL-72/2 transformed cell line human CVCL_A6TA CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228811 CVCL_A6TC ATL-72T transformed cell line human CVCL_A6TC CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228812 CVCL_A6TB ATL-72b transformed cell line human CVCL_A6TB CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228813 CVCL_A6UV RMM-A1 cancer cell line Norway rat CVCL_A6UV CL:0000010 Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757; Breed/subspecies: Fischer 344. Male Characteristics: Tumorigenic 127228814 CVCL_A6UU RMM-C cancer cell line Norway rat CVCL_A6UU CL:0000010 Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757; Breed/subspecies: Fischer 344. Male Characteristics: Established from the transplantable tumor RMM Doubling time: 17.2 hours (Note=At 10th passage), 14.8 hours (Note=At 30th passage) (PubMed=26949998) 127228815 CVCL_A6UX MDCK-II Rab10-KO spontaneously immortalized cell line dog CVCL_A6UX CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45247; RAB10 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228816 CVCL_A6UW RMM-CAF cancer cell line Norway rat CVCL_A6UW CL:0000010 Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757; Breed/subspecies: Fischer 344. Male Characteristics: Non-tumorigenic 127228817 CVCL_A6UZ MDCK-II Rab11/25-KO spontaneously immortalized cell line dog CVCL_A6UZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45248; RAB11A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45249; RAB11B; Knockout cell: Method=CRISPR/Cas9; VGNC; 45265; RAB25 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228818 CVCL_A6UY MDCK-II Rab11-KO spontaneously immortalized cell line dog CVCL_A6UY CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; 45248; RAB11A; Knockout cell: Method=CRISPR/Cas9; VGNC; 45249; RAB11B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel. Female 127228819 CVCL_A6UN COLO 320DM#3 SIRT1 KO cl.4 cancer cell line human CVCL_A6UN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14929; SIRT1; Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228820 CVCL_A6UM COLO 320DM#3 SIRT1 KO cl.3 cancer cell line human CVCL_A6UM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14929; SIRT1; Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228821 CVCL_A6UP COLO 320DM#3 SIRT1 KO cl.5 cancer cell line human CVCL_A6UP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14929; SIRT1; Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228822 CVCL_A6UR NP-2/CD4/CCR6 cancer cell line human CVCL_A6UR CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 1607; CCR6; Transfected with: HGNC; 1678; CD4; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male 127228823 CVCL_A6UQ COLO 320DM#3 SIRT1 KO cl.6 cancer cell line human CVCL_A6UQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14929; SIRT1; Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228824 CVCL_A6UT C8166/CCR5 transformed cell line human CVCL_A6UT CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 1606; CCR5 Population: Caucasian; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127228825 CVCL_A6US NP-2/CD4/FPRL1 cancer cell line human CVCL_A6US CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 1678; CD4; Transfected with: HGNC; 3827; FPR2; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male 127228826 CVCL_A6UF TD-2 fLuc-CXCR4 cancer cell line house mouse CVCL_A6UF CL:0000010 Transfected with: MGI; MGI:109563; Cxcr4; Transfected with: UniProtKB; P08659; Firefly luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228827 CVCL_A6UE TD-2 fLuc-CCR7 cancer cell line house mouse CVCL_A6UE CL:0000010 Transfected with: MGI; MGI:103011; Ccr7; Transfected with: UniProtKB; P08659; Firefly luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228828 CVCL_A6UH EL16 embryonic stem cell CVCL_A6UH CL:0000010 Karyotypic information: 40,XX [30%]; 39,X0 [70%] (PubMed=10192391); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: Cast/EiJ x 129SvJae. Female 127228829 CVCL_A6UG 7C8 [Mouse hybridoma against rat Cav1] hybridoma house mouse CVCL_A6UG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P41350; Rat Cav1 (Note=Also reacts with human and mouse). 127228830 CVCL_A6UJ COLO 320DM#3 cancer cell line human CVCL_A6UJ CL:0000010 Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female Characteristics: Contains multiple DMs with amplified MYC (PubMed=3164477) 127228831 CVCL_A6UI EL16.7 embryonic stem cell CVCL_A6UI CL:0000010 Karyotypic information: 40,XX, one chromosome X from M.m.musculus and the other from M.m.castaneus (PubMed=10520993); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: Cast/EiJ x 129SvJae. Female 127228832 CVCL_A6UL COLO 320DM#3 SIRT1 KO cl.2 cancer cell line human CVCL_A6UL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14929; SIRT1; Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228833 CVCL_A6UK COLO 320DM#3 SIRT1 KO cl.1 cancer cell line human CVCL_A6UK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14929; SIRT1; Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228834 CVCL_A6UB T6 [Human LCL] transformed cell line human CVCL_A6UB CL:0000010 Population: Japanese; Karyotypic information: 47,XX,+2 (PubMed=15262425); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228835 CVCL_A6UA T5 [Human LCL] transformed cell line human CVCL_A6UA CL:0000010 Population: Japanese; Karyotypic information: 46,Y,add(X)(p22) (PubMed=15262425); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228836 CVCL_A6UD TD-2 fLuc cancer cell line house mouse CVCL_A6UD CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228837 CVCL_A6UC TD-2 cancer cell line house mouse CVCL_A6UC CL:0000010 Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228838 CVCL_A6RS GEM-322 cancer cell line CVCL_A6RS CL:0000010 Cell type: Erythrophore; CL=CL_0000574; Breed/subspecies: Ryukin. Unspecified Group: Fish cell line 127228839 CVCL_A6RR GEM-49 cancer cell line CVCL_A6RR CL:0000010 Cell type: Erythrophore; CL=CL_0000574; Breed/subspecies: Comet. Unspecified Group: Fish cell line 127228840 CVCL_A6RU IP-B12 cancer cell line Norway rat CVCL_A6RU CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: Fischer 344/DuCrj. Male Characteristics: Secretes PTHrP Doubling time: 17.9 hours (PubMed=12853701) 127228841 CVCL_A6RT IP-P cancer cell line Norway rat CVCL_A6RT CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: Fischer 344/DuCrj. Male Characteristics: Established from the transplantable tumor IP Doubling time: 17.5 hours (PubMed=12853701) 127228842 CVCL_A6RW N0003 post-immortalized transformed cell line human CVCL_A6RW CL:0000010 Population: Japanese; Karyotypic information: 46,XX,add(7)(q22),+12,der(13;14)(q10;q10) (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228843 CVCL_A6RV N0003 pre-immortalized transformed cell line human CVCL_A6RV CL:0000010 Population: Japanese; Karyotypic information: 45,XX,der(13;14)(q10;q10) (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228844 CVCL_A6RY N0005 post-immortalized transformed cell line human CVCL_A6RY CL:0000010 Population: Japanese; Karyotypic information: 46,XY,add(3)(p25),add(8)(q24.3),del(17)(p11.2) (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228845 CVCL_A6RX N0005 pre-immortalized transformed cell line human CVCL_A6RX CL:0000010 Population: Japanese; Karyotypic information: 46,XY (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228846 CVCL_A6RK MFVD A5 transformed cell line house mouse CVCL_A6RK CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Male 127228847 CVCL_A6RJ MFVD parental transformed cell line house mouse CVCL_A6RJ CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Male 127228848 CVCL_A6RM MFVD E2 transformed cell line house mouse CVCL_A6RM CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Male 127228849 CVCL_A6RL MFVD A6 transformed cell line house mouse CVCL_A6RL CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA58](NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Omics: Proteome analysis by 2D-DE/MS Male 127228850 CVCL_A6RN MSP.1 undefined cell line type human CVCL_A6RN CL:0000010 Discontinued: ATCC; CRL-2774; true. Unspecified 127228851 CVCL_A6RQ HuOS cancer cell line human CVCL_A6RQ CL:0000010 Population: Japanese; Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male Doubling time: 30 hours (PubMed=433590) 127228852 CVCL_A6RP 1A7 hybridoma house mouse CVCL_A6RP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 14.G2a. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11786 127228853 CVCL_A6RC TROMA-2 hybridoma CVCL_A6RC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05784; Mouse Krt18. 127228854 CVCL_A6RB MAO A-7E10 hybridoma house mouse CVCL_A6RB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228855 CVCL_A6RE 3C7.14 hybridoma house mouse CVCL_A6RE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2. 127228856 CVCL_A6RD 2G1.1.12 hybridoma house mouse CVCL_A6RD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2. 127228857 CVCL_A6RG 12H5 hybridoma house mouse CVCL_A6RG CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P01137; Human TGFB1. 127228858 CVCL_A6RF 2D7.20 hybridoma house mouse CVCL_A6RF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2. 127228859 CVCL_A6RI 4A11 hybridoma house mouse CVCL_A6RI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01137; Human TGFB1. 127228860 CVCL_A6RH 2G7 [Mouse hybridoma against human TFGB1/2/3] hybridoma house mouse CVCL_A6RH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01137; Human TGFB1; Monoclonal antibody target: UniProtKB; P61812; Human TGFB2; Monoclonal antibody target: UniProtKB; P10600; Human TGFB3. 127228861 CVCL_A6QZ MAO A-4F10 hybridoma house mouse CVCL_A6QZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228862 CVCL_A6QY MAO A-3C9 hybridoma house mouse CVCL_A6QY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228863 CVCL_A6RA MAO A-7B10 hybridoma house mouse CVCL_A6RA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228864 CVCL_A6ST ATL-23 transformed cell line human CVCL_A6ST CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228865 CVCL_A6SS ATL-20 transformed cell line human CVCL_A6SS CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228866 CVCL_A6SV ATL-6 transformed cell line human CVCL_A6SV CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228867 CVCL_A6SU ATL-26C transformed cell line human CVCL_A6SU CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228868 CVCL_A6SX ATL-41T transformed cell line human CVCL_A6SX CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228869 CVCL_A6SW ATL-40T transformed cell line human CVCL_A6SW CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228870 CVCL_A6SZ ATL-46T transformed cell line human CVCL_A6SZ CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228871 CVCL_A6SY ATL-67T transformed cell line human CVCL_A6SY CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228872 CVCL_A6SL ATL-42T cancer cell line human CVCL_A6SL CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228873 CVCL_A6SK ED-50823 transformed cell line human CVCL_A6SK CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: IL2 dependent 127228874 CVCL_A6SN ATL-13 transformed cell line human CVCL_A6SN CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 127228875 CVCL_A6SM ATL-11-6 transformed cell line human CVCL_A6SM CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228876 CVCL_A6SP ATL-14T transformed cell line human CVCL_A6SP CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228877 CVCL_A6SR ATL-18C transformed cell line human CVCL_A6SR CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228878 CVCL_A6SQ ATL-17C transformed cell line human CVCL_A6SQ CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228879 CVCL_A6SD N6803 post-immortalized transformed cell line human CVCL_A6SD CL:0000010 Population: Japanese; Karyotypic information: 47,XY,dup(3)(q27;q13),+8 (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228880 CVCL_A6SC N6803 pre-immortalized transformed cell line human CVCL_A6SC CL:0000010 Population: Japanese; Karyotypic information: 46,XY (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228881 CVCL_A6SF LLKF undefined cell line type CVCL_A6SF CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Fibroblast; CL=CL_0000057. Male 127228882 CVCL_A6SE ASMF undefined cell line type CVCL_A6SE CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. 127228883 CVCL_A6SH ATL-48Tb(-) cancer cell line human CVCL_A6SH CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228884 CVCL_A6SG ATL-55T(-) cancer cell line human CVCL_A6SG CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228885 CVCL_A6SJ ED-70423C cancer cell line human CVCL_A6SJ CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228886 CVCL_A6SI ED-41214 cancer cell line human CVCL_A6SI CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228887 CVCL_A6RZ N0005-A1 transformed cell line human CVCL_A6RZ CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228888 CVCL_A6SB N0013 post-immortalized transformed cell line human CVCL_A6SB CL:0000010 Population: Japanese; Karyotypic information: 46,XX,add(2)(q37),der(11)t(11;12)(p15;q13) (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228889 CVCL_A6SA N0013 pre-immortalized transformed cell line human CVCL_A6SA CL:0000010 Population: Japanese; Karyotypic information: 46,XX (PubMed=11520562); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228890 CVCL_A6PQ MANDAG4-4G1 hybridoma house mouse CVCL_A6PQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (AA 654-895 = Beta-dystroglycan). 127228891 CVCL_A6PP MANDAG3-4F7 hybridoma house mouse CVCL_A6PP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (AA 654-895 = Beta-dystroglycan). 127228892 CVCL_A6PS MANHINGE1A-6F11 hybridoma house mouse CVCL_A6PS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog). 127228893 CVCL_A6PR MANHINGE4A-5C11 hybridoma house mouse CVCL_A6PR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228894 CVCL_A6PU MANHINGE1C-5D12 hybridoma house mouse CVCL_A6PU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228895 CVCL_A6PT MANHINGE1B-10F9 hybridoma house mouse CVCL_A6PT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228896 CVCL_A6PW MANHINGE2B-9C11 hybridoma house mouse CVCL_A6PW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228897 CVCL_A6PV MANHINGE2A-8B11 hybridoma house mouse CVCL_A6PV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228898 CVCL_A6PI MANDYS3-6A9 hybridoma house mouse CVCL_A6PI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus). 127228899 CVCL_A6PH 22Rv1-CabR2 cancer cell line human CVCL_A6PH CL:0000010 Sequence variation: Mutation; HGNC; 7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:63584; Cabazitaxel; Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Male Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745) 127228900 CVCL_A6PK MANEX7B-8E11 hybridoma house mouse CVCL_A6PK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog). 127228901 CVCL_A6PJ MANEX6-4H4 hybridoma house mouse CVCL_A6PJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228902 CVCL_A6PM MANDAG1-7A11 hybridoma house mouse CVCL_A6PM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (AA 654-895 = Beta-dystroglycan). 127228903 CVCL_A6PL MANEX7C-6F7 hybridoma house mouse CVCL_A6PL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228904 CVCL_A6PN MANDAG2-7D11 hybridoma house mouse CVCL_A6PN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (AA 654-895 = Beta-dystroglycan). 127228905 CVCL_A6PA MANEX1B-1D6 hybridoma house mouse CVCL_A6PA CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228906 CVCL_A6PC MANDYS10-2E10 hybridoma house mouse CVCL_A6PC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse). 127228907 CVCL_A6PB MANDYS1-3B7 hybridoma house mouse CVCL_A6PB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse, pig and rabbit). 127228908 CVCL_A6PE Sp1/7-2 hybridoma house mouse CVCL_A6PE CL:0000010 Anecdotal: Together with Sp2/3-3 (Cellosaurus=CVCL_A6PD) these are the first hybridomas to have been created. Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC) 127228909 CVCL_A6PD Sp2/3-3 hybridoma house mouse CVCL_A6PD CL:0000010 Anecdotal: Together with Sp1/7-2 (Cellosaurus=CVCL_A6PE) these are the first hybridomas to have been created. Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC) 127228910 CVCL_A6PG 22Rv1-CabR1 cancer cell line human CVCL_A6PG CL:0000010 Sequence variation: Mutation; HGNC; 7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:63584; Cabazitaxel; Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Male Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745) 127228911 CVCL_A6PF Sp1/HL hybridoma house mouse CVCL_A6PF CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC). 127228912 CVCL_A6QR CK-5H5 hybridoma house mouse CVCL_A6QR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228913 CVCL_A6QQ CK-2A7 hybridoma house mouse CVCL_A6QQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228914 CVCL_A6QT TROMA-3 hybridoma CVCL_A6QT CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P19001; Mouse Krt19. 127228915 CVCL_A6QS TROMA-1 hybridoma CVCL_A6QS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11679; Mouse Krt8. 127228916 CVCL_A6QV ESC-BLC 1 T1 embryonic stem cell house mouse CVCL_A6QV CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129/Sv-ter/+. Male 127228917 CVCL_A6QU ESC-BLC 1 embryonic stem cell house mouse CVCL_A6QU CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129/Sv-ter/+. Male 127228918 CVCL_A6QX MAO B-1C2 hybridoma house mouse CVCL_A6QX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P27338; Human MAOB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8176 127228919 CVCL_A6QW ESC-BLC 1 T2/K26 embryonic stem cell house mouse CVCL_A6QW CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129/Sv-ter/+. Male 127228920 CVCL_A6QJ CK-JAC hybridoma house mouse CVCL_A6QJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228921 CVCL_A6QI CK-ART hybridoma house mouse CVCL_A6QI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P00565; Chicken CKM. 127228922 CVCL_A6QL CK-JOE hybridoma house mouse CVCL_A6QL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228923 CVCL_A6QK CK-JIL hybridoma house mouse CVCL_A6QK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228924 CVCL_A6QN CK-1F7 hybridoma house mouse CVCL_A6QN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P12277; Human CKB. 127228925 CVCL_A6QM CK-1B7 hybridoma house mouse CVCL_A6QM CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P06732; Human CKM. 127228926 CVCL_A6QP CK-5D11 hybridoma house mouse CVCL_A6QP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06732; Human CKM. 127228927 CVCL_A6QB MANHINGE4B-9B1 hybridoma house mouse CVCL_A6QB CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228928 CVCL_A6QA MANHINGE3C-10E12 hybridoma house mouse CVCL_A6QA CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228929 CVCL_A6QD MANCHO1-2C7 hybridoma house mouse CVCL_A6QD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228930 CVCL_A6QC MANHINGE4C-10F2 hybridoma house mouse CVCL_A6QC CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228931 CVCL_A6QF MANCHO9-8C10 hybridoma house mouse CVCL_A6QF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228932 CVCL_A6QE MANCHO8-5C5 hybridoma house mouse CVCL_A6QE CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228933 CVCL_A6QH MANCHO19-5D12 hybridoma house mouse CVCL_A6QH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228934 CVCL_A6QG MANCHO16-9C2 hybridoma house mouse CVCL_A6QG CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228935 CVCL_A6PY MANHINGE3A-6D6 hybridoma house mouse CVCL_A6PY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228936 CVCL_A6PX MANHINGE2C-8D11 hybridoma house mouse CVCL_A6PX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228937 CVCL_A6PZ MANHINGE3B-12D2 hybridoma house mouse CVCL_A6PZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228938 CVCL_A5ZT LERS-1 transformed cell line Norway rat CVCL_A5ZT CL:0000010 Miscellaneous: Cell line has been lost (PubMed=2788356) Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Lewis. Female 127228939 CVCL_A5ZS FIRT-1 transformed cell line Norway rat CVCL_A5ZS CL:0000010 Miscellaneous: Cell line has been lost (PubMed=2788356) Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Breed/subspecies: Fischer 344. Female 127228940 CVCL_A5ZV HOZOT finite cell line human CVCL_A5ZV CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Unspecified 127228941 CVCL_A5ZU LERT-1 transformed cell line Norway rat CVCL_A5ZU CL:0000010 Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Breed/subspecies: Lewis. Female 127228942 CVCL_A5ZX UHOMi003-A induced pluripotent stem cell human CVCL_A5ZX From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228943 CVCL_A5ZW JSNK-1 transformed cell line pig CVCL_A5ZW CL:0000010 Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632. Unspecified 127228944 CVCL_A5ZZ UHOMi005-A induced pluripotent stem cell human CVCL_A5ZZ From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228945 CVCL_A5ZY UHOMi004-A induced pluripotent stem cell human CVCL_A5ZY From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228946 CVCL_A5ZL HEL-N1 cancer cell line human CVCL_A5ZL CL:0000010 Sequence variation: Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Subline that does not expresses KIT (PubMed=7538619) Doubling time: 19.0 +- 0.8 hours (Note=In serum-containing medium), 24.0 +- 1.1 hours (Note=In serum-free medium) (PubMed=7538619) 127228947 CVCL_A5ZK U937/EVI1 cancer cell line human CVCL_A5ZK CL:0000010 Sequence variation: Gene fusion; HGNC; 16063; MLLT10 + HGNC; 15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line); Sequence variation: Mutation; HGNC; 9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; 12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 3498; MECOM; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Male Characteristics: Transduced with a MECOM/EVI1-IRES-EGFP construct 127228948 CVCL_A5ZN BCBL-2 cancer cell line human CVCL_A5ZN CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Transformant: Human herpesvirus 8 (HHV-8/KSHV)(NCBI-Taxonomy; 37296). Male 127228949 CVCL_A5ZM HEL-P1 cancer cell line human CVCL_A5ZM CL:0000010 Sequence variation: Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Subline that highly expresses KIT and GYPA (PubMed=7538619) Doubling time: 18.9 +- 1.4 hours (Note=In serum-containing medium), 23.6 +- 0.9 hours (Note=In serum-free medium) (PubMed=7538619) 127228950 CVCL_A5ZP SWI3a-26 spontaneously immortalized cell line CVCL_A5ZP CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Biotechnology: Cell line for recombinase mediated cassette exchange (RMCE) that was generated by random integration of a FRT-flanked GFP reporter It contains a single copy of the GFP reporter transgene at a genetic locus that is protected from silencing. The integrated GFP cassette contains a selection trap that allows for selection of recombinant cells upon RMCE (PubMed=25804355). Female Characteristics: Transduced with the pEFFS-EGFP-dneo vector that contains eGFP under the control of the EF1a promoter The eGFP gene is flanked by a wild type FRT site and a synthetic variant (F3). A selection trap, an ATG-deleted, promoterless neo (Dneo) gene is located downstream of eGFP. When eGFP is exchanged by Flp-mediated recombination against a cassette including a promoter and start codon, Dneo becomes complemented and the cell becomes resistant against the antibiotic G418, thus allowing for selection of recombinant cells (PubMed=22174749). 127228951 CVCL_A5ZR FIRS-1 transformed cell line Norway rat CVCL_A5ZR CL:0000010 Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Fischer 344. Female 127228952 CVCL_A5ZQ LO-HM-7 hybridoma Norway rat CVCL_A5ZQ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu. 127228953 CVCL_A5ZD HBCHU.15 transformed cell line human CVCL_A5ZD CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228954 CVCL_A5ZC HBCHU.09 transformed cell line human CVCL_A5ZC CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228955 CVCL_A5ZF HBCHU.18 transformed cell line human CVCL_A5ZF CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228956 CVCL_A5ZE HBCHU.16 transformed cell line human CVCL_A5ZE CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228957 CVCL_A5ZH Org MHH.1 hybrid cell line CVCL_A5ZH CL:0000010 Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine. Group: Hybridoma fusion partner cell line 127228958 CVCL_A5ZG HBCHU.20 transformed cell line human CVCL_A5ZG CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228959 CVCL_A5ZJ NH cancer cell line human CVCL_A5ZJ From: Suzukawa K.; University of Tsukuba; Tsukuba; Japan CL:0000010 Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526). 127228960 CVCL_A5ZI JOK-1/5.3 cancer cell line human CVCL_A5ZI CL:0000010 Transfected with: HGNC; 1685; CD5; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228961 CVCL_A5XZ HE-30 transformed cell line CVCL_A5XZ CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA30](NCBI-Taxonomy; 1891767). 127228962 CVCL_A5XY HE-239 transformed cell line CVCL_A5XY CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA239](NCBI-Taxonomy; 1891767). 127228963 CVCL_A5YA PNK-86 finite cell line CVCL_A5YA CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Virology: Susceptible to infection by herpes simplex virus, adenovirus type 7 (Ad7) and parainfluenza viruses types 1 to 3 Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 27 127228964 CVCL_A5XR NCI-H460/TPT10 ABCG2 KO cancer cell line human CVCL_A5XR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 74; ABCG2; Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Characteristics: Compared to the parent cell line, no longer resistant to topotecan (PubMed=33425914) 127228965 CVCL_A5XQ NCI-H460/TPT10 cancer cell line human CVCL_A5XQ CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:63632; Topotecan; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Doubling time: 22.46 +- 0.85 hours (PubMed=33425914) 127228966 CVCL_A5XT A4xS hybrid cell line pig CVCL_A5XT CL:0000010 Characteristics: Hybrid of pig embryonic kidney cells with pig splenocytes (Patent=RU2545720); Virology: Susceptible to infection by African swine fever virus (AFSV) (PubMed=26182658). Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 87 127228967 CVCL_A5XS AM-3 telomerase immortalized cell line human CVCL_A5XS CL:0000010 Transfected with: HGNC; 1582; CCND1; Transfected with: HGNC; 1773; CDK4 (with p.Arg24Cys); Transfected with: HGNC; 11730; TERT; Transfected with: HGNC; 11998; TP53 (with p.Met1_Ala159del) Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684; Cell type: Ameloblast; CL=CL_0000059. Female 127228968 CVCL_A5XV M3-1 clone 650A spontaneously immortalized cell line CVCL_A5XV CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228969 CVCL_A5XU PPK-66B finite cell line pig CVCL_A5XU CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. 127228970 CVCL_A5XX T91M cancer cell line human CVCL_A5XX CL:0000010 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Derived from parent cell line after 800 rads of X-radiation (PubMed=5660764) Doubling time: 27-28 hours (DOI=10.2172/4683311) Problematic cell line: Contaminated Parent cell line (T-1) has been shown to be a HeLa derivative. 127228971 CVCL_A5XW M3-1 clone 650AB spontaneously immortalized cell line CVCL_A5XW CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Obtained after irradiation of parent cell line (650A) 127228972 CVCL_A5XJ ONS-99 cancer cell line human CVCL_A5XJ CL:0000010 Population: Japanese. Male 127228973 CVCL_A5XI ZK cancer cell line human CVCL_A5XI CL:0000010 Population: Japanese; Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. 127228974 CVCL_A5XL MINT2 cancer cell line human CVCL_A5XL CL:0000010 Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684. Male Doubling time: ~45 hours (PubMed=15943790) 127228975 CVCL_A5XK MINT1 cancer cell line human CVCL_A5XK CL:0000010 Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684. Male Doubling time: ~45 hours (PubMed=15943790) 127228976 CVCL_A5XN ONS-20 cancer cell line human CVCL_A5XN CL:0000010 Population: Japanese; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 127228977 CVCL_A5XM MINT3 cancer cell line human CVCL_A5XM CL:0000010 Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684. Male Doubling time: ~45 hours (PubMed=15943790) 127228978 CVCL_A5XP ZK-2 cancer cell line human CVCL_A5XP CL:0000010 Population: Japanese. Unspecified 127228979 CVCL_A5XB NULC-1 cancer cell line human CVCL_A5XB CL:0000010 Population: Japanese. Unspecified 127228980 CVCL_A5XA GC302 hybridoma house mouse CVCL_A5XA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human 40 kDa stomach oncofetal antigen. 127228981 CVCL_A5XD CSTO-1 hybridoma house mouse CVCL_A5XD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human stomach adenocarcinoma-associated antigen. 127228982 CVCL_A5XC NULC-2 cancer cell line human CVCL_A5XC CL:0000010 Population: Japanese; Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. 127228983 CVCL_A5XF LCT-6 cancer cell line human CVCL_A5XF CL:0000010 Population: Japanese; Derived from site: In situ; Larynx; UBERON=UBERON_0001737. 127228984 CVCL_A5XE FU-GC-16 cancer cell line human CVCL_A5XE CL:0000010 Population: Japanese; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 127228985 CVCL_A5XH ZK-1 cancer cell line human CVCL_A5XH CL:0000010 Population: Japanese; Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Male Doubling time: 26 hours (PubMed=22575259) 127228986 CVCL_A5XG OKK-1 cancer cell line human CVCL_A5XG CL:0000010 Population: Japanese; Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764. Male 127228987 CVCL_A5YZ RUBHU.09 transformed cell line human CVCL_A5YZ CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228988 CVCL_A5ZB RABHU.02 transformed cell line human CVCL_A5ZB CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228989 CVCL_A5ZA RABHU.01 transformed cell line human CVCL_A5ZA CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228990 CVCL_A5YS HAVCH.03 transformed cell line CVCL_A5YS CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Group: Non-human primate cell line 127228991 CVCL_A5YR HAVCH.02 transformed cell line CVCL_A5YR CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Group: Non-human primate cell line 127228992 CVCL_A5YU HBCHU.02 transformed cell line human CVCL_A5YU CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228993 CVCL_A5YT HAVHU.01 transformed cell line human CVCL_A5YT CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228994 CVCL_A5YW RUBHU.02 transformed cell line human CVCL_A5YW CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228995 CVCL_A5YV HBCHU.01 transformed cell line human CVCL_A5YV CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228996 CVCL_A5YY RUBHU.08 transformed cell line human CVCL_A5YY CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228997 CVCL_A5YX RUBHU.03 transformed cell line human CVCL_A5YX CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228998 CVCL_A5YK ARH-77 clone A5P3 transformed cell line human CVCL_A5YK CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line); Transfected with: MGI; MGI:1349162; Sdc1; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Problematic cell line: Misclassified Parent cell line (ARH-77) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 127228999 CVCL_A5YJ BMEV transformed cell line CVCL_A5YJ CL:0000010 Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 127229000 CVCL_A5YM ACB-985 cancer cell line human CVCL_A5YM CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Unspecified Characteristics: Produces IgG kappa 127229001 CVCL_A5YL MER cancer cell line human CVCL_A5YL CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Unspecified 127229002 CVCL_A5YN C23/11 transformed cell line human CVCL_A5YN CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 16-18 hours (Note=At passage <10), 20-23 hours (Note=At 42th passage) (CelloPub=CLPUB00607) Problematic cell line: Misclassified Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (CelloPub=CLPUB00607). 127229003 CVCL_A5YQ HAVCH.01 transformed cell line CVCL_A5YQ CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Group: Non-human primate cell line 127229004 CVCL_A5YP HET-37 hybrid cell line CVCL_A5YP CL:0000010 Group: Hybridoma fusion partner cell line. 127229005 CVCL_A5YC KR-92 finite cell line CVCL_A5YC CL:0000010 Derived from site: In situ; Intestine; UBERON=UBERON_0000160. 127229006 CVCL_A5YB KEK-92 finite cell line CVCL_A5YB CL:0000010 Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160. Unspecified 127229007 CVCL_A5YE CGFR-Ca-1 spontaneously immortalized cell line dog CVCL_A5YE CL:0000010 Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630. Unspecified 127229008 CVCL_A5YD CC0066 transformed cell line human CVCL_A5YD CL:0000010 Karyotypic information: 47,XY,r(14) (PubMed=16152642); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 92063005; true Male Part of: ECACC chromosomal abnormality collection 127229009 CVCL_A5YG CGFR-Ca-3 telomerase immortalized cell line dog CVCL_A5YG CL:0000010 Transfected with: HGNC; 11730; TERT Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630. Unspecified 127229010 CVCL_A5YF CGFR-Ca-2 spontaneously immortalized cell line dog CVCL_A5YF CL:0000010 Sequence variation: Mutation; VGNC; 47719; TP53; Unexplicit; Not described; Zygosity=Unspecified (PubMed=15365251) Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630. Unspecified 127229011 CVCL_A5YI BMET telomerase immortalized cell line CVCL_A5YI CL:0000010 Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 127229012 CVCL_A5YH BMES spontaneously immortalized cell line CVCL_A5YH CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 127229013 CVCL_A5VX NCL2 [Human lung carcinoma] cancer cell line human CVCL_A5VX CL:0000010 Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Established from a nude mouse xenograft of CL2 Doubling time: 30 hours (PubMed=1497905) 127229014 CVCL_A5VW F-49-1 cancer cell line human CVCL_A5VW CL:0000010 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (AV3) has been shown to be a HeLa derivative. 127229015 CVCL_A5VZ TruHD-Q43Q17M telomerase immortalized cell line human CVCL_A5VZ CL:0000010 Sequence variation: Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717); Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229016 CVCL_A5VY TruHD-Q21Q18F telomerase immortalized cell line human CVCL_A5VY CL:0000010 Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229017 CVCL_A5VP F9-11 spontaneously immortalized cell line house mouse CVCL_A5VP CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Mixture of cells containing small integrations of yeast DNA (27% of cells), cells containing large numbers of small extrachromosomal elements (32% of cells, Fig 2C) and cells containing no yeast DNA (40% of cells) (PubMed=8710496). 127229018 CVCL_A5VR F9-13 spontaneously immortalized cell line house mouse CVCL_A5VR CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496) 127229019 CVCL_A5VQ F9-12 spontaneously immortalized cell line house mouse CVCL_A5VQ CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Mixture of cells with small integrations of yeast DNA (23%), cells with large numbers of small extrachromosomal elements (17%), cells with very large integrations of yeast DNA (18%), cells with a large novel chromosome (14%) and cells with no signal (28%) (PubMed=8710496) 127229020 CVCL_A5VT F9-5 spontaneously immortalized cell line house mouse CVCL_A5VT CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496) 127229021 CVCL_A5VS F9-15 spontaneously immortalized cell line house mouse CVCL_A5VS CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496) 127229022 CVCL_A5VV ICGi029-A induced pluripotent stem cell human CVCL_A5VV From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple; p.Asn515del (c.1543_1545delAAC); ClinVar=VCV000181070; Zygosity=Heterozygous (PubMed=33892289) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229023 CVCL_A5VU ICGi028-A induced pluripotent stem cell human CVCL_A5VU From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; 4801; HADHA; Simple; p.Glu510Gln (c.1528G>C); ClinVar=VCV000100085; Zygosity=Heterozygous (PubMed=33887580) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229024 CVCL_A5VH UT-SCC-91 cancer cell line human CVCL_A5VH CL:0000010 Derived from site: In situ; Nose, skin; UBERON=UBERON_0015476. 127229025 CVCL_A5VG UT-SCC-115 cancer cell line human CVCL_A5VG CL:0000010 Derived from site: Metastatic; Not specified. 127229026 CVCL_A5VJ Tu-107 cancer cell line human CVCL_A5VJ CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229027 CVCL_A5VI UT-SCC-59A cancer cell line human CVCL_A5VI CL:0000010 Derived from site: Metastatic; Temple, skin; UBERON=UBERON_8480028. Male 127229028 CVCL_A5VL Tu-323 cancer cell line human CVCL_A5VL CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229029 CVCL_A5VK Tu-159 cancer cell line human CVCL_A5VK CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229030 CVCL_A5VN QZG undefined cell line type human CVCL_A5VN CL:0000010 Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107. 127229031 CVCL_A5VM Tu-325 cancer cell line human CVCL_A5VM CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229032 CVCL_A5VB U-2OSMR cancer cell line human CVCL_A5VB CL:0000010 Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127229033 CVCL_A5VA S2:spi4 spontaneously immortalized cell line fruit fly CVCL_A5VA CL:0000010 Transfected with: FlyBase_Gene; FBgn0005672; Spi; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R. Male Group: Insect cell line 127229034 CVCL_A5VD UCLA-PL3 transformed cell line human CVCL_A5VD CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229035 CVCL_A5VC U-2OSTR cancer cell line human CVCL_A5VC CL:0000010 Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol); Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127229036 CVCL_A5VF UT-SCC-105 cancer cell line human CVCL_A5VF CL:0000010 Derived from site: In situ; Face, skin; UBERON=UBERON_1000021. 127229037 CVCL_A5VE UT-SCC-111 cancer cell line human CVCL_A5VE CL:0000010 Derived from site: In situ; Face, skin; UBERON=UBERON_1000021. 127229038 CVCL_A5WY OUMS-16 transformed cell line human CVCL_A5WY CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from a chronic lymphatic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229039 CVCL_A5WX PC-5Ly transformed cell line human CVCL_A5WX CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from a lung carcinoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000027. Male 127229040 CVCL_A5WZ FU-MK-1 hybridoma house mouse CVCL_A5WZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. 127229041 CVCL_A5WQ GM16131 transformed cell line human CVCL_A5WQ CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16131; probable Male 127229042 CVCL_A5WP GM16126 transformed cell line human CVCL_A5WP CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 9 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16126; probable Female 127229043 CVCL_A5WS UM-UC-3 LLWO1 cancer cell line human CVCL_A5WS CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (from parent cell line); Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del) Population: Caucasian; Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. Male Characteristics: Transfected with the plasmid pUHD172-1neo which contains a rtTA under the control of the CMV promoter The reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=12914669). 127229044 CVCL_A5WR GM16330 transformed cell line human CVCL_A5WR CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16330; probable Unspecified 127229045 CVCL_A5WU GM16345 transformed cell line human CVCL_A5WU CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16345; probable Female 127229046 CVCL_A5WT UM-UC-3 LLWO2F cancer cell line human CVCL_A5WT CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 9588; PTEN; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 9281; PPP1CA (with a N-terminal His6-HA tag); Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. Male Characteristics: Expresses PPP1CA induced by doxycycline Transfected with the plasmid 6-HA-PP1alpha-pTEP4m plasmid that express a 6His-HA tagged PP1C1 undert the control of a Teto/CMV promoter.; Characteristics: Transfected with the plasmid pUHD172-1neo which contains a rtTA under the control of the CMV promoter The reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=12914669). 127229047 CVCL_A5WW NPC-TY861 cancer cell line human CVCL_A5WW CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728. Male Doubling time: 18 hours (DOI=10.11334/jibi1954.34.1Supplement1_329) 127229048 CVCL_A5WV NPC-204 cancer cell line human CVCL_A5WV CL:0000010 Population: Chinese; Taiwan; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376). Doubling time: 24-30 hours (DOI=10.2183/pjab1945.46.453) 127229049 CVCL_A5WI GM16292 transformed cell line human CVCL_A5WI CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16292; probable Female 127229050 CVCL_A5WH GM16291 transformed cell line human CVCL_A5WH CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16291; probable Female 127229051 CVCL_A5WK GM16294 transformed cell line human CVCL_A5WK CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16294; probable Female 127229052 CVCL_A5WJ GM16293 transformed cell line human CVCL_A5WJ CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16293; probable Female 127229053 CVCL_A5WM GM16333 transformed cell line human CVCL_A5WM CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16333; probable Female 127229054 CVCL_A5WL GM16295 transformed cell line human CVCL_A5WL CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16295; probable Male 127229055 CVCL_A5WN GM16101 transformed cell line human CVCL_A5WN CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16101; probable Female 127229056 CVCL_A5WA TruHD-Q50Q40F telomerase immortalized cell line human CVCL_A5WA CL:0000010 Sequence variation: Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717); Sequence variation: Mutation; HGNC; 4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717); Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229057 CVCL_A5WC GM16286 transformed cell line human CVCL_A5WC CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16286; probable Female 127229058 CVCL_A5WB GM16285 transformed cell line human CVCL_A5WB CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16285; probable Female 127229059 CVCL_A5WE GM16288 transformed cell line human CVCL_A5WE CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16288; probable Male 127229060 CVCL_A5WD GM16287 transformed cell line human CVCL_A5WD CL:0000010 Sequence variation: Gene deletion; HGNC; 50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16287; probable Male 127229061 CVCL_A5WG GM16290 transformed cell line human CVCL_A5WG CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16290; probable Female 127229062 CVCL_A5WF GM16289 transformed cell line human CVCL_A5WF CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; GM16289; probable Female 127229063 CVCL_A6FG RG11/15 hybridoma house mouse CVCL_A6FG CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype). 127229064 CVCL_A6FF ONS-82 cancer cell line human CVCL_A6FF CL:0000010 Population: Japanese. Unspecified 127229065 CVCL_A6FI LO-MG1-15 hybridoma Norway rat CVCL_A6FI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1. 127229066 CVCL_A6FH LO-MG1-13 hybridoma Norway rat CVCL_A6FH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1. 127229067 CVCL_A6FK LO-MG2a-7 hybridoma Norway rat CVCL_A6FK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229068 CVCL_A6FJ LO-MG2a-3 hybridoma Norway rat CVCL_A6FJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229069 CVCL_A6FM MAR 80.2 hybridoma house mouse CVCL_A6FM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1a). 127229070 CVCL_A6FL LO-MG2b-1 hybridoma Norway rat CVCL_A6FL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01867; Mouse immunoglobulin heavy chain gamma-2b. 127229071 CVCL_A6FA UNESP-MM4 cancer cell line dog CVCL_A6FA CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000027; Breed/subspecies: Teckel. Female Doubling time: 10.28 hours (PubMed=33195606) 127229072 CVCL_A6FC NCC-SS4-C1 cancer cell line human CVCL_A6FC CL:0000010 Sequence variation: Gene fusion; HGNC; 11340; SS18 + HGNC; 11335; SSX1; Name(s)=SS18-SSX1 (PubMed=33611700) Population: Japanese Omics: SNP array analysis. Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.); Doubling time: ~245 hours (PubMed=33611700) Part of: NCC sarcoma cell line panel 127229073 CVCL_A6FB NCC-DDLPS3-C1 cancer cell line human CVCL_A6FB CL:0000010 Population: Japanese; Derived from site: In situ; Right thigh; UBERON=UBERON_0000376. Omics: SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.); Doubling time: ~47 hours (PubMed=33677797) Part of: NCC sarcoma cell line panel 127229074 CVCL_A6FE ONS-86 cancer cell line human CVCL_A6FE CL:0000010 Population: Japanese; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 127229075 CVCL_A6FD ONS-84 cancer cell line human CVCL_A6FD CL:0000010 Population: Japanese; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 127229076 CVCL_A6EV UNESP-CM11 cancer cell line dog CVCL_A6EV CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Mixed breed. Female Doubling time: 7.45 hours (PubMed=33195606) 127229077 CVCL_A6EU UNESP-CM9 cancer cell line dog CVCL_A6EU CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Mixed breed. Female Doubling time: 8.95 hours (PubMed=33195606) 127229078 CVCL_A6EX UNESP-CM61 cancer cell line dog CVCL_A6EX CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Teckel. Female Doubling time: 13.06 hours (PubMed=33195606) 127229079 CVCL_A6EW UNESP-CM60 cancer cell line dog CVCL_A6EW CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Teckel. Female Doubling time: 11.79 hours (PubMed=33195606) 127229080 CVCL_A6EZ UNESP-MM3 cancer cell line dog CVCL_A6EZ CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000027; Breed/subspecies: Teckel. Female Doubling time: 34.17 hours (PubMed=33195606) 127229081 CVCL_A6EY UNESP-MM1 cancer cell line dog CVCL_A6EY CL:0000010 Derived from site: In situ; Bone; UBERON=UBERON_0002481; Breed/subspecies: Poodle. Female Doubling time: 25.41 hours (PubMed=33195606) 127229082 CVCL_A6EN MARM-4 hybridoma house mouse CVCL_A6EN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat IgM heavy chain. 127229083 CVCL_A6EM MARL-5 hybridoma house mouse CVCL_A6EM CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Rat Ig lambda light chains. 127229084 CVCL_A6EP MARM-7 hybridoma house mouse CVCL_A6EP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat IgM heavy chain. 127229085 CVCL_A6ER UNESP-CM1 cancer cell line dog CVCL_A6ER CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Poodle. Female Doubling time: 6.31 hours (PubMed=33195606) 127229086 CVCL_A6EQ MARG2a-7 hybridoma house mouse CVCL_A6EQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20760; Rat immunoglobulin heavy chain gamma-2A. 127229087 CVCL_A6ET UNESP-CM5 cancer cell line dog CVCL_A6ET CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Teckel. Female Doubling time: 7.5 hours (PubMed=33195606) 127229088 CVCL_A6ES UNESP-CM4 cancer cell line dog CVCL_A6ES CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Teckel. Female Doubling time: 5.1 hours (PubMed=33195606) 127229089 CVCL_A6GH LO-DNP-1 hybridoma Norway rat CVCL_A6GH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229090 CVCL_A6GG LO-DNP-45 hybridoma Norway rat CVCL_A6GG CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229091 CVCL_A6GJ LO-DNP-16 hybridoma Norway rat CVCL_A6GJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229092 CVCL_A6GI LO-DNP-2 hybridoma Norway rat CVCL_A6GI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229093 CVCL_A6GL LO-DNP-11 hybridoma Norway rat CVCL_A6GL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229094 CVCL_A6GK LO-DNP-61 hybridoma Norway rat CVCL_A6GK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229095 CVCL_A6GN LO-DNP-64 hybridoma Norway rat CVCL_A6GN CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229096 CVCL_A6GM LO-DNP-57 hybridoma Norway rat CVCL_A6GM CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl group (DNP). 127229097 CVCL_A6GB LO-MA-10 hybridoma Norway rat CVCL_A6GB CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01878; Mouse immunoglobulin heavy chain alpha. 127229098 CVCL_A6GA LO-MA-7 hybridoma Norway rat CVCL_A6GA CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01878; Mouse immunoglobulin heavy chain alpha. 127229099 CVCL_A6GD LO-MG-7 hybridoma Norway rat CVCL_A6GD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma. 127229100 CVCL_A6GC MAR 103.6 hybridoma house mouse CVCL_A6GC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1b). 127229101 CVCL_A6GF LO-HA-9 hybridoma Norway rat CVCL_A6GF CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229102 CVCL_A6GE MARG2c-5 hybridoma house mouse CVCL_A6GE CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C. 127229103 CVCL_A6FW LO-MD-6 hybridoma Norway rat CVCL_A6FW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01881; Mouse immunoglobulin heavy chain delta. 127229104 CVCL_A6FV LO-MO-1 hybridoma Norway rat CVCL_A6FV CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127229105 CVCL_A6FY LO-MG2a-9 hybridoma Norway rat CVCL_A6FY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229106 CVCL_A6FX LO-MD-8 hybridoma Norway rat CVCL_A6FX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01881; Mouse immunoglobulin heavy chain delta. 127229107 CVCL_A6FZ LO-MG3-13 hybridoma Norway rat CVCL_A6FZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P03987; Mouse immunoglobulin heavy chain gamma-3. 127229108 CVCL_A6FN LO-MK-2 hybridoma Norway rat CVCL_A6FN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig kappa light chains. 127229109 CVCL_A6FQ LO-BG-1 hybridoma Norway rat CVCL_A6FQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Porphyromonas gingivalis (strain ATCC 33277). 127229110 CVCL_A6FP LO-MK-3 hybridoma Norway rat CVCL_A6FP CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Mouse Ig kappa light chains. 127229111 CVCL_A6FS LO-SM-11 hybridoma Norway rat CVCL_A6FS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Streptococcus mutans cell wall antigens. 127229112 CVCL_A6FR LO-SM-2 hybridoma Norway rat CVCL_A6FR CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Streptococcus mutans cell wall antigens. 127229113 CVCL_A6FU LO-CD2b hybridoma Norway rat CVCL_A6FU CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P06729; Human CD2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-802 127229114 CVCL_A6FT LO-panB-a hybridoma Norway rat CVCL_A6FT CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Human leucocytes. 127229115 CVCL_A6DE EB-Y8 hybridoma Norway rat CVCL_A6DE CL:0000010 Monoclonal antibody isotype: IgG2c, kappa; Monoclonal antibody target: Yersinia enterocolitica serogroup O:8 lipopolysaccharide. 127229116 CVCL_A6DD EB-A7 hybridoma Norway rat CVCL_A6DD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:27680; Galactomannan. 127229117 CVCL_A6DG LO-MG2a-2 hybridoma Norway rat CVCL_A6DG CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229118 CVCL_A6DF LO-MG1-2 hybridoma Norway rat CVCL_A6DF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1. 127229119 CVCL_A6DI LO-MG3-7 hybridoma Norway rat CVCL_A6DI CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P03987; Mouse immunoglobulin heavy chain gamma-3. 127229120 CVCL_A6DH LO-MG2b-2 hybridoma Norway rat CVCL_A6DH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01867; Mouse immunoglobulin heavy chain gamma-2b. 127229121 CVCL_A6DK LO-MM-9 hybridoma Norway rat CVCL_A6DK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu. 127229122 CVCL_A6DJ LO-MK-1 hybridoma Norway rat CVCL_A6DJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig kappa light chains. 127229123 CVCL_A6DA EB-A4 hybridoma Norway rat CVCL_A6DA CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:27680; Galactomannan. 127229124 CVCL_A6DC EB-A6 hybridoma Norway rat CVCL_A6DC CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:27680; Galactomannan. 127229125 CVCL_A6DB EB-A5 hybridoma Norway rat CVCL_A6DB CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:27680; Galactomannan. 127229126 CVCL_A6CT LO-CD4-a hybridoma Norway rat CVCL_A6CT CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P01730; Human CD4. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89012101 127229127 CVCL_A6CS LO-CD2a hybridoma Norway rat CVCL_A6CS CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized siplizumab (MEDI-507) therapeutic antibody Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P06729; Human CD2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11423 127229128 CVCL_A6CV LO-CD6-a hybridoma Norway rat CVCL_A6CV CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 127229129 CVCL_A6CU LO-CD4-b hybridoma Norway rat CVCL_A6CU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01730; Human CD4. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89012102 127229130 CVCL_A6CX EB-A1 hybridoma Norway rat CVCL_A6CX CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:27680; Galactomannan. 127229131 CVCL_A6CW LO-Tmat hybridoma Norway rat CVCL_A6CW CL:0000010 Monoclonal antibody isotype: IgG2a. 127229132 CVCL_A6CZ EB-A3 hybridoma Norway rat CVCL_A6CZ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:27680; Galactomannan. 127229133 CVCL_A6CY EB-A2 hybridoma Norway rat CVCL_A6CY CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI:27680; Galactomannan. 127229134 CVCL_A6CL LO-PL3-a hybridoma Norway rat CVCL_A6CL CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41. 127229135 CVCL_A6CK LO-CD5-a hybridoma Norway rat CVCL_A6CK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06127; Human CD5. 127229136 CVCL_A6CN LO-PL4 hybridoma Norway rat CVCL_A6CN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21926; Human CD9. 127229137 CVCL_A6CM LO-PL3-b hybridoma Norway rat CVCL_A6CM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41. 127229138 CVCL_A6CP LO-Tact-1 hybridoma Norway rat CVCL_A6CP CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25. 127229139 CVCL_A6CR LO-DR-a hybridoma Norway rat CVCL_A6CR CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Human HLA-DR. 127229140 CVCL_A6CQ LO-Tact-2 hybridoma Norway rat CVCL_A6CQ CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25. 127229141 CVCL_A6EF MARG2b-8 hybridoma house mouse CVCL_A6EF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20761; Rat immunoglobulin heavy chain gamma-2B. 127229142 CVCL_A6EE MARG2b-3 hybridoma house mouse CVCL_A6EE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20761; Rat immunoglobulin heavy chain gamma-2B. 127229143 CVCL_A6EH MARG2c-3 hybridoma house mouse CVCL_A6EH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C. 127229144 CVCL_A6EG MARG2c-2 hybridoma house mouse CVCL_A6EG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C. 127229145 CVCL_A6EJ MARK-2 hybridoma house mouse CVCL_A6EJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1a). 127229146 CVCL_A6EI MARK-1 hybridoma house mouse CVCL_A6EI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig kappa light chains. 127229147 CVCL_A6EL MARL-4 hybridoma house mouse CVCL_A6EL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Rat Ig lambda light chains. 127229148 CVCL_A6EK MARL-15 hybridoma house mouse CVCL_A6EK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig lambda light chains. 127229149 CVCL_A6EB MARG1-1 hybridoma house mouse CVCL_A6EB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20759; Rat immunoglobulin heavy chain gamma-1. 127229150 CVCL_A6EA MARE-1 hybridoma house mouse CVCL_A6EA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01855; Rat immunoglobulin heavy chain epsilon. 127229151 CVCL_A6ED MARG2a-8 hybridoma house mouse CVCL_A6ED CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20760; Rat immunoglobulin heavy chain gamma-2A. 127229152 CVCL_A6EC MARG1-2 hybridoma house mouse CVCL_A6EC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20759; Rat immunoglobulin heavy chain gamma-1. 127229153 CVCL_A6DU LO-VX-4 hybridoma Norway rat CVCL_A6DU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229154 CVCL_A6DT LO-VX-10 hybridoma Norway rat CVCL_A6DT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229155 CVCL_A6DW LO-VX-9 hybridoma Norway rat CVCL_A6DW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229156 CVCL_A6DV LO-VX-6 hybridoma Norway rat CVCL_A6DV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229157 CVCL_A6DY MARA-2 hybridoma house mouse CVCL_A6DY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Rat IgA heavy chain. 127229158 CVCL_A6DX MARA-1 hybridoma house mouse CVCL_A6DX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat IgA heavy chain. 127229159 CVCL_A6DZ MARD-3 hybridoma house mouse CVCL_A6DZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01883; Rat immunoglobulin heavy chain delta. 127229160 CVCL_A6DM LO-MM-8 hybridoma Norway rat CVCL_A6DM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu. 127229161 CVCL_A6DL LO-MM-3 hybridoma Norway rat CVCL_A6DL CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu. 127229162 CVCL_A6DN LO-ME-2 hybridoma Norway rat CVCL_A6DN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon. 127229163 CVCL_A6DQ LO-Ea-10 hybridoma Norway rat CVCL_A6DQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Erwinia amylovora. 127229164 CVCL_A6DP LO-ME-3 hybridoma Norway rat CVCL_A6DP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon. 127229165 CVCL_A6DS LO-Ea-18 hybridoma Norway rat CVCL_A6DS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Erwinia amylovora. 127229166 CVCL_A6DR LO-Ea-15 hybridoma Norway rat CVCL_A6DR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Erwinia amylovora. 127229167 CVCL_A6BC LO-HL-4 hybridoma Norway rat CVCL_A6BC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human Ig lambda light chains. 127229168 CVCL_A6BB LO-HL-3 hybridoma Norway rat CVCL_A6BB CL:0000010 Monoclonal antibody isotype: IgG2a, lambda; Monoclonal antibody target: Human Ig lambda light chains. 127229169 CVCL_A6BE LO-HApoB-2 hybridoma Norway rat CVCL_A6BE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229170 CVCL_A6BD LO-HApoB-1 hybridoma Norway rat CVCL_A6BD CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229171 CVCL_A6BG LO-HApoB-4 hybridoma Norway rat CVCL_A6BG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229172 CVCL_A6BF LO-HApoB-3 hybridoma Norway rat CVCL_A6BF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229173 CVCL_A6BI LO-HApoB-6 hybridoma Norway rat CVCL_A6BI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229174 CVCL_A6BH LO-HApoB-5 hybridoma Norway rat CVCL_A6BH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229175 CVCL_A6AZ LO-HG-23 hybridoma Norway rat CVCL_A6AZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgG (all 4 classes). 127229176 CVCL_A6AY LO-HG-22 hybridoma Norway rat CVCL_A6AY CL:0000010 Monoclonal antibody isotype: IgG2c, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229177 CVCL_A6BA LO-HL-2 hybridoma Norway rat CVCL_A6BA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human Ig lambda light chains. 127229178 CVCL_A6AR LO-HG-1 hybridoma Norway rat CVCL_A6AR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human IgG (all 4 classes). 127229179 CVCL_A6AQ LO-HD-3 hybridoma Norway rat CVCL_A6AQ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01880; Human immunoglobulin heavy chain delta. 127229180 CVCL_A6AT LO-HG-6 hybridoma Norway rat CVCL_A6AT CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229181 CVCL_A6AS LO-HG-3 hybridoma Norway rat CVCL_A6AS CL:0000010 Monoclonal antibody isotype: IgG2c, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229182 CVCL_A6AV LO-HG-19 hybridoma Norway rat CVCL_A6AV CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229183 CVCL_A6AU LO-HG-7 hybridoma Norway rat CVCL_A6AU CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229184 CVCL_A6AX LO-HG-21 hybridoma Norway rat CVCL_A6AX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgG (all 4 classes). 127229185 CVCL_A6AW LO-HG-20 hybridoma Norway rat CVCL_A6AW CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229186 CVCL_A6AJ LO-RK-1b-1 hybridoma Norway rat CVCL_A6AJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype). 127229187 CVCL_A6AI LO-RK-1a-1 hybridoma Norway rat CVCL_A6AI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1a allotype). 127229188 CVCL_A6AL LO-RG-1 hybridoma Norway rat CVCL_A6AL CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rabbit IgG heavy chain. 127229189 CVCL_A6AK LO-RK-1b-2 hybridoma Norway rat CVCL_A6AK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype). 127229190 CVCL_A6AN LO-HM-8 hybridoma Norway rat CVCL_A6AN CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu. 127229191 CVCL_A6AM LO-HM-2 hybridoma Norway rat CVCL_A6AM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu. 127229192 CVCL_A6AP LO-HD-1 hybridoma Norway rat CVCL_A6AP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01880; Human immunoglobulin heavy chain delta. 127229193 CVCL_A6CD LO-HRP-17 hybridoma Norway rat CVCL_A6CD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229194 CVCL_A6CC LO-HRP-16 hybridoma Norway rat CVCL_A6CC CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229195 CVCL_A6CF LO-HRP-19 hybridoma Norway rat CVCL_A6CF CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229196 CVCL_A6CE LO-HRP-18 hybridoma Norway rat CVCL_A6CE CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229197 CVCL_A6CH LO-VG2 hybridoma Norway rat CVCL_A6CH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Xenopus laevis vitellogenin. 127229198 CVCL_A6CG LO-VG1 hybridoma Norway rat CVCL_A6CG CL:0000010 Monoclonal antibody isotype: IgG2; Monoclonal antibody target: Xenopus laevis vitellogenin. 127229199 CVCL_A6CJ LO-CD1-a hybridoma Norway rat CVCL_A6CJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P06126; Human CD1A. 127229200 CVCL_A6CI LO-VG3 hybridoma Norway rat CVCL_A6CI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Xenopus laevis vitellogenin. 127229201 CVCL_A6BZ LO-HRP-13 hybridoma Norway rat CVCL_A6BZ CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229202 CVCL_A6CB LO-HRP-15 hybridoma Norway rat CVCL_A6CB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229203 CVCL_A6CA LO-HRP-14 hybridoma Norway rat CVCL_A6CA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229204 CVCL_A6BS LO-HK-1 hybridoma Norway rat CVCL_A6BS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Human Ig kappa light chains. 127229205 CVCL_A6BR LO-HE-7 hybridoma Norway rat CVCL_A6BR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01854; Human immunoglobulin heavy chain epsilon. 127229206 CVCL_A6BU LO-HL-1 hybridoma Norway rat CVCL_A6BU CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: Human Ig lambda light chains. 127229207 CVCL_A6BT LO-HK-3 hybridoma Norway rat CVCL_A6BT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human Ig kappa light chains. 127229208 CVCL_A6BW LO-HRP-9 hybridoma CVCL_A6BW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229209 CVCL_A6BV LO-HRP-8 hybridoma CVCL_A6BV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229210 CVCL_A6BY LO-HRP-12 hybridoma Norway rat CVCL_A6BY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229211 CVCL_A6BX LO-HRP-10 hybridoma CVCL_A6BX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229212 CVCL_A6BK LO-HA-1 hybridoma Norway rat CVCL_A6BK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1. 127229213 CVCL_A6BM LO-HA-3 hybridoma Norway rat CVCL_A6BM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229214 CVCL_A6BL LO-HA-2 hybridoma Norway rat CVCL_A6BL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1. 127229215 CVCL_A6BN LO-HA-4 hybridoma Norway rat CVCL_A6BN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229216 CVCL_A6BQ LO-HA-6 hybridoma Norway rat CVCL_A6BQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229217 CVCL_A6BP LO-HA-5 hybridoma Norway rat CVCL_A6BP CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229218 CVCL_A6AB UHOMi006-A induced pluripotent stem cell human CVCL_A6AB From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229219 CVCL_A6AA UHOMi007-A induced pluripotent stem cell human CVCL_A6AA From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Donor information: Established from a healthy heavy smoker; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229220 CVCL_A6AD 1E4-1D9 hybridoma house mouse CVCL_A6AD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P51654; Human GPC3. 127229221 CVCL_A6AC Tet-293/Ins6 transformed cell line human CVCL_A6AC CL:0000010 Transfected with: HGNC; 6081; INS; Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Secretes insulin induced by doxycyclin; Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 127229222 CVCL_A6AF 1E2-1D11 hybridoma house mouse CVCL_A6AF CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229223 CVCL_A6AE 1E4-1C2 hybridoma house mouse CVCL_A6AE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229224 CVCL_A6AH 1E2-2C9 hybridoma house mouse CVCL_A6AH CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229225 CVCL_A6AG 1E2-2B8 hybridoma house mouse CVCL_A6AG CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229226 CVCL_A7PP WS6KO finite cell line human CVCL_A7PP CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 19 PDL (PubMed=4083160) 127229227 CVCL_A7PR WS8KO finite cell line human CVCL_A7PR CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 19 PDL (PubMed=4083160) 127229228 CVCL_A7PQ WS7KO finite cell line human CVCL_A7PQ CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229229 CVCL_A7PT WS10KO finite cell line human CVCL_A7PT CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 17 PDL (PubMed=4083160) 127229230 CVCL_A7PS WS9KO finite cell line human CVCL_A7PS CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 12 PDL (PubMed=4083160) 127229231 CVCL_A7PV NHSF41 finite cell line human CVCL_A7PV CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 50 PDL (PubMed=4083160) 127229232 CVCL_A7PU WS12KO finite cell line human CVCL_A7PU CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 28 PDL (PubMed=4083160) 127229233 CVCL_A7PH WS10S finite cell line human CVCL_A7PH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229234 CVCL_A7PG MBC-1 cancer cell line human CVCL_A7PG CL:0000010 Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Unspecified 127229235 CVCL_A7PJ WS1KO finite cell line human CVCL_A7PJ CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 10 PDL (PubMed=4083160) 127229236 CVCL_A7PI WS11KO finite cell line human CVCL_A7PI CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 26 PDL (PubMed=4083160) 127229237 CVCL_A7PL WS3KO finite cell line human CVCL_A7PL CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 11 PDL (PubMed=4083160) 127229238 CVCL_A7PK WS2KO finite cell line human CVCL_A7PK CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229239 CVCL_A7PN WS5KO finite cell line human CVCL_A7PN CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 28 PDL (PubMed=4083160) 127229240 CVCL_A7PM WS4KO finite cell line human CVCL_A7PM CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 13 PDL (PubMed=4083160) 127229241 CVCL_A7PB K-TL-1 cancer cell line human CVCL_A7PB CL:0000010 Population: Japanese; Derived from site: In situ; Hair follicle, outer root sheath; UBERON=UBERON_0005942. Female Doubling time: 10 days (PubMed=6165463) 127229242 CVCL_A7PA T3-2 [Rat tooth germ] telomerase immortalized cell line Norway rat CVCL_A7PA CL:0000010 Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844; Cell type: Odontoblast; CL=CL_0000060; Breed/subspecies: Sprague Dawley. 127229243 CVCL_A7PD AWT KoTa finite cell line human CVCL_A7PD CL:0000010 Population: Japanese; Karyotypic information: 46,XY,del(11)(p13) (JCRB=KURB2102); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229244 CVCL_A7PC MGH9009-1 cancer cell line human CVCL_A7PC CL:0000010 Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027. Unspecified 127229245 CVCL_A7PF CFS414_1G10 transformed cell line CVCL_A7PF CL:0000010 Transfected with: UniProtKB; J7RUA5; Staphylococcus aureus Cas9; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; X5DSL3; Anaplasma marginale mCherry fluorescent protein; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Continental Chestnut Flanked White. Male Characteristics: Constitutively expresses nuclear GFP (nGFP) and pac and conditionally expresses S.aureus Cas9 and mCherry in the presence of Cre recombinase; Characteristics: A FLEx-SaCas9-P2A-mCherry construct was transferred using a PiggyBac transposon vector Group: Bird cell line 127229246 CVCL_A7PE CFS414_F6 transformed cell line CVCL_A7PE CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Continental Chestnut Flanked White. Male Group: Bird cell line 127229247 CVCL_A7QQ U2OS EGFP-H2B cancer cell line human CVCL_A7QQ CL:0000010 Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Transfected with: HGNC; 4761; H2BC11; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127229248 CVCL_A7QP YTH 3.2.6 hybridoma Norway rat CVCL_A7QP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P09564; Human CD7. 127229249 CVCL_A7QS LUMCi046-A induced pluripotent stem cell human CVCL_A7QS From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 25947; KLHL24; Simple; p.Met1Arg (c.2T>G); Zygosity=Heterozygous (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229250 CVCL_A7QR LUMCi045-A induced pluripotent stem cell human CVCL_A7QR From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 25947; KLHL24; Simple; p.Met1Arg (c.2T>G); Zygosity=Heterozygous (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229251 CVCL_A7QU LGLL-CL1 transformed cell line human CVCL_A7QU CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Population: Caucasian; Italian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229252 CVCL_A7QT LUMCi039-A induced pluripotent stem cell human CVCL_A7QT From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 6294; KCNQ1; Simple; p.Arg594Gln (c.1781G>A); ClinVar=VCV000053018; Zygosity=Heterozygous (PubMed=27470144) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229253 CVCL_A7QW M-2478 finite cell line human CVCL_A7QW CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 127229254 CVCL_A7QV LGLL-2 transformed cell line human CVCL_A7QV CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Population: African; Ethiopian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229255 CVCL_A7QI B82CAPR spontaneously immortalized cell line house mouse CVCL_A7QI CL:0000010 Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; Selected for resistance to: ChEBI; CHEBI:17698; Chloramphenicol; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male 127229256 CVCL_A7QH MIN6 rho0 transformed cell line house mouse CVCL_A7QH CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: C57BL/6 IT6 transgenic. Unspecified Characteristics: Cell line devoid of mitochondrial DNA (rho0) Obtained by growth of parental cell line with bis-4-piperidyle-dichloride (PubMed=8824267). 127229257 CVCL_A7QK A3D8 hybridoma house mouse CVCL_A7QK CL:0000010 Monoclonal antibody isotype: IgG1 (PubMed=2646376); IgM (PubMed=6466869; PubMed=6863545); Monoclonal antibody target: UniProtKB; P16070; Human CD44. 127229258 CVCL_A7QJ SHSY-5Y Tet-On SNCA cancer cell line human CVCL_A7QJ CL:0000010 Sequence variation: Mutation; HGNC; 427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 11138; SNCA; Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Inducible expression of SNCA upon treatment with doxycycline Serves as a model for both dopaminergic neuronal biology and a-synuclein pathology (Millipore=SCC291).; Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 127229259 CVCL_A7QM ED-S/ADM cancer cell line human CVCL_A7QM CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 127229260 CVCL_A7QL Hermes-2 hybridoma CVCL_A7QL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16070; Human CD44. 127229261 CVCL_A7QN YTH 66.9 hybridoma Norway rat CVCL_A7QN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P31358; Human CD52. 127229262 CVCL_A7QA ATL-2/ADM cl-1 transformed cell line human CVCL_A7QA CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 127229263 CVCL_A7QC RIN-AhGh cancer cell line Norway rat CVCL_A7QC CL:0000010 Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: NEDH. Male 127229264 CVCL_A7QB ATL-2/ADM cl-2 transformed cell line human CVCL_A7QB CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 127229265 CVCL_A7QE RIN 1046-44 cancer cell line Norway rat CVCL_A7QE CL:0000010 Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: NEDH. Male Characteristics: Does not secrete glucagon, nor insulin, nor somatostatin (PubMed=2879852) 127229266 CVCL_A7QD RIN-AhLh cancer cell line Norway rat CVCL_A7QD CL:0000010 Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: NEDH. Male 127229267 CVCL_A7QG RIN-5AH-T2 cancer cell line Norway rat CVCL_A7QG CL:0000010 Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: NEDH. Male 127229268 CVCL_A7QF RIN 1046-43 cancer cell line Norway rat CVCL_A7QF CL:0000010 Transformant: X-Ray(NCIt; C17262); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: NEDH. Male Characteristics: Secretes insulin and somatostatin (PubMed=2879852) 127229269 CVCL_A7PX NHSF63 finite cell line human CVCL_A7PX CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 42 PDL (PubMed=4083160) 127229270 CVCL_A7PW NHSF5 finite cell line human CVCL_A7PW CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 53 PDL (PubMed=4083160) 127229271 CVCL_A7PZ SALT-3/ADM cl-2 cancer cell line human CVCL_A7PZ CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: T-cell; CL=CL_0000084. Male 127229272 CVCL_A7PY NHSF64 finite cell line human CVCL_A7PY CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 37 PDL (PubMed=4083160) 127229273 CVCL_A7NN UTP-L12 cancer cell line human CVCL_A7NN CL:0000010 Sequence variation: Gene fusion; HGNC; 3446; ERG + HGNC; 4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=8187069) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female 127229274 CVCL_A7NM IRTA21 cancer cell line human CVCL_A7NM CL:0000010 Sequence variation: Gene fusion; HGNC; 3446; ERG + HGNC; 4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=7794765) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Doubling time: ~99 hours (PubMed=7794765) 127229275 CVCL_A7NP CS-R cancer cell line human CVCL_A7NP CL:0000010 Unspecified 127229276 CVCL_A7NR NU-T1 hybridoma house mouse CVCL_A7NR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06729; Human CD2. 127229277 CVCL_A7NQ SALT-3 cancer cell line human CVCL_A7NQ CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: T-cell; CL=CL_0000084. Male 127229278 CVCL_A7NT KOS-1 cancer cell line human CVCL_A7NT CL:0000010 Population: Japanese; Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406. Female Doubling time: 27.4 hours (PubMed=10948649) 127229279 CVCL_A7NS NU-T2 hybridoma house mouse CVCL_A7NS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P29016; Human CD1B. 127229280 CVCL_A7NF IMS-BC2 cancer cell line human CVCL_A7NF CL:0000010 Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9650450; PubMed=10071072) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Doubling time: 36 hours (PubMed=9650450) 127229281 CVCL_A7NE IMS-BC1 cancer cell line human CVCL_A7NE CL:0000010 Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9650450; PubMed=10071072) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Doubling time: 48 hours (PubMed=9650450) 127229282 CVCL_A7NH SZ-117 hybridoma house mouse CVCL_A7NH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08253; Human MMP2 (Note=Also recognizes filamin A). 127229283 CVCL_A7NG UACC-SARC1 cancer cell line human CVCL_A7NG CL:0000010 Omics: Array-based CGH. Female Characteristics: Obtained from a radiation-induced sarcoma Doubling time: 28.3 hours (PubMed=25644184) 127229284 CVCL_A7NJ 82.3 cancer cell line human CVCL_A7NJ CL:0000010 Population: Caucasian; Italian; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male Characteristics: Shows cross-resistance to gemcitabine, 5-fluorouracil, carboplatin and oxaliplatin (PubMed=33922695); Characteristics: Established from a 4th generation xenograft maintained in NOD/SCID mice (PubMed=33922695) Doubling time: 48-53 hours (PubMed=33922695) 127229285 CVCL_A7NI 2XSB cancer cell line human CVCL_A7NI CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; 19291; CSMD3; Simple; p.Trp3337Ter (c.10010G>A); Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; 2976; DNMT1; Simple; c.2586+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33707600); Sequence variation: Mutation; HGNC; 6697; LRP5; Simple; p.Arg428Ter (c.1282C>T); ClinVar=VCV000006269; Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; 7765; NF1; None_reported; -; Zygosity=- (PubMed=33707600); Sequence variation: Mutation; HGNC; 8059; NUMA1; Simple; p.Leu1167Alafs*39 (c.3499_3500delCT); Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Pro38Ser (c.112C>T); ClinVar=VCV000127688; Zygosity=Homozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His178Asp (c.532C>G); ClinVar=VCV000482223; Zygosity=Homozygous (PubMed=33707600) Population: Caucasian; Derived from site: In situ; Right brachial nerve; UBERON=UBERON_0001814. Omics: Deep exome analysis; Omics: SNP array analysis Female Doubling time: 28.0 +- 3.09 hours (Note=At 6th passage), 27.3 +- 4.06 hours (Note=At 54th passage) (PubMed=33707600) 127229286 CVCL_A7NL IRTA17 cancer cell line human CVCL_A7NL CL:0000010 Sequence variation: Gene fusion; HGNC; 3446; ERG + HGNC; 4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=7794765) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Doubling time: ~79 hours (PubMed=7794765) 127229287 CVCL_A7NK RRBL1 cancer cell line human CVCL_A7NK CL:0000010 Sequence variation: Gene fusion; HGNC; 990; BCL2 + HGNC; 5477; IGH; Name(s)=IGH-BCL2 (PubMed=17675267) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229288 CVCL_A7NB Sf-21-CB spontaneously immortalized cell line CVCL_A7NB CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Biotechnology: Used for the production of the MSD Animal Health porcine circovirus type 2 (PCV2) vaccine Porcilis PCV Used to produce the PCV2 ORF2 capsid protein.; Biotechnology: Used for the production of the MSD Animal Health classical swine fever virus (CSFV) vaccine Porcilis Pesti Used to produce the CSFV envelope glycoprotein E2. Female Group: Insect cell line; Group: Recombinant protein production insect cell line; Group: Vaccine production cell line 127229289 CVCL_A7NA LSA-D6 cancer cell line CVCL_A7NA CL:0000010 Transformant: Feline sarcoma virus (strain Snyder-Theilen)(NCBI-Taxonomy; 11780); Derived from site: In situ; Thymus; UBERON=UBERON_0002370. Unspecified Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity 127229290 CVCL_A7ND GM28037 finite cell line human CVCL_A7ND CL:0000010 Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28037); Sequence variation: Mutation; HGNC; 11474; SURF1; Simple; p.Tyr117Ter (c.351T>G); Zygosity=Heterozygous (Coriell=GM28037) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229291 CVCL_A7NC WAe009-A-58 embryonic stem cell human CVCL_A7NC From: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 2207; COL4A5 (Note=1 of 2 alleles) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229292 CVCL_A7MU SAEC-H7 embryonic stem cell CVCL_A7MU CL:0000010 Derived from site: In situ; Morula; UBERON=UBERON_0000085; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Doubling time: 1.7 days (PubMed=34044158) Group: Fish cell line 127229293 CVCL_A7MT BHK21-MERS-Rep spontaneously immortalized cell line CVCL_A7MT CL:0000010 Transfected with: UniProtKB; K9N7C7; Middle East respiratory syndrome-related coronavirus replicase polyprotein 1ab; Transfected with: UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus nucleoprotein (N); Transfected with: UniProtKB; P27652; Renilla-type luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Transfected with a pBAC-CMV-MERS-CoV replicon construct The MERS-CoV replicon contains the genes encoding the MERS-CoV polyproteins 1a and 1b and the N protein, neo, and the renilla-type luciferase (Rluc) gene (PubMed=33616893). 127229294 CVCL_A7MW SAEC-C1 embryonic stem cell CVCL_A7MW CL:0000010 Derived from site: In situ; Gastrula; UBERON=UBERON_0004734; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Group: Fish cell line 127229295 CVCL_A7MV SAEC-A3 embryonic stem cell CVCL_A7MV CL:0000010 Derived from site: In situ; Morula; UBERON=UBERON_0000085; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Doubling time: 1.7 days (PubMed=34044158) Group: Fish cell line 127229296 CVCL_A7MY LSA-D4-C cancer cell line CVCL_A7MY CL:0000010 Transformant: Feline sarcoma virus (strain Snyder-Theilen)(NCBI-Taxonomy; 11780); Derived from site: In situ; Thymus; UBERON=UBERON_0002370. Unspecified Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity 127229297 CVCL_A7MX SAEC-F1 embryonic stem cell CVCL_A7MX CL:0000010 Derived from site: In situ; Gastrula; UBERON=UBERON_0004734; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Group: Fish cell line 127229298 CVCL_A7MZ LSA-D4-K17 cancer cell line CVCL_A7MZ CL:0000010 Transformant: Feline sarcoma virus (strain Snyder-Theilen)(NCBI-Taxonomy; 11780); Derived from site: In situ; Thymus; UBERON=UBERON_0002370. Unspecified Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity 127229299 CVCL_A7NV MCS-2 [Mouse hybridoma against human ANPEP] hybridoma house mouse CVCL_A7NV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P15144; Human ANPEP/CD13. 127229300 CVCL_A7NU MCS-1 [Mouse hybridoma against sialyl Lewis X] hybridoma house mouse CVCL_A7NU CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: ChEBI; CHEBI:61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X). 127229301 CVCL_A7NX WAe001-A-72 embryonic stem cell human CVCL_A7NX From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 24678; FTO Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229302 CVCL_A7NW PRHC-1 cancer cell line human CVCL_A7NW CL:0000010 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Virology: Resistant of the cytopathogenic effect of poliovirus infection (PubMed=3037186) 127229303 CVCL_A7NZ RTG spontaneously immortalized cell line Norway rat CVCL_A7NZ CL:0000010 Derived from site: In situ; Embryonic tooth bud, dental papilla, incisor; UBERON=UBERON_0003317; Breed/subspecies: Wistar. Unspecified Doubling time: ~19 hours (PubMed=293368) 127229304 CVCL_A7NY VMCs transformed cell line house mouse CVCL_A7NY CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: BALB/c. Doubling time: ~15 hours (PubMed=8228520) 127229305 CVCL_A7LL RUCDRi002-A-10 induced pluripotent stem cell human CVCL_A7LL From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229306 CVCL_A7LK RUCDRi002-A-9 induced pluripotent stem cell human CVCL_A7LK From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229307 CVCL_A7LN RUCDRi002-A-12 induced pluripotent stem cell human CVCL_A7LN From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229308 CVCL_A7LM RUCDRi002-A-11 induced pluripotent stem cell human CVCL_A7LM From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229309 CVCL_A7LP RUCDRi002-A-13 induced pluripotent stem cell human CVCL_A7LP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229310 CVCL_A7LR RUCDRi002-A-15 induced pluripotent stem cell human CVCL_A7LR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (with p.Asp10Ala and p.His840Ala = dCas9); Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 a dCas9-VPR-2A-tdTomato-WPRE construct containing dCas9 fused to heterotrimeric VPR transactivator consisting of VP64, p65, and RTA domains along with a tdTomato and a woodchuck hepatitis post-transcriptional regulatory element (WPRE) was introduced in the AAVS1 safe harbor locus (PubMed=34481190) 127229311 CVCL_A7LQ RUCDRi002-A-14 induced pluripotent stem cell human CVCL_A7LQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229312 CVCL_A7LD RUCDRi002-A-1 induced pluripotent stem cell human CVCL_A7LD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229313 CVCL_A7LC DMBi001-A-1 induced pluripotent stem cell human CVCL_A7LC From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 6482; LAMA2 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229314 CVCL_A7LF RUCDRi002-A-3 induced pluripotent stem cell human CVCL_A7LF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229315 CVCL_A7LE RUCDRi002-A-2 induced pluripotent stem cell human CVCL_A7LE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229316 CVCL_A7LH RUCDRi002-A-6 induced pluripotent stem cell human CVCL_A7LH From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229317 CVCL_A7LG RUCDRi002-A-4 induced pluripotent stem cell human CVCL_A7LG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229318 CVCL_A7LJ RUCDRi002-A-8 induced pluripotent stem cell human CVCL_A7LJ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229319 CVCL_A7LI RUCDRi002-A-7 induced pluripotent stem cell human CVCL_A7LI From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229320 CVCL_A7KZ UNIMGi003-A induced pluripotent stem cell human CVCL_A7KZ From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy CL:0000010 Sequence variation: Mutation; HGNC; 2482; CSTB; Repeat_expansion; c.-210CCCCGCCCCGCG[(2_3)]; ClinVar=VCV000008398; Zygosity=Unspecified (PubMed=33865103) Population: Caucasian; Italian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229321 CVCL_A7LB CMC-hiPSC-022 induced pluripotent stem cell human CVCL_A7LB From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea CL:0000010 Population: Korean; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Deep exome analysis; Omics: SNP array analysis; Omics: Transcriptome analysis by RNAseq 127229322 CVCL_A7LA UNIMGi004-A induced pluripotent stem cell human CVCL_A7LA From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy CL:0000010 Sequence variation: Mutation; HGNC; 2482; CSTB; Repeat_expansion; c.-210CCCCGCCCCGCG[(2_3)]; ClinVar=VCV000008398; Zygosity=Unspecified (PubMed=33865103) Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229323 CVCL_A7KS WMUi031-A induced pluripotent stem cell human CVCL_A7KS From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 8108; OCRL; Simple; p.Met876Asnfs (c.2626dupA); Zygosity=Hemizygous (PubMed=33765594) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127229324 CVCL_A7KR SCVIi011-A induced pluripotent stem cell human CVCL_A7KR From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 6251; KCNH2; Simple; p.Leu987Argfs*70 (c.2960delT); ClinVar=VCV000943648; Zygosity=Heterozygous (PubMed=34051449) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229325 CVCL_A7KU ZNHi001-B induced pluripotent stem cell human CVCL_A7KU From: Zhongnan Hospital of Wuhan University; Wuhan; China CL:0000010 Sequence variation: Mutation; HGNC; 16627; CHEK2; Simple; p.Arg180Cys (c.538C>T) (p.Arg223Cys, c.667C>T); ClinVar=VCV000128081; Zygosity=Heterozygous (PubMed=33780728) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229326 CVCL_A7KT ZNHi001-A induced pluripotent stem cell human CVCL_A7KT From: Zhongnan Hospital of Wuhan University; Wuhan; China CL:0000010 Sequence variation: Mutation; HGNC; 16627; CHEK2; Simple; p.Arg180Cys (c.538C>T) (p.Arg223Cys, c.667C>T); ClinVar=VCV000128081; Zygosity=Heterozygous (PubMed=33780728) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229327 CVCL_A7KW REGUi013-A induced pluripotent stem cell human CVCL_A7KW From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Array-based CGH Male 127229328 CVCL_A7KV REGUi012-A induced pluripotent stem cell human CVCL_A7KV From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Array-based CGH Male 127229329 CVCL_A7KY REGUi011-A induced pluripotent stem cell human CVCL_A7KY From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France. CL:0000010 127229330 CVCL_A7KX REGUi014-A induced pluripotent stem cell human CVCL_A7KX From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Array-based CGH Male 127229331 CVCL_A7MM IMGTi003-B induced pluripotent stem cell human CVCL_A7MM From: Research Institute of Medical Genetics; Tomsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: We assigned the IMGTi003-B name for consistency with the IMGTi003-A cell line 127229332 CVCL_A7ML TAF11 finite cell line human CVCL_A7ML CL:0000010 Population: Caucasian; Karyotypic information: 46,XY,r(8)(p23;q24.3); 45,XY,-8 (PubMed=33070101); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Male 127229333 CVCL_A7MN IMGTi003-C induced pluripotent stem cell human CVCL_A7MN From: Research Institute of Medical Genetics; Tomsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: We assigned the IMGTi003-C name for consistency with the IMGTi003-A cell line 127229334 CVCL_A7MQ ICGi024-B induced pluripotent stem cell human CVCL_A7MQ From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH; Omics: SNP array analysis Male Caution: We assigned the ICGi024-B name for consistency with the ICGi024-A cell line 127229335 CVCL_A7MP IMGTi003-D induced pluripotent stem cell human CVCL_A7MP From: Research Institute of Medical Genetics; Tomsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: We assigned the IMGTi003-D name for consistency with the IMGTi003-A cell line 127229336 CVCL_A7MS TAF12 finite cell line human CVCL_A7MS CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH Male 127229337 CVCL_A7MR ICGi024-C induced pluripotent stem cell human CVCL_A7MR From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH; Omics: SNP array analysis Male Caution: We assigned the ICGi024-C name for consistency with the ICGi024-A cell line 127229338 CVCL_A7ME PER.C6 TetR transformed cell line human CVCL_A7ME From: Johnson & Johnson Janssen; Beerse; Belgium CL:0000010 Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR Transformant: Adenovirus 5 [Note=E1](NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072; Cell type: Retinoblast; CL=CL_4023129. Biotechnology: Used for the production of the Janssen SARS-CoV-2 (COVID-19) vaccine (Trade name: Ad26.COV2.S) (DrugBank=DB15857) In the context of the vaccine production, the tetR repressor blocks the expression of the SARS-CoV-2 spike protein gene during production of the recombinant adenoviral vector, thereby optimising vector production. Unspecified Group: Vaccine production cell line 127229339 CVCL_A7MD WTC-mEGFP-TERF2-cl25 induced pluripotent stem cell human CVCL_A7MD CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 TERF2 has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 127229340 CVCL_A7MG ICGi025-B induced pluripotent stem cell human CVCL_A7MG From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH; Omics: SNP array analysis Male Caution: We assigned the ICGi025-B name for consistency with the ICGi025-A cell line 127229341 CVCL_A7MF CCA-OF cancer cell line CVCL_A7MF CL:0000010 Transformant: N-nitrosodimethylamine (NDMA(ChEBI; CHEBI:35807); Transformant: Opisthorchis felineus(NCBI-Taxonomy; 147828). Male Characteristics: Obtained by both Opisthorchis felineus infection and N-nitrosodimethylamine treatment (PubMed=33862109) Doubling time: 23.2 +- 2.7 hours (PubMed=33862109) 127229342 CVCL_A7MI ICGi025-D induced pluripotent stem cell human CVCL_A7MI From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH; Omics: SNP array analysis Male Caution: We assigned the ICGi025-D name for consistency with the ICGi025-A cell line 127229343 CVCL_A7MH ICGi025-C induced pluripotent stem cell human CVCL_A7MH From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH; Omics: SNP array analysis Male Caution: We assigned the ICGi025-C name for consistency with the ICGi025-A cell line 127229344 CVCL_A7MK ICGi025-F induced pluripotent stem cell human CVCL_A7MK From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH; Omics: SNP array analysis Male Caution: We assigned the ICGi025-F name for consistency with the ICGi025-A cell line 127229345 CVCL_A7MJ ICGi025-E induced pluripotent stem cell human CVCL_A7MJ From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Array-based CGH; Omics: SNP array analysis Male Caution: We assigned the ICGi025-E name for consistency with the ICGi025-A cell line 127229346 CVCL_A7MA RUCDRi002-A-24 induced pluripotent stem cell human CVCL_A7MA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229347 CVCL_A7MC FAHZUi001-A induced pluripotent stem cell human CVCL_A7MC From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 22947; NLRP7; Simple; p.Gln421Ter (c.1261C>T); Zygosity=Homozygous (PubMed=34087990) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229348 CVCL_A7MB RUCDRi002-A-25 induced pluripotent stem cell human CVCL_A7MB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229349 CVCL_A7LT RUCDRi002-A-17 induced pluripotent stem cell human CVCL_A7LT From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (with p.Asp10Ala and p.His840Ala = dCas9); Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 a CAG-dCas9-KRAB-T2A-tdTomato-WPRE construct was introduced in the AAVS1 safe harbor locus 127229350 CVCL_A7LS RUCDRi002-A-16 induced pluripotent stem cell human CVCL_A7LS From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (with p.Asp10Ala and p.His840Ala = dCas9); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR); Transfected with: tdTomato, a bright red fluorescent protein derived from drFP583 (DsRed) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 a CAG-dCas9-KRAB-T2A-tdTomato-EF1a-puroR construct was introduced in the AAVS1 safe harbor locus 127229351 CVCL_A7LV RUCDRi002-A-19 induced pluripotent stem cell human CVCL_A7LV From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 TTN was tagged at the C-terminus with mEGFP 127229352 CVCL_A7LU RUCDRi002-A-18 induced pluripotent stem cell human CVCL_A7LU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229353 CVCL_A7LX RUCDRi002-A-21 induced pluripotent stem cell human CVCL_A7LX From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229354 CVCL_A7LW RUCDRi002-A-20 induced pluripotent stem cell human CVCL_A7LW From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229355 CVCL_A7LZ RUCDRi002-A-23 induced pluripotent stem cell human CVCL_A7LZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229356 CVCL_A7LY RUCDRi002-A-22 induced pluripotent stem cell human CVCL_A7LY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229357 CVCL_A7JJ TMPi002-A induced pluripotent stem cell human CVCL_A7JJ From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229358 CVCL_A7JI TMPi001-B induced pluripotent stem cell human CVCL_A7JI From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229359 CVCL_A7JL TMPi003-A induced pluripotent stem cell human CVCL_A7JL From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229360 CVCL_A7JK TMPi002-B induced pluripotent stem cell human CVCL_A7JK From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229361 CVCL_A7JN TMPi004-A induced pluripotent stem cell human CVCL_A7JN From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229362 CVCL_A7JM TMPi003-B induced pluripotent stem cell human CVCL_A7JM From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229363 CVCL_A7JP TMPi004-B induced pluripotent stem cell human CVCL_A7JP From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229364 CVCL_A7JB IGIBi007-A induced pluripotent stem cell human CVCL_A7JB From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India CL:0000010 Sequence variation: Mutation; HGNC; 9416; PRKG2; Simple; p.Asn164Lysfs*2 (c.491dup); ClinVar=VCV001326258; Zygosity=Homozygous (PubMed=33887582) Population: Indian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229365 CVCL_A7JA VRISGi001-A induced pluripotent stem cell human CVCL_A7JA From: Vinmec Research Insitute of Stem Cell and Gene Technology; Hanoi; Vietnam CL:0000010 Population: Southeast Asian; Vietnamese; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 127229366 CVCL_A7JD JSPHi001-A induced pluripotent stem cell human CVCL_A7JD From: Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University; Nanjing; China CL:0000010 Sequence variation: Mutation; HGNC; 6636; LMNA; Simple; p.Arg335Trp (c.1003C>T); ClinVar=VCV000036473; Zygosity=Heterozygous (PubMed=33887581) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229367 CVCL_A7JC PLAFMCi004-A induced pluripotent stem cell human CVCL_A7JC From: Chinese PLA General Hospital; Beijing; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229368 CVCL_A7JF SDUBMSi011-A induced pluripotent stem cell human CVCL_A7JF From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 20323; SMOC2; Simple; p.Leu359Arg (c.1076T>G); Zygosity=Heterozygous (PubMed=33892290) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229369 CVCL_A7JE HEBHMUi007-A induced pluripotent stem cell human CVCL_A7JE From: Hebei Medical University; Shijiazhuang; China CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229370 CVCL_A7JH TMPi001-A induced pluripotent stem cell human CVCL_A7JH From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229371 CVCL_A7JG CIBi009-A induced pluripotent stem cell human CVCL_A7JG From: Cell Inspire Biotechnology; Shenzhen; China CL:0000010 Sequence variation: Mutation; HGNC; 6547; LDLR; Simple; p.Leu414Arg (c.1241T>G); ClinVar=VCV000251747; Zygosity=Heterozygous (PubMed=33892292); Sequence variation: Mutation; HGNC; 603; APOB; Simple; p.Asp540Tyr (c.1618G>T); ClinVar=VCV000925431; Zygosity=Heterozygous (PubMed=33892292) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229372 CVCL_A7IY FLENIi001-A induced pluripotent stem cell human CVCL_A7IY From: Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia; Buenos Aires; Argentina CL:0000010 Sequence variation: Mutation; HGNC; 9508; PSEN1; Simple; p.Thr119Ile (c.356C>T); ClinVar=VCV000625849; Zygosity=Heterozygous (PubMed=33839546) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229373 CVCL_A7IX HEBHMUi006-A induced pluripotent stem cell human CVCL_A7IX From: Hebei Medical University; Shijiazhuang; China CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: hPSCreg; HEBHMUi006-A; true Male 127229374 CVCL_A7IZ PUMCHi014-A induced pluripotent stem cell human CVCL_A7IZ From: Peking Union Medical College Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; 23198; CYP4V2; Simple; c.802-8_810del17insGC (IVS6-8 del/insGC); ClinVar=VCV000039271; Zygosity=Heterozygous (PubMed=33857831); Sequence variation: Mutation; HGNC; 23198; CYP4V2; Simple; p.Trp340Ter (c.1020G>A); ClinVar=VCV000039248; Zygosity=Heterozygous (PubMed=33857831) Population: Chinese; Han; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229375 CVCL_A7IQ SHCDNi005-A induced pluripotent stem cell human CVCL_A7IQ From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; 18060; ARX; Simple; p.Gln503Alafs*28 (c.1507_1508del); Zygosity=Hemizygous (PubMed=34968892) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229376 CVCL_A7IP CSUASOi007-A induced pluripotent stem cell human CVCL_A7IP From: Central South University, Aier School of Ophthalmology; Changsha; China. CL:0000010 127229377 CVCL_A7IS CMES40-OC embryonic stem cell CVCL_A7IS CL:0000010 Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR); Transfected with: mCerulean3, a bright cyan fluorescent protein derived from GFP Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using CRISPR/Cas9 a P2A-mCerulean3-T2A-pac construct was knocked in at the c-terminus of one allele of POU5F1/OCT4 (PubMed=33799281) Group: Non-human primate cell line 127229378 CVCL_A7IR 46C-Dip2c KO embryonic stem cell house mouse CVCL_A7IR CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1920179; Dip2c; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; X5DSL3; Anaplasma marginale mCherry fluorescent protein; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129P2/Ola. Male 127229379 CVCL_A7IU UALGi002-A induced pluripotent stem cell human CVCL_A7IU From: Universidade do Algarve; Faro; Portugal CL:0000010 Population: Caucasian; Portuguese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229380 CVCL_A7IT SYSUe008-A embryonic stem cell human CVCL_A7IT From: Sun Yat-sen University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 24865; GPAM Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229381 CVCL_A7IW PUMCSMi001-A induced pluripotent stem cell human CVCL_A7IW From: School of Basic Medicine, Peking Union Medical College; Beijing; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229382 CVCL_A7IV UALGi001-A induced pluripotent stem cell human CVCL_A7IV From: Universidade do Algarve; Faro; Portugal CL:0000010 Population: Caucasian; Portuguese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229383 CVCL_A7KK BCHi006-B induced pluripotent stem cell human CVCL_A7KK From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Asp471Glufs*37 (c.1412delA); Zygosity=Heterozygous (PubMed=33714067) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229384 CVCL_A7KJ BCHi006-A induced pluripotent stem cell human CVCL_A7KJ From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Asp471Glufs*37 (c.1412delA); Zygosity=Heterozygous (PubMed=33714067) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229385 CVCL_A7KM SCVIi007-A induced pluripotent stem cell human CVCL_A7KM From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple; p.Arg1712Gln (c.5135G>A); ClinVar=VCV000036642; Zygosity=Heterozygous (PubMed=34352619) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229386 CVCL_A7KL SCVIi006-A induced pluripotent stem cell human CVCL_A7KL From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple; p.Glu1356Lys (c.4066G>A); ClinVar=VCV000164294; Zygosity=Heterozygous (PubMed=34352619) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229387 CVCL_A7KN SCVIi008-A induced pluripotent stem cell human CVCL_A7KN From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple; p.Arg723Cys (c.2167C>T); ClinVar=VCV000014095; Zygosity=Heterozygous (PubMed=34352619) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229388 CVCL_A7KQ SCVIi010-A induced pluripotent stem cell human CVCL_A7KQ From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 6251; KCNH2; Simple; p.Ser624Cys (c.1870A>T); ClinVar=VCV000644725; Zygosity=Heterozygous (PubMed=34051449) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229389 CVCL_A7KP SCVIi009-A induced pluripotent stem cell human CVCL_A7KP From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; 6251; KCNH2; Simple; p.Gly572Ser (c.1714G>A); ClinVar=VCV000067248; Zygosity=Heterozygous (PubMed=34051449) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229390 CVCL_A7KC BCHi002-B induced pluripotent stem cell human CVCL_A7KC From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Arg558Thrfs*9 (c.1671dupA) (c.1671_1672insA); ClinVar=VCV000156643; Zygosity=Heterozygous (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229391 CVCL_A7KB BCHi002-A induced pluripotent stem cell human CVCL_A7KB From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Arg558Thrfs*9 (c.1671dupA) (c.1671_1672insA); ClinVar=VCV000156643; Zygosity=Heterozygous (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229392 CVCL_A7KE BCHi003-B induced pluripotent stem cell human CVCL_A7KE From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Leu629Ter (c.1886T>A); Zygosity=Mosaic (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229393 CVCL_A7KD BCHi003-A induced pluripotent stem cell human CVCL_A7KD From: Children's Hospital Boston; Boston; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Established from a patient that is mosaic for a CDKL5 p.Leu629Ter mutation, but this cell line does not contain this mutation 127229394 CVCL_A7KG BCHi004-B induced pluripotent stem cell human CVCL_A7KG From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Asp135Gly (c.404A>G); Zygosity=Mosaic (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229395 CVCL_A7KF BCHi004-A induced pluripotent stem cell human CVCL_A7KF From: Children's Hospital Boston; Boston; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Established from a patient that is mosaic for a CDKL5 p.Asp135Gly mutation, but this cell line does not contain this mutation 127229396 CVCL_A7KI BCHi005-B induced pluripotent stem cell human CVCL_A7KI From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Arg550Ter (c.1648C>T); ClinVar=VCV000143780; Zygosity=Heterozygous (PubMed=33714067) Population: Latino or Hispanic; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229397 CVCL_A7KH BCHi005-A induced pluripotent stem cell human CVCL_A7KH From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Arg550Ter (c.1648C>T); ClinVar=VCV000143780; Zygosity=Heterozygous (PubMed=33714067) Population: Latino or Hispanic; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229398 CVCL_A7JZ BCHi001-A induced pluripotent stem cell human CVCL_A7JZ From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; 11411; CDKL5; Simple; p.Val718Met (c.2152G>A); ClinVar=VCV000143796; Zygosity=Mosaic (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229399 CVCL_A7JY TMPi009-B induced pluripotent stem cell human CVCL_A7JY From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229400 CVCL_A7KA BCHi001-B induced pluripotent stem cell human CVCL_A7KA From: Children's Hospital Boston; Boston; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Established from a patient that is mosaic for a CDKL5 p.Val718Met mutation, but this cell line does not contain this mutation 127229401 CVCL_A7JR TMPi005-B induced pluripotent stem cell human CVCL_A7JR From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229402 CVCL_A7JQ TMPi005-A induced pluripotent stem cell human CVCL_A7JQ From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229403 CVCL_A7JT TMPi006-B induced pluripotent stem cell human CVCL_A7JT From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229404 CVCL_A7JS TMPi006-A induced pluripotent stem cell human CVCL_A7JS From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229405 CVCL_A7JV TMPi007-B induced pluripotent stem cell human CVCL_A7JV From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229406 CVCL_A7JU TMPi007-A induced pluripotent stem cell human CVCL_A7JU From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229407 CVCL_A7JX TMPi009-A induced pluripotent stem cell human CVCL_A7JX From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229408 CVCL_A7JW TMPi008-A induced pluripotent stem cell human CVCL_A7JW From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229409 CVCL_A7XX 58F8dc1 hybridoma Norway rat CVCL_A7XX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp) apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229410 CVCL_A7XW 28G2dc1 hybridoma Norway rat CVCL_A7XW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp) apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229411 CVCL_A7XZ N1-2A8 hybridoma house mouse CVCL_A7XZ From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O96555; Plasmodium vivax ookinete surface protein (Pvs25). Group: Malaria research cell line 127229412 CVCL_A7XY N1-1H10 hybridoma house mouse CVCL_A7XY From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O96555; Plasmodium vivax ookinete surface protein (Pvs25). Group: Malaria research cell line 127229413 CVCL_A7XP BoMaMa-J2imm Tlr4-/- transformed cell line house mouse CVCL_A7XP From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229414 CVCL_A7XR BoMaMa-J2imm Tlr7-/- transformed cell line house mouse CVCL_A7XR From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2176882; Tlr7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229415 CVCL_A7XQ BoMaMa-J2imm Tlr6-/- transformed cell line house mouse CVCL_A7XQ From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341296; Tlr6 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229416 CVCL_A7XT BoMaMa-J2imm Tlr9-/- GFP transformed cell line house mouse CVCL_A7XT From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229417 CVCL_A7XS BoMaMa-J2imm Tlr9-/- transformed cell line house mouse CVCL_A7XS From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229418 CVCL_A7XV 23A3dc1 hybridoma Norway rat CVCL_A7XV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp) apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229419 CVCL_A7XU 19H8dc1 hybridoma Norway rat CVCL_A7XU CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P04934; Plasmodium falciparum (isolate Camp) merozoite surface protein 1 (MSP1). Group: Malaria research cell line 127229420 CVCL_A7XH BoMaMa-J2imm Ticam2-/- transformed cell line house mouse CVCL_A7XH From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229421 CVCL_A7XG BoMaMa-J2imm Ticam1-/- Ticam2-/- transformed cell line house mouse CVCL_A7XG From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1; Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229422 CVCL_A7XJ BoMaMa-J2imm Tlr1-/- transformed cell line house mouse CVCL_A7XJ From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341295; Tlr1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229423 CVCL_A7XI BoMaMa-J2imm Tirap-/- transformed cell line house mouse CVCL_A7XI From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2152213; Tirap Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229424 CVCL_A7XL BoMaMa-J2imm Tlr2-/- Tlr4-/- transformed cell line house mouse CVCL_A7XL From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2; Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229425 CVCL_A7XK BoMaMa-J2imm Tlr2-/- transformed cell line house mouse CVCL_A7XK From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229426 CVCL_A7XN BoMaMa-J2imm Tlr3-/- transformed cell line house mouse CVCL_A7XN From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2156367; Tlr3 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229427 CVCL_A7XM BoMaMa-J2imm Tlr2-/- Tlr9-/- transformed cell line house mouse CVCL_A7XM From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2; Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229428 CVCL_A7XB BoMaMa-J2imm Irf3-/- Irf7-/- transformed cell line house mouse CVCL_A7XB From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1859179; Irf3; Knockout cell: Method=KO mouse; MGI; MGI:1859212; Irf7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229429 CVCL_A7XA BoMaMa-J2imm Irf3-/- transformed cell line house mouse CVCL_A7XA From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1859179; Irf3 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229430 CVCL_A7XD BoMaMa-J2imm Myd88-/- transformed cell line house mouse CVCL_A7XD From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229431 CVCL_A7XC BoMaMa-J2imm Irf7-/- transformed cell line house mouse CVCL_A7XC From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1859212; Irf7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229432 CVCL_A7XF BoMaMa-J2imm Ticam1-/- transformed cell line house mouse CVCL_A7XF From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229433 CVCL_A7XE BoMaMa-J2imm Myd88-/- Ticam1-/- transformed cell line house mouse CVCL_A7XE From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88; Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229434 CVCL_A7YY 293/mNOD2 transformed cell line human CVCL_A7YY CL:0000010 Transfected with: MGI; MGI:2429397; Nod2; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229435 CVCL_A7YX 293/hNOD2 transformed cell line human CVCL_A7YX CL:0000010 Transfected with: HGNC; 5331; NOD2; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229436 CVCL_A7YZ HEK-Blue Null2-k transformed cell line human CVCL_A7YZ CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229437 CVCL_A7YQ HEK-Blue hNOD1 transformed cell line human CVCL_A7YQ CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 16390; NOD1; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229438 CVCL_A7YP HEK-Blue Null1 transformed cell line human CVCL_A7YP CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229439 CVCL_A7YS HEK-Blue mNOD1 transformed cell line human CVCL_A7YS CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: MGI; MGI:1341839; Nod1; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229440 CVCL_A7YR HEK-Blue hNOD2 transformed cell line human CVCL_A7YR CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 5331; NOD2; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229441 CVCL_A7YU 293/Null transformed cell line human CVCL_A7YU CL:0000010 Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229442 CVCL_A7YT HEK-Blue mNOD2 transformed cell line human CVCL_A7YT CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: MGI; MGI:2429397; Nod2; Transfected with: UniProtKB; P33967; B.cereus Bsr; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229443 CVCL_A7YW 293/mNOD1 transformed cell line human CVCL_A7YW CL:0000010 Transfected with: MGI; MGI:1341839; Nod1; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229444 CVCL_A7YV 293/hNOD1 transformed cell line human CVCL_A7YV CL:0000010 Transfected with: HGNC; 16390; NOD1; Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229445 CVCL_A7YI 293-SARS2-S transformed cell line human CVCL_A7YI CL:0000010 Transfected with: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S); Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stable expression of the SARS-CoV-2 Spike protein For optimal expression, the C-terminal ER-retention signal has been removed. Has a functional furin cleavage site. Recommended for cell-cell fusion assays with ACE2-expressing cells (InvivoGen). Group: SARS-CoV-2 research cell line 127229446 CVCL_A7YH 297-17 hybridoma house mouse CVCL_A7YH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Plasmodium sp thrombospondin-related anonymous protein (TRAP) (Note=Immunization with a synthetic peptide).. Group: Malaria research cell line 127229447 CVCL_A7YK HEK-Blue hACE2 transformed cell line human CVCL_A7YK CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: HGNC; 13557; ACE2; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites Group: SARS-CoV-2 research cell line 127229448 CVCL_A7YJ 293-SARS2-S-dfur transformed cell line human CVCL_A7YJ CL:0000010 Transfected with: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S); Transfected with: UniProtKB; P33967; B.cereus Bsr Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stable expression of the SARS-CoV-2 Spike protein with an inactive furin (dfur) cleavage site facilitating improved surface expression and detection for flow cytometry For optimal expression, the C-terminal ER-retention signal has been removed (InvivoGen). Group: SARS-CoV-2 research cell line 127229449 CVCL_A7YM HEK-Blue Null2 transformed cell line human CVCL_A7YM CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229450 CVCL_A7YL HEK-Blue Null1-v transformed cell line human CVCL_A7YL CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229451 CVCL_A7YN HEK-Blue Null1-k transformed cell line human CVCL_A7YN CL:0000010 Transfected with: HGNC; 439; ALPP; Transfected with: UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites 127229452 CVCL_A7YA N1-1A5 hybridoma house mouse CVCL_A7YA From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG2; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (19 kDa fragment) (Note=Also reacts with isolate 3D7). Group: Malaria research cell line 127229453 CVCL_A7YC S1-1G3 hybridoma house mouse CVCL_A7YC From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (42 kDa fragment). Group: Malaria research cell line 127229454 CVCL_A7YB S1-1D7 hybridoma house mouse CVCL_A7YB From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (42 kDa fragment). Group: Malaria research cell line 127229455 CVCL_A7YE S1-4A4 hybridoma house mouse CVCL_A7YE From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (42 kDa fragment). Group: Malaria research cell line 127229456 CVCL_A7YD S1-3D6 hybridoma house mouse CVCL_A7YD From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (19 kDa fragment) (Note=Also reacts with isolate 3D7). Group: Malaria research cell line 127229457 CVCL_A7YG 141-32 hybridoma house mouse CVCL_A7YG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium sp thrombospondin-related anonymous protein (TRAP) (Note=Immunization with a synthetic peptide).. Group: Malaria research cell line 127229458 CVCL_A7YF 250-30 hybridoma house mouse CVCL_A7YF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium sp thrombospondin-related anonymous protein (TRAP) (Note=Immunization with a synthetic peptide).. Group: Malaria research cell line 127229459 CVCL_A7VV N3-1D7 hybridoma house mouse CVCL_A7VV From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229460 CVCL_A7VU N3-1C8 hybridoma house mouse CVCL_A7VU From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229461 CVCL_A7VX N4-1F6 hybridoma house mouse CVCL_A7VX From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229462 CVCL_A7VW N3-2D9 hybridoma house mouse CVCL_A7VW From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229463 CVCL_A7VZ N4-2E3 hybridoma house mouse CVCL_A7VZ From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229464 CVCL_A7VY N4-1G6 hybridoma house mouse CVCL_A7VY From: Long C.A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229465 CVCL_A7VN 4C1 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VN CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229466 CVCL_A7VM 3D3 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229467 CVCL_A7VP 4C6 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229468 CVCL_A7VR 2F2 [Mouse hybridoma against P.vivax csp] hybridoma house mouse CVCL_A7VR CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08677; Plasmodium vivax circumsporozoite protein. Group: Malaria research cell line 127229469 CVCL_A7VQ 2D4 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229470 CVCL_A7VT 2E10.2 hybridoma house mouse CVCL_A7VT CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P08677; Plasmodium vivax circumsporozoite protein. Group: Malaria research cell line 127229471 CVCL_A7VS LET1 transformed cell line house mouse CVCL_A7VS CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Virology: Supports spreading influenza virus infection in the absence of exogenous protease (PubMed=24243730) Doubling time: <24 hours (PubMed=24243730) 127229472 CVCL_A7VF SeGB spontaneously immortalized cell line CVCL_A7VF CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Can grow at temperatures ranging from 15 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229473 CVCL_A7VE 3D11 [Mouse hybridoma against P.berghei csp] hybridoma house mouse CVCL_A7VE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P06915; Plasmodium berghei circumsporozoite protein. Group: Malaria research cell line 127229474 CVCL_A7VH SeGE-22 spontaneously immortalized cell line CVCL_A7VH CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Can grow at temperatures ranging from 25 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229475 CVCL_A7VG SeGE-12 spontaneously immortalized cell line CVCL_A7VG CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Can grow at temperatures ranging from 25 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229476 CVCL_A7VJ 2A10 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229477 CVCL_A7VI SeGF spontaneously immortalized cell line CVCL_A7VI CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Characteristics: Can grow at temperatures ranging from 15 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229478 CVCL_A7VL 3C2 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VL CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229479 CVCL_A7VK 3C1 hybridoma house mouse CVCL_A7VK CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229480 CVCL_A7VB OUMS-15 transformed cell line human CVCL_A7VB CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229481 CVCL_A7VA OUMS-14 transformed cell line human CVCL_A7VA CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229482 CVCL_A7VD 3D1 [Mouse hybridoma against monkeypox virus vCCI] hybridoma house mouse CVCL_A7VD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6YLY9; Monkeypox virus (strain MPXV_ZAI1979_005) CC-type chemokine-binding protein (vCCI). 127229483 CVCL_A7VC OUMS-17 transformed cell line human CVCL_A7VC CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from a chronic lymphatic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229484 CVCL_A7WW BrMi-J2imm Tlr9-/- transformed cell line house mouse CVCL_A7WW From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229485 CVCL_A7WV BrMi-J2imm Tlr7-/- transformed cell line house mouse CVCL_A7WV From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2176882; Tlr7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229486 CVCL_A7WY BoMaMa-J2imm Casp1-/- transformed cell line house mouse CVCL_A7WY From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:96544; Casp1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229487 CVCL_A7WX BoMaMa-J2imm transformed cell line house mouse CVCL_A7WX From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229488 CVCL_A7WZ BoMaMa-J2imm Cd14-/- transformed cell line house mouse CVCL_A7WZ From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:88318; Cd14 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229489 CVCL_A7WN BrMi-J2imm Ticam1-/- transformed cell line house mouse CVCL_A7WN From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229490 CVCL_A7WQ BrMi-J2imm Tlr1-/- transformed cell line house mouse CVCL_A7WQ From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341295; Tlr1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229491 CVCL_A7WP BrMi-J2imm Ticam2-/- transformed cell line house mouse CVCL_A7WP From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229492 CVCL_A7WS BrMi-J2imm Tlr3-/- transformed cell line house mouse CVCL_A7WS From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2156367; Tlr3 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229493 CVCL_A7WR BrMi-J2imm Tlr2-/- transformed cell line house mouse CVCL_A7WR From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229494 CVCL_A7WU BrMi-J2imm Tlr6-/- transformed cell line house mouse CVCL_A7WU From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341296; Tlr6 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229495 CVCL_A7WT BrMi-J2imm Tlr4-/- transformed cell line house mouse CVCL_A7WT From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229496 CVCL_A7WG g12 hybridoma house mouse CVCL_A7WG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q08505; Plasmodium berghei p23-like protein. Group: Malaria research cell line 127229497 CVCL_A7WF c7 hybridoma house mouse CVCL_A7WF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium berghei 52 kDa phosphoprotein. Group: Malaria research cell line 127229498 CVCL_A7WI L1.6 hybridoma house mouse CVCL_A7WI CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q25645; Plasmodium berghei merozoite surface protein 1. Group: Malaria research cell line 127229499 CVCL_A7WH F4.4 hybridoma house mouse CVCL_A7WH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q25645; Plasmodium berghei merozoite surface protein 1. Group: Malaria research cell line 127229500 CVCL_A7WK BrMi-J2imm transformed cell line house mouse CVCL_A7WK From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229501 CVCL_A7WJ W3.5 hybridoma house mouse CVCL_A7WJ CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Plasmodium berghei erythrocytic-stage exoantigen. Group: Malaria research cell line 127229502 CVCL_A7WM BrMi-J2imm Myd88-/- Tirap-/- transformed cell line house mouse CVCL_A7WM From: Golenbock D.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88; Knockout cell: Method=KO mouse; MGI; MGI:2152213; Tirap Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229503 CVCL_A7WL BrMi-J2imm Myd88-/- Ticam1-/- transformed cell line house mouse CVCL_A7WL CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88; Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229504 CVCL_A7WA em13.5 hybridoma house mouse CVCL_A7WA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P90574; Plasmodium chabaudi 93 kDa erythrocyte membrane protein (Pc(em)-93). Group: Malaria research cell line 127229505 CVCL_A7WC em16.8 hybridoma house mouse CVCL_A7WC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium chabaudi 65 kDa erythrocyte membrane protein (Pc(em)-65). Group: Malaria research cell line 127229506 CVCL_A7WB em16.3 hybridoma house mouse CVCL_A7WB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium chabaudi 65 kDa erythrocyte membrane protein (Pc(em)-65). Group: Malaria research cell line 127229507 CVCL_A7WE b5 hybridoma house mouse CVCL_A7WE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q08168; Plasmodium berghei 58 kDa phosphoprotein. Group: Malaria research cell line 127229508 CVCL_A7WD em17.4 hybridoma house mouse CVCL_A7WD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium chabaudi 46 kDa erythrocyte membrane protein (Pc(em)-46). Group: Malaria research cell line 127229509 CVCL_A7TT WIL2-A3 transformed cell line human CVCL_A7TT CL:0000010 Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Male 127229510 CVCL_A7TS RPMI-7882 transformed cell line human CVCL_A7TS CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229511 CVCL_A7TV BA886 finite cell line CVCL_A7TV CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632); Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257) 127229512 CVCL_A7TU 1H8 [Mouse hybridoma against human BMSC] hybridoma house mouse CVCL_A7TU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human 80 kDa protein on bone marrow stromal cells. 127229513 CVCL_A7TX BPA987 finite cell line CVCL_A7TX CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632) 127229514 CVCL_A7TW BA987 finite cell line CVCL_A7TW CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632; PubMed=8300237) 127229515 CVCL_A7TZ Bushpig 1194 finite cell line CVCL_A7TZ CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Male Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229516 CVCL_A7TY Buffalo 595 finite cell line CVCL_A7TY CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Female Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229517 CVCL_A7TL RPMI-7712 transformed cell line human CVCL_A7TL CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229518 CVCL_A7TK RPMI-7662 transformed cell line human CVCL_A7TK CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229519 CVCL_A7TN RPMI-7722 transformed cell line human CVCL_A7TN CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229520 CVCL_A7TM RPMI-7762 transformed cell line human CVCL_A7TM CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229521 CVCL_A7TP RPMI-7672 transformed cell line human CVCL_A7TP CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229522 CVCL_A7TR RPMI-7912 transformed cell line human CVCL_A7TR CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229523 CVCL_A7TQ RPMI-7822 transformed cell line human CVCL_A7TQ CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229524 CVCL_A7TD RPMI-7572 transformed cell line human CVCL_A7TD CL:0000010 Karyotypic information: 47,XY,+21; 48,XY,+21+C (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229525 CVCL_A7TC RPMI-7492 transformed cell line human CVCL_A7TC CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229526 CVCL_A7TF RPMI-7532 transformed cell line human CVCL_A7TF CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229527 CVCL_A7TE RPMI-7852 transformed cell line human CVCL_A7TE CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229528 CVCL_A7TH RPMI-7542 transformed cell line human CVCL_A7TH CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229529 CVCL_A7TG RPMI-7732 transformed cell line human CVCL_A7TG CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229530 CVCL_A7TJ RPMI-7592 transformed cell line human CVCL_A7TJ CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229531 CVCL_A7TI RPMI-7582 transformed cell line human CVCL_A7TI CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229532 CVCL_A7SZ RPMI-7462 transformed cell line human CVCL_A7SZ CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229533 CVCL_A7TB RPMI-8092 transformed cell line human CVCL_A7TB CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229534 CVCL_A7TA RPMI-7552 transformed cell line human CVCL_A7TA CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229535 CVCL_A7UU B-LCL-HROC68 transformed cell line human CVCL_A7UU HLA typing: A*02:01:01,29:02:01; B*13:02:01,47:03:01; C*06:02:01,16:01:01; DPB1*01:01:01,04:01:01; DQA1*02:01:01; DQB1*02:02:01; DRB1*07:01:01 (CLS=302078) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229536 CVCL_A7UT B-LCL-HROC60 transformed cell line human CVCL_A7UT HLA typing: A*02:01:01,11:01:01; B*20:02:01,55:01:01; C*03:03:01,05:01:01; DPB1*04:01:01; DQA1*01:01:01,01:03:01; DQB1*05:01:01,06:03:01; DRB1*01:01:01,13:01:01 (CLS=302004) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229537 CVCL_A7UW A549-hACE2 (HA-FLAG) cancer cell line human CVCL_A7UW From: Garcia-Sastre A.; The Icahn School of Medicine at Mount Sinai Medical School; New York; USA CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 13557; ACE2; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Expresses ACE2 with C-terminal HA and FLAG tags under the control the CMV promoter (BEI_Resources=NR-53522) Group: SARS-CoV-2 research cell line 127229538 CVCL_A7UV A549-hACE2 [BEI resources] cancer cell line human CVCL_A7UV From: Baric R.; Department of Epidemiology, University of North Carolina at Chapel Hill; Chapel Hill; USA CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 13557; ACE2; Transfected with: UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Expresses ACE2 under the control of the EF1a promoter (BEI_Resources=NR-53821) Group: SARS-CoV-2 research cell line 127229539 CVCL_A7UY DBT piD-2 transformed cell line house mouse CVCL_A7UY CL:0000010 Transformant: Rous sarcoma virus (strain Schmidt-Ruppin)(NCBI-Taxonomy; 11889); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: BALB/c x DBA/2. Female Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285) 127229540 CVCL_A7UX DBT piD-10 transformed cell line house mouse CVCL_A7UX CL:0000010 Transformant: Rous sarcoma virus (strain Schmidt-Ruppin)(NCBI-Taxonomy; 11889); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: BALB/c x DBA/2. Female Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285) 127229541 CVCL_A7UZ DBT piD-3 transformed cell line house mouse CVCL_A7UZ CL:0000010 Transformant: Rous sarcoma virus (strain Schmidt-Ruppin)(NCBI-Taxonomy; 11889); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: BALB/c x DBA/2. Female Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285) 127229542 CVCL_A7UM B-LCL-HROC102 transformed cell line human CVCL_A7UM From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229543 CVCL_A7UL B-LCL-HROC278 transformed cell line human CVCL_A7UL HLA typing: A*01:03:01,25:01:01; B*07:02:01,18:01:01; C*07:02:01,12:03:01; DPB1*02:01:02,04:01:02; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:02:01; DRB1*04:01:01,15:01:01 (CLS=302051) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229544 CVCL_A7UN B-LCL-HROC43 transformed cell line human CVCL_A7UN HLA typing: A*01:01:01,02:01:01; B*15:01:01,37:01:01; C*03:03:01,06:02:01; DPB1*01:01:01,05:01:01; DQA1*01:05:01,05:05:01; DQB1*03:01:01,05:01:01; DRB1*10:01:01,12:01:01 (CLS=302067) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229545 CVCL_A7UQ B-LCL-HROC50 transformed cell line human CVCL_A7UQ HLA typing: A*02:01:01,03:01:01; B*07:02:01,27:01:01; C*06:02:01,07:02:01; DPB1*04:01:01; DQA1*01:02:01,02:01:01; DQB1*03:03:02,06:02:01; DRB1*07:01:01,15:01:01 (CLS=302069) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229546 CVCL_A7UP B-LCL-HROC46 transformed cell line human CVCL_A7UP HLA typing: A*01:01:01,02:01:01; B*07:02:01,08:01:01; C*07:01:01,07:02:01; DPB1*01:01:01,19:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01 (CLS=302068) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229547 CVCL_A7US B-LCL-HROC59 transformed cell line human CVCL_A7US HLA typing: A*03:01:01,24:02:01; B*01:02:01,27:05:02; C*02:02:02,07:02:01; DPB1*04:01:01,14:01:01; DQA1*01:02:01,03:03:01; DQB1*03:02:01,06:02:01; DRB1*04:01:01,15:01:01 (CLS=302073) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229548 CVCL_A7UR B-LCL-HROC57 transformed cell line human CVCL_A7UR HLA typing: A*01:01:01,02:01:01; B*08:01:01,27:01:01; C*06:02:01,07:01:01; DPB1*02:01:02,04:01:01; DQA1*02:01:01,05:01:01; DQB1*02:01:01,03:03:02; DRB1*03:01:01,07:01:01 (CLS=302072) From: Linnebacher M.; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229549 CVCL_A7UE BPA593/1 finite cell line CVCL_A7UE CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237) 127229550 CVCL_A7UD BPA291 finite cell line CVCL_A7UD CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237) 127229551 CVCL_A7UG BSV-793 finite cell line CVCL_A7UG CL:0000010 Derived from site: In situ; Limb, saphenous vein; UBERON=UBERON_0007318; Cell type: Endothelial cell of vein; CL=CL_0002543. 127229552 CVCL_A7UF SBE-189 finite cell line CVCL_A7UF CL:0000010 Derived from site: In situ; Brain, microvascular endothelium; UBERON=UBERON_0000955+UBERON_0008339; Cell type: Endothelial cell; CL=CL_0000115. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00633) 127229553 CVCL_A7UI Vero-Luc2p spontaneously immortalized cell line green monkey CVCL_A7UI CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Biotechnology: Used in a quantitative and sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis (PubMed=20585113) Female Characteristics: Stably expresses luciferase Luc2p which is tagged with a PEST sequence which promotes rapid turnover Therefore, luciferase activity reflects the current level of protein synthesis (PubMed=20585113).; Characteristics: Transduced with a Luc2P-IRES-eGFP construct Group: Non-human primate cell line 127229554 CVCL_A7UH E5 finite cell line CVCL_A7UH CL:0000010 Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=3329310; PubMed=3900854) 127229555 CVCL_A7UK HEK-293T-hACE2 transformed cell line human CVCL_A7UK CL:0000010 Transfected with: HGNC; 13557; ACE2; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Transformant: Simian virus 40 (SV40) [Note=tsA](NCBI-Taxonomy; 1891767); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Expresses ACE2 under the control of the EF1a promoter (BEI_Resources=NR-52511) Group: SARS-CoV-2 research cell line 127229556 CVCL_A7UJ Vero E6-high ACE2 spontaneously immortalized cell line green monkey CVCL_A7UJ CL:0000010 Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Characteristics: Obtained by sorting Vero E6 cells for cells expressing high levels of endogenous ACE2; Characteristics: Application in SARS-CoV-2 research Group: Non-human primate cell line 127229557 CVCL_A7UA Sable 1194 finite cell line CVCL_A7UA CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Female Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229558 CVCL_A7UC BPA191 finite cell line CVCL_A7UC CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237) 127229559 CVCL_A7UB Eland 895 finite cell line CVCL_A7UB CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Female Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229560 CVCL_A7RR FHNG-00 transformed cell line human CVCL_A7RR HLA typing: A*23:01:01,24:39; B*44:03:01:01,40:02:01; C*04:01:01:01,02:02:02:01; DPA1*01:03:01:01,02:01:01:02; DPB1*16:01:01,10:01:01; DQA1*03:01:01,05:05:01; DQB1*03:05:01,03:01:01:03; DRB1*04:03:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229561 CVCL_A7RQ FHSL-00 transformed cell line human CVCL_A7RQ HLA typing: A*30:02:01:01; B*07:02:01,35:01:01:02; C*07:02:01:03,04:01:01:01; DPA1*01:03:01:01,01:03:01:04; DPB1*04:01:01:01,02:01:02; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229562 CVCL_A7RT FHNG-01 transformed cell line human CVCL_A7RT HLA typing: A*24:39,29:02:01:01; B*15:17:01:01,40:02:01; C*07:01:02,02:02:02:01; DPA1*01:03:01:01; DPB1*02:01:02,16:01:01; DQA1*01:02:01,05:05:01; DQB1*06:04:01,03:01:01:03; DRB1*13:02:01,11:01:01:01; DRB3*03:01:01,02:02:01:02 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229563 CVCL_A7RS FHES-00 transformed cell line human CVCL_A7RS HLA typing: A*02:01:01:01,24:02:01:01; B*35:01:01:02,35:12:01; C*04:01:01:01; DPA1*01:03:01:05; DPB1*04:02:01:02; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:07:01; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229564 CVCL_A7RV WAe009-A-62 embryonic stem cell human CVCL_A7RV From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 6294; KCNQ1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229565 CVCL_A7RU FHES-01 transformed cell line human CVCL_A7RU HLA typing: A*68:03:01,02:01:01:01; B*40:02:01; C*03:05,02:02:02:01; DPA1*01:03:01:04,02:02:02; DPB1*02:01:02,05:01:01; DQA1*03:01:01,05:05:01; DQB1*03:02:01,03:01:01:03; DRB1*04:07:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229566 CVCL_A7RX WAe009-A-59 embryonic stem cell human CVCL_A7RX From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 4808; HAND2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229567 CVCL_A7RW WAe009-A-61 embryonic stem cell human CVCL_A7RW From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 12010; TPM1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229568 CVCL_A7RJ LEO-10 transformed cell line human CVCL_A7RJ HLA typing: A*03:01:01:01; B*07:02:01; C*07:02:01:03; DPA1*01:03:01:02; DPB1*04:01:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229569 CVCL_A7RI AL-10 transformed cell line human CVCL_A7RI HLA typing: A*26:01:01:01; B*38:01:01; C*12:03:01:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:02:01; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229570 CVCL_A7RL FHBN transformed cell line human CVCL_A7RL HLA typing: A*02:01:01:01; B*15:01:01:01,44:03:01:01; C*03:03:01:01,04:09N; DPA1*01:03:01:01,01:03:01:02; DPB1*04:01:01:01(350:01),13:01:01; DQA1*02:01:01,01:02:01; DQB1*02:02:01:01,06:02:01; DRB1*07:01:01,15:01:01; DRB4*01:01:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229571 CVCL_A7RK FH90 transformed cell line human CVCL_A7RK HLA typing: A*11:01:01:01,26:01:01:01; B*35:01:01:02; C*08:01:01; C*03:03:01:01; DPA1*02:02:02,01:03:01:01; DPB1*05:01:01,02:01:02; DQA1*05:03,01:04:01; DQB1*03:01:01:01,05:03:01; DRB1*14:03:01,14:07:01; DRB3*01:01:02,02:02:01:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229572 CVCL_A7RN FHJQ-01 transformed cell line human CVCL_A7RN HLA typing: A*24:02:01:02L,01:01:01:01; B*37:01:01,08:01:01:01; C*01:02:01,07:01:01:01; DPA1*01:03:01:02,02:01:02; DPB1*04:01:01:01,01:01:01; DQA1*03:03:01:01,05:01:01:02; DQB1*03:01:01:01,02:01:01; DRB1*04:07:01,03:01:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229573 CVCL_A7RM FHJQ-00 transformed cell line human CVCL_A7RM HLA typing: A*24:02:01:02L,02:01:01:01; B*37:01:01,07:02:01; C*01:02:01,07:02:01:03; DPA1*01:03:01:01,01:03:01:02; DPB1*04:01:01:01,02:01:02; DQA1*03:03:01:01,05:05:01; DQB1*03:01:01:01,03:01:01:03; DRB1*04:07:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229574 CVCL_A7RP FHSL-01 transformed cell line human CVCL_A7RP HLA typing: A*11:01:01:01; B*07:02:01; C*07:02:01:03; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*01:02:01,03:03:01:01; DQB1*06:02:01,03:01:01:01; DRB1*15:01:01,04:01:01; DRB4*01:03:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229575 CVCL_A7RB FH81 transformed cell line human CVCL_A7RB HLA typing: A*01:01:01:01,02:01:01:01; B*40:02:01,07:05:01:01; C*02:02:02:01,15:23; DPA1*01:03:01:04,01:03:01:05; DPB1*04:02:01:01(105:01),04:01:01:01(126:01); DQA1*01:02:02,05:05:01; DQB1*05:02:01,03:01:01:03; DRB1*16:02:01:02,01:03; DRB5*02:02 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229576 CVCL_A7RA FH80 transformed cell line human CVCL_A7RA HLA typing: A*02:01:01:01,02:03:01; B*40:01:02; C*03:17,07:02:01:01; DPA1*02:02:02; DPB1*135:01,05:01:01; DQA1*01:04:01,03:02; DQB1*05:03:01,03:03:02; DRB1*14:54:01,09:01:02; DRB3*02:02:01:01; DRB4*01:03:02 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229577 CVCL_A7RD FH83 transformed cell line human CVCL_A7RD HLA typing: A*02:01:01:01; B*07:02:01,40:02:01; C*07:02:01:03,02:06:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229578 CVCL_A7RC FH82 transformed cell line human CVCL_A7RC CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229579 CVCL_A7RF FH86 transformed cell line human CVCL_A7RF CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229580 CVCL_A7RE FH85 transformed cell line human CVCL_A7RE HLA typing: A*03:01:01:01,32:01:01; B*18:01:01:02,40:02:01; C*07:01:01:01,15:02:01:02; DPA1*01:03:01:02,02:02:02; DPB1*04:02:01:02(105:01),04:01:01:01(126:01); DQA1*05:05:01,03:01:01; DQB1*03:01:01:03,03:02:01; DRB1*11:01:01:01,04:03:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229581 CVCL_A7RH FH89 transformed cell line human CVCL_A7RH HLA typing: A*02:01:01:01; B*15:01:01:01; C*03:04:01:01; DPA1*01:03:01:02,01:03:01:03; DPB1*03:01:01(124:01),04:01:01:01(350:01); DQA1*03:01:01; DQB1*03:02:01; DRB1*04:01:01; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229582 CVCL_A7RG FH87 transformed cell line human CVCL_A7RG HLA typing: A*02:01:01:01,01:01:01:01; B*40:02:01,08:01:01:01; C*15:02:01:02,07:01:01:01; DPA1*01:03:01:01; DPB1*02:01:02; DQA1*02:01:01,05:01:01:02; DQB1*02:02:01:01,02:01:01; DRB1*07:01:01,03:01:01; DRB3*01:01:02; DRB4*01:01:01:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229583 CVCL_A7QY M-4581 finite cell line human CVCL_A7QY CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127229584 CVCL_A7QX M-3773 finite cell line human CVCL_A7QX CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127229585 CVCL_A7QZ FH79 transformed cell line human CVCL_A7QZ HLA typing: A*11:01:01:01,02:01:01:01; B*18:01:01:02,50:01:01; C*07:36,06:02:01:02; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*05:05:01,02:01:01; DQB1*03:01:01:03,02:02:01:01; DRB1*11:01:01:01,07:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229586 CVCL_A7SS UM-55 transformed cell line human CVCL_A7SS CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229587 CVCL_A7SR UM-3 [Human LCL] transformed cell line human CVCL_A7SR CL:0000010 Miscellaneous: Source of immortalizing EBV is cell line UM-1 (Cellosaurus=CVCL_VJ00) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229588 CVCL_A7SU UM-39 transformed cell line human CVCL_A7SU CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229589 CVCL_A7ST UM-56 transformed cell line human CVCL_A7ST CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229590 CVCL_A7SW UM-11 transformed cell line human CVCL_A7SW CL:0000010 Miscellaneous: Source of immortalizing EBV is cell line UM-3 (Cellosaurus=CVCL_A7SR) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229591 CVCL_A7SV UM-10 transformed cell line human CVCL_A7SV CL:0000010 Miscellaneous: Source of immortalizing EBV is cell line UM-3 (Cellosaurus=CVCL_A7SR) Population: Caucasian; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229592 CVCL_A7SY RPMI-7402 transformed cell line human CVCL_A7SY CL:0000010 Karyotypic information: 47,XY,+21; 46,XY (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229593 CVCL_A7SX RPMI-7422 transformed cell line human CVCL_A7SX CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229594 CVCL_A7SK OUMS-9 transformed cell line human CVCL_A7SK CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000027. Male 127229595 CVCL_A7SJ OUMS-8 transformed cell line human CVCL_A7SJ CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229596 CVCL_A7SM OUMS-11A transformed cell line human CVCL_A7SM CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229597 CVCL_A7SL OUMS-10 transformed cell line human CVCL_A7SL CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000027. Male 127229598 CVCL_A7SN OUMS-11B transformed cell line human CVCL_A7SN CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229599 CVCL_A7SQ OUMS-13 transformed cell line human CVCL_A7SQ CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229600 CVCL_A7SP OUMS-12 transformed cell line human CVCL_A7SP CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from acute myelogenous leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229601 CVCL_A7SC OUMS-21 [1972] transformed cell line human CVCL_A7SC CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Caution: Two cell lines named OUMS-21 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SC) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9131) 127229602 CVCL_A7SB OUMS-20 transformed cell line human CVCL_A7SB CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229603 CVCL_A7SE OUMS-3 transformed cell line human CVCL_A7SE CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229604 CVCL_A7SD OUMS-22 [1972] transformed cell line human CVCL_A7SD CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Two cell lines named OUMS-22 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SD) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9132) 127229605 CVCL_A7SG OUMS-5 transformed cell line human CVCL_A7SG CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229606 CVCL_A7SF OUMS-4 transformed cell line human CVCL_A7SF CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229607 CVCL_A7SI OUMS-7 transformed cell line human CVCL_A7SI CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229608 CVCL_A7SH OUMS-6 transformed cell line human CVCL_A7SH CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000027. Male 127229609 CVCL_A7RZ LUMCi046-A-1 induced pluripotent stem cell human CVCL_A7RZ From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 25947; KLHL24; Simple_edited; c.-3A>G; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992); Sequence variation: Mutation; HGNC; 25947; KLHL24; Simple_corrected; p.Met1Arg (c.2T>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229610 CVCL_A7RY LUMCi045-A-1 induced pluripotent stem cell human CVCL_A7RY From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 25947; KLHL24; Simple_corrected; p.Met1Arg (c.2T>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992); Sequence variation: Mutation; HGNC; 25947; KLHL24; Simple_edited; p.Val2Val (c.6A>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229611 CVCL_A7SA OUMS-18 transformed cell line human CVCL_A7SA CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229612 CVCL_A7AA HeLa M KIF13B-KO cancer cell line human CVCL_A7AA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14405; KIF13B Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229613 CVCL_A7AC R15_Spike hybridoma house mouse CVCL_A7AC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127229614 CVCL_A7AB HeLa M KIF13A/B-DKO cancer cell line human CVCL_A7AB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14566; KIF13A; Knockout cell: Method=CRISPR/Cas9; HGNC; 14405; KIF13B Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229615 CVCL_A7AE R31_Spike hybridoma house mouse CVCL_A7AE CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127229616 CVCL_A7AD R22_Spike hybridoma house mouse CVCL_A7AD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127229617 CVCL_A7AG S1D7_Spike hybridoma house mouse CVCL_A7AG CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127229618 CVCL_A7AF R52_Spike hybridoma house mouse CVCL_A7AF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127229619 CVCL_A6ZZ HeLa M KIF13A-KO cancer cell line human CVCL_A6ZZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 14566; KIF13A Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229620 CVCL_A6ZS 40LB spontaneously immortalized cell line house mouse CVCL_A6ZS CL:0000010 Transfected with: MGI; MGI:1344376; Tnfsf13b; Transfected with: MGI; MGI:88337; Cd40lg; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Can be used as feeder cells for B cell culture Support efficient proliferation and survival of B cells (PubMed=21897376). 127229621 CVCL_A6ZR 3T3/40L spontaneously immortalized cell line house mouse CVCL_A6ZR CL:0000010 Transfected with: MGI; MGI:88337; Cd40lg; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 127229622 CVCL_A6ZU T49-25 hybridoma house mouse CVCL_A6ZU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229623 CVCL_A6ZT ABC-31 cancer cell line human CVCL_A6ZT CL:0000010 Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (PubMed=33829270) Population: Japanese; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Resistant to the tyrosine kinase inhibitor osimertinib Has activated IGF1R (PubMed=33829270). 127229624 CVCL_A6ZW KM2048 hybridoma CVCL_A6ZW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229625 CVCL_A6ZV KM1978 hybridoma CVCL_A6ZV CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229626 CVCL_A6ZY HeLa M Rab8-DKO cancer cell line human CVCL_A6ZY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 7007; RAB8A; Knockout cell: Method=CRISPR/Cas9; HGNC; 30273; RAB8B Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229627 CVCL_A6ZX KM2051 hybridoma CVCL_A6ZX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229628 CVCL_A6ZK id5P cancer cell line Norway rat CVCL_A6ZK CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Transformant: N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA)(ChEBI; CHEBI:141568); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI. Male 127229629 CVCL_A6ZJ d5krm3 cancer cell line Norway rat CVCL_A6ZJ CL:0000010 Transformant: N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA)(ChEBI; CHEBI:141568); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4666) 127229630 CVCL_A6ZM id5krm7 cancer cell line Norway rat CVCL_A6ZM CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Transformant: N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA)(ChEBI; CHEBI:141568); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4668) 127229631 CVCL_A6ZL id5krm3 cancer cell line Norway rat CVCL_A6ZL CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Transformant: N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA)(ChEBI; CHEBI:141568); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4669) 127229632 CVCL_A6ZN BD1B hybridoma CVCL_A6ZN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9R100; Mouse Cdh17. 127229633 CVCL_A6ZQ MOMA-2 [Mouse/rat hybridoma against mouse macrophages and monocytes] hybridoma CVCL_A6ZQ CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Mouse macrophages and monocytes intracellular antigen. 127229634 CVCL_A6ZP MOMA-1 [Mouse/rat hybridoma against mouse Siglec1] hybridoma CVCL_A6ZP CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q62230; Mouse Siglec1/Cd169. 127229635 CVCL_A6ZC AQP4(E5505-3D12-129) hybridoma house mouse CVCL_A6ZC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23). 127229636 CVCL_A6ZB AQP4(E5504-2G2-105) hybridoma house mouse CVCL_A6ZB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23). 127229637 CVCL_A6ZE DP2(D5203-1D8-31) hybridoma house mouse CVCL_A6ZE CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9Z2J6; Mouse Ptgdr2. 127229638 CVCL_A6ZD AQP4(E5507-3A1-113) hybridoma house mouse CVCL_A6ZD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23). 127229639 CVCL_A6ZF BLG-139-3 factor-dependent cell line house mouse CVCL_A6ZF CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Pro-B cell; CL=CL_0000826; Breed/subspecies: C3H. Characteristics: Transfected with a LexA-d1EGFP reporter that consists of 8 tandem copies of a LexA binding element, a minimal promoter from mouse Ifnb and d1EGFP (destabilized EGFP) (PubMed=15225556) Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse 127229640 CVCL_A6ZI d5krm7 cancer cell line Norway rat CVCL_A6ZI CL:0000010 Transformant: N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA)(ChEBI; CHEBI:141568); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4665) 127229641 CVCL_A6ZH rRCCd5 cancer cell line Norway rat CVCL_A6ZH CL:0000010 Transformant: N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA)(ChEBI; CHEBI:141568); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI. Male 127229642 CVCL_A6XY Cys-SN2(N3323) hybridoma house mouse CVCL_A6XY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9ULM6; Human CNOT6. 127229643 CVCL_A6XX Cys-SN2(N3316) hybridoma house mouse CVCL_A6XX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (isoform SN2). 127229644 CVCL_A6XZ Cys-SN2(N3331) hybridoma house mouse CVCL_A6XZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (isoform SN2). 127229645 CVCL_A6XQ LCHi002-B induced pluripotent stem cell human CVCL_A6XQ From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; 2962; DYNC2H1; Simple; p.Thr3836Ile (c.11507C>T); Zygosity=Heterozygous (PubMed=37413951); Sequence variation: Mutation; HGNC; 7983; NR5A1; Unexplicit; Ex3del and part of Ex4; Zygosity=Heterozygous (PubMed=37413951); Sequence variation: Mutation; HGNC; 8783; PDE4D; Simple; p.Gly93Ser (c.277G>A); Zygosity=Heterozygous (PubMed=37413951); Sequence variation: Mutation; HGNC; 16700; ZFPM2; Simple; p.Asn1087Ser (c.3260A>G); Zygosity=Heterozygous (PubMed=37413951) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229646 CVCL_A6XP LCHi002-A induced pluripotent stem cell human CVCL_A6XP From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; 2962; DYNC2H1; Simple; p.Thr3836Ile (c.11507C>T); Zygosity=Heterozygous (from autologous cell line LCHi002-A); Sequence variation: Mutation; HGNC; 7983; NR5A1; Unexplicit; Ex3del and part of Ex4; Zygosity=Heterozygous (from autologous cell line LCHi002-A); Sequence variation: Mutation; HGNC; 8783; PDE4D; Simple; p.Gly93Ser (c.277G>A); Zygosity=Heterozygous (from autologous cell line LCHi002-A); Sequence variation: Mutation; HGNC; 16700; ZFPM2; Simple; p.Asn1087Ser (c.3260A>G); Zygosity=Heterozygous (from autologous cell line LCHi002-A) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: hPSCreg; LCHi002-A; true Male 127229647 CVCL_A6XS UNINAi001-B induced pluripotent stem cell human CVCL_A6XS From: University of Naples Federico II; Napoli; Italy CL:0000010 Sequence variation: Mutation; HGNC; 6297; KCNQ3; Simple; p.Phe534Ilefs*15 (c.1599dupT); ClinVar=VCV000205978; Zygosity=Homozygous (from autologous cell line UNINAi001-A) Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229648 CVCL_A6XR UNINAi001-A induced pluripotent stem cell human CVCL_A6XR From: University of Naples Federico II; Napoli; Italy CL:0000010 Sequence variation: Mutation; HGNC; 6297; KCNQ3; Simple; p.Phe534Ilefs*15 (c.1599dupT); ClinVar=VCV000205978; Zygosity=Homozygous (PubMed=33799276) Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229649 CVCL_A6XU CCR4aN(Y6206) hybridoma house mouse CVCL_A6XU CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q9ULM6; Human CNOT6. 127229650 CVCL_A6XT UNINAi002-A induced pluripotent stem cell human CVCL_A6XT From: University of Naples Federico II; Napoli; Italy CL:0000010 Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229651 CVCL_A6XW Cys-SN2(N3312) hybridoma house mouse CVCL_A6XW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (isoform SN2). 127229652 CVCL_A6XV Cys-SN2(N3306) hybridoma house mouse CVCL_A6XV CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (isoform SN2). 127229653 CVCL_A6XI WTC-mEGFP-EZH2-cl18 induced pluripotent stem cell human CVCL_A6XI CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 EZH2 has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 127229654 CVCL_A6XH WTC-mEGFP-POLR2A-cl74 induced pluripotent stem cell human CVCL_A6XH CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 POLR2A has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 127229655 CVCL_A6XK CSUi003-A induced pluripotent stem cell human CVCL_A6XK From: Central South University; Changsha; China CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229656 CVCL_A6XJ CSUi002-A induced pluripotent stem cell human CVCL_A6XJ From: Central South University; Changsha; China CL:0000010 Sequence variation: Mutation; HGNC; 3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (PubMed=33706202) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229657 CVCL_A6XM LCHi001-A induced pluripotent stem cell human CVCL_A6XM From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; 644; AR; Simple; p.Ile900Phe (c.2698A>T); ClinVar=VCV000464801; Zygosity=Hemizygous (PubMed=34233262) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229658 CVCL_A6XL CSUi004-A induced pluripotent stem cell human CVCL_A6XL From: Central South University; Changsha; China CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229659 CVCL_A6XN LCHi001-B induced pluripotent stem cell human CVCL_A6XN From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; 644; AR; Simple; p.Ile900Phe (c.2698A>T); ClinVar=VCV000464801; Zygosity=Hemizygous (PubMed=34233262) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229660 CVCL_A6XA NCD-2 hybridoma Norway rat CVCL_A6XA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10288; Chicken CDH2 (Note=Also reacts with Xenopus). 127229661 CVCL_A6XC HAM1C transformed cell line human CVCL_A6XC CL:0000010 Population: Japanese; Transformant: Human T-lymphotropic virus 1 (HTLV-1)(NCBI-Taxonomy; 11908); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Characteristics: IL2 dependent 127229662 CVCL_A6XB PCD-1 hybridoma CVCL_A6XB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10287; Mouse Cdh3. 127229663 CVCL_A6XE USFi002-A induced pluripotent stem cell human CVCL_A6XE From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; 3756; FLNC; Simple; p.Asp2116Argfs*37 (c.6345_6352delTGACAAGC); ClinVar=VCV000959711; Zygosity=Heterozygous (PubMed=34088019) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229664 CVCL_A6XD USFi001-A induced pluripotent stem cell human CVCL_A6XD From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; 3951; FXN; Repeat_expansion; IVS1 GAA[781]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=34034220); Sequence variation: Mutation; HGNC; 3951; FXN; Repeat_expansion; IVS1 GAA[1092]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=34034220) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229665 CVCL_A6XG USFi004-A induced pluripotent stem cell human CVCL_A6XG From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple; p.Asp600Valfs*56 (c.1799delA); ClinVar=VCV000202020; Zygosity=Heterozygous (PubMed=34034221) Population: Caribbean; Haitian and Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229666 CVCL_A6XF USFi003-A induced pluripotent stem cell human CVCL_A6XF From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; 6636; LMNA; Simple; p.Arg541Cys (c.1621C>T); ClinVar=VCV000048046; Zygosity=Heterozygous (PubMed=34029931) Population: Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229667 CVCL_A6YZ AQP4(E5415A-1H6-68) hybridoma house mouse CVCL_A6YZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23). 127229668 CVCL_A6YY AQP4(E5413-1G11-49) hybridoma house mouse CVCL_A6YY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23). 127229669 CVCL_A6ZA AQP4(E5415B-1H7-79) hybridoma house mouse CVCL_A6ZA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23). 127229670 CVCL_A6YR CHO hAQP4-M1 spontaneously immortalized cell line CVCL_A6YR CL:0000010 Transfected with: HGNC; 637; AQP4 (isoform M1); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127229671 CVCL_A6YQ AQP4(D15107-3D7-33) hybridoma house mouse CVCL_A6YQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (isoform M23) (Note=Also reacts with mouse). 127229672 CVCL_A6YT CHO hAQP4-M23 spontaneously immortalized cell line CVCL_A6YT CL:0000010 Transfected with: HGNC; 637; AQP4 (isoform M23); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127229673 CVCL_A6YS CHO hAQP4-M1/M23 spontaneously immortalized cell line CVCL_A6YS CL:0000010 Transfected with: HGNC; 637; AQP4 (isoform M1); Transfected with: HGNC; 637; AQP4 (isoform M23); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127229674 CVCL_A6YV AQP4(D12092-1C3-02) hybridoma house mouse CVCL_A6YV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (isoform M23). 127229675 CVCL_A6YU AQP4(C9401-A3-29) hybridoma house mouse CVCL_A6YU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (isoform M23). 127229676 CVCL_A6YX AQP4(E5209-1C8-22) hybridoma house mouse CVCL_A6YX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23). 127229677 CVCL_A6YW AQP4(E5206-1B10-8) hybridoma house mouse CVCL_A6YW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (isoform M23) (Note=Also reacts with human). 127229678 CVCL_A6YJ Glut1(D4418-30) hybridoma house mouse CVCL_A6YJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229679 CVCL_A6YI Glut1(D4402-6) hybridoma house mouse CVCL_A6YI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229680 CVCL_A6YL hTobC(Y5432) hybridoma house mouse CVCL_A6YL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229681 CVCL_A6YK Glut1(D4404-9) hybridoma house mouse CVCL_A6YK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229682 CVCL_A6YN hTobC(Y5444) hybridoma house mouse CVCL_A6YN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229683 CVCL_A6YM hTobC(Y5443) hybridoma house mouse CVCL_A6YM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229684 CVCL_A6YP hTobC(Y5452) hybridoma house mouse CVCL_A6YP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229685 CVCL_A6YB Cys-SN2(N3349) hybridoma house mouse CVCL_A6YB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (isoform SN2). 127229686 CVCL_A6YA Cys-SN2(N3338) hybridoma house mouse CVCL_A6YA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (isoform SN2). 127229687 CVCL_A6YD Glut1(D3638-22) hybridoma house mouse CVCL_A6YD CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229688 CVCL_A6YC Cys-SN2(N3372) hybridoma house mouse CVCL_A6YC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (isoform SN2). 127229689 CVCL_A6YF Glut1(D4425-2) hybridoma house mouse CVCL_A6YF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229690 CVCL_A6YE Glut1(D3643-9) hybridoma house mouse CVCL_A6YE CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229691 CVCL_A6YH Glut1(D4417-14) hybridoma house mouse CVCL_A6YH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229692 CVCL_A6YG Glut1(D4416-3) hybridoma house mouse CVCL_A6YG CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229693 CVCL_A7HH Ctrl. BS PBiPS37-Sv4F-1 induced pluripotent stem cell human CVCL_A7HH CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127229694 CVCL_A7HG WAe009-A-55 embryonic stem cell human CVCL_A7HG From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243); Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; p.Asn210Asn (c.630C>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229695 CVCL_A7HJ iPSC 09-25 induced pluripotent stem cell human CVCL_A7HJ CL:0000010 Sequence variation: Mutation; HGNC; 1480; CAPN3; Simple; p.Lys254Glu (c.760A>G); Zygosity=Heterozygous (PubMed=33862537); Sequence variation: Mutation; HGNC; 1480; CAPN3; Simple; p.Pro637Hisfs*25 (c.1910delC); Zygosity=Heterozygous (PubMed=33862537) Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229696 CVCL_A7HI iPSC 08-46 induced pluripotent stem cell human CVCL_A7HI CL:0000010 Sequence variation: Mutation; HGNC; 1480; CAPN3; Simple; p.Arg490Trp (c.1468C>T); ClinVar=VCV000166790; Zygosity=Heterozygous (PubMed=33862537); Sequence variation: Mutation; HGNC; 1480; CAPN3; Simple; p.Arg788Serfs*14 (c.2362_2363delAGinsTCATCT); ClinVar=VCV000017618; Zygosity=Heterozygous (PubMed=33862537) Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229697 CVCL_A7HL iPSC 09-88 induced pluripotent stem cell human CVCL_A7HL CL:0000010 Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229698 CVCL_A7HK ESi100-A induced pluripotent stem cell human CVCL_A7HK From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127229699 CVCL_A7HN CalJa ESC 1 embryonic stem cell CVCL_A7HN CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX,-20,+mar (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229700 CVCL_A7HM iPSC 11-03 induced pluripotent stem cell human CVCL_A7HM CL:0000010 Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127229701 CVCL_A7HB WAe009-A-49 embryonic stem cell human CVCL_A7HB From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229702 CVCL_A7HA UKAi003-A-2 induced pluripotent stem cell human CVCL_A7HA From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 6192; JAK2; Simple_corrected; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=UKAi003-A-2) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229703 CVCL_A7HD WAe009-A-52 embryonic stem cell human CVCL_A7HD From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=By CRISPR/Cas9 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229704 CVCL_A7HC WAe009-A-51 embryonic stem cell human CVCL_A7HC From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229705 CVCL_A7HF WAe009-A-54 embryonic stem cell human CVCL_A7HF From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243); Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; p.Asn210Asn (c.630C>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229706 CVCL_A7HE WAe009-A-53 embryonic stem cell human CVCL_A7HE From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; 2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229707 CVCL_A7GW UKAi002-A-1 induced pluripotent stem cell human CVCL_A7GW From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 8861; PF4 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Established from a patient that has a JAK2 p.Val617Phe mutation, but this cell line does not contain this mutation 127229708 CVCL_A7GV UKAi002-B induced pluripotent stem cell human CVCL_A7GV From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (hPSCreg=UKAi002-B) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229709 CVCL_A7GY UKAi003-A induced pluripotent stem cell human CVCL_A7GY CL:0000010 Sequence variation: Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (hPSCreg=UKAi003-A) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229710 CVCL_A7GX UKAi002-B-1 induced pluripotent stem cell human CVCL_A7GX From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 8861; PF4; Sequence variation: Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=34391098) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229711 CVCL_A7GZ UKAi003-A-1 induced pluripotent stem cell human CVCL_A7GZ From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (hPSCreg=UKAi003-A-1); Sequence variation: Mutation; HGNC; 6192; JAK2; Simple_corrected; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UKAi003-A-1) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229712 CVCL_A7GN MHHi009-A-4 induced pluripotent stem cell human CVCL_A7GN From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Transfected with: RedStar(nuc), a red fluorescent protein Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229713 CVCL_A7GQ IIMCBi001-A induced pluripotent stem cell human CVCL_A7GQ From: International Institute of Molecular and Cell Biology; Warsaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229714 CVCL_A7GP MHHi009-A-eGFP induced pluripotent stem cell human CVCL_A7GP From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptome analysis by RNAseq Male 127229715 CVCL_A7GS SIGi001-A-14 induced pluripotent stem cell human CVCL_A7GS CL:0000010 Population: Caucasian; Cell type: Epithelial cell; CL=CL_0000066. Discontinued: ECACC; 66541213; true Female Characteristics: Contains a HA tag at the C-terminal of both alleles of MAPT (hPSCreg=SIGi001-A-14) 127229716 CVCL_A7GR IIMCBi002-A induced pluripotent stem cell human CVCL_A7GR From: International Institute of Molecular and Cell Biology; Warsaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229717 CVCL_A7GU UKAi002-A induced pluripotent stem cell human CVCL_A7GU From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Established from a patient that has a JAK2 p.Val617Phe mutation, but this cell line does not contain this mutation 127229718 CVCL_A7GT SIGi001-A-16 induced pluripotent stem cell human CVCL_A7GT CL:0000010 Sequence variation: Mutation; HGNC; 6893; MAPT; Simple_edited; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Homozygous; Note=By method not specified (hPSCreg=SIGi001-A-16); Sequence variation: Mutation; HGNC; 6893; MAPT; Simple_edited; c.1866+16C>T (IVS10+16C>T) (c.915+16C>T) (g.123819C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (hPSCreg=SIGi001-A-16) Population: Caucasian; Cell type: Epithelial cell; CL=CL_0000066. Discontinued: ECACC; 66541215; true Female Characteristics: Contains a HA tag at the C-terminal of both alleles of MAPT (hPSCreg=SIGi001-A-16) 127229719 CVCL_A7II WAe001-A-60 embryonic stem cell human CVCL_A7II From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 1494; ALX1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229720 CVCL_A7IH WAe001-A-63 embryonic stem cell human CVCL_A7IH From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 270; PARP1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229721 CVCL_A7IK WAe001-A-65 embryonic stem cell human CVCL_A7IK From: Nanfang Hospital, Southern Medical University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 160; ACTL6B Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229722 CVCL_A7IJ WAe001-A-58 embryonic stem cell human CVCL_A7IJ CL:0000010 Transfected with: UniProtKB; P0DTC9; Human SARS coronavirus 2 (SARS-CoV-2) nucleoprotein (N); Transfected with: UniProtKB; P42212; EYFP (modified GFP at L-46, 64-LG-65, L-68, A-72, T-153, A-163, G-175, Y-203 and L-231); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR); Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Transduced with a pB-TRE-[SARS-CoV-2-N]-EF1a-rtTA-2A-puroR-2A-EGFP construct In the presence of doxycycline rtTA undergo conformational change, binds to the TRE and activates SARS-CoV-2 N protein expression (PubMed=33771478). Group: SARS-CoV-2 research cell line 127229723 CVCL_A7IM UOMi005-A induced pluripotent stem cell human CVCL_A7IM From: University of Manitoba; Winnipeg; Canada CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: While the patient has a a 7.3 kb deletion in her mitochondrial DNA, this cell line does not show this deletion (PubMed=33756177; PubMed=33807701) 127229724 CVCL_A7IL WAe009-A-39 embryonic stem cell human CVCL_A7IL From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 7027; MERTK Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229725 CVCL_A7IN UOMi006-A induced pluripotent stem cell human CVCL_A7IN From: University of Manitoba; Winnipeg; Canada CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: While the patient has a a 5 kb deletion in her mitochondrial DNA, this cell line does not show this deletion (PubMed=33807701; PubMed=33901817) 127229726 CVCL_A7IA CalJa ESC 13 embryonic stem cell CVCL_A7IA CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229727 CVCL_A7IC CalJa ESC 15 embryonic stem cell CVCL_A7IC CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229728 CVCL_A7IB CalJa ESC 14 embryonic stem cell CVCL_A7IB CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229729 CVCL_A7IE CalJa ESC 17 embryonic stem cell CVCL_A7IE CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Donor information: Embryo is sibling to that giving rise to CalJa ESC 16 (Cellosaurus=CVCL_A7ID); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229730 CVCL_A7ID CalJa ESC 16 embryonic stem cell CVCL_A7ID CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XY [4/9]; 46,X,+19 [2/9]; 47,XY,+19 [3/9] (PubMed=33711687); Donor information: Embryo is sibling to that giving rise to CalJa ESC 17 (Cellosaurus=CVCL_A7IE); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229731 CVCL_A7IG CPGHi003-A induced pluripotent stem cell human CVCL_A7IG From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; 8768; AIFM1; Simple; p.Arg422Gln (c.1265G>A); ClinVar=VCV000162480; Zygosity=Hemizygous (PubMed=34088005) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229732 CVCL_A7IF CPGHi002-A-1 induced pluripotent stem cell human CVCL_A7IF From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; 854; ATP6V1B2; Simple_corrected; p.Arg506Ter (c.1516C>T); ClinVar=VCV000203442; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33714068) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229733 CVCL_A7HX CalJa ESC 10 embryonic stem cell CVCL_A7HX CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229734 CVCL_A7HW CalJa ESC 9 embryonic stem cell CVCL_A7HW CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229735 CVCL_A7HZ CalJa ESC 12 embryonic stem cell CVCL_A7HZ CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XY [2/7]; 46,XY,del(13p) [4/7]; 46,XY,del(3q),del(13p) [1/7] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229736 CVCL_A7HY CalJa ESC 11 embryonic stem cell CVCL_A7HY CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229737 CVCL_A7HP CalJa ESC 2 embryonic stem cell CVCL_A7HP CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229738 CVCL_A7HR CalJa ESC 4 embryonic stem cell CVCL_A7HR CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX [2/6]; 46,XX,-20,+mar [1/6]; 47,XX,+5 [2/6]; 47,XX,+5,del(5p),del(13p) [1/6] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229739 CVCL_A7HQ CalJa ESC 3 embryonic stem cell CVCL_A7HQ CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX,del(13p) (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229740 CVCL_A7HT CalJa ESC 6 embryonic stem cell CVCL_A7HT CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229741 CVCL_A7HS CalJa ESC 5 embryonic stem cell CVCL_A7HS CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229742 CVCL_A7HV CalJa ESC 8 embryonic stem cell CVCL_A7HV CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX,del(13p) [5/8]; 46,XX,-1,+4,del(4q),del(13p) [1/8]; 46,XX,+4,-5,del(4q) [1/8]; 47,XX,+15,del(13p) [1/8] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229743 CVCL_A7HU CalJa ESC 7 embryonic stem cell CVCL_A7HU CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XY [2/5]; 46,XY,del(1p) [2/5]; 45,X,del(1p) [1/5] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229744 CVCL_A7FF WS9001 transformed cell line human CVCL_A7FF CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229745 CVCL_A7FE WS8901 transformed cell line human CVCL_A7FE CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229746 CVCL_A7FH WS12101 transformed cell line human CVCL_A7FH CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229747 CVCL_A7FG WS9401 transformed cell line human CVCL_A7FG CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229748 CVCL_A7FJ WS14101 transformed cell line human CVCL_A7FJ CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229749 CVCL_A7FI WS12701 transformed cell line human CVCL_A7FI CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229750 CVCL_A7FL WS6401 transformed cell line human CVCL_A7FL CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229751 CVCL_A7FK WS5802 transformed cell line human CVCL_A7FK CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229752 CVCL_A7FB 7B5 hybridoma house mouse CVCL_A7FB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O14965; Human AURKA. 127229753 CVCL_A7FA 2E1 [Mouse hybridoma against human AURKA] hybridoma house mouse CVCL_A7FA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O14965; Human AURKA. 127229754 CVCL_A7FD WS6104 transformed cell line human CVCL_A7FD CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229755 CVCL_A7FC WS10001 transformed cell line human CVCL_A7FC CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Homozygous (PubMed=10543396) Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229756 CVCL_A7EU UT-SCC-122 cancer cell line human CVCL_A7EU CL:0000010 Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Male 127229757 CVCL_A7ET UT-SCC-114 cancer cell line human CVCL_A7ET CL:0000010 Derived from site: In situ; Oral cavity, lower lip; UBERON=UBERON_0001835. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Male 127229758 CVCL_A7EW HCC4006-OsiR cancer cell line human CVCL_A7EW CL:0000010 Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI:90943; Osimertinib (AZD9291); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male 127229759 CVCL_A7EV PF130 cancer cell line human CVCL_A7EV CL:0000010 Sequence variation: Mutation; HGNC; 6840; MAP2K1; Simple; p.Glu102_Lys104delinsGln (c.303_310del8ins); Zygosity=Unspecified (PubMed=33669371) Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male 127229760 CVCL_A7EY 35C1 hybridoma house mouse CVCL_A7EY CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O14965; Human AURKA (Note=Also reacts with mouse). 127229761 CVCL_A7EX NCI-H1975 CS cancer cell line human CVCL_A7EX CL:0000010 Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 3236; EGFR; Simple_edited; p.Cys797Ser (c.2389T>A); ClinVar=VCV000376342; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=32928921); Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127229762 CVCL_A7EZ 1A3 [Mouse hybridoma against human AURKA] hybridoma house mouse CVCL_A7EZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O14965; Human AURKA. 127229763 CVCL_A7EM UT-SCC-73 cancer cell line human CVCL_A7EM CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Female 127229764 CVCL_A7EL UT-SCC-72 cancer cell line human CVCL_A7EL CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Male 127229765 CVCL_A7EN UT-SCC-81 cancer cell line human CVCL_A7EN CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Male 127229766 CVCL_A7EQ UT-SCC-95 cancer cell line human CVCL_A7EQ CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Val143Gly (c.428T>G); ClinVar=VCV000486556; Zygosity=Heterozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Female 127229767 CVCL_A7EP UT-SCC-87 cancer cell line human CVCL_A7EP CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ile255Phe (c.763A>T); ClinVar=VCV000376621; Zygosity=Homozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Female 127229768 CVCL_A7ES UT-SCC-112 cancer cell line human CVCL_A7ES CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Female 127229769 CVCL_A7ER UT-SCC-99 cancer cell line human CVCL_A7ER CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Male 127229770 CVCL_A7GG SDUBMSi005-A induced pluripotent stem cell human CVCL_A7GG From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 1748; CDH1; Simple; p.Thr560Arg (c.1679C>G); ClinVar=VCV000234554; Zygosity=Heterozygous (PubMed=33770698) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229771 CVCL_A7GF SDUBMSi008-A induced pluripotent stem cell human CVCL_A7GF From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 2207; COL4A5; Simple; p.Arg266Ter (c.796C>T); ClinVar=VCV000024325; Zygosity=Hemizygous (PubMed=33878711) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229772 CVCL_A7GI SDUBMSi004-A induced pluripotent stem cell human CVCL_A7GI From: School of Basic Medical Sciences, Shandong University; Jinan; China. CL:0000010 Female 127229773 CVCL_A7GH SDUBMSi003-A induced pluripotent stem cell human CVCL_A7GH From: School of Basic Medical Sciences, Shandong University; Jinan; China. CL:0000010 Male 127229774 CVCL_A7GK MHHi021-A induced pluripotent stem cell human CVCL_A7GK From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple; p.Arg723Gly (c.2167C>G); ClinVar=VCV000042885; Zygosity=Heterozygous (PubMed=33578365) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: MYH7 mutation indicated incorrectly as being at c.2169C>G in PubMed=33578365 127229775 CVCL_A7GJ SIAISi013-A induced pluripotent stem cell human CVCL_A7GJ From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China. CL:0000010 127229776 CVCL_A7GM MHHi009-A induced pluripotent stem cell human CVCL_A7GM From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229777 CVCL_A7GL MHHi021-B induced pluripotent stem cell human CVCL_A7GL From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; 7577; MYH7; Simple; p.Arg723Gly (c.2167C>G); ClinVar=VCV000042885; Zygosity=Heterozygous (PubMed=33578365) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: MYH7 mutation indicated incorrectly as being at c.2169C>G in PubMed=33578365 127229778 CVCL_A7GA MHHi001-A-5 induced pluripotent stem cell human CVCL_A7GA From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Transfected with: GCaMP6f, a green fluorescent calcium sensor; Transfected with: RedStar(nuc), a red fluorescent protein Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female Characteristics: Using TALEN two constructs, a CAG-promoter driven GCamP6f and a CAG-prpmoter driven RedStar(nuc) were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=33571874) 127229779 CVCL_A7GC GZHMCi007-A induced pluripotent stem cell human CVCL_A7GC From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 18078; ZBTB7A Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229780 CVCL_A7GB GZHMCi006-A induced pluripotent stem cell human CVCL_A7GB From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China CL:0000010 Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Male 127229781 CVCL_A7GE SDUBMSi007-A induced pluripotent stem cell human CVCL_A7GE From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 2207; COL4A5; Simple; p.Arg266Ter (c.796C>T); ClinVar=VCV000024325; Zygosity=Hemizygous (PubMed=33878711) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229782 CVCL_A7GD SDUBMSi006-A induced pluripotent stem cell human CVCL_A7GD From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; 2204; COL4A3; Simple; p.Gly1406Arg (c.4216G>A); Zygosity=Heterozygous (PubMed=33601099); Sequence variation: Mutation; HGNC; 2204; COL4A3; Simple; p.Gly1415Arg (c.4243G>A); Zygosity=Heterozygous (PubMed=33601099) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229783 CVCL_A7FV 8H3 [Mouse hybridoma against human WRN] hybridoma house mouse CVCL_A7FV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229784 CVCL_A7FU 4H12 [Mouse hybridoma against human WRN] hybridoma house mouse CVCL_A7FU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229785 CVCL_A7FX JAWSII/EGFP spontaneously immortalized cell line house mouse CVCL_A7FX CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Dendritic cell; CL=CL_0000451; Breed/subspecies: C57BL/6 Trp53-/-. 127229786 CVCL_A7FW HEC-LTT conditionally immortalized cell line human CVCL_A7FW CL:0000010 Transfected with: HGNC; 11730; TERT; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR; Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del); Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16; Characteristics: In the presence of doxycycline, hTERT and SV40-TAg expression are activated, resulting in high cell proliferation and unlimited expansion In the absence of the doxycycline, cells stop proliferating and can be maintained in a growth-arrested state that reflects the status of endothelial cells in vivo (PubMed=26345505). 127229787 CVCL_A7FZ C3-luc transformed cell line house mouse CVCL_A7FZ CL:0000010 Transfected with: UniProtKB; P08659; Firefly luciferase; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd) Transformant: Human papillomavirus type 16 (HPV16)(NCBI-Taxonomy; 333760); Breed/subspecies: C57BL/6. Unspecified 127229788 CVCL_A7FY JAWSII/IL-12 spontaneously immortalized cell line house mouse CVCL_A7FY CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Transfected with: MGI; MGI:96539; Il12a; Transfected with: MGI; MGI:96540; Il12b Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Dendritic cell; CL=CL_0000451; Breed/subspecies: C57BL/6 Trp53-/-. 127229789 CVCL_A7FN WS12001 transformed cell line human CVCL_A7FN CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Tyr463Ter (c.1389T>A) (c.1620T>A); Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229790 CVCL_A7FM WS11701 transformed cell line human CVCL_A7FM CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; c.3460-7T>A (IVS29-7T>A); Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229791 CVCL_A7FP WS25401 transformed cell line human CVCL_A7FP CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Ala1306Serfs*13 (c.3915dupA) (c.4146insA); ClinVar=VCV000005448; Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229792 CVCL_A7FR 3D12 hybridoma house mouse CVCL_A7FR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229793 CVCL_A7FQ NSYM transformed cell line human CVCL_A7FQ CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized 127229794 CVCL_A7FT 4F8 [Mouse hybridoma against human WRN] hybridoma house mouse CVCL_A7FT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229795 CVCL_A7FS 4D9 hybridoma house mouse CVCL_A7FS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229796 CVCL_A7DD N0014 transformed cell line human CVCL_A7DD CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 125 PDL (PubMed=9365237) 127229797 CVCL_A7DC N0012 transformed cell line human CVCL_A7DC CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 103 PDL (PubMed=9365237) 127229798 CVCL_A7DF N0103 transformed cell line human CVCL_A7DF CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 30 PDL (PubMed=9365237) 127229799 CVCL_A7DE N0102 transformed cell line human CVCL_A7DE CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237) 127229800 CVCL_A7DH N4702 transformed cell line human CVCL_A7DH CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237) 127229801 CVCL_A7DG N0104 transformed cell line human CVCL_A7DG CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 136 PDL (PubMed=9365237) 127229802 CVCL_A7DJ 1E7 [Mouse hybridoma against mouse Celf3] hybridoma house mouse CVCL_A7DJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8CIN6; Mouse Celf3. 127229803 CVCL_A7DI N7401 transformed cell line human CVCL_A7DI CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 75 PDL (PubMed=9365237) 127229804 CVCL_A7CZ N0009 transformed cell line human CVCL_A7CZ CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 58 PDL (PubMed=9365237) 127229805 CVCL_A7DB N0011 transformed cell line human CVCL_A7DB CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 65 PDL (PubMed=9365237) 127229806 CVCL_A7DA N0010 transformed cell line human CVCL_A7DA CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 75 PDL (PubMed=9365237) 127229807 CVCL_A7CS WS12301 transformed cell line human CVCL_A7CS CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229808 CVCL_A7CR WS11901 transformed cell line human CVCL_A7CR CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229809 CVCL_A7CU N0002 transformed cell line human CVCL_A7CU CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 56 PDL (PubMed=9365237) 127229810 CVCL_A7CT N0001 transformed cell line human CVCL_A7CT CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237) 127229811 CVCL_A7CW N0006 transformed cell line human CVCL_A7CW CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 150 PDL (PubMed=9365237) 127229812 CVCL_A7CV N0004 transformed cell line human CVCL_A7CV CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 66 PDL (PubMed=9365237) 127229813 CVCL_A7CY N0008 transformed cell line human CVCL_A7CY CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 149 PDL (PubMed=9365237) 127229814 CVCL_A7CX N0007 transformed cell line human CVCL_A7CX CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 111 PDL (PubMed=9365237) 127229815 CVCL_A7CK WS11601 transformed cell line human CVCL_A7CK CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229816 CVCL_A7CJ WS11301 transformed cell line human CVCL_A7CJ CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237); Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229817 CVCL_A7CM WS0702 transformed cell line human CVCL_A7CM CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229818 CVCL_A7CL WS0701 transformed cell line human CVCL_A7CL CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229819 CVCL_A7CN WS0801 transformed cell line human CVCL_A7CN CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229820 CVCL_A7CQ WS11801 transformed cell line human CVCL_A7CQ CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229821 CVCL_A7CP WS6201 transformed cell line human CVCL_A7CP CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Glu1149fs (c.3446delA) (c.3677delA); Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229822 CVCL_A7EE UT-SCC-79A cancer cell line human CVCL_A7EE CL:0000010 Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857. Omics: Deep exome analysis Female 127229823 CVCL_A7ED UT-SCC-63A cancer cell line human CVCL_A7ED CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828. Omics: Deep exome analysis Male 127229824 CVCL_A7EG UT-SCC-59B cancer cell line human CVCL_A7EG CL:0000010 Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Male 127229825 CVCL_A7EF UT-SCC-59C cancer cell line human CVCL_A7EF CL:0000010 Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857. Omics: Deep exome analysis Male 127229826 CVCL_A7EI UT-SCC-79B cancer cell line human CVCL_A7EI CL:0000010 Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Female 127229827 CVCL_A7EH UT-SCC-63B cancer cell line human CVCL_A7EH CL:0000010 Derived from site: Metastatic; Not specified. Male 127229828 CVCL_A7EK UT-SCC-65 cancer cell line human CVCL_A7EK CL:0000010 Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733; Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Male 127229829 CVCL_A7EJ UT-SCC-67 cancer cell line human CVCL_A7EJ CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; c.560-2A>G; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Transcriptome analysis by microarray Female 127229830 CVCL_A7EA UT-SCC-76B cancer cell line human CVCL_A7EA CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Deep exome analysis Male Caution: UT-SCC-76A and UT-SCC-76B are supposed to originate from the same patient but have totally different STR profiles 127229831 CVCL_A7EC UT-SCC-126A cancer cell line human CVCL_A7EC CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Leu130Phe (c.388C>T); ClinVar=VCV000216466; Zygosity=Heterozygous (PubMed=29970484); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu171Lys (c.511G>A); ClinVar=VCV000141566; Zygosity=Heterozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, lower lip; UBERON=UBERON_0001835. Omics: Array-based CGH; Omics: Deep exome analysis; Omics: Transcriptome analysis by microarray Female 127229832 CVCL_A7EB UT-SCC-110A cancer cell line human CVCL_A7EB CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=29970484) Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764. Omics: Array-based CGH; Omics: Deep exome analysis; Omics: Transcriptome analysis by microarray Male 127229833 CVCL_A7DT SCCNij172 cancer cell line human CVCL_A7DT CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229834 CVCL_A7DS SCCNij167 cancer cell line human CVCL_A7DS CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229835 CVCL_A7DV SCCNij202 cancer cell line human CVCL_A7DV CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; c.783-1G>T; ClinVar=VCV000634661; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229836 CVCL_A7DU SCCNij185 cancer cell line human CVCL_A7DU CL:0000010 Sequence variation: Mutation; HGNC; 6342; KIT; Simple; p.His708Asn (c.2122C>A); Zygosity=Unspecified (PubMed=33802339); Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=33802339); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro153Serfs*13 (c.457_469del); Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229837 CVCL_A7DX UT-SCC-74A cancer cell line human CVCL_A7DX CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Deep exome analysis; Omics: Transcriptome analysis by microarray Male 127229838 CVCL_A7DW UT-SCC-54C cancer cell line human CVCL_A7DW CL:0000010 Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027. Omics: Deep exome analysis Female Caution: UT-SCC-54A, UT-SCC-54B and UT-SCC-54C are supposed to originate from the same patient but the STR profile of UT-SCC-54C is totally different from that of the two other cell lines 127229839 CVCL_A7DZ UT-SCC-76A cancer cell line human CVCL_A7DZ CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Array-based CGH; Omics: Deep exome analysis; Omics: Transcriptome analysis by microarray Male Caution: UT-SCC-76A and UT-SCC-76B are supposed to originate from the same patient but have totally different STR profiles 127229840 CVCL_A7DY UT-SCC-74B cancer cell line human CVCL_A7DY CL:0000010 Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Omics: Deep exome analysis Male 127229841 CVCL_A7DL Anti-Dgcr14 hybridoma house mouse CVCL_A7DL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O70279; Mouse Ess2/Dgcr14. 127229842 CVCL_A7DK Anti-6330403k07Rik hybridoma house mouse CVCL_A7DK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8VBZ2; Mouse 6330403k07Rik. 127229843 CVCL_A7DN A5201A hybridoma house mouse CVCL_A7DN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q92542; Human NCSTN. 127229844 CVCL_A7DM KN7 hybridoma CVCL_A7DM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Anti-idiotypic against monoclonal antibody TG40-BP1. 127229845 CVCL_A7DP A5226A hybridoma house mouse CVCL_A7DP CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; Q92542; Human NCSTN. 127229846 CVCL_A7DR SCCNij153 cancer cell line human CVCL_A7DR CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Unspecified (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229847 CVCL_A7DQ HepG2-NIAS cancer cell line human CVCL_A7DQ CL:0000010 Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Can not only rapidly activate hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity but also induce the formation of bile canaliculus-like structures by utilizing a collagen vitrigel membrane as a culture substratum (RCB=RCB4679) 127229848 CVCL_A7BB CT30 somatic stem cell human CVCL_A7BB CL:0000010 Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319. Female Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4938); Doubling time: 19.4 +- 1.6 hours (PubMed=29249463) 127229849 CVCL_A7BA CT29 somatic stem cell human CVCL_A7BA CL:0000010 Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319. Male Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4937); Doubling time: 22.6 +- 2.5 hours (PubMed=29249463) 127229850 CVCL_A7BD MEF_Hsp47 KO-11 spontaneously immortalized cell line house mouse CVCL_A7BD CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:88283; Serpinh1 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 127229851 CVCL_A7BC MEF_Hsp47 WT-1 spontaneously immortalized cell line house mouse CVCL_A7BC CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Control cell line for MEF_Hsp47 KO-11 (Cellosaurus=CVCL_A7BD) and MEF_Hsp47 KO-13 (Cellosaurus=CVCL_A7BE) 127229852 CVCL_A7BF PSA4 cancer cell line house mouse CVCL_A7BF CL:0000010 Breed/subspecies: 129/Sv. 127229853 CVCL_A7BE MEF_Hsp47 KO-13 spontaneously immortalized cell line house mouse CVCL_A7BE CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:88283; Serpinh1 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 127229854 CVCL_A7BH eIF2ak(4KO) transformed cell line house mouse CVCL_A7BH CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229855 CVCL_A7BG PSA5-E cancer cell line house mouse CVCL_A7BG CL:0000010 Derived from site: In situ; Visceral endoderm; UBERON=UBERON_0004877; Breed/subspecies: 129/Sv. 127229856 CVCL_A7AY HEK-DsupdeltaC transformed cell line human CVCL_A7AY CL:0000010 Transfected with: UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup (with p.Lys360_Lys445del); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229857 CVCL_A7AX HEK-DsupKD transformed cell line human CVCL_A7AX CL:0000010 Knockout cell: Method=shRNA knockdown; UniProtKB; P0DOW4; Dsup; Transfected with: UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Expresses Dsup under the control of a constitutive CAG promoter 127229858 CVCL_A7AZ CT27 somatic stem cell human CVCL_A7AZ CL:0000010 Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319. Female Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4936); Doubling time: 24.0 +- 1.7 hours (PubMed=29249463) 127229859 CVCL_A7AQ MCC138c cancer cell line human CVCL_A7AQ CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048. Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice 127229860 CVCL_A7AP MCC121c cancer cell line human CVCL_A7AP CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048. Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice 127229861 CVCL_A7AS HeLa PRDX6 KO cancer cell line human CVCL_A7AS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 16753; PRDX6 Miscellaneous: Cell line information from personal communication of Laflamme C Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229862 CVCL_A7AR MCC148c cancer cell line human CVCL_A7AR CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048. Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice 127229863 CVCL_A7AU HeLa/Fucci(CA)5 cancer cell line human CVCL_A7AU CL:0000010 Transfected with: HGNC; 24576; CDT1 (with p.Ser101_Leu546del and p.Arg68Ala, p.Arg69Ala and p.Leu70Ala); Transfected with: HGNC; 17493; GMNN (with p.Tyr111_Ile209del); Transfected with: UniProtKB; A0A6G7QPQ8; Montipora monasteriata AzaleaB5; Transfected with: Ricordea sp h2-3, a bright green fluorescent protein. Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(CA5) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct; Characteristics: Transfected with the Fucci(CA)5 probe which consist of the fusion of AzaleaB5 to the ubiquitination domain of human CDT1 (aa 1-100) but with the Cy motif 68-RRL-70 replaced by AAA and of h2-3 to the ubiquitination domain of human geminin (aa 1-110) 127229864 CVCL_A7AT CFS414 transformed cell line CVCL_A7AT CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Continental Chestnut Flanked White. Omics: Genome sequenced; Omics: Transcriptome analysis by RNAseq Male Doubling time: ~23.9 hours (PubMed=35288582) Group: Bird cell line 127229865 CVCL_A7AW HEK-Dsup transformed cell line human CVCL_A7AW CL:0000010 Transfected with: UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Expresses Dsup under the control of a constitutive CAG promoter 127229866 CVCL_A7AV HeLa/Fucci(SA)5 cancer cell line human CVCL_A7AV CL:0000010 Transfected with: HGNC; 24576; CDT1 (with p.Met1_Thr29del and p.Ser121_Leu546del); Transfected with: HGNC; 17493; GMNN (with p.Tyr111_Ile209del); Transfected with: UniProtKB; A0A6G7QPQ8; Montipora monasteriata AzaleaB5; Transfected with: Ricordea sp h2-3, a bright green fluorescent protein. Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(SA5) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct; Characteristics: Transfected with the Fucci(SA)5 probe which consist of the fusion of AzaleaB5 to the ubiquitination domain of human CDT1 (aa 30-120) and of h2-3 to the ubiquitination domain of human geminin (aa 1-110) 127229867 CVCL_A7AI HeLa M Rab10-KO cancer cell line human CVCL_A7AI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 9759; RAB10 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229868 CVCL_A7AH S3D8_Spike hybridoma house mouse CVCL_A7AH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S). 127229869 CVCL_A7AK TSD-B4S cancer cell line Norway rat CVCL_A7AK CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Breed/subspecies: Sprague Dawley. Male Doubling time: 13.4 hours (Note=At 5th passage) (PubMed=24723111) 127229870 CVCL_A7AJ HeLa M Rab22-DKO cancer cell line human CVCL_A7AJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 9764; RAB22A; Knockout cell: Method=CRISPR/Cas9; HGNC; 9771; RAB31 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229871 CVCL_A7AM TSD-P cancer cell line Norway rat CVCL_A7AM CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Breed/subspecies: Sprague Dawley. Male Doubling time: 12.1 hours (Note=At 25th passage) (PubMed=24723111) 127229872 CVCL_A7AL TSD-F9R cancer cell line Norway rat CVCL_A7AL CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Breed/subspecies: Sprague Dawley. Male Doubling time: 15.7 hours (Note=At 5th passage) (PubMed=24723111) 127229873 CVCL_A7AN MS-K cancer cell line house mouse CVCL_A7AN CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeNSlc. Male Doubling time: 9.4 hours (PubMed=2043753) 127229874 CVCL_A7CC WS10201 transformed cell line human CVCL_A7CC CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229875 CVCL_A7CB WS9801 transformed cell line human CVCL_A7CB CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229876 CVCL_A7CE WS10901 transformed cell line human CVCL_A7CE CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Caution: Indicated as originating from a 60 year old female in PubMed=9365237 and from a 43 year old female in PubMed=10543396 127229877 CVCL_A7CD WS10501 transformed cell line human CVCL_A7CD CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229878 CVCL_A7CG WS9601 transformed cell line human CVCL_A7CG CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229879 CVCL_A7CF WS11201 transformed cell line human CVCL_A7CF CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys168Alafs*10 (c.502_503delAA) (c.733_734delAA); ClinVar=VCV000403979; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Indicated as originating from a 49 year old female in PubMed=9365237 and from a 48 year old male in PubMed=10543396 127229880 CVCL_A7CI WS10801 transformed cell line human CVCL_A7CI CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229881 CVCL_A7CH WS10101 transformed cell line human CVCL_A7CH CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229882 CVCL_A7BZ WS24002 transformed cell line human CVCL_A7BZ CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229883 CVCL_A7BY WS10402 transformed cell line human CVCL_A7BY CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229884 CVCL_A7CA WS9101 transformed cell line human CVCL_A7CA CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229885 CVCL_A7BR WS5801 transformed cell line human CVCL_A7BR CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229886 CVCL_A7BQ WS6801 transformed cell line human CVCL_A7BQ CL:0000010 Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229887 CVCL_A7BT WS0101 transformed cell line human CVCL_A7BT CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237); Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229888 CVCL_A7BS WS6501 transformed cell line human CVCL_A7BS CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229889 CVCL_A7BV WS11001 transformed cell line human CVCL_A7BV CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229890 CVCL_A7BU WS2101 transformed cell line human CVCL_A7BU CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229891 CVCL_A7BX WS23703 transformed cell line human CVCL_A7BX CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396); Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Indicated as originating from a 51 year old male in PubMed=9365237 and from a 39 year old male in PubMed=10543396 127229892 CVCL_A7BW WS23702 transformed cell line human CVCL_A7BW CL:0000010 Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237); Sequence variation: Mutation; HGNC; 12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229893 CVCL_A7BJ eIF2ak(4KO+PERK) transformed cell line house mouse CVCL_A7BJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Transfected with: MGI; MGI:1353449; Eif2ak2 (FLAG-tagged) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229894 CVCL_A7BI eIF2ak(4KO+HRI) transformed cell line house mouse CVCL_A7BI CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Transfected with: MGI; MGI:1353448; Eif2ak1 (FLAG-tagged) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229895 CVCL_A7BL eIF2ak(4KO+GCN2) transformed cell line house mouse CVCL_A7BL CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Transfected with: MGI; MGI:1353427; Eif2ak4 (FLAG-tagged) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229896 CVCL_A7BK eIF2ak(4KO+PKR) transformed cell line house mouse CVCL_A7BK CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Transfected with: MGI; MGI:1341830; Eif2ak3 (FLAG-tagged) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229897 CVCL_A7BN TFL-21-7G hybridoma house mouse CVCL_A7BN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A2A288; Human ZC3H12D. 127229898 CVCL_A7BM WT(MEF) SV40-immortalized transformed cell line house mouse CVCL_A7BM CL:0000010 Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229899 CVCL_A7BP NP-2/CD4/RDC1 cancer cell line human CVCL_A7BP CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 1678; CD4; Transfected with: HGNC; 23692; ACKR3; Transfected with: UniProtKB; P00552; Transposon Tn5 neo; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male 150517732 CVCL_A0BH PS2C501 hybridoma house mouse CVCL_A0BH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4226 150517733 CVCL_A0BI PS1Z134 hybridoma house mouse CVCL_A0BI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4228 150517734 CVCL_A0BJ PS1Z125 hybridoma house mouse CVCL_A0BJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4229 150517735 CVCL_A0BK HK1A523 hybridoma house mouse CVCL_A0BK CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11876 150517736 CVCL_A0BL HK1D106.4 hybridoma house mouse CVCL_A0BL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11937 150517737 CVCL_A0BM HK1G464.3 hybridoma house mouse CVCL_A0BM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11983 150517738 CVCL_A0BN HK1G586.1 hybridoma house mouse CVCL_A0BN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12026 150517739 CVCL_A0BA PSM773 hybridoma house mouse CVCL_A0BA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517740 CVCL_A0BB PS1P351 hybridoma house mouse CVCL_A0BB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517741 CVCL_A0BC PS1R163 hybridoma house mouse CVCL_A0BC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517742 CVCL_A0BD PS2C109 hybridoma house mouse CVCL_A0BD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4227 150517743 CVCL_A0BE PS2C807 hybridoma house mouse CVCL_A0BE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4223 150517744 CVCL_A0BF PS2C837 hybridoma house mouse CVCL_A0BF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4224 150517745 CVCL_A0BG PS2C634 hybridoma house mouse CVCL_A0BG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4225 150517746 CVCL_A0AW PR18 hybridoma house mouse CVCL_A0AW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P28906; Human CD34. 150517747 CVCL_A0AX PSA399 hybridoma house mouse CVCL_A0AX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517748 CVCL_A0AY PSB999 hybridoma house mouse CVCL_A0AY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517749 CVCL_A0AZ PSJ206 hybridoma house mouse CVCL_A0AZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517750 CVCL_A0AP NK92.39 hybridoma house mouse CVCL_A0AP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P40200; Human CD96. 150517751 CVCL_A0AQ SKII.4 hybridoma house mouse CVCL_A0AQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P15151; Human PVR/CD155. 150517752 CVCL_A0AR 12.2 hybridoma house mouse CVCL_A0AR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q95460; Human MR1. 150517753 CVCL_A0AS 26.5 hybridoma house mouse CVCL_A0AS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q95460; Human MR1 (Note=Also reacts with bovine, mouse and rat). 150517754 CVCL_A0AT CHO-S r34.1 (clone D8) spontaneously immortalized cell line CVCL_A0AT CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Expresses the murine 34.1 monoclonal antibody against the N-terminus of HSV-1 glycoprotein D (gD) (HIVReagentProgram=ARP-13578) Doubling time: ~24 hours (PubMed=30502324) 150517755 CVCL_A0AU UCSC.PG128.CHO.S.F4 spontaneously immortalized cell line CVCL_A0AU CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Expresses the PGT128 neutralizing monoclonal antibody against the HIV-1 gp120, specifically to the V3 glycan (HIVReagentProgram=ARP-13590) 150517756 CVCL_A0AV K6.1 hybridoma house mouse CVCL_A0AV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P28906; Human CD34. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11085 150517757 CVCL_A0CI Pro104.C55.1 hybridoma house mouse CVCL_A0CI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5277 150517758 CVCL_A0CJ Pro104.D9.1 hybridoma house mouse CVCL_A0CJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6077 150517759 CVCL_A0CK Pro104.K81.15 hybridoma house mouse CVCL_A0CK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6078 150517760 CVCL_A0CL CEMx174/SIVmac316 clone 3D8 hybrid cell line human CVCL_A0CL CL:0000010 Virology: Infected with simian immunodeficiency virus isolate SIVmac316 (HIVReagentProgram=ARP-13239). 150517761 CVCL_A0CM 902 hybridoma house mouse CVCL_A0CM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (AA 33-511 = gp120). 150517762 CVCL_A0CN SCL1-CD4 clone 6 cancer cell line human CVCL_A0CN CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Val197Ter; Zygosity=Unspecified (from parent cell line); Transfected with: HGNC; 1678; CD4; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Face, skin; UBERON=UBERON_1000021. Female 150517763 CVCL_A0CP RCMGi006-A induced pluripotent stem cell human CVCL_A0CP From: Research Centre for Medical Genetics; Moscow; Russia CL:0000010 Population: Caucasian; Russian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517764 CVCL_A0CA 1G10 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CA CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517765 CVCL_A0CB 1G7 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CB CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517766 CVCL_A0CC 8E7 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517767 CVCL_A0CD 9G2 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517768 CVCL_A0CE 1D9 [Mouse hybridoma against HIV-1 isolate HXB2 tat] hybridoma house mouse CVCL_A0CE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04608; HIV-1 isolate HXB2 tat. 150517769 CVCL_A0CF 1C6.5 hybridoma house mouse CVCL_A0CF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20881; HIV-2 isolate ST vpx. 150517770 CVCL_A0CG 6D2.6 hybridoma house mouse CVCL_A0CG CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20881; HIV-2 isolate ST vpx. 150517771 CVCL_A0CH Pro104.C25.1 hybridoma house mouse CVCL_A0CH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6076 150517772 CVCL_A0BX VCaP-CR cancer cell line human CVCL_A0BX CL:0000010 Sequence variation: Gene fusion; HGNC; 3446; ERG + HGNC; 11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from parent cell line); Sequence variation: Mutation; HGNC; 7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412. Omics: Deep proteome analysis; Omics: Transcriptome analysis by RNAseq Male Characteristics: Derived after a passage of the parent cell line in castrated nude mice; Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line) Doubling time: ~60 hours (PubMed=34402095) 150517773 CVCL_A0BY CHO MGAT1- A244_N332-rgp120 5F spontaneously immortalized cell line CVCL_A0BY CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces a gp120 from a modified A244 isolate (A244_N332-rgp120) where a glycosylation was moved from Asn-334 to Asn-332 It is enriched for mannose-5 glycans. The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD) (PubMed=30071025). 150517774 CVCL_A0BP HK1H247 hybridoma house mouse CVCL_A0BP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12162 150517775 CVCL_A0BQ S14-1 transformed cell line house mouse CVCL_A0BQ CL:0000010 Transformant: Simian virus 40 (SV40) [Note=tsA255](NCBI-Taxonomy; 1891767); Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Sertoli cell; CL=CL_0000216; Breed/subspecies: BALB/c. Male Characteristics: Expresses transferrin and SGP-2, lacks a FSH response, and is capable of forming epithelial tumors in nude mice (PubMed=8214009) 150517776 CVCL_A0BR NCC-ssRMS2-C1 cancer cell line human CVCL_A0BR CL:0000010 Sequence variation: Mutation; HGNC; 7611; MYOD1; None_reported; -; Zygosity=- (PubMed=34164773) Population: Japanese; Derived from site: In situ; Back; UBERON=UBERON_0001137. Omics: SNP array analysis Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.); Doubling time: ~41 hours (PubMed=34164773) Part of: NCC sarcoma cell line panel 150517777 CVCL_A0BT CHO MGAT1- TZ97008-rgp120 2D7 spontaneously immortalized cell line CVCL_A0BT CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1; Transfected with: HIV-1 isolate TZ97008 env (gp120); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces a gp120 from a clade C isolate (TZ97008-rgp120) and enriched for mannose-5 glycans The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD). Group: Serum/protein free medium cell line 150517778 CVCL_A0BU CHO MGAT1- TZ97008-rgp120 3E5 spontaneously immortalized cell line CVCL_A0BU CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1; Transfected with: HIV-1 isolate TZ97008 env (gp120); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces a gp120 from a clade C isolate (TZ97008-rgp120) and enriched for mannose-5 glycans The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD). Group: Serum/protein free medium cell line 150517779 CVCL_A0BV 34.1 hybridoma house mouse CVCL_A0BV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q05059; Human herpesvirus 1 (strain F) glycoprotein D (gD) (Note=Recognizes the p.Lys26_Gln52 N-terminal region used as a purification tag). 150517780 CVCL_A0BW LAPC4-CR cancer cell line human CVCL_A0BW CL:0000010 Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line) Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027. Omics: Deep proteome analysis; Omics: Transcriptome analysis by RNAseq Male Characteristics: Derived after 4 passages of the parent cell line in castrated nude mice; Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line) Doubling time: ~50 hours (PubMed=34402095) 150517781 CVCL_A0AG 183-H12-5C hybridoma house mouse CVCL_A0AG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P03347; HIV-1 isolate BH10 gag (AA 133-363 = p24). 150517782 CVCL_A0AH 4B2 [Macaca B-cell transformed] transformed cell line CVCL_A0AH CL:0000010 Transformant: Rhesus lymphocryptovirus (Macacine herpesvirus 4)(NCBI-Taxonomy; 45455); Derived from site: In situ; Lymph node; UBERON=UBERON_0000027; Cell type: B-cell; CL=CL_0000236. Unspecified Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; E7CWP5; Simian immunodeficiency virus (isolate SIVmac239) (SIV-mac) env (gp41) Group: Non-human primate cell line 150517783 CVCL_A0AI 6E6 [Macaca B-cell transformed] transformed cell line CVCL_A0AI CL:0000010 Transformant: Rhesus lymphocryptovirus (Macacine herpesvirus 4)(NCBI-Taxonomy; 45455); Derived from site: In situ; Lymph node; UBERON=UBERON_0000027; Cell type: B-cell; CL=CL_0000236. Unspecified Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; E7CWP5; Simian immunodeficiency virus (isolate SIVmac239) (SIV-mac) env (gp41) Group: Non-human primate cell line 150517784 CVCL_A0AJ Cr24.1 hybridoma house mouse CVCL_A0AJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; O95727; Human CRTAM/CD355. 150517785 CVCL_A0AK CR24.2.8 hybridoma house mouse CVCL_A0AK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; O95727; Human CRTAM/CD355. 150517786 CVCL_A0AL 2.29 hybridoma house mouse CVCL_A0AL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O95944; Human NCR2/CD336. 150517787 CVCL_A0AM 3.43 hybridoma house mouse CVCL_A0AM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O95944; Human NCR2/CD336. 150517788 CVCL_A0AN 11A8 hybridoma house mouse CVCL_A0AN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q15762; Human CD226. 150517789 CVCL_A0AA 168B17-46-34 hybridoma house mouse CVCL_A0AA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517790 CVCL_A0AB 168B17-46-50 hybridoma house mouse CVCL_A0AB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517791 CVCL_A0AC 168B17-46-70 hybridoma house mouse CVCL_A0AC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517792 CVCL_A0AD 168B17-46-92 hybridoma house mouse CVCL_A0AD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517793 CVCL_A0AE 168A51-2 hybridoma house mouse CVCL_A0AE CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517794 CVCL_A0AF 168A51-42 hybridoma house mouse CVCL_A0AF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517795 CVCL_A0JP JTUi005-A induced pluripotent stem cell human CVCL_A0JP From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; 53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=62 GGC repeats (PubMed=36244083); Sequence variation: Mutation; HGNC; 53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=100 GGC repeats (PubMed=36244083) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517796 CVCL_A0JQ OFi001-A induced pluripotent stem cell human CVCL_A0JQ From: OrganFactory; Kiheung; South Korea CL:0000010 Population: East Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 150517797 CVCL_A0JR OFi002-A induced pluripotent stem cell human CVCL_A0JR From: OrganFactory; Kiheung; South Korea CL:0000010 Population: East Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male 150517798 CVCL_A0JS YCMi004-A induced pluripotent stem cell human CVCL_A0JS From: Yonsei University College of Medicine; Seoul; South Korea CL:0000010 Sequence variation: Mutation; HGNC; 12403; TTN; Simple; p.Arg23351Ter (c.70051C>T); ClinVar=VCV000405145; Zygosity=Heterozygous (PubMed=34952434) Population: Korean; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517799 CVCL_A0JT YCMi005-A induced pluripotent stem cell human CVCL_A0JT From: Yonsei University College of Medicine; Seoul; South Korea CL:0000010 Sequence variation: Mutation; HGNC; 12010; TPM1; Simple; p.Glu192Lys (c.574G>A); ClinVar=VCV000031882; Zygosity=Heterozygous (PubMed=35176663) Population: Korean; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517800 CVCL_A0JU IUFi001-A induced pluripotent stem cell human CVCL_A0JU From: Leibniz Research Institute For Environmental Medicine; Dusseldorf; Germany CL:0000010 Sequence variation: Mutation; HGNC; 3438; ERCC6; Simple; p.Lys337Ter (c.1009A>T) (A1088T); ClinVar=VCV000550722; Zygosity=Heterozygous (PubMed=34271225); Sequence variation: Mutation; HGNC; 3438; ERCC6; Simple; p.Arg857Ter (c.2569C>T); ClinVar=VCV000553383; Zygosity=Heterozygous (PubMed=34271225) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517801 CVCL_A0JV SANi006-A induced pluripotent stem cell human CVCL_A0JV From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 31928; NBEAL2; Simple; p.Cys2190Alafs*23 (c.6568delT); ClinVar=VCV000982280; Zygosity=Heterozygous (PubMed=34237592); Sequence variation: Mutation; HGNC; 31928; NBEAL2; Simple; p.Leu2646Pro (c.7937T>C); ClinVar=VCV000982281; Zygosity=Heterozygous (PubMed=34237592) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 150517802 CVCL_A0JW SANi007-A induced pluripotent stem cell human CVCL_A0JW From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 3309; ELANE; Simple; c.614delG; Zygosity=Heterozygous (PubMed=34229202) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 150517803 CVCL_A0JH 31H12 hybridoma house mouse CVCL_A0JH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517804 CVCL_A0JI 45F6 hybridoma house mouse CVCL_A0JI CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517805 CVCL_A0JJ SDW18.1.1 hybridoma house mouse CVCL_A0JJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01375; Human TNF. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9228 150517806 CVCL_A0JK 4C3 [Mouse hybridoma against human MSMB] hybridoma house mouse CVCL_A0JK CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9121; Registration: Upjohn Culture Collection; UC HB-17 150517807 CVCL_A0JL 7A5F9 hybridoma house mouse CVCL_A0JL CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9224; Registration: Upjohn Culture Collection; UC HB-18 150517808 CVCL_A0JM 8H4C7 hybridoma house mouse CVCL_A0JM CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9225; Registration: Upjohn Culture Collection; UC HB-19 150517809 CVCL_A0JN 11C11B11 hybridoma house mouse CVCL_A0JN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9226; Registration: Upjohn Culture Collection; UC HB-20 150517810 CVCL_A0JA M32-8 hybridoma house mouse CVCL_A0JA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Gly719Cys). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012127 150517811 CVCL_A0JB M80-14 hybridoma house mouse CVCL_A0JB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Leu861Gln). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201315 150517812 CVCL_A0JC M85-13 hybridoma house mouse CVCL_A0JC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Leu858Arg). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012125 150517813 CVCL_A0JD 177E6 hybridoma house mouse CVCL_A0JD CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: Salmonella enteritidis subserogroup OD1 lipopolysaccharide (LPS) O:9 antigen (Note=Also reacts with subserogroup OD3). 150517814 CVCL_A0JE 178H11 hybridoma house mouse CVCL_A0JE CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: Salmonella enteritidis subserogroup OD1 lipopolysaccharide (LPS) O:9 antigen. 150517815 CVCL_A0JF 24E6 hybridoma house mouse CVCL_A0JF CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517816 CVCL_A0JG 29E1 hybridoma house mouse CVCL_A0JG CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517817 CVCL_A0IW M120 hybridoma house mouse CVCL_A0IW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Gly863Asp). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201304 150517818 CVCL_A0IX M121#1 hybridoma house mouse CVCL_A0IX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Asp761Tyr). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201303 150517819 CVCL_A0IY M122#1 hybridoma house mouse CVCL_A0IY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Val769Leu). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201316 150517820 CVCL_A0IZ M20-18 hybridoma house mouse CVCL_A0IZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Gly719Ser). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012118 150517821 CVCL_A0KQ UNIBSi016-A induced pluripotent stem cell human CVCL_A0KQ From: University of Brescia; Brescia; Italy CL:0000010 Sequence variation: Mutation; HGNC; 29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252); Sequence variation: Mutation; HGNC; 29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517822 CVCL_A0KR UNIBSi016-B induced pluripotent stem cell human CVCL_A0KR From: University of Brescia; Brescia; Italy CL:0000010 Sequence variation: Mutation; HGNC; 29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252); Sequence variation: Mutation; HGNC; 29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517823 CVCL_A0KS UNIBSi016-C induced pluripotent stem cell human CVCL_A0KS From: University of Brescia; Brescia; Italy CL:0000010 Sequence variation: Mutation; HGNC; 29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252); Sequence variation: Mutation; HGNC; 29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517824 CVCL_A0KT LANCEi020-A-1 induced pluripotent stem cell human CVCL_A0KT From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517825 CVCL_A0KU LANCEi020-A-10 induced pluripotent stem cell human CVCL_A0KU From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776); Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; c.3713-30_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517826 CVCL_A0KV LANCEi020-A-2 induced pluripotent stem cell human CVCL_A0KV From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517827 CVCL_A0KW LANCEi020-A-3 induced pluripotent stem cell human CVCL_A0KW From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517828 CVCL_A0KX LANCEi020-A-4 induced pluripotent stem cell human CVCL_A0KX From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 3603; FBN1 (Note=1 of 2 alleles) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517829 CVCL_A0KI KUTTAMi002-A induced pluripotent stem cell human CVCL_A0KI From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517830 CVCL_A0KJ KUTTAMi003-A induced pluripotent stem cell human CVCL_A0KJ From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517831 CVCL_A0KK EMe-NH6W523S1 induced pluripotent stem cell human CVCL_A0KK From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517832 CVCL_A0KL EMe-NH6W523XS7 induced pluripotent stem cell human CVCL_A0KL From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Sequence variation: Mutation; HGNC; 11079; SLC9A6; Simple; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous (PubMed=34182254) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517833 CVCL_A0KM EMe-NH6W523K5 induced pluripotent stem cell human CVCL_A0KM From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Sequence variation: Mutation; HGNC; 11079; SLC9A6; Simple_corrected; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=34182254) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517834 CVCL_A0KN EMe-NH6W523K17 induced pluripotent stem cell human CVCL_A0KN From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Sequence variation: Mutation; HGNC; 11079; SLC9A6; Simple_corrected; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=34182254) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517835 CVCL_A0KP UNIBSi015-A induced pluripotent stem cell human CVCL_A0KP From: University of Brescia; Brescia; Italy. CL:0000010 150517836 CVCL_A0KA HEBHMUi009-A induced pluripotent stem cell human CVCL_A0KA From: Hebei Medical University; Shijiazhuang; China CL:0000010 Sequence variation: Mutation; HGNC; 613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34218115) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517837 CVCL_A0KB UCLi014-A induced pluripotent stem cell human CVCL_A0KB From: University College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 19977; RDH12; Simple; p.Phe254Leufs*24 (c.759delC); ClinVar=VCV000812389; Zygosity=Heterozygous (PubMed=34216980) Population: Kurdistani and Tunisian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517838 CVCL_A0KC UCLi015-A induced pluripotent stem cell human CVCL_A0KC From: University College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; 19977; RDH12; Simple; p.Asn207Asp (c.619A>G); ClinVar=VCV000805924; Zygosity=Homozygous (PubMed=34216980) Population: Pakistani; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517839 CVCL_A0KD UCLAi005-A induced pluripotent stem cell human CVCL_A0KD From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517840 CVCL_A0KE UCLAi005-B induced pluripotent stem cell human CVCL_A0KE From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517841 CVCL_A0KF UCLAi005-C induced pluripotent stem cell human CVCL_A0KF From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517842 CVCL_A0KG CUIMCi003-A induced pluripotent stem cell human CVCL_A0KG From: Columbia University Irving Medical Center; New York; USA CL:0000010 Sequence variation: Mutation; HGNC; 16876; ARNT2; Simple; p.Pro130Ala (c.388C>G); Zygosity=Heterozygous; Note=De novo mutation (PubMed=34214899; PubMed=35390757) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517843 CVCL_A0KH KUTTAMi001-A induced pluripotent stem cell human CVCL_A0KH From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517844 CVCL_A0JX SANi008-A induced pluripotent stem cell human CVCL_A0JX From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 1968; LYST; Simple; p.Glu1441Valfs*11 (c.4322_4325delAGAG); ClinVar=VCV001173104; Zygosity=Heterozygous (PubMed=34224985); Sequence variation: Mutation; HGNC; 1968; LYST; Simple; p.Asn3376Ser (c.10127A>G); ClinVar=VCV000065529; Zygosity=Heterozygous (PubMed=34224985) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male 150517845 CVCL_A0JY SANi009-A induced pluripotent stem cell human CVCL_A0JY From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; 566; AP3B1; Simple; p.Lys59Asnfs*5 (c.177delA); ClinVar=VCV000224763; Zygosity=Heterozygous (PubMed=34182253); Sequence variation: Mutation; HGNC; 566; AP3B1; Simple; c.1839_1842delTAGA; ClinVar=VCV000224764; Zygosity=Heterozygous (PubMed=34182253) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517846 CVCL_A0JZ SANi010-A induced pluripotent stem cell human CVCL_A0JZ From: Sanquin; Amsterdam; Netherlands CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517847 CVCL_A0HN 3G5 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517848 CVCL_A0HP 4C11 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HP CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517849 CVCL_A0HQ 4F6 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517850 CVCL_A0HR 7A5 hybridoma house mouse CVCL_A0HR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517851 CVCL_A0HS 8E4 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517852 CVCL_A0HU 9D8 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517853 CVCL_A0HF 1A1/B2 hybridoma house mouse CVCL_A0HF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Opisthorchis felineus 105 Kda excretory-secretory antigen. Group: Patented cell line 150517854 CVCL_A0HG 10E4 hybridoma house mouse CVCL_A0HG CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517855 CVCL_A0HH 16A3 hybridoma house mouse CVCL_A0HH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517856 CVCL_A0HI 1B5 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HI CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517857 CVCL_A0HJ 1D2 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517858 CVCL_A0HK 21H1 hybridoma house mouse CVCL_A0HK CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517859 CVCL_A0HL 2H9 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HL CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517860 CVCL_A0HM 3E6 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HM CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517861 CVCL_A0HA THP18 cancer cell line human CVCL_A0HA CL:0000010 Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517862 CVCL_A0HB THP18-deltaA3A cancer cell line human CVCL_A0HB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 17343; APOBEC3A; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517863 CVCL_A0HC THP18-deltaA3A/B cancer cell line human CVCL_A0HC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 17343; APOBEC3A; Knockout cell: Method=CRISPR/Cas9; HGNC; 17352; APOBEC3B; Sequence variation: Gene fusion; HGNC; 2457; CSNK2A1 + HGNC; 13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517864 CVCL_A0HD 1D6 hybridoma house mouse CVCL_A0HD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; M1G6I5; Opisthorchis viverrini tetraspanin 2A (Ov-TSP-2). 150517865 CVCL_A0HE 3F5 [Mouse hybridoma against O.viverrini Ov-TSP-2] hybridoma house mouse CVCL_A0HE CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; M1G6I5; Opisthorchis viverrini tetraspanin 2A (Ov-TSP-2). 150517866 CVCL_A0GU Mel-XY2 cancer cell line human CVCL_A0GU HLA typing: A*30,33; B*18,65 (PubMed=17448240) CL:0000010 Population: Caucasian; Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097. Male Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2831 150517867 CVCL_A0GV Mel-XY3 cancer cell line human CVCL_A0GV HLA typing: A*02:01,23; B*18,18 (PubMed=17448240) CL:0000010 Population: Caucasian; Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097. Male Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2832 150517868 CVCL_A0GW MGPK alphaVbeta6-C5 spontaneously immortalized cell line pig CVCL_A0GW CL:0000010 Transfected with: VGNC; 30323; Bovine ITGAV; Transfected with: VGNC; 30331; Bovine ITGB6; Transfected with: UniProtKB; P00552; Transposon Tn5 neo. Unspecified Virology: Combined treatment of the parent cell line with BVDV NS5A siRNA, interferon alpha and ribavirin has cured the cell line from bovine viral diarrhea virus (BVDV) infection (PubMed=34092457); Virology: Susceptible to infection by foot-and-mouth disease virus (PubMed=34092457) Problematic cell line: Misidentified Grand-parent cell line (LF-BK) was originally thought to be of bovine origin but originates from pig. 150517869 CVCL_A0GX MB5 transformed cell line human CVCL_A0GX CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S) 150517870 CVCL_A0GY MC8 transformed cell line human CVCL_A0GY CL:0000010 Transformant: Epstein-Barr virus (EBV)(NCBI-Taxonomy; 10376); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Human SARS coronavirus 2 (SARS-CoV-2) spike protein (S) 150517871 CVCL_A0GZ 5210-87-13 hybridoma CVCL_A0GZ CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; Q9UH17; Human APOBEC3B (Note=Also partially reacts with APOBEC3A and APOBEC3G). 150517872 CVCL_A0IP K5-116-2-1 hybridoma house mouse CVCL_A0IP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11253 150517873 CVCL_A0IQ K5-70 hybridoma house mouse CVCL_A0IQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11251 150517874 CVCL_A0IR T5-86 hybridoma house mouse CVCL_A0IR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11254 150517875 CVCL_A0IS T6-16 hybridoma house mouse CVCL_A0IS CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11346 150517876 CVCL_A0IT M116 hybridoma house mouse CVCL_A0IT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Gly719Ala). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201301 150517877 CVCL_A0IU M117-10 hybridoma house mouse CVCL_A0IU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Asn826Ser). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201320 150517878 CVCL_A0IV M118#7 hybridoma house mouse CVCL_A0IV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (with p.Ala839Thr). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201302 150517879 CVCL_A0IG 31-6-1 hybridoma house mouse CVCL_A0IG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00143 150517880 CVCL_A0IH JEV_1 hybridoma house mouse CVCL_A0IH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P27395; Japanese encephalitis virus (JEV) polyprotein (AA 1-105 = Capsid protein C). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00258 150517881 CVCL_A0II JEV_2 hybridoma house mouse CVCL_A0II CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P27395; Japanese encephalitis virus (JEV) polyprotein (AA 1-105 = Capsid protein C). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00259 150517882 CVCL_A0IJ 4G12 [Mouse hybridoma against ASFV CD2v] hybridoma house mouse CVCL_A0IJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0A7W5A6; African swine fever virus (isolate DB/LN/2018) CD2 homolog (CD2v). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19947 150517883 CVCL_A0IK UN1 hybridoma house mouse CVCL_A0IK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16150; Human SPN/CD43. 150517884 CVCL_A0IL UMG1 hybridoma house mouse CVCL_A0IL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16150; Human SPN/CD43. Group: Patented cell line; Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 16001 150517885 CVCL_A0IM CDina26 hybridoma house mouse CVCL_A0IM CL:0000010 Biotechnology: Was used to produce the monoclonal antibody begelomab (Begedina) which was evaluated as a therapeutic agent against steroid-resistant acute graft-versus-host disease Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26. Group: Patented cell line; Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 12002 150517886 CVCL_A0IN K5-107 hybridoma house mouse CVCL_A0IN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11252 150517887 CVCL_A0IA 1B-4971 hybridoma house mouse CVCL_A0IA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517888 CVCL_A0IB anti-MERS CoV P1 hybridoma house mouse CVCL_A0IB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00331 150517889 CVCL_A0IC anti-MERS CoV P3 hybridoma house mouse CVCL_A0IC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00332 150517890 CVCL_A0ID 124-11-2 hybridoma house mouse CVCL_A0ID CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00142 150517891 CVCL_A0IE 137-2-1 hybridoma house mouse CVCL_A0IE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00145 150517892 CVCL_A0IF 28-2-3 hybridoma house mouse CVCL_A0IF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00144 150517893 CVCL_A0HV 1A-3187 hybridoma house mouse CVCL_A0HV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517894 CVCL_A0HW 1A-4246 hybridoma house mouse CVCL_A0HW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517895 CVCL_A0HX 1B-3246 hybridoma house mouse CVCL_A0HX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517896 CVCL_A0HY 1B-3440 hybridoma house mouse CVCL_A0HY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517897 CVCL_A0HZ 1B-4863 hybridoma house mouse CVCL_A0HZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517898 CVCL_A0FL HCA-770H hybridoma house mouse CVCL_A0FL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517899 CVCL_A0FM HCA-784H hybridoma house mouse CVCL_A0FM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517900 CVCL_A0FN HCA-803H hybridoma house mouse CVCL_A0FN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517901 CVCL_A0FP HCA-805 hybridoma house mouse CVCL_A0FP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517902 CVCL_A0FQ HCA-805HDR hybridoma house mouse CVCL_A0FQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517903 CVCL_A0FR HCA-838H hybridoma house mouse CVCL_A0FR CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517904 CVCL_A0FS HDA-202 hybridoma house mouse CVCL_A0FS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517905 CVCL_A0FD HCA-57HDR hybridoma house mouse CVCL_A0FD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517906 CVCL_A0FE HCA-627 hybridoma house mouse CVCL_A0FE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5284 150517907 CVCL_A0FF HCA-646HD hybridoma house mouse CVCL_A0FF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517908 CVCL_A0FG HCA-656 hybridoma house mouse CVCL_A0FG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517909 CVCL_A0FH HCA-660HD hybridoma house mouse CVCL_A0FH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517910 CVCL_A0FI HCA-671H hybridoma house mouse CVCL_A0FI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517911 CVCL_A0FJ HCA-69H hybridoma house mouse CVCL_A0FJ CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517912 CVCL_A0FK HCA-713 hybridoma house mouse CVCL_A0FK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517913 CVCL_A0FA HCA-293HDR hybridoma house mouse CVCL_A0FA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517914 CVCL_A0FB HCA-350DHR hybridoma house mouse CVCL_A0FB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517915 CVCL_A0FC HCA-507HD hybridoma house mouse CVCL_A0FC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517916 CVCL_A0ES W112 6G-2 hybridoma house mouse CVCL_A0ES CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human T-cell receptor variable beta-5.3. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9927 150517917 CVCL_A0ET 2D1 [Mouse hybridoma against human TcRv beta-8.1] hybridoma house mouse CVCL_A0ET CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human T-cell receptor variable beta-8.1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9928 150517918 CVCL_A0EU 79RD27 finite cell line human CVCL_A0EU CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517919 CVCL_A0EV AT3NG finite cell line human CVCL_A0EV CL:0000010 Sequence variation: Mutation; HGNC; 795; ATM; Simple; p.Ser2860del (c.8575TCT[1]) (c.8578_8580delTCT) (Ser1512del); ClinVar=VCV000003018; Zygosity=Homozygous (PubMed=7792600) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 150517920 CVCL_A0EW HCA-155H hybridoma house mouse CVCL_A0EW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517921 CVCL_A0EX HCA-212 hybridoma house mouse CVCL_A0EX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517922 CVCL_A0EY HCA-231H hybridoma house mouse CVCL_A0EY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517923 CVCL_A0EZ HCA-290 hybridoma house mouse CVCL_A0EZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517924 CVCL_A0GM 2A5 [Mouse hybridoma against human IL1RL1] hybridoma house mouse CVCL_A0GM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10189 150517925 CVCL_A0GN FB9 hybridoma house mouse CVCL_A0GN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10190 150517926 CVCL_A0GP HB12 hybridoma house mouse CVCL_A0GP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10191 150517927 CVCL_A0GQ ST2-BA-1.1-07E04-02B07-02G06 hybridoma house mouse CVCL_A0GQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10431 150517928 CVCL_A0GR ST2-BA-1.1-09F08-02D04-01F05 hybridoma house mouse CVCL_A0GR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10432 150517929 CVCL_A0GS Mel-XX4 cancer cell line human CVCL_A0GS HLA typing: A*24,33; B*18,65 (PubMed=17448240) CL:0000010 Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542. Female Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2829 150517930 CVCL_A0GT Mel-XY1 cancer cell line human CVCL_A0GT HLA typing: A*02:01,23; B*18,37 (PubMed=17448240) CL:0000010 Population: Caucasian; Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2830 150517931 CVCL_A0GE NCC-cOV1-C1 cancer cell line human CVCL_A0GE CL:0000010 Population: Japanese; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Omics: SNP array analysis Female Doubling time: 40 hours (DOI=10.2198/jelectroph.65.23) 150517932 CVCL_A0GF LK1 [Mouse ESC] embryonic stem cell house mouse CVCL_A0GF CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: C57BL/6. Male 150517933 CVCL_A0GG GSI-1 embryonic stem cell house mouse CVCL_A0GG CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129X1/SvJ. Unspecified 150517934 CVCL_A0GH HEK293-mST2L transformed cell line human CVCL_A0GH CL:0000010 Transfected with: MGI; MGI:98427; Il1rl1; Transfected with: UniProtKB; P08659; Firefly luciferase Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: The expression of the luciferase reporter gene is under the control of a NF-kappaB-inducible promoter 150517935 CVCL_A0GI CNTO2549 hybridoma CVCL_A0GI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517936 CVCL_A0GJ CNTO8195 hybridoma CVCL_A0GJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517937 CVCL_A0GK CNTO9195 hybridoma CVCL_A0GK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517938 CVCL_A0GL CNTO9383 hybridoma CVCL_A0GL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517939 CVCL_A0GA 4B2 [Mouse/rat hybridoma against mouse Clec7a] hybridoma CVCL_A0GA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10151 150517940 CVCL_A0GB RH1 [Mouse/rat hybridoma against mouse Clec7a] hybridoma CVCL_A0GB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10152 150517941 CVCL_A0GC SC30 hybridoma CVCL_A0GC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10153 150517942 CVCL_A0GD CHO dhfr- Clone 20/1 spontaneously immortalized cell line CVCL_A0GD CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 150517943 CVCL_A0FT HDA-676 hybridoma house mouse CVCL_A0FT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517944 CVCL_A0FU HDA-907 hybridoma house mouse CVCL_A0FU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5286 150517945 CVCL_A0FV HDA-1018 hybridoma house mouse CVCL_A0FV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517946 CVCL_A0FW HDA-1606 hybridoma house mouse CVCL_A0FW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517947 CVCL_A0FX HDA-1884 hybridoma house mouse CVCL_A0FX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517948 CVCL_A0FY HDA-1937 hybridoma house mouse CVCL_A0FY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517949 CVCL_A0FZ HDA-2003 hybridoma house mouse CVCL_A0FZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517950 CVCL_A0DJ PF1-6.1.1.3 hybridoma house mouse CVCL_A0DJ CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5168 150517951 CVCL_A0DK PF1-11-2-1 hybridoma house mouse CVCL_A0DK CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6863 150517952 CVCL_A0DL PF1-11.2.1.4 hybridoma house mouse CVCL_A0DL CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5169 150517953 CVCL_A0DM EL-4 6.1 cancer cell line house mouse CVCL_A0DM CL:0000010 Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; Selected for resistance to: ChEBI; CHEBI:472805; Ouabain; Transformant: 7,12-dimethyltetraphene (DMBA(ChEBI; CHEBI:59032); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Unspecified 150517954 CVCL_A0DN RL119 hybridoma CVCL_A0DN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P18572; Mouse Cd147. 150517955 CVCL_A0DP RL388 hybridoma CVCL_A0DP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10852; Mouse Slc3a2/Cd98. 150517956 CVCL_A0DQ RL73 hybridoma CVCL_A0DQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P18572; Mouse Cd147. 150517957 CVCL_A0DB PF8-2-43-1 hybridoma house mouse CVCL_A0DB CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG4, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6575 150517958 CVCL_A0DC NC17 hybridoma CVCL_A0DC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04401; Mouse Il5. Group: Patented cell line 150517959 CVCL_A0DD TB13 hybridoma CVCL_A0DD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04401; Mouse Il5. Group: Patented cell line 150517960 CVCL_A0DE MCIR1 cancer cell line human CVCL_A0DE CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=34214199); Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (PubMed=34214199) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Transcriptome analysis by RNAseq Male Characteristics: Obtained from a ibrutinib-resistant tumor clone Doubling time: 32 hours (PubMed=34214199) 150517961 CVCL_A0DF 293C18P transformed cell line human CVCL_A0DF CL:0000010 Transfected with: UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Group: Patented cell line; Group: Serum/protein free medium cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201913 150517962 CVCL_A0DG PF1-4-1-1 hybridoma house mouse CVCL_A0DG CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6862 150517963 CVCL_A0DH PF1-4.1.1.1 hybridoma house mouse CVCL_A0DH CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5166 150517964 CVCL_A0DI PF1-4.13.1.1 hybridoma house mouse CVCL_A0DI CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5167 150517965 CVCL_A0CY PF8-1-66-1 hybridoma house mouse CVCL_A0CY CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6573 150517966 CVCL_A0CZ PF8-2-112-1 hybridoma house mouse CVCL_A0CZ CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG4, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6574 150517967 CVCL_A0DA PF8-2-177-1 hybridoma house mouse CVCL_A0DA CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG4, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6576 150517968 CVCL_A0CQ RBME-6 spontaneously immortalized cell line CVCL_A0CQ CL:0000010 Unspecified Doubling time: ~63 hours (PubMed=34230000). Group: Tick cell line 150517969 CVCL_A0CR PF8-1-116-1 hybridoma house mouse CVCL_A0CR CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6566 150517970 CVCL_A0CS PF8-1-132-1 hybridoma house mouse CVCL_A0CS CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6567 150517971 CVCL_A0CT PF8-1-136-3 hybridoma house mouse CVCL_A0CT CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6568 150517972 CVCL_A0CU PF8-1-257-1 hybridoma house mouse CVCL_A0CU CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6569 150517973 CVCL_A0CV PF8-1-268-1 hybridoma house mouse CVCL_A0CV CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6570 150517974 CVCL_A0CW PF8-1-314-1 hybridoma house mouse CVCL_A0CW CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6571 150517975 CVCL_A0CX PF8-1-46-1 hybridoma house mouse CVCL_A0CX CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6572 150517976 CVCL_A0EK XMMPS-OP1 hybridoma house mouse CVCL_A0EK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 1 core lipopolysaccharide (LPS). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9384 150517977 CVCL_A0EL XMMPS-OP2 hybridoma house mouse CVCL_A0EL CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 2 core lipopolysaccharide (LPS). 150517978 CVCL_A0EM 5A6.E9 hybridoma house mouse CVCL_A0EM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04234; Human CD3D. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9772 150517979 CVCL_A0EN deltaTCAR-3 hybridoma house mouse CVCL_A0EN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; B7Z8K6; Human TRDC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9578 150517980 CVCL_A0EP RS2A-2-H-7 hybridoma house mouse CVCL_A0EP CL:0000010 Characteristics: Isotype switched derivative of deltaTCAR-3; Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; B7Z8K6; Human TRDC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10110 150517981 CVCL_A0EQ 3A8 [Mouse hybridoma against human TRAC] hybridoma house mouse CVCL_A0EQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P01848; Human TRAC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9900 150517982 CVCL_A0ER 3D6 hybridoma house mouse CVCL_A0ER CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P01848; Human TRAC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9901 150517983 CVCL_A0EC Prost 185 hybridoma house mouse CVCL_A0EC CL:0000010 Monoclonal antibody isotype: IgG1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11425 150517984 CVCL_A0ED Prost 30 hybridoma house mouse CVCL_A0ED CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human prostate epithelial-specific antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11424 150517985 CVCL_A0EE Prost C219 hybridoma house mouse CVCL_A0EE CL:0000010 Monoclonal antibody isotype: IgM. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11893 150517986 CVCL_A0EF Prost C37 hybridoma house mouse CVCL_A0EF CL:0000010 Monoclonal antibody isotype: IgM. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11892 150517987 CVCL_A0EG XMMEN-J5D hybridoma house mouse CVCL_A0EG CL:0000010 Monoclonal antibody isotype: IgG2a. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9083 150517988 CVCL_A0EH XMMEN-LY1 hybridoma house mouse CVCL_A0EH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella minnesota R595 core lipopolysaccharide (LPS). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9082 150517989 CVCL_A0EI XMMEN-LY2 hybridoma house mouse CVCL_A0EI CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella minnesota R595 core lipopolysaccharide (LPS). 150517990 CVCL_A0EJ XMMPS-605 hybridoma house mouse CVCL_A0EJ CL:0000010 Monoclonal antibody isotype: IgG2; Monoclonal antibody target: Pseudomonas aeruginosa strain PAC 605 core lipopolysaccharide (LPS). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8909 150517991 CVCL_A0DZ IgM-8 hybridoma house mouse CVCL_A0DZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgM. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201850 150517992 CVCL_A0EA Prost 130 hybridoma house mouse CVCL_A0EA CL:0000010 Monoclonal antibody isotype: IgG1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11427 150517993 CVCL_A0EB Prost 16 hybridoma house mouse CVCL_A0EB CL:0000010 Monoclonal antibody isotype: IgG1. 150517994 CVCL_A0DR HSB.2-A7-D2 cancer cell line human CVCL_A0DR CL:0000010 Sequence variation: Gene fusion; HGNC; 10879; STIL + HGNC; 11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line); Sequence variation: Mutation; HGNC; 3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Produces high level of IL2 in response to IL1 150517995 CVCL_A0DS HSB.2-A7-D9 cancer cell line human CVCL_A0DS CL:0000010 Sequence variation: Gene fusion; HGNC; 10879; STIL + HGNC; 11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line); Sequence variation: Mutation; HGNC; 3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Produces high level of IL2 in response to IL1 150517996 CVCL_A0DT HSB.2-C5-B2 cancer cell line human CVCL_A0DT CL:0000010 Sequence variation: Gene fusion; HGNC; 10879; STIL + HGNC; 11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line); Sequence variation: Mutation; HGNC; 3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Produces high level of IL2 in response to IL1 150517997 CVCL_A0DU hIL1Rm10 hybridoma house mouse CVCL_A0DU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P14778; Human IL1R1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10556 150517998 CVCL_A0DV ASE [Anopheles] spontaneously immortalized cell line CVCL_A0DV CL:0000010 Unspecified Group: Insect cell line; Group: Malaria research cell line. 150517999 CVCL_A0DW HeLa S3 AGO2KO cancer cell line human CVCL_A0DW CL:0000010 Knockout cell: Method=ZFN; HGNC; 3263; AGO2 Population: African American; Transformant: Human papillomavirus type 18 (HPV18)(NCBI-Taxonomy; 333761); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Omics: scRNAseq analysis Female 150518000 CVCL_A0DX RM3/1 hybridoma house mouse CVCL_A0DX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163. 150518001 CVCL_A0DY MAC 2-158 hybridoma house mouse CVCL_A0DY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163. 150518002 CVCL_A0RX 1E5 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0RX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518003 CVCL_A0RY 1G5 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0RY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518004 CVCL_A0RZ 4G2 hybridoma house mouse CVCL_A0RZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518005 CVCL_A0RP MS-3 hybridoma house mouse CVCL_A0RP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasma salivarium. 150518006 CVCL_A0RQ MS-4 hybridoma house mouse CVCL_A0RQ CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Mycoplasma salivarium. 150518007 CVCL_A0RR MS-5 [Mouse hybridoma against M.salivarium] hybridoma house mouse CVCL_A0RR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasma salivarium. 150518008 CVCL_A0RS RB1-MAbP2 hybridoma house mouse CVCL_A0RS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10093 150518009 CVCL_A0RT TEC-11 hybridoma house mouse CVCL_A0RT CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12311 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965. 150518010 CVCL_A0RU TEC-4 hybridoma house mouse CVCL_A0RU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12312 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965. 150518011 CVCL_A0RV 3C8 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0RV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P06400; Human RB1 (Note=Binds to the C-terminal end) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12313 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518012 CVCL_A0RW 1D1 hybridoma house mouse CVCL_A0RW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518013 CVCL_A0RH MH-3 hybridoma house mouse CVCL_A0RH CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: Mycoplasma hyorhinis. 150518014 CVCL_A0RI MO-1 hybridoma house mouse CVCL_A0RI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mycoplasma orale. 150518015 CVCL_A0RJ MO-2 hybridoma house mouse CVCL_A0RJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasma orale. 150518016 CVCL_A0RK MO-3 hybridoma house mouse CVCL_A0RK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mycoplasma orale. 150518017 CVCL_A0RL MP-1 hybridoma house mouse CVCL_A0RL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasma pneumoniae. 150518018 CVCL_A0RM MS-1 [Mouse hybridoma against M.salivarium] hybridoma house mouse CVCL_A0RM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mycoplasma salivarium. 150518019 CVCL_A0RN MS-2 [Mouse hybridoma against M.salivarium] hybridoma house mouse CVCL_A0RN CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: Mycoplasma salivarium. 150518020 CVCL_A0RA AL-3 hybridoma house mouse CVCL_A0RA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Acholeplasma laidlawii. 150518021 CVCL_A0RB MA-1 [Mouse hybridoma against M.arginini] hybridoma house mouse CVCL_A0RB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mycoplasma arginini. 150518022 CVCL_A0RC MA-2 hybridoma house mouse CVCL_A0RC CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Mycoplasma arginini. 150518023 CVCL_A0RD MA-3 hybridoma house mouse CVCL_A0RD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Mycoplasma arginini. 150518024 CVCL_A0RE MA-4 hybridoma house mouse CVCL_A0RE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasma arginini. 150518025 CVCL_A0RF MH-1 [Mouse hybridoma against M.hyorhinis] hybridoma house mouse CVCL_A0RF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasma hyorhinis. 150518026 CVCL_A0RG MH-2 [Mouse hybridoma against M.hyorhinis] hybridoma house mouse CVCL_A0RG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasma hyorhinis. 150518027 CVCL_A0SY MRIi027-A induced pluripotent stem cell human CVCL_A0SY From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518028 CVCL_A0SZ MRIi024-A induced pluripotent stem cell human CVCL_A0SZ From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10854; SHOX2; Simple; p.His259Gln (c.777C>A) (p.His283Gln, c.849C>A); Zygosity=Heterozygous (PubMed=32976766) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518029 CVCL_A0TA MRIi016-A induced pluripotent stem cell human CVCL_A0TA From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; 10854; SHOX2; Simple; c.*28T>C; dbSNP=rs138912749; Zygosity=Heterozygous (PubMed=32976766) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518030 CVCL_A0SQ U2OS ATXN3 KO cancer cell line human CVCL_A0SQ From: Durcan T.M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 7106; ATXN3; Sequence variation: Mutation; HGNC; 9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Miscellaneous: Cell line information from personal communication of Laflamme C Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 150518031 CVCL_A0SR NCC-GCTB2-C1 cancer cell line human CVCL_A0SR CL:0000010 Sequence variation: Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34304386) Population: Japanese; Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772. Omics: SNP array analysis Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.); Doubling time: 64 hours (PubMed=34304386) Part of: NCC sarcoma cell line panel 150518032 CVCL_A0SS NCC-GCTB3-C1 cancer cell line human CVCL_A0SS CL:0000010 Sequence variation: Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34304386) Population: Japanese; Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772. Omics: SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.); Doubling time: 26 hours (PubMed=34304386) Part of: NCC sarcoma cell line panel 150518033 CVCL_A0ST HL60/MRI cancer cell line human CVCL_A0ST CL:0000010 Sequence variation: Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Cell line established from the transplantable tumor of the same name 150518034 CVCL_A0SU LCPHi001-A induced pluripotent stem cell human CVCL_A0SU From: The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital; Liaocheng; China CL:0000010 Sequence variation: Mutation; HGNC; 4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=34464855); Sequence variation: Mutation; HGNC; 4177; GBA1; Simple; p.Ala495Pro (c.1483G>C) (A456P); ClinVar=VCV000093450; Zygosity=Heterozygous (PubMed=34464855); Sequence variation: Mutation; HGNC; 4177; GBA1; Simple; p.Val499Val (c.1497G>C) (V460V); ClinVar=VCV000093451; Zygosity=Heterozygous (PubMed=34464855) Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518035 CVCL_A0SV BIUi001-A induced pluripotent stem cell human CVCL_A0SV From: Bar Ilan University; Ramat Gan; Israel CL:0000010 Sequence variation: Mutation; HGNC; 29456; TOR1AIP1; Simple; p.Arg321Ter (c.961C>T); ClinVar=VCV000804380; Zygosity=Homozygous (PubMed=34560421) Population: Arab; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518036 CVCL_A0SW BIUi002-A induced pluripotent stem cell human CVCL_A0SW From: Bar Ilan University; Ramat Gan; Israel CL:0000010 Sequence variation: Mutation; HGNC; 29456; TOR1AIP1; Simple; p.Arg321Ter (c.961C>T); ClinVar=VCV000804380; Zygosity=Homozygous (PubMed=34560421) Population: Arab; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518037 CVCL_A0SX MRIi026-A induced pluripotent stem cell human CVCL_A0SX From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518038 CVCL_A0SI mHypoE-36 transformed cell line house mouse CVCL_A0SI CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Female 150518039 CVCL_A0SJ mHypoE-43 transformed cell line house mouse CVCL_A0SJ CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Miscellaneous: Sex of donor from personal communication of Belsham D.D Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Female 150518040 CVCL_A0SK mHypoA-Kiss/GFP-1 transformed cell line house mouse CVCL_A0SK CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Male 150518041 CVCL_A0SL mHypoA-Kiss/GFP-2 transformed cell line house mouse CVCL_A0SL CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Male 150518042 CVCL_A0SM mHypoA-Kiss/GFP-3 transformed cell line house mouse CVCL_A0SM CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus, arcuate nucleus; UBERON=UBERON_0001932; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Female 150518043 CVCL_A0SN mHypoA-Kiss/GFP-4 transformed cell line house mouse CVCL_A0SN CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus, anteroventral periventricular nucleus; UBERON=UBERON_0002690; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Female 150518044 CVCL_A0SP HEK293T ATXN3 KO transformed cell line human CVCL_A0SP From: Durcan T.M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 7106; ATXN3; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Miscellaneous: Cell line information from personal communication of Laflamme C Transformant: Adenovirus 5(NCBI-Taxonomy; 28285); Transformant: Simian virus 40 (SV40) [Note=tsA](NCBI-Taxonomy; 1891767); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518045 CVCL_A0SA 4H6 hybridoma house mouse CVCL_A0SA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760 While this hybridoma is not described by the patent, 6 other hybridomas are described in both sources thus this one was probably produced in an identical manner.. 150518046 CVCL_A0SB 7F12 hybridoma house mouse CVCL_A0SB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518047 CVCL_A0SC mHypoE-2 transformed cell line house mouse CVCL_A0SC CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Miscellaneous: Cell line no longer available (personal communication of Belsham D.D.) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518048 CVCL_A0SD mHypoE-19 transformed cell line house mouse CVCL_A0SD CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Miscellaneous: Cell line no longer available (personal communication of Belsham D.D.) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518049 CVCL_A0SE mHypoE-22 transformed cell line house mouse CVCL_A0SE CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Miscellaneous: Cell line no longer available (personal communication of Belsham D.D.) Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518050 CVCL_A0SF mHypoE-20 transformed cell line house mouse CVCL_A0SF CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518051 CVCL_A0SG mHypoE-25 transformed cell line house mouse CVCL_A0SG CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518052 CVCL_A0SH mHypoE-29 transformed cell line house mouse CVCL_A0SH CL:0000010 Transfected with: UniProtKB; P00552; Transposon Tn5 neo Transformant: Simian virus 40 (SV40)(NCBI-Taxonomy; 1891767); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Male 150518053 CVCL_A0PV IIID5 spontaneously immortalized cell line CVCL_A0PV CL:0000010 Derived from site: In situ; Blastula; UBERON=UBERON_0000307. Omics: Transcriptome analysis by RNAseq Characteristics: Bright, vacuoles; immovable, forms blastula-like sphere Group: Cnidaria cell line 150518054 CVCL_A0PW IIIB6 spontaneously immortalized cell line CVCL_A0PW CL:0000010 Miscellaneous: Cell line has been lost. Omics: Transcriptome analysis by RNAseq Characteristics: Bright, vacuoles; immovable, forms gastrula-like sphere Group: Cnidaria cell line 150518055 CVCL_A0PX EL4-Zbtb1 KO cancer cell line house mouse CVCL_A0PX CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2442326; Zbtb1 Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Omics: miRNA expression profiling Unspecified 150518056 CVCL_A0PY 18/1 hybridoma house mouse CVCL_A0PY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00746; Human CFD. 150518057 CVCL_A0PZ C18/3 hybridoma house mouse CVCL_A0PZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08603; Human CFH. 150518058 CVCL_A0PN GPC3-7C8 hybridoma house mouse CVCL_A0PN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P51654; Human GPC3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201009 150518059 CVCL_A0PP IVB6 spontaneously immortalized cell line CVCL_A0PP CL:0000010 Omics: Transcriptome analysis by RNAseq. Characteristics: Brilliant brown; forms cell aggregates; immovable Group: Cnidaria cell line 150518060 CVCL_A0PQ IIC5 spontaneously immortalized cell line CVCL_A0PQ CL:0000010 Omics: Transcriptome analysis by RNAseq. Characteristics: Brilliant brown; forms filopodia; movable Group: Cnidaria cell line 150518061 CVCL_A0PR IVB4 spontaneously immortalized cell line CVCL_A0PR CL:0000010 Omics: Transcriptome analysis by RNAseq. Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable Doubling time: 4-5 days (PubMed=33899125) Group: Cnidaria cell line 150518062 CVCL_A0PS IVC4 spontaneously immortalized cell line CVCL_A0PS CL:0000010 Omics: Transcriptome analysis by RNAseq. Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable Doubling time: 4-5 days (PubMed=33899125) Group: Cnidaria cell line 150518063 CVCL_A0PT IVD1 spontaneously immortalized cell line CVCL_A0PT CL:0000010 Omics: Transcriptome analysis by RNAseq. Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable Doubling time: 4-5 days (PubMed=33899125) Group: Cnidaria cell line 150518064 CVCL_A0PU IVC6 spontaneously immortalized cell line CVCL_A0PU CL:0000010 Omics: Transcriptome analysis by RNAseq. Characteristics: Bright, vacuoles; immovable, forms cell sheet Group: Cnidaria cell line 150518065 CVCL_A0PF 2C9 [Mouse hybridoma against aflatoxin M1] hybridoma house mouse CVCL_A0PF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI:78576; Aflatoxin M1 (AFM1). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201018 150518066 CVCL_A0PG 4F12 [Mouse hybridoma against aflatoxin] hybridoma house mouse CVCL_A0PG CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518067 CVCL_A0PH 4F3 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0PH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518068 CVCL_A0PI 8E11 hybridoma house mouse CVCL_A0PI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518069 CVCL_A0PJ 8F6 hybridoma house mouse CVCL_A0PJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518070 CVCL_A0PK DE7 hybridoma house mouse CVCL_A0PK CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFB1, AFG2 and AFM1). 150518071 CVCL_A0PL 2G6 [Mouse hybridoma against aflatoxins G] hybridoma house mouse CVCL_A0PL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518072 CVCL_A0PM S-95-7 hybridoma house mouse CVCL_A0PM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A5P8NB39; Influenza A virus isolate A/California/7/2009 hemagglutinin (HA). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201024 150518073 CVCL_A0PA 1C10 [Mouse hybridoma against aflatoxin G1] hybridoma house mouse CVCL_A0PA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFG2). 150518074 CVCL_A0PB 1C11 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0PB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201013 150518075 CVCL_A0PC 1C8 [Mouse hybridoma against aflatoxin G1] hybridoma house mouse CVCL_A0PC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFG2). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201017 150518076 CVCL_A0PD 1D3 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0PD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518077 CVCL_A0PE 1E10 hybridoma house mouse CVCL_A0PE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518078 CVCL_A0QW ZN-5 hybridoma house mouse CVCL_A0QW From: Trevarrow B.; Institute of Neuroscience, University of Oregon; Eugene; USA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q90460; Danio rerio alcama/cd166a. 150518079 CVCL_A0QX ZN-8 hybridoma house mouse CVCL_A0QX From: Trevarrow B.; Institute of Neuroscience, University of Oregon; Eugene; USA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q90460; Danio rerio alcama/cd166a. 150518080 CVCL_A0QY AL-1 hybridoma house mouse CVCL_A0QY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Acholeplasma laidlawii. 150518081 CVCL_A0QZ AL-2 hybridoma house mouse CVCL_A0QZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Acholeplasma laidlawii. 150518082 CVCL_A0QP CGMCC-18525 hybridoma house mouse CVCL_A0QP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI:189548; 3,5-dinitrosalicylic acid hydrazide (DNSH). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18525 150518083 CVCL_A0QQ 30G8 hybridoma house mouse CVCL_A0QQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Mycoplasma gallisepticum strain R. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15207 150518084 CVCL_A0QR 34H1 hybridoma house mouse CVCL_A0QR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mycoplasma gallisepticum strain R. 150518085 CVCL_A0QS 35A6 hybridoma house mouse CVCL_A0QS CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; F8WJY4; Mycoplasma gallisepticum strain R MGC3 (crMA) (Note=Also reacts with other strains, but not avirulent strain F). Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5244 150518086 CVCL_A0QT 35H5 hybridoma house mouse CVCL_A0QT CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Mycoplasma gallisepticum strain R. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15206 150518087 CVCL_A0QU 38B7 hybridoma house mouse CVCL_A0QU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Mycoplasma gallisepticum strain R. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15205 150518088 CVCL_A0QV 39E8 hybridoma house mouse CVCL_A0QV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Mycoplasma gallisepticum strain R. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15208 150518089 CVCL_A0QG BRCA84D hybridoma house mouse CVCL_A0QG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line 150518090 CVCL_A0QH GB8 hybridoma house mouse CVCL_A0QH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518091 CVCL_A0QI OVCA22 hybridoma house mouse CVCL_A0QI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518092 CVCL_A0QJ PRCA157 hybridoma house mouse CVCL_A0QJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line 150518093 CVCL_A0QK SG27 hybridoma house mouse CVCL_A0QK CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518094 CVCL_A0QL TDH6 hybridoma house mouse CVCL_A0QL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518095 CVCL_A0QM TES7 hybridoma house mouse CVCL_A0QM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518096 CVCL_A0QN L20 hybridoma house mouse CVCL_A0QN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8913 150518097 CVCL_A0QA D10/4 hybridoma house mouse CVCL_A0QA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00746; Human CFD. 150518098 CVCL_A0QB L20/3 hybridoma house mouse CVCL_A0QB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08603; Human CFH. 150518099 CVCL_A0QC M13/12 hybridoma house mouse CVCL_A0QC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00751; Human CFB. 150518100 CVCL_A0QD P21/15 hybridoma house mouse CVCL_A0QD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00751; Human CFB. 150518101 CVCL_A0QE BRCA68D hybridoma house mouse CVCL_A0QE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518102 CVCL_A0QF BRCA69D hybridoma house mouse CVCL_A0QF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line 150518103 CVCL_A0NT 203E3 hybridoma house mouse CVCL_A0NT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11. 150518104 CVCL_A0NU 2H4 [Mouse hybridoma against human CALCA] hybridoma house mouse CVCL_A0NU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014232 150518105 CVCL_A0NV CGMCC-10417 hybridoma house mouse CVCL_A0NV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10417 150518106 CVCL_A0NW 277 34B3 20170123 hybridoma house mouse CVCL_A0NW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q5H943; Human CT83. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02527 150518107 CVCL_A0NX LT006 hybridoma house mouse CVCL_A0NX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q16552; Human IL17A Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017102 150518108 CVCL_A0NY LT007 hybridoma house mouse CVCL_A0NY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q16552; Human IL17A. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017165 150518109 CVCL_A0NZ 10C9 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0NZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2). 150518110 CVCL_A0NL 7.10D7 hybridoma house mouse CVCL_A0NL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518111 CVCL_A0NM 7.10H2 hybridoma house mouse CVCL_A0NM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518112 CVCL_A0NN ZH68-2A4 hybridoma house mouse CVCL_A0NN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; B0F9T9; Trichinella spiralis serine protease Ts-ZH68. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18317 150518113 CVCL_A0NP WN10-1H9 hybridoma house mouse CVCL_A0NP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; B0F9T2; Trichinella spiralis Ts-WN10. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18316 150518114 CVCL_A0NQ C2C12-hITGA11 spontaneously immortalized cell line house mouse CVCL_A0NQ CL:0000010 Transfected with: HGNC; 6136; ITGA11; Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Female 150518115 CVCL_A0NR 203E1H5 hybridoma house mouse CVCL_A0NR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3318 150518116 CVCL_A0NS 234H11E8 hybridoma house mouse CVCL_A0NS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3319 150518117 CVCL_A0ND 7.4A3 hybridoma house mouse CVCL_A0ND CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518118 CVCL_A0NE 7.7G5 hybridoma house mouse CVCL_A0NE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3899 150518119 CVCL_A0NF 7.8B3 hybridoma house mouse CVCL_A0NF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518120 CVCL_A0NG 7.8C9 hybridoma house mouse CVCL_A0NG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518121 CVCL_A0NH 7.8H12 hybridoma house mouse CVCL_A0NH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518122 CVCL_A0NI 7.9D4 hybridoma house mouse CVCL_A0NI CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518123 CVCL_A0NJ 7.9G8 hybridoma house mouse CVCL_A0NJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518124 CVCL_A0NK 7.9H5 hybridoma house mouse CVCL_A0NK CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518125 CVCL_A0NA 7.2A1 hybridoma house mouse CVCL_A0NA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518126 CVCL_A0NB 7.2F5 hybridoma house mouse CVCL_A0NB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518127 CVCL_A0NC 7.2H2 hybridoma house mouse CVCL_A0NC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518128 CVCL_A0LR TRNDi012-H induced pluripotent stem cell human CVCL_A0LR From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518129 CVCL_A0LS TRNDi012-I induced pluripotent stem cell human CVCL_A0LS From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518130 CVCL_A0LT EURACi006-A induced pluripotent stem cell human CVCL_A0LT From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple; p.Gly548Valfs*15 (c.1643delG); ClinVar=VCV000202035; Zygosity=Heterozygous (PubMed=34134068) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518131 CVCL_A0LU EURACi006-A-1 induced pluripotent stem cell human CVCL_A0LU From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple_corrected; p.Gly548Valfs*15 (c.1643delG); ClinVar=VCV000202035; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34134068) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518132 CVCL_A0LV EURACi007-A induced pluripotent stem cell human CVCL_A0LV From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple; p.Asn346Leufs*12 (c.1035-5203_1171-13298del); Zygosity=Heterozygous (PubMed=34298432) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518133 CVCL_A0LW EURACi008-A induced pluripotent stem cell human CVCL_A0LW From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; 9024; PKP2; Simple; p.Asn346Leufs*12 (c.1035-5203_1171-13298del); Zygosity=Heterozygous (PubMed=34298432) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: While harboring the same PKP2 mutation as a family member from which EURACi007-A (Cellosaurus=CVCL_A0LV) was derived, the donor of this cell line did not show any symptom of arrhythmogenic right ventricular dysplasia 150518134 CVCL_A0LX EURACi009-A induced pluripotent stem cell human CVCL_A0LX From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518135 CVCL_A0LY AIBNi001-A induced pluripotent stem cell human CVCL_A0LY From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518136 CVCL_A0LJ TRNDi012-A induced pluripotent stem cell human CVCL_A0LJ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518137 CVCL_A0LK TRNDi012-B induced pluripotent stem cell human CVCL_A0LK From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=34139597) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518138 CVCL_A0LL TRNDi012-C induced pluripotent stem cell human CVCL_A0LL From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518139 CVCL_A0LM TRNDi012-D induced pluripotent stem cell human CVCL_A0LM From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518140 CVCL_A0LN TRNDi012-E induced pluripotent stem cell human CVCL_A0LN From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518141 CVCL_A0LP TRNDi012-F induced pluripotent stem cell human CVCL_A0LP From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518142 CVCL_A0LQ TRNDi012-G induced pluripotent stem cell human CVCL_A0LQ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; 171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518143 CVCL_A0LB LANCEi020-A-8 induced pluripotent stem cell human CVCL_A0LB From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518144 CVCL_A0LC LANCEi020-A-9 induced pluripotent stem cell human CVCL_A0LC From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 3603; FBN1 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518145 CVCL_A0LG MCRIi024-A induced pluripotent stem cell human CVCL_A0LG From: Murdoch Children's Research Institute; Melbourne; Australia CL:0000010 Sequence variation: Mutation; HGNC; 129; ACTA1; Simple; p.Gly148Asp (c.443G>A); Zygosity=Heterozygous (PubMed=34157503) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518146 CVCL_A0LH MCRIi024-A-1 induced pluripotent stem cell human CVCL_A0LH From: Murdoch Children's Research Institute; Melbourne; Australia CL:0000010 Sequence variation: Mutation; HGNC; 129; ACTA1; Simple_corrected; p.Gly148Asp (c.443G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34157503) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518147 CVCL_A0LI BCHNi001-A induced pluripotent stem cell human CVCL_A0LI From: Department of Nephrology, Beijing Children's Hospital Affiliated to Capital Medical University; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; 18758; BBS7; Simple; p.Asp252Asn (c.754G>A); Zygosity=Heterozygous (PubMed=34146953); Sequence variation: Mutation; HGNC; 18758; BBS7; Simple; c.849+1G>C; ClinVar=VCV001507819; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34146953) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518148 CVCL_A0KY LANCEi020-A-5 induced pluripotent stem cell human CVCL_A0KY From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 3603; FBN1 (Note=1 of 2 alleles) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518149 CVCL_A0KZ LANCEi020-A-6 induced pluripotent stem cell human CVCL_A0KZ From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 3603; FBN1 (Note=1 of 2 alleles) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518150 CVCL_A0LA LANCEi020-A-7 induced pluripotent stem cell human CVCL_A0LA From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518151 CVCL_A0MS 6.2E5 hybridoma house mouse CVCL_A0MS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3897 150518152 CVCL_A0MT 6.3G9 hybridoma house mouse CVCL_A0MT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3649 150518153 CVCL_A0MU 6.4B4 hybridoma house mouse CVCL_A0MU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. 150518154 CVCL_A0MV 6.6B5 hybridoma house mouse CVCL_A0MV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. 150518155 CVCL_A0MW 6.8B4 hybridoma house mouse CVCL_A0MW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. 150518156 CVCL_A0MX 6.8G6 hybridoma house mouse CVCL_A0MX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3645 150518157 CVCL_A0MY 7.1C5 hybridoma house mouse CVCL_A0MY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3900 150518158 CVCL_A0MZ 7.1G10 hybridoma house mouse CVCL_A0MZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3898 150518159 CVCL_A0MK SNUe003-A-3 embryonic stem cell human CVCL_A0MK From: Seoul National University; Seoul; South Korea CL:0000010 Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP); Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR) Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a T2A-EGFP-polyA-PGKp-PuroR-polyA construct was introduced at the C-terminus of MYH6 (PubMed=35427904) 150518160 CVCL_A0ML FDC-P1 Beta6 factor-dependent cell line house mouse CVCL_A0ML CL:0000010 Transfected with: MGI; MGI:96615; Itgb6; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: DBA/2. 150518161 CVCL_A0MM NIH 3T3 Beta6 spontaneously immortalized cell line house mouse CVCL_A0MM CL:0000010 Transfected with: MGI; MGI:96615; Itgb6; Transfected with: UniProtKB; P00552; Transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NIH Swiss. Male 150518162 CVCL_A0MN 6.1A8 hybridoma house mouse CVCL_A0MN CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3647 150518163 CVCL_A0MP 6.2A1 hybridoma house mouse CVCL_A0MP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3896 150518164 CVCL_A0MQ 6.2B1 hybridoma house mouse CVCL_A0MQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3646 150518165 CVCL_A0MR 6.2B10 hybridoma house mouse CVCL_A0MR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3648 150518166 CVCL_A0MC AUi001-A induced pluripotent stem cell human CVCL_A0MC From: Aarhus University; Aarhus; Denmark CL:0000010 Sequence variation: Mutation; HGNC; 6118; IRF3; Simple; p.Arg285Gln (c.854G>A); ClinVar=VCV000208454; Zygosity=Heterozygous Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518167 CVCL_A0MD AUi002-A induced pluripotent stem cell human CVCL_A0MD From: Aarhus University; Aarhus; Denmark. CL:0000010 150518168 CVCL_A0ME HRMSDUi001-A induced pluripotent stem cell human CVCL_A0ME From: Hospital for Reproductive Medicine Affiliated to Shandong University; Jinan; China CL:0000010 Population: Chinese; Han; Karyotypic information: 45,XY,der(13;14)(q10;q10) (PubMed=34284274); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518169 CVCL_A0MF KUMi002-A induced pluripotent stem cell human CVCL_A0MF From: Korea University Medical School Hospital; Seoul; South Korea CL:0000010 Population: Korean; Donor information: Established from a patient suffering from chronic myeloid leukemia with BCR-ABL but has a normal karyotype; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 150518170 CVCL_A0MG KUMi001-A induced pluripotent stem cell human CVCL_A0MG From: Korea University Medical School Hospital; Seoul; South Korea CL:0000010 Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=34280890) Population: Korean; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 150518171 CVCL_A0MH XMMPS-OP3 hybridoma house mouse CVCL_A0MH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 3 core lipopolysaccharide (LPS). 150518172 CVCL_A0MI XMMPS-OP4 hybridoma house mouse CVCL_A0MI CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 4 core lipopolysaccharide (LPS). 150518173 CVCL_A0MJ XMMPS-OP7 hybridoma house mouse CVCL_A0MJ CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 7 core lipopolysaccharide (LPS). 150518174 CVCL_A0LZ AIBNi002-A induced pluripotent stem cell human CVCL_A0LZ From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518175 CVCL_A0MA NCUFi001-A induced pluripotent stem cell human CVCL_A0MA From: Niccolo Cusano University Foundation; Rome; Italy CL:0000010 Sequence variation: Mutation; HGNC; 6294; KCNQ1; Simple; p.Gly314Ser (c.940G>A) (p.Gly187Ser, c.559G>A); ClinVar=VCV000003123; Zygosity=Heterozygous (PubMed=34130155) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518176 CVCL_A0MB UGOTSAi001-A induced pluripotent stem cell human CVCL_A0MB From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden. CL:0000010 Female 150518177 CVCL_A0ZX MUSIi015-A induced pluripotent stem cell human CVCL_A0ZX From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; 4174; GATA6; Simple; p.Glu51Lys (c.151G>T); Zygosity=Heterozygous (PubMed=35853413); Sequence variation: Mutation; HGNC; 32058; ZYG11A; Simple; p.Leu475Pro (c.1424T>C); Zygosity=Heterozygous (PubMed=35853413) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518178 CVCL_A0ZY MUSIi001-A-1 induced pluripotent stem cell human CVCL_A0ZY From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; 914; B2M Population: Southeast Asian; Thai; Derived from site: In situ; Abdomen, skin, dermis; Note=From a cesarean section scar; UBERON=UBERON_0001416+UBERON_0002067. Female 150518179 CVCL_A0ZZ ZJUi005-A [Wrong name] induced pluripotent stem cell human CVCL_A0ZZ From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; 3603; FBN1; Simple; p.Cys2245Tyr (c.6734G>A); ClinVar=VCV000968455; Zygosity=Heterozygous (PubMed=34298435) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: There are 2 cell lines generated by the same group with the same name This cell line should be renamed. 150518180 CVCL_A0ZP NCTC 2168 spontaneously immortalized cell line house mouse CVCL_A0ZP CL:0000010 Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Group: Serum/protein free medium cell line 150518181 CVCL_A0ZQ NCTC 1742 cancer cell line house mouse CVCL_A0ZQ CL:0000010 Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190; Breed/subspecies: C3H/HeN. Male 150518182 CVCL_A0ZR NCTC 2049 spontaneously immortalized cell line house mouse CVCL_A0ZR CL:0000010 Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190; Breed/subspecies: C3H/HeN. Male 150518183 CVCL_A0ZS PLAFMCi005-A induced pluripotent stem cell human CVCL_A0ZS From: Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; 11630; HNF1B; Simple; c.544+3_544+6delAAGT; ClinVar=VCV000635668; Zygosity=Heterozygous (PubMed=34359001) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518184 CVCL_A0ZT UMi031-A induced pluripotent stem cell human CVCL_A0ZT From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518185 CVCL_A0ZU UMi031-A-2 induced pluripotent stem cell human CVCL_A0ZU From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; 7773; NF2; Simple_edited; p.Leu64Pro (c.191T>C); ClinVar=VCV001006297; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34352618) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518186 CVCL_A0ZV MUSIi013-A induced pluripotent stem cell human CVCL_A0ZV From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Population: Southeast Asian; Thai; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: Natural killer cell; CL=CL_0000623. Female 150518187 CVCL_A0ZW MUSIi014-A induced pluripotent stem cell human CVCL_A0ZW From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; 32058; ZYG11A; Simple; p.Leu475Pro (c.1424T>C); Zygosity=Heterozygous (PubMed=35193007) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518188 CVCL_A0ZH UWRBTi003-C induced pluripotent stem cell human CVCL_A0ZH From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; 3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518189 CVCL_A0ZI UWRBTi004-A induced pluripotent stem cell human CVCL_A0ZI From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; 3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518190 CVCL_A0ZJ UWRBTi004-B induced pluripotent stem cell human CVCL_A0ZJ From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; 3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518191 CVCL_A0ZK UWRBTi004-C induced pluripotent stem cell human CVCL_A0ZK From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; 3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (from autologous cell lines UWRBTi004-A and UWRBTi004-B) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518192 CVCL_A0ZL HIHTFi001-A induced pluripotent stem cell human CVCL_A0ZL From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 21168; RHOT1; Simple_edited; p.Ser156Ala (c.466T>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34359002) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518193 CVCL_A0ZM HIHTFi001-B induced pluripotent stem cell human CVCL_A0ZM From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 21168; RHOT1; Simple_edited; p.Arg272Gln (c.815G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34359002) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518194 CVCL_A0ZN HIHTFi001-C induced pluripotent stem cell human CVCL_A0ZN From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; 21168; RHOT1; Simple_edited; p.Lys572Arg (c.1714_1716AAA>CGG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34359002) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518195 CVCL_A0YA OSRi010-A induced pluripotent stem cell human CVCL_A0YA From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; 15573; SETBP1; Simple; p.Ile871Thr (c.2612T>C); ClinVar=VCV000001031; Zygosity=Heterozygous (hPSCreg=OSRi010-A) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518196 CVCL_A0YB OSRi010-A-1 induced pluripotent stem cell human CVCL_A0YB From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; 15573; SETBP1; Simple_corrected; p.Ile871Thr (c.2612T>C); ClinVar=VCV000001031; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=OSRi010-A-1) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518197 CVCL_A0YC AIBNi003-A induced pluripotent stem cell human CVCL_A0YC From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518198 CVCL_A0YD AIBNi004-A induced pluripotent stem cell human CVCL_A0YD From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518199 CVCL_A0YE AIBNi005-A induced pluripotent stem cell human CVCL_A0YE From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518200 CVCL_A0YF AIBNi006-A induced pluripotent stem cell human CVCL_A0YF From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518201 CVCL_A0XV ZMAC-4 factor-dependent cell line pig CVCL_A0XV CL:0000010 Derived from site: In situ; Fetal lung, alveolus; UBERON=UBERON_0005597+UBERON_0002299; Cell type: Alveolar macrophage; CL=CL_0000583; Breed/subspecies: Landrace x Yorkshire x Duroc. Unspecified Characteristics: CSF1 dependent; Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=21191013); Virology: Supports high level of replication of African swine fever virus attenuated strain OURT88/3 (PubMed=32515659) Doubling time: 3.9 +- 0.3 days (PubMed=32515659) 150518202 CVCL_A0XW PCIi032-A induced pluripotent stem cell human CVCL_A0XW From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518203 CVCL_A0XX PCIi033-A induced pluripotent stem cell human CVCL_A0XX From: Phenocell SAS; Grasse; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518204 CVCL_A0XY OSRi009-A induced pluripotent stem cell human CVCL_A0XY From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; 15573; SETBP1; Simple; p.Asp868Asn (c.2602G>A); ClinVar=VCV000001032; Zygosity=Heterozygous (hPSCreg=OSRi009-A) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518205 CVCL_A0XZ OSRi009-A-1 induced pluripotent stem cell human CVCL_A0XZ From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; 15573; SETBP1; Simple_corrected; p.Asp868Asn (c.2602G>A); ClinVar=VCV000001032; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=OSRi009-A-1) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518206 CVCL_A0XN 12 060 cancer cell line human CVCL_A0XN CL:0000010 Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male Doubling time: 6.6 days (PubMed=33251771) 150518207 CVCL_A0XP 12 073 cancer cell line human CVCL_A0XP CL:0000010 Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810. Male Doubling time: 4.2 days (PubMed=33251771) 150518208 CVCL_A0XQ 12 075 cancer cell line human CVCL_A0XQ CL:0000010 Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810. Female Doubling time: 13.6 days (PubMed=33251771) 150518209 CVCL_A0XR 12 079 cancer cell line human CVCL_A0XR CL:0000010 Derived from site: In situ; Brain, left parieto-occipital lobe. Female Doubling time: 2.3 days (PubMed=33251771) 150518210 CVCL_A0XS 13 019 cancer cell line human CVCL_A0XS CL:0000010 Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male Doubling time: 1.6 days (PubMed=33251771) 150518211 CVCL_A0XT 13 025 cancer cell line human CVCL_A0XT CL:0000010 Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808. Male Doubling time: 4.7 days (PubMed=33251771) 150518212 CVCL_A0XU CL2621 spontaneously immortalized cell line CVCL_A0XU From: Boehringer Ingelheim Animal Health, Inc.; St Joseph; USA. CL:0000010 Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Unspecified Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) Group: Non-human primate cell line Problematic cell line: Misidentified Parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque. 150518213 CVCL_A0XF 11 045 cancer cell line human CVCL_A0XF CL:0000010 Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808. Male Doubling time: 2.3 days (PubMed=33251771) 150518214 CVCL_A0XG 11 068 cancer cell line human CVCL_A0XG CL:0000010 Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809. Male Doubling time: 3.5 days (PubMed=33251771) 150518215 CVCL_A0XH 11 091 cancer cell line human CVCL_A0XH CL:0000010 Derived from site: In situ; Brain, left fronto-parietal lobe. Female Doubling time: 13.4 days (PubMed=33251771) 150518216 CVCL_A0XI 12 040 cancer cell line human CVCL_A0XI CL:0000010 Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809. Male Doubling time: 6.7 days (PubMed=33251771) 150518217 CVCL_A0XJ 12 041 cancer cell line human CVCL_A0XJ CL:0000010 Derived from site: In situ; Brain, left parieto-occipital lobe. Female Doubling time: 2.2 days (PubMed=33251771) 150518218 CVCL_A0XK 12 046 cancer cell line human CVCL_A0XK CL:0000010 Derived from site: In situ; Brain, right temporo-occipital lobe. Female Doubling time: 10.3 days (PubMed=33251771) 150518219 CVCL_A0XL 12 058 cancer cell line human CVCL_A0XL CL:0000010 Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male Doubling time: 8.5 days (PubMed=33251771) 150518220 CVCL_A0XM 12 059 cancer cell line human CVCL_A0XM CL:0000010 Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808. Female Doubling time: 5.8 days (PubMed=33251771) 150518221 CVCL_A0ZA UWRBTi001-B induced pluripotent stem cell human CVCL_A0ZA From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518222 CVCL_A0ZB UWRBTi001-C induced pluripotent stem cell human CVCL_A0ZB From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518223 CVCL_A0ZC UWRBTi002-A induced pluripotent stem cell human CVCL_A0ZC From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518224 CVCL_A0ZD UWRBTi002-B induced pluripotent stem cell human CVCL_A0ZD From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518225 CVCL_A0ZE UWRBTi002-C induced pluripotent stem cell human CVCL_A0ZE From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518226 CVCL_A0ZF UWRBTi003-A induced pluripotent stem cell human CVCL_A0ZF From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; 3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (from autologous cell lines UWRBTi003-B and UWRBTi003-C) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518227 CVCL_A0ZG UWRBTi003-B induced pluripotent stem cell human CVCL_A0ZG From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; 3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518228 CVCL_A0YW 4TCYA1 hybridoma house mouse CVCL_A0YW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P24522; Human GADD45A. 150518229 CVCL_A0YX MDA-MB-231bo cancer cell line human CVCL_A0YX CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Omics: Transcriptome analysis by RNAseq Female Characteristics: Metastatic to bone Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the bone metastatic cells and repeating this procedure 11 times. Group: Triple negative breast cancer (TNBC) cell line 150518230 CVCL_A0YY MDA-MB-231br cancer cell line human CVCL_A0YY CL:0000010 Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Metastatic to brain Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the brain metastatic cells and repeating this procedure 6 times. Group: Triple negative breast cancer (TNBC) cell line 150518231 CVCL_A0YZ UWRBTi001-A induced pluripotent stem cell human CVCL_A0YZ From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518232 CVCL_A0YP MHHi022-A induced pluripotent stem cell human CVCL_A0YP From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; 1078; BMPR2; Simple; p.His533Arg (c.1598A>G); ClinVar=VCV000425962; Zygosity=Heterozygous (PubMed=34388490) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518233 CVCL_A0YQ MHHi023-A induced pluripotent stem cell human CVCL_A0YQ From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; 1078; BMPR2; Simple; p.Cys84_Ser140del (c.248-1_418+1del171) (Ex3del); Zygosity=Heterozygous (PubMed=34388490) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518234 CVCL_A0YR MHHi024-A induced pluripotent stem cell human CVCL_A0YR From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; 1078; BMPR2; Simple; p.Arg491Trp (c.1471C>T); ClinVar=VCV000008802; Zygosity=Heterozygous (PubMed=34388490) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518235 CVCL_A0YS UKEi070-A induced pluripotent stem cell human CVCL_A0YS From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=34375846) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518236 CVCL_A0YT UKEi070-A-1 induced pluripotent stem cell human CVCL_A0YT From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple_corrected; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=Causes aberrant splicing By CRISPR/Cas9 (PubMed=34375846). Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518237 CVCL_A0YU UKEi070-A-2 induced pluripotent stem cell human CVCL_A0YU From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=34375846); Sequence variation: Mutation; HGNC; 7551; MYBPC3; Simple_edited; p.Arg943Ter (c.2827C>T); ClinVar=VCV000037039; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34375846) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518238 CVCL_A0YV 30T.14 hybridoma house mouse CVCL_A0YV CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P24522; Human GADD45A. 150518239 CVCL_A0YG AIBNi007-A induced pluripotent stem cell human CVCL_A0YG From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518240 CVCL_A0YH AIBNi008-A induced pluripotent stem cell human CVCL_A0YH From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518241 CVCL_A0YI AIBNi009-A induced pluripotent stem cell human CVCL_A0YI From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518242 CVCL_A0YJ AIBNi010-A induced pluripotent stem cell human CVCL_A0YJ From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518243 CVCL_A0YK AIBNi011-A induced pluripotent stem cell human CVCL_A0YK From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518244 CVCL_A0YL AIBNi012-A induced pluripotent stem cell human CVCL_A0YL From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518245 CVCL_A0YM NERCi001-A induced pluripotent stem cell human CVCL_A0YM From: National Engineering and Research Center of Human Stem Cell; Changsha; China CL:0000010 Sequence variation: Mutation; HGNC; 11730; TERT; Simple; p.Arg599Gln (c.1796G>A); ClinVar=VCV000635412; Zygosity=Heterozygous (hPSCreg=NERCi001-A); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; p.Ser947Pro (c.2839T>C); ClinVar=VCV000635413; Zygosity=Heterozygous (hPSCreg=NERCi001-A); Sequence variation: Mutation; HGNC; 11730; TERT; Simple; p.Glu1116Gln (c.3346G>C); ClinVar=VCV000635414; Zygosity=Heterozygous (hPSCreg=NERCi001-A) Derived from site: In situ; Placenta; UBERON=UBERON_0001987; Cell type: Mesenchymal stem cell; CL=CL_0000134. Male 150518246 CVCL_A0YN TJCi001-A induced pluripotent stem cell human CVCL_A0YN From: TJC Life; Seoul; South Korea CL:0000010 Population: Southeast Asian; Vietnamese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Male 150518247 CVCL_A0WA A549-A2-ESO cancer cell line human CVCL_A0WA CL:0000010 Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Transfected with: HGNC; 24198; CTAG1A; Transfected with: HGNC; 4931; HLA-A (allele A*2); Transfected with: CBG, click beetle green luciferase; Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Transduced with both a CBG-T2A-GFP construct and a NY-ESO-1-T2A-HLA-A2 construct 150518248 CVCL_A0WB BT-IMF spontaneously immortalized cell line CVCL_A0WB CL:0000010 Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160; Cell type: Myofibroblast; CL=CL_0000186. Unspecified 150518249 CVCL_A0WC GreenTad-HF1 spontaneously immortalized cell line CVCL_A0WC CL:0000010 Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811; Cell type: Fibroblast; CL=CL_0000057